<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" xml:lang="en"><front id="4681cd9a-acb9-413b-bebe-586bdd06f27b"><journal-meta id="cd92622d-247b-472b-9fb5-ccb7520b612c"><journal-id journal-id-type="hwp" id="07b801b7-47e9-4b02-94f3-2a18b2be2436">bmjresp</journal-id><journal-id journal-id-type="publisher-id" id="f22efc26-a867-4427-bf45-a702d943a554">bmjresp</journal-id><journal-title-group id="75f4331d-f038-4cb0-898d-ee5e0ee4e0ca"><journal-title id="5d99ba1a-b1c3-4090-a08e-a0f08eb6b7c9">BMJ Open Respiratory Research</journal-title><abbrev-journal-title id="000356a4-931e-4e49-80b1-187a61f6571a">BMJ Open Resp Res</abbrev-journal-title></journal-title-group><issn pub-type="ppub" id="cf43808b-e2e2-49cb-8048-9ddd6273f6f1"/><issn pub-type="epub" id="7e6ac8c7-0188-4a18-bac2-f0442c805acb">2052-4439</issn><publisher id="5b040497-5771-4716-87c2-62501ac6a37f"><publisher-name id="905d790a-3d6e-4a0c-b10e-e17eeac72d34">BMJ Open Respiratory Research</publisher-name><publisher-loc id="889afbb2-f485-4685-9dfa-ff3e8ce860ea">BMA House, Tavistock Square, London, WC1H 9JR</publisher-loc></publisher></journal-meta><article-meta id="5d3078a9-4fb4-406d-9580-78643437e3e2"><article-id pub-id-type="publisher-id" id="c0e3d961-b3df-40ca-8a50-1425c415e571">10.1136/bmjresp-2019-000431</article-id><article-id pub-id-type="doi" id="c3008e5e-87a9-464e-a098-672daa10d91c">bmjresp-2019-000431</article-id><article-id pub-id-type="paw-acronomy" id="8cd30ff1-1a24-4e9d-993d-1c7a239241e2">bmjresp</article-id><article-categories id="851f6912-80c7-412b-af51-5eb57c68f73a"><subj-group subj-group-type="display-channel" id="fc342c1c-bf5c-48cf-a977-fe02c4b3caff"><subject id="4620f1e0-416c-45e4-ba9b-a23520e10130">Original manuscript</subject></subj-group><subj-group subj-group-type="heading" specific-use="Section-Head" id="9f146cad-02df-4fea-a786-0866d7f48173"><subject id="75ac856f-29fd-4b49-bab4-b0433dea4195">Chronic obstructive pulmonary disease</subject></subj-group><subj-group subj-group-type="hwp-journal-coll" id="ed089889-b83c-46be-b60b-76556ce5adca"><subject id="f9feba7c-6ca3-46de-aee4-1c36f6171cc6">2215</subject><subject id="23ee4495-46b7-48a5-b4d9-db5d8d4bfa00">1506</subject></subj-group></article-categories><title-group id="334d57ae-3de9-4f0b-9a2a-1d8011f70c13">  <article-title id="ac10b2c5-c10f-4bec-9f53-1a493562e4be"><named-content data-class="jrnlQueryRef" id="d408f1c6-2413-4185-ac0f-34fef66c871f" data-message="{'funcToCall': 'highlightQuery'}" data-event="click" data-topic="action" data-channel="query" specific-use="start" content-type="jrnlQueryRef" data-query-type="action" data-query-for="author" data-query-ref="true" data-type="start" rid="1555068417015" data-replied="true"/>Serum biomarkers and outcomes in patients with moderate COPD: a sub<named-content id="48361caf-1b08-44db-9ac1-c920bb98c63b" data-cid="1555285381" content-type="del cts-3" specific-use="1555285398445" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 7:43am" data-track-detail="" data-time="1555285398445" data-username="Ariel (COPYEDITOR)" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c">-</named-content>study of the randomised SUMMIT trial</article-title></title-group><contrib-group section="front" node-xpath="article-meta" next-xpath="author-notes" data-group="author" id="9d869c9a-f2c6-4d0c-9668-b2b5f348b94f"><contrib corresp="yes" contrib-type="author" id="author-33503242" data-id="author-33503242" data-edited-node="true"><name id="2ca74b3d-58a4-4644-8f07-badb62500b08"><surname id="5414fe63-77f2-43b8-866d-de630231472e">Celli</surname><given-names id="1678a96a-9f46-4772-b0e3-db8ae344df12">Bartolome R</given-names><prefix id="b0545688-f2ca-4044-be11-ca4c249166e0">Dr</prefix></name><xref id="87ea7dfc-5df8-4651-8251-c698d974d42c" rid="aff1" ref-type="aff">1</xref><xref ref-type="corresp" rid="cor1" id="5b3b59d4-e22d-4f33-bc9d-5e756eeb4a0a">*</xref><email id="c87e9e40-65d5-4ead-ae4a-2e1234d46e80">bcelli@copdnet.org</email><contrib-id contrib-id-type="orcid" data-retain="true" id="915e421e-0e11-472e-8650-e313df6247ee">http://orcid.org/0000-0002-7266-8371</contrib-id></contrib><contrib contrib-type="author" id="author-65004701" data-id="author-65004701"><name id="a016dd23-61bc-482e-be25-3dc83ed2f3b8"><surname id="1e7c4309-f0d0-4cd1-8c91-0a7b448c15eb">Anderson</surname><given-names id="683eeb4f-60a5-41ba-a8b7-a14505a8273d">Julie A</given-names><prefix id="99c9c362-4524-4955-bd7e-77e682babfc2">Dr</prefix></name><xref ref-type="aff" rid="aff2" id="95dff916-ed59-45ce-ab78-2f6267f1c59e">2</xref><email id="55bfb3d4-804d-4825-9328-5f89d181c468">julie.a.anderson@gsk.com</email></contrib><contrib contrib-type="author" id="author-65004723" data-id="author-65004723"><name id="7e0f834b-7122-45bc-b4e7-90d1f7a5c4dc"><surname id="4c08278b-30df-4893-836d-493cf287ea46">Brook</surname><given-names id="d857d8a8-0103-4c9d-9529-81486c83e973">Robert</given-names><prefix id="80110dd8-ce2a-445c-9276-7b3295e6b825">Dr</prefix></name><xref ref-type="aff" rid="aff3" id="1f491b19-7860-46a3-b3e7-e2a853643862">3</xref><email id="ebc733ef-cd6a-4da1-b751-01ae689c16bc">robdbrok@med.umich.edu</email></contrib><contrib contrib-type="author" id="author-44191862" data-id="author-44191862"><name id="ae4d2ce8-49b1-4a6a-a86b-f3eea2d3a4f2"><surname id="a0f34c55-5eab-41a6-bac8-54c6e12a61a7">Calverley</surname><given-names id="f34edf8b-d091-4482-a4ee-71b21eb295dd">Peter</given-names></name><xref ref-type="aff" rid="aff4" id="f61e4c19-a578-40f9-afa6-73f727395b00">4</xref><email id="cedac038-34e2-4ec6-a881-95d1244f5328">pmacal@liverpool.ac.uk</email></contrib><contrib contrib-type="author" id="author-65004964" data-id="author-65004964"><name id="e40e3526-cc36-460a-8f2f-0807870387fe"><surname id="ceb36986-0ff5-4858-86c3-72bc8715e8d6">Cowans</surname><given-names id="1fe6cee2-0202-43eb-86b3-89f065f7d188">Nicholas J</given-names><prefix id="6fb34d34-6519-4147-9b7c-8b40b9e40d23">Dr</prefix></name><xref ref-type="aff" rid="aff5, aff6" id="1d6ddb13-f7c9-41b0-a4de-207ee7ac1416">5,6</xref><email id="835132fb-46f6-40f9-977f-7828d35c53fb">nick.cowans@veramed.co.uk</email></contrib><contrib contrib-type="author" id="author-33503871" data-id="author-33503871"><name id="e4004b54-a04d-4598-80ac-3fd7a69ee2bb"><surname id="70db157a-42a2-49bc-99ac-7909b95e3581">Crim</surname><given-names id="1688c083-a3e7-4848-a9a7-aa18c62d4728">Courtney</given-names><prefix id="054cbf39-b0e5-4ff4-ac2b-b2bcc0ab169c">Dr</prefix></name><xref ref-type="aff" rid="aff7" id="95989a51-8ad4-438d-b608-a5b86f21531e">7</xref><email id="56eb5830-23d7-46cf-8f66-2677979544d2">courtney.c.crim@gsk.com</email></contrib><contrib contrib-type="author" id="author-65005347" data-id="author-65005347" data-edited-node="true"><name id="69a42425-26dc-415a-95bb-3ce98aaf0dd9"><surname id="000c078b-05b3-4efe-add2-2f3933dc5a1f">Dixon</surname><given-names id="f118b9e2-f285-42a4-8144-9b4e4870d2fc">Ian</given-names><prefix id="d08301e0-c26f-4a78-8c86-02c3fc48d7a6">Dr</prefix></name><xref id="6807cfb0-5c7c-4169-9228-7ea6d37d6b23" rid="aff5, aff6" ref-type="aff">5,6</xref><email id="de6ae6f9-4d55-4b36-8369-4fb09ab3a171">ian.dixon@veramed.co.uk</email></contrib><contrib contrib-type="author" id="author-32448419" data-id="author-32448419"><name id="cd0227df-a528-47b4-982c-c4e26867ade4"><surname id="6f983226-8037-431d-98b4-5595164f3121">Kim</surname><given-names id="7961d33c-d687-4eba-82a0-e7ee0e4b41f4">Victor</given-names><prefix id="5e5fdc07-c103-42a9-a35b-fb8f21120775">Dr</prefix></name><xref ref-type="aff" rid="aff8" id="38535127-ae4e-46fa-b6c6-b222af1a1a82">8</xref><email id="8f2604d2-998a-4f65-a695-8f44f6a2bc19">Victor.Kim@tuhs.temple.edu</email></contrib><contrib contrib-type="author" id="author-43803928" data-id="author-43803928"><name id="be1aeaf3-0c62-4c0f-886f-22b03e7c86dc"><surname id="abb2430f-eb0c-4e98-ba5c-77855c8a9194">Martinez</surname><given-names id="d0359286-3238-4fe9-b86e-4c85d61222b8">Fernando J</given-names><prefix id="91f74e79-c73c-43e3-9c41-2319982a1e7e">Dr</prefix></name><xref ref-type="aff" rid="aff9" id="535bcb65-c96f-44d1-9fa3-4501cbe57ffe">9</xref><email id="50c01b1d-8b73-4670-b0a3-a025bfe9654f">fjm2003@med.cornell.edu</email></contrib><contrib contrib-type="author" id="author-65005429" data-id="author-65005429"><name id="25ba4f18-eb7c-45ec-848f-d15e7f6e046c"><surname id="cbccfa13-1933-4b4d-9379-f363afbb7392">Morris</surname><given-names id="b3922ce8-fd04-4945-b7b7-e96173058744">Andrea</given-names><prefix id="4a928e91-5362-474e-be3e-7a9c5fda70c6">Dr</prefix></name><xref ref-type="aff" rid="aff7" id="f5a02c48-e311-403d-91ab-3219dbfac976">7</xref><email id="92832565-71a2-4791-a3a7-531789b22833">andrea.n.morris@gsk.com</email></contrib><contrib contrib-type="author" id="author-33503944" data-id="author-33503944"><name id="2fba420d-9122-4698-9d95-17d8dcb047d3"><surname id="23343a17-30fb-4d0f-9116-0c94312be4d1">Newby</surname><given-names id="cf6e4da3-34a9-4cda-97fb-e86bb739736d">David E</given-names><prefix id="79e52f97-1dce-433b-90e2-c98749577373">Dr</prefix></name><xref ref-type="aff" rid="aff10" id="ca65cb5f-bfdf-436d-a050-1f46dae9d1b6">10</xref><email id="e273163a-d6f1-4a79-83d7-85e88ef5584e">d.e.newby@ed.ac.uk</email></contrib><contrib contrib-type="author" id="author-33506396" data-id="author-33506396"><name id="6f915d02-fd2d-459a-8641-e908012e2fd9"><surname id="314d6204-705e-4e38-af1e-839d5bfbf0cb">Yates</surname><given-names id="320ba9b9-6263-4b94-8cf4-459da5c5ea1f">Julie</given-names><prefix id="646870b0-6ea4-4ca1-a7ee-846febb6e89e">Dr</prefix></name><xref ref-type="aff" rid="aff7" id="866a1fa9-438e-4025-a2f5-86be155834f6">7</xref><email id="9d135080-f3c5-4ee4-9d3c-4295e911ed56">julie.c.yates@gsk.com</email></contrib><contrib contrib-type="author" id="author-33506303" data-id="author-33506303"><name id="1cb1996e-f504-4775-a4a8-5a6b44de1075"><surname id="79fd319a-5c32-4ef3-9e7b-874d0ec67e88">Vestbo</surname><given-names id="a3135764-f497-43c7-9d43-6a93f1ce802e">Joergen</given-names><prefix id="69911f0f-609c-4c8c-85f1-65fb8b12d488">Dr</prefix></name><xref ref-type="aff" rid="aff11" id="17089ee1-9ff8-44ef-9575-8b1009d85c90">11</xref><email id="cc6d5eed-374a-4a59-91c7-03d7135e1837">jorgen.vestbo@manchester.ac.uk</email></contrib><aff section="front" node-xpath="contrib-group" prev-xpath="contrib[last()]" id="aff1" data-id="aff1" data-edited-node="true"><label id="ce7f95c4-c29d-4908-a598-78ef6e988ce9">1</label><named-content content-type="dept" id="36692193-7e73-4889-93e7-ee777b013265">Pulmonary and Critical Care Division</named-content>, <named-content content-type="institution" id="ef36fb5c-8929-4a5b-bdfa-4c87db909561">Brigham and Women's Hospital</named-content>, <named-content content-type="city" id="feeb3785-3b7f-42af-94ec-9ef08948fbbd">Boston</named-content>, <named-content content-type="state" data-valid-state="true" id="e8648c51-f964-4d2c-b481-bbe2b96dc324">Massachusetts</named-content>, <named-content content-type="country" id="f72731ea-288a-400f-9319-61858bdb3534">USA</named-content></aff><aff section="front" node-xpath="contrib-group" prev-xpath="contrib[last()]" id="aff2" data-id="aff2"><label id="6cbff0ae-2007-4093-92e6-382201f47e12">2</label><named-content content-type="dept" id="ab3bbecb-5d11-4097-a133-84306f4e0fac">Research &amp; Development</named-content>, <named-content content-type="institution" id="ed23dfbc-3e3c-4922-82ac-e98b2232d399">GlaxoSmithKline Plc Stockley Park</named-content>, <named-content content-type="city" id="879c6c6f-ba69-4bfc-b254-7be32f95b58c">Uxbridge</named-content>, <named-content content-type="state" data-valid-state="false" id="65fcb2cf-837d-44fb-aff4-f2e5c981768f">Middlesex</named-content>, <named-content content-type="country" id="99d86215-8c57-443f-8280-817f09c4e9ea">UK</named-content></aff><aff section="front" node-xpath="contrib-group" prev-xpath="contrib[last()]" id="aff3" data-id="aff3"><label id="3a19fa7f-1be8-49ba-9ffc-771f1de144f6">3</label><named-content content-type="dept" id="9d8282c9-cccb-4d60-9f92-9055d2204211">Division of Cardiovascular Medicine</named-content>, <named-content content-type="institution" id="a2f5f9af-1727-4de7-bf7b-a35d98c08fe4">University of Michigan</named-content>, <named-content content-type="city" id="9beddead-14f1-4fb5-9371-848af4cf795f">Ann Arbor</named-content>, <named-content content-type="state" data-valid-state="true" id="1bd85f61-88c2-4479-bd9a-ec844f4de3a5">Michigan</named-content>, <named-content content-type="country" id="c7d64f28-adf2-4738-8cb8-eaff9e72c216">USA</named-content></aff><aff section="front" node-xpath="contrib-group" prev-xpath="contrib[last()]" id="aff4" data-id="aff4"><label id="975b6e81-22c3-4446-9401-be1fa9bc83de">4</label><named-content content-type="dept" id="30e714f8-56ae-4d13-8149-a0324fb0e0d9">Department of Medicine, Clinical Sciences Centre, University of Liverpool</named-content>, <named-content content-type="institution" id="c2d3fd3f-de1e-4029-a18d-9b8f91ccbba5">University Hospital Aintree</named-content>, <named-content content-type="city" id="6f8ea109-4477-4447-9d48-be17f1cac4ca">Liverpool</named-content>, <named-content content-type="state" data-valid-state="false" id="35343191-ea61-4edf-b9f1-b6497d85c862">Liverpool</named-content>, <named-content content-type="country" id="a5fec015-7d8c-4ee9-9f69-5279211b01aa">UK</named-content></aff><aff section="front" node-xpath="contrib-group" prev-xpath="contrib[last()]" id="aff5" data-id="aff5"><named-content rid="7e7651ab-9dfe-4547-8a1c-0b4eeafc6ba2" data-class="jrnlQueryRef" data-type="start" id="8964a764-fda5-4a7e-b6bd-b015c0da130b" data-message="{'funcToCall': 'highlightQuery'}" data-event="click" data-topic="action" data-channel="query" specific-use="start" content-type="jrnlQueryRef" data-query-type="action" data-query-for="author" data-query-ref="true" data-query-from="copyeditor" data-replied="true"/><label id="a5bc6428-1f99-4562-bc0e-bbc47e1bbf70">5</label><named-content content-type="institution" id="656c5067-3fa7-47b9-8242-801622de09ce">GlaxoSmithKline Plc Stockley Park</named-content>, <named-content content-type="city" id="91e52c14-43a8-4624-92c8-47e02e973b5f">Uxbridge</named-content>, <named-content content-type="state" id="dbc31201-0dc4-4ca6-bf63-8540631fbf58" data-valid-state="false">Middlesex</named-content>, <named-content content-type="country" id="3d44913d-77af-4423-8215-8f40b2d984b4">UK</named-content></aff><aff section="front" node-xpath="contrib-group" prev-xpath="contrib[last()]" id="aff6" data-id="aff6" data-edited-node="true"><label id="b80e62b0-caa6-4371-b811-f3a636095602">6</label><named-content content-type="institution" id="11c3984e-3dca-4e20-b954-05e95bc27c71">Veramed Ltd</named-content>, <named-content content-type="city" id="92faa810-ec6b-4d75-b560-346d5b094e60">Twickenham</named-content>, <named-content content-type="country" id="cf7f230b-2762-4142-bcbb-666d2705419e">UK</named-content></aff><aff section="front" node-xpath="contrib-group" prev-xpath="contrib[last()]" id="aff7" data-id="aff7"><label id="f21a02bf-19ae-4658-9f97-b0094565e6fc">7</label><named-content content-type="institution" id="7391860f-efa1-4aaa-a5f8-34588e470d1b">GlaxoSmithKline Research Triangle Park</named-content>, <named-content content-type="city" id="441e5394-e518-4430-a16d-e1e4bcd1f6d8">Research Triangle Park</named-content>, <named-content content-type="state" data-valid-state="true" id="59e7bff3-8456-41bf-8927-c09f340c28a1">North Carolina</named-content>, <named-content content-type="country" id="1b14df18-98f4-48ec-85ee-1aa271c9ab84">USA</named-content></aff><aff section="front" node-xpath="contrib-group" prev-xpath="contrib[last()]" id="aff9" data-id="aff8" data-element-added="true"><label id="8b961e18-40d1-441e-a5cd-75620b169232">8</label><named-content content-type="dept" id="e8007d34-c9e0-4c8e-95c9-e2fc68d42828">Department of Medicine</named-content>, <named-content content-type="institution" id="f39c5dcb-00ed-41a9-a038-1eadf4002f43">Temple University School of Medicine</named-content>, <named-content content-type="city" id="548f0e9e-2bc1-49e3-8fdd-29872b15c0e7">Philadelphia</named-content>, <named-content content-type="state" data-valid-state="true" id="b39d076c-c1ba-4961-bbe5-08fe03d8ae3f">Pennsylvania</named-content>, <named-content content-type="country" id="a99ec3ce-d49e-4253-9b3f-d2b0d0a72835">USA</named-content></aff><aff section="front" node-xpath="contrib-group" prev-xpath="contrib[last()]" id="aff10" data-id="aff9" data-edited-node="true"><label id="7c5a8197-7f81-4f4f-b6e3-fad6a0d96b52">9</label><named-content content-type="dept" id="0a67e331-db1b-46fb-94d4-fca4212655e0">Joan and Sanford I. Weill Department of Medicine</named-content>, <named-content content-type="institution" id="e19de6ad-834f-4356-aa78-ee58ec6d3560">Weill Cornell Medicine Samuel J Wood Library</named-content>, <named-content content-type="city" id="890794c0-cd9e-400f-90fc-66bd8fd682b5">New York City</named-content>, <named-content content-type="state" data-valid-state="true" id="e7140d55-7fd8-4e19-934c-c92e5b0755da">New York</named-content>, <named-content content-type="country" id="07823902-1b78-471d-83c5-ab648d8545f4">USA</named-content></aff><aff section="front" node-xpath="contrib-group" prev-xpath="contrib[last()]" id="aff11" data-id="aff10"><label id="d02ff757-74eb-405a-a0d5-957c845594da">10</label><named-content content-type="dept" id="54a00962-0afe-433f-a733-0555e8a70107">British Heart Foundation Centre for Cardiovascular Science</named-content>, <named-content content-type="institution" id="edbd258a-90eb-4c77-8c62-52002dfc2c73">University of Edinburgh</named-content>, <named-content content-type="city" id="0a3647e1-74b5-4382-916e-112c9edc9005">Edinburgh</named-content>, <named-content content-type="state" data-valid-state="false" id="f1728239-cade-4791-a9c4-7a15a60fc7d0">Edinburgh</named-content>, <named-content content-type="country" id="27adf3ea-e1bf-426f-b10e-0c9987e3a186">UK</named-content></aff><aff section="front" node-xpath="contrib-group" prev-xpath="contrib[last()]" id="aff12" data-id="aff11" data-edited-node="true"><label id="7d18c0de-6d6d-46fd-a98a-d1f442fd9996">11</label><named-content content-type="dept" id="ca091522-5795-4dcb-9fb0-6be6e793beca">Division of Infection, Immunity and Respiratory Medicine and Allergy, Manchester Academic Health Science Centre, The University of Manchester</named-content>, <named-content content-type="institution" id="ca56187e-d417-4bed-826d-3736b920d724">Central Manchester University Hospitals NHS Foundation Trust</named-content>, <named-content content-type="city" id="fa009b56-2943-46da-bc44-5130bc82c261">Manchester</named-content>, <named-content content-type="country" id="05de0859-5e84-4c7a-a20d-c4bd5e0016b5">UK</named-content></aff><aff section="front" node-xpath="contrib-group" prev-xpath="contrib[last()]" id="aff8" data-id="aff1555498628721" data-track="del" data-cid="1555071346216" data-username="Gowtham Ram (PREEDITOR)" data-userid="preeditor gowthamram" data-time="1555071346216" data-callback="kriya.general.reorderLinks"><label id="68058034-29bc-49e5-8db6-760846d7f757">12</label><named-content content-type="institution" id="c0c870a7-16a3-49ab-963d-fe1d1390ce9b">Veramed Ltd., Twickenham, UK</named-content>, <named-content content-type="city" id="daa0efe2-6ca7-4e66-9a29-7fa1711c5b59">Twickenham</named-content>, <named-content content-type="country" id="d1b49753-5276-4873-8c9a-c3ab356dc020">UK</named-content></aff></contrib-group><contrib-group content-type="section" id="acb9b4f5-f1dd-4fab-a932-a3febb25ff99"><contrib contrib-type="editor" id="author-33900211"><name id="75c529a0-f965-4e98-a125-0def19a4bfd8"><surname id="a322dd01-3bd5-4de9-8aa8-ce3aee046c86">Chapman</surname><given-names id="147bcdc2-e4c0-422f-a159-54c8f61ad4ae">StephenJ</given-names><prefix id="c205dadb-b402-44e0-896c-4d77b0bf6ec8">Dr</prefix></name><xref ref-type="aff" rid="ae-aff1" id="522600a9-b26d-4129-9a2f-6625f7f969e6"/></contrib><contrib contrib-type="editor" id="author-33900211"><name id="812a78d2-e062-468f-9ac6-26b4854767f7"><surname id="0f27df60-0139-498a-9f4b-dbde3f9898a5">Chapman</surname><given-names id="b6200e2d-41e4-4151-aead-9172a188ac1c">StephenJ</given-names><prefix id="874b17b3-3854-4add-89bf-858483cad45b">Dr</prefix></name><xref ref-type="aff" rid="ae-aff2" id="14e7ff3a-eb86-47f3-82c3-ab35451f195a"/></contrib><aff id="ae-aff1" data-id="ae-aff1"><department id="04facd67-4dd9-4a04-9d80-5457cc99ef3a">Respiratory Medicine</department>, <institution id="7db58296-008a-433f-8d4d-b417cf053432">Oxford University Hospitals</institution>, <city id="7171abd3-4e09-469d-83ca-43a2dfbccc38">Oxford</city>, <country id="3f8e36a6-c31f-4f68-850c-78b077594b2a">UK</country></aff><aff id="ae-aff2" data-id="ae-aff2"><department id="19c8cdba-fdef-4fb1-8006-b8eb36f46700">Respiratory Medicine</department>, <institution id="7e8cf491-e59e-4784-9238-9e40ef25dc94">Oxford University Hospitals</institution>, <city id="1b89040d-31f8-49cb-ab3d-a07c6946623f">Oxford</city>, <country id="08d4b1b5-74b6-4682-b978-0aa507be681c">UK</country></aff></contrib-group><author-notes id="7ff0bc2d-e28e-4aa5-90cb-e4ce8359a5ed"><fn fn-type="supplement" section="front" node-xpath="author-notes" prev-xpath="contrib-group[last()]" data-label="Supplement" id="fn1" data-id="fn1" data-edited-node="true"><label id="89196f24-3ba7-4367-bed3-c29ca86e30ea">supplement</label><p id="4a574ed8-a871-4132-8711-4d9866dc989b">Additional material is published online only. To view please visit the journal online (<ext-link data-class="jrnlExtLink" ext-link-type="uri" xlink:href="http://dx.doi.org/10.1136/bmjresp-2019-000431" id="41f5074b-3ab9-4824-9817-3683e56b4c66">http://dx.doi.org/10.1136/bmjresp-2019-000431</ext-link>).</p></fn><fn fn-type="con" section="front" node-xpath="author-notes" prev-xpath="contrib-group[last()]" data-label="Contributors" id="fn2" data-id="fn2" data-edited-node="true"><label id="ebcc6f39-c10b-402c-b39a-5612be5e6e07">Contributors</label><p id="cac6b97d-e783-414f-9582-2ffbc9e4ebbb">Study design: BCR, JAA, RB, PC, CC, ID, FJM, DEN, JY and JV. Data collection: JAA, CC, NJC and JY. Database search: N/A. Data analysis/interpretation: BCR, JAA, RB, PC, NJC, CC, ID, VK, FJM, AM, DEN, JY and JV. Writing/reviewing of the manuscript: BCR, JAA, RB, PC, NJC, CC, ID, VK, FJM, AM, DEN, JY and JV. Final approval of the manuscript: all authors.</p></fn><fn fn-type="data-sharing-statement" section="front" node-xpath="author-notes" prev-xpath="contrib-group[last()]" data-label="Data sharing statement" id="fn3" data-id="fn3" data-edited-node="true"><label id="d6d4c303-9cd6-4c2e-9cb3-52639de7d584">Data availability statement</label><p id="904eeb05-31dd-43f2-98dd-e24af1dd7fb4">Information on GSK’s data sharing commitments and requesting access to anonymised individual participant data and associated documents can be found at <a href="http://www.clinicalstudydatarequest.com" target="_blank" id="58431563-5c04-46ce-8372-938344021556">www.clinicalstudydatarequest.com</a></p></fn><fn fn-type="conflict" data-label="Competing interests" id="fn4" data-id="fn4"><label id="abe49a24-5d2a-466f-8877-37dcea703bcd">Competing interests</label><p id="bd0aca6d-eac8-4d3e-ac2a-91435c6010b3">None declared.</p></fn><fn fn-type="provenance-and-peer-review" data-label="Provenance and peer review" id="fn5" data-id="fn5"><label id="d5b4d8ff-49bd-4c1e-b176-876800775954">Provenance and peer review</label><p id="b83a7dcd-3a05-4b78-aaaf-143acd2e63eb">Not commissioned; internally peer reviewed.</p></fn><corresp section="front" node-xpath="author-notes" prev-xpath="contrib-group[last()]" data-id="cor1" id="6e7e0ae1-cdee-4941-8261-7183c04090ec"><name data-class="jrnlAuthor" id="b7707141-2a70-4097-94f1-4ddd271a2933"><prefix id="3a2d0b84-d3db-4641-8136-d34e43309c8f">Dr</prefix> <given-names id="c20fcfd5-ad98-4a9c-89e1-eb37e2fda041">Bartolome R</given-names> <surname id="e30b8df7-e529-4c3c-aeba-685163ce06d1">Celli</surname></name>; <email id="55c0cf74-437d-4829-a514-344b4af5ac5c">bcelli@copdnet.org</email></corresp><fn fn-type="ethics" section="front" node-xpath="author-notes" prev-xpath="contrib-group[last()]" data-label="Ethics approval" id="5c814365-f2c8-4081-8517-91993fb54d7c" data-track="ins" data-cid="1555069652612" data-username="Gowtham Ram (PREEDITOR)" data-userid="preeditor gowthamram" data-time="1555069652612" data-edited-node="true"><label id="981f2752-5df5-4af5-8b25-4e30a2146f3e">Ethics approval</label><p id="556f05ec-4724-4c3c-9ab9-0496c303e0c9">All patients provided written informed consent. The study was approved by local ethics committees and was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines. Members of the Steering Committee Jørgen Vestbo (cochair, UK), Robert Brook (USA), Peter Calverley (UK), Bartolome Celli (USA), Fernando Martinez (USA), David Newby (UK), Courtney Crim, (cochair, GlaxoSmithKline plc, USA), Julie Anderson (GlaxoSmithKline plc, UK) and Julie Yates (GlaxoSmithKline plc, USA). Members of the Independent Data Monitoring Committee Peter Lange (chair, Denmark), Richard Kay (UK), Mark Dransfield (USA) and Sanjay Rajagopalan (USA). Members of the Clinical Endpoint Committee Robert Wise (chair, USA), Dennis Niewoehner (USA), Camilo Gomez (USA), Sheldon Madger (Canada), Martin Denvir (UK) and Pierre Amarenco (France).</p></fn><fn fn-type="consent" data-label="Patient consent" data-track="ins" data-cid="1555069812795" data-username="Gowtham Ram (PREEDITOR)" data-userid="preeditor gowthamram" data-time="1555069812795" id="0183ea92-da13-4338-9ef8-43d7d96ff957"><label id="cb7020a3-d648-45e4-b9d7-e799c0c2fe4e">Patient consent for publication</label><p id="1ecb0c77-cf42-4233-bb3b-5064de902a82">Not required.</p></fn><fn fn-type="present-address" section="front" node-xpath="author-notes" prev-xpath="contrib-group[last()]" data-label="†" id="a516a49d-d68f-4f60-b55a-6cf4abb931f8" data-id="pa1555319348054" data-track="del" data-cid="1555319348030" data-username="Gowtham Ram (TYPESETTER)" data-userid="typesetter gowthamram" data-time="1555319348030"><label id="d6389c49-7467-4c82-8d46-4b863253efe1">†</label><p id="ce68908d-638c-44dc-9eb1-6b7a9db25213"><named-content content-type="institution" id="ca05d16a-ad60-4bc8-8e3e-3a8a307f6a62">Temple University School of Medicine</named-content>, <named-content content-type="state" id="a63547f4-ae40-4740-8b79-79f7a98e5162">Pennsylvania</named-content>, <named-content content-type="city" id="34978123-160e-4341-b4f2-22a49ac5e629">Philadelphia</named-content>, <named-content content-type="country" id="fd45232d-2517-4e3a-a1ee-f1054edadb9a">United States</named-content></p></fn></author-notes><pub-date section="front" node-xpath="article-meta" node-prev-xpath="//author-notes" node-next-xpath="//history" pub-type="ppub" id="9161d6e0-16c4-47ae-82a8-ec29899c3147"><day id="badb3fb6-b040-4145-93a5-b2a171c26257">04</day><month id="53a9e611-398f-4e0f-a9f8-e69be262b39f">05</month><year id="7e0114dc-5fc1-4206-8c62-88f7dfed0cc2">2019</year></pub-date><pub-date section="front" node-xpath="article-meta" node-prev-xpath="//author-notes" node-next-xpath="//history" pub-type="epub" id="5345d947-2cf3-45bf-8ede-e61ef9dddeb9"><day id="04213390-c125-4aa3-bada-6a43009eca28">04</day><month id="5e2974e2-e8bc-4dda-b8da-677d429a88ea">05</month><year id="bddb00dc-728b-464b-b2d5-e6826552f76a">2019</year></pub-date><volume section="front" node-xpath="article-meta" node-next-xpath="//history" id="411a05be-8fc5-4cc6-a232-73129d51ca6f">6</volume><issue section="front" node-xpath="article-meta" node-next-xpath="//history" id="23e0e19b-3fd8-4eff-a1f3-ed0f629da297">1</issue><elocation-id section="front" node-xpath="article-meta" node-next-xpath="//history" id="b668dd19-4125-4ee2-b4b3-16de8b1538d9">e000431</elocation-id><history id="c5b7739d-1c3a-4064-ba1c-c5e119723b26" data-edited-node="true"><date date-type="received" id="e7ae8441-48ed-460d-8b8f-ae9961182bb1"><day id="396bf5ce-15af-4d46-8d15-629a59c08ddb">20</day><month id="266d0c93-e4ac-4cc5-87c2-88c3b72d6818">03</month><year id="d4a8ffe7-bfd5-41f6-b7bd-c792d1dce912">2019</year></date><date date-type="rev-recd" id="ed76b8b9-72a2-4ccd-a905-0a0c6f21dc94"><day id="4dba4e51-8161-4449-bec5-0fa82fed4ed7">29</day><month id="1348c9c0-2f83-4bd8-9915-67c0bd7032c3">03</month><year id="0dc42cbe-9ccf-40b4-9606-91d2b4d8e2e9">2019</year></date></history><permissions data-type="ccbync40" id="28b21eec-7536-430f-a9ff-3b01624726bd"><copyright-statement data-statement="new" id="3e954b57-93dc-4c9f-82e6-063f06e7babb">© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</copyright-statement><copyright-year id="71e45ace-0f42-4a00-bbdb-263a16c38fb9">2019</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" id="8672ef6b-1982-490e-99f5-e04e345c16a9"><license-p id="2d894b8c-7c93-43bb-8fc0-241e8c261066">This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" id="c6428207-a2e1-47bb-84cd-a9b6f9a6a75e">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>.</license-p></license></permissions><files id="b5e4ea5d-d03d-4ffd-9d92-053f33610610"><file file-type="Research Checklist" file_category="" file_name="bmjresp-2019-000431-File001.docx" submission_medium="online" id="66cc1561-5562-429e-bfca-f3fb3821b134"><file_createddate id="4808fd83-d2b1-403c-b54f-7b54ce8c3f77">2019-03-18 10:52:28.28</file_createddate><file-format id="05184ecb-61b9-4e7e-8a4d-6e86a967e7ac">docx</file-format><file-extension id="7fc95e59-bb0c-4bdc-8974-04afdeb75dae">docx</file-extension><file-name id="e6969f5a-8603-428a-b3f6-20f440d05160">SUMMIT_biomarker response letter(Thorax transfer)_BMJOpenRespirRes_18March2019.docx</file-name><file-caption id="99199650-3481-40d5-8e91-9754afe61732"/><file_tag id="1bd8ac5e-295b-40bb-bf59-9b6c91c2f262"/><attribute attr_name="File Designation" id="1732b93e-76c2-4e5f-9dd0-14b88f45231f">Research Checklist</attribute></file><file file-type="Main Document" file_category="" file_name="bmjresp-2019-000431-File002.docx" submission_medium="online" id="8cb63596-075d-4643-9565-f5347c3787d2"><file_createddate id="35bc083a-9171-4b9b-becf-122cb1eb4ef2">2019-03-29 11:43:10.10</file_createddate><file-format id="2d7887a8-122a-457d-8b60-a796fccbc146">docx</file-format><file-extension id="5e55a220-176c-48d8-bf8c-09fc04b76279">docx</file-extension><file-name id="b5a00dc3-a4a2-4916-98f1-462213b630b4">SUMMIT_biomarker_MainMS_29MAR2019.docx</file-name><file-caption id="87b9d509-4a64-4611-934d-41ff150c15e0"/><file_tag id="4206b8cf-b582-4f21-ad56-b1b878eff447"/><attribute attr_name="File Designation" id="dbf5e1da-d095-404e-872f-cdaea3f7c9cd">Main Document</attribute></file><file file-type="Mono Image" file_category="" file_name="bmjresp-2019-000431-File003.jpg" submission_medium="online" id="c5131c2a-2679-4e40-bad3-66d4183a1e08"><file_createddate id="91ba0d2d-df03-47d0-bc8e-f4dac986ee95">2019-03-29 11:49:00.0</file_createddate><file-format id="8fe87d7c-9bbb-44f1-913c-dfb25f4e6fb6">jpg</file-format><file-extension id="81154eff-91b3-4b59-af68-69a85c28af06">jpg</file-extension><file-name id="a18d7ad3-b941-43c8-b6b6-ff4cf7c80011">SUMMIT_biomarker_Fig1_29MAR2019.jpg</file-name><file-caption id="d543753c-2149-4be4-9d33-5dee1ec969e5">Figure 1 Consort diagram of the patients included in the systemic biomarker study completed only in the United States, as part of the SUMMIT international trial.</file-caption><file_tag id="0372a7d7-f272-46b5-b713-24502506b689"/><attribute attr_name="File Designation" id="01db1688-b8cf-42b1-9d39-fed29849e2b5">Mono Image</attribute></file><file file-type="Colour Image" file_category="" file_name="bmjresp-2019-000431-File004.jpg" submission_medium="online" id="3d91048e-d4b0-4081-8d7d-20ce9a4177e7"><file_createddate id="2ebf82b6-57cc-45ce-b3c8-a340b16d6856">2019-03-29 11:43:28.28</file_createddate><file-format id="3c8fdfde-f8a5-4c4e-9290-350a63df07f4">jpg</file-format><file-extension id="abf4f729-05fa-4f93-9b8d-b671ddc410eb">jpg</file-extension><file-name id="6c6408e2-ee14-485f-a54a-be9ccd22847b">SUMMIT_biomarker_Fig2_29MAR2019.jpg</file-name><file-caption id="7579c83f-5673-4e0e-9378-06d3b3c10eef">Figure 2 Relationship between baseline biomarker concentration and percent predicted FEV1.</file-caption><file_tag id="a7981fed-efcc-45db-a4f6-9b253dcac10f"/><attribute attr_name="File Designation" id="7f526e59-8e27-4337-af7e-5ebfb1754c90">Colour Image</attribute></file><file file-type="Colour Image" file_category="" file_name="bmjresp-2019-000431-File005.jpg" submission_medium="online" id="c49f182e-abd6-40a1-8677-ab638ecd0ca3"><file_createddate id="2776651c-8c2e-4c08-b87c-2a0be5c70811">2019-03-29 11:43:17.17</file_createddate><file-format id="9d8c3452-c5ed-430d-a843-8b056d282880">jpg</file-format><file-extension id="c1376b82-3cea-4b93-a034-6f8b4dbf302d">jpg</file-extension><file-name id="a380042c-0aac-403c-a175-960572274592">SUMMIT_biomarker_Fig3_29MAR2019.jpg</file-name><file-caption id="f22c2172-3419-4c34-9fd5-fed4830312b0">Figure 3 Kaplan–Meier plots of time to death by tertile groups for CRP and fibrinogen.</file-caption><file_tag id="b2a33a86-319b-42f5-b828-e11d7516776e"/><attribute attr_name="File Designation" id="c8162044-18c1-4d27-b9ec-2ead5af29ae9">Colour Image</attribute></file><file file-type="Supplementary File" file_category="" file_name="bmjresp-2019-000431-File006.pdf" submission_medium="online" id="a9f48815-a84c-4108-9917-dfeb9bb90b39"><file_createddate id="44d22153-e1c8-4a83-865f-a75a9a24b46b">2019-03-29 11:43:11.11</file_createddate><file-format id="519441e2-a2f1-4c12-a50d-0f5c902a9d78">pdf</file-format><file-extension id="9385a201-4578-4f0d-9860-4f4ed221320a">pdf</file-extension><file-name id="40767b6f-c445-4670-a5f0-0435f721493c">SUMMIT_biomarker_Supplement_29MAR2019.pdf</file-name><file-caption id="be5e17be-e23e-4c61-8eb2-72ddb9cdc92d"/><file_tag id="40b27edc-3db4-4ce6-aab2-4d7e5596dd5c"/><attribute attr_name="File Designation" id="bc97dafb-ba4f-4b1d-8542-589272754764">Supplementary File</attribute></file></files><abstract id="88c09665-fdde-4b89-b7c3-4e85508a3f7a"><title data-level="1" id="db1906a8-9290-4b0a-847c-f75c1395a96a">Abstract</title><title data-level="2" data-head-type="bold" id="a9afff43-be25-435e-9667-14f715f5ee40">Rationale</title><p data-head-type="bold" id="002de62e-c124-4076-ab22-a06d28f3f1b0">Systemic levels of C<named-content data-cid="1555285382" id="ef15f03e-7c47-4049-956c-78a48aa37f5d" content-type="del cts-3" specific-use="1555285604785" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 7:46am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555285604785">-</named-content><named-content data-cid="1555285383" id="dcc0a433-4e61-4994-9605-97423010dcd6" content-type="ins cts-3" specific-use="1555285605151" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 7:46am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555285605151"> </named-content>reactive protein (<named-content id="c7f5e71b-66a1-40b6-b81d-454a461d74ff" data-cid="c7f5e71b-66a1-40b6-b81d-454a461d74ff" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ABBR" data-track-detail="" data-tag-desc="ABBR" data-tag-type="ABBR" data-offset="39" data-match=" (CRP)" data-pattern="" data-tag-index="1_1" data-time="" data-username="" data-userid="">CRP</named-content>), surfactant protein D (<named-content id="de0d2829-2e52-4791-b590-8113c9843474" data-cid="de0d2829-2e52-4791-b590-8113c9843474" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ABBR" data-track-detail="" data-tag-desc="ABBR" data-tag-type="ABBR" data-offset="67" data-match=" (SPD)" data-pattern="" data-tag-index="1_2" data-time="" data-username="" data-userid="">SPD</named-content>), fibrinogen, soluble receptor of activated glycogen end-product (<named-content id="c711995d-4b3c-441c-bfdc-c25e6c0ab460" data-cid="c711995d-4b3c-441c-bfdc-c25e6c0ab460" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ABBR" data-track-detail="" data-tag-desc="ABBR" data-tag-type="ABBR" data-offset="137" data-match=" (sRAGE)" data-pattern="" data-tag-index="1_3" data-time="" data-username="" data-userid="">sRAGE</named-content>) and club cell protein 16 (CC-16) have been associated with chronic obstructive pulmonary disease (<named-content id="b041d469-33f7-4600-8047-a5eaede4426b" data-cid="b041d469-33f7-4600-8047-a5eaede4426b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ABBR" data-track-detail="" data-tag-desc="ABBR" data-tag-type="ABBR" data-offset="242" data-match=" (COPD)" data-pattern="" data-tag-index="1_4" data-time="" data-username="" data-userid="">COPD</named-content>) outcomes. However, they require validation in different cohorts.</p><title data-level="2" data-head-type="bold" id="0afe4b62-9dbb-4776-a9cd-45cbc334ee95">Objectives</title><p data-head-type="bold" id="d3d1b7a7-8aa2-4714-896c-43b05bb3b3cf">Relate systemic levels of those proteins to forced expiratory volume in <named-content id="216e8465-07cf-4db8-a515-53fb81de719f" data-cid="216e8465-07cf-4db8-a515-53fb81de719f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="72" data-match="1 s" data-replace="1" data-pattern="$1" data-tag-index="2_3" data-time="" data-username="" data-userid="">1</named-content><named-content id="550df1ba-a0d6-4a3e-b0b0-636ffb1cfe44" data-cid="550df1ba-a0d6-4a3e-b0b0-636ffb1cfe44" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣s' to ' s'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="73" data-match="1 s" data-replace=" s" data-pattern=" s" data-tag-index="2_3" data-track-change=" s" data-time="" data-username="" data-userid=""> s</named-content> (FEV<sub id="de7993d2-5682-4c21-a49f-242d36983d34">1</sub>) decline, exacerbations, hospitalisations and mortality in COPD <named-content id="9dcf91e2-2949-46e7-9478-a0ead5f3b1e7" data-cid="9dcf91e2-2949-46e7-9478-a0ead5f3b1e7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="146" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="2_5" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> (FEV<sub id="639b1993-0ffd-43a8-90c1-ce7eb1f9a8dc">1</sub> of<named-content id="05899abf-2908-4401-a6b2-917b898c037a" data-cid="05899abf-2908-4401-a6b2-917b898c037a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣≥' to '⍽≥'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="163" data-match="of ≥50 and" data-replace=" ≥" data-pattern=" $2" data-tag-index="2_1" data-track-change=" ≥" data-time="" data-username="" data-userid=""> ≥</named-content><named-content data-cid="1555285384" id="01d43343-7850-4634-a2ba-c572241e3984" content-type="del cts-3" specific-use="1555285645355" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 7:47am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555285645355"> </named-content><named-content id="69065497-f2cd-48a5-a0e7-ef5cc89a0faf" data-cid="69065497-f2cd-48a5-a0e7-ef5cc89a0faf" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="167" data-match="of ≥50 and" data-replace="50" data-pattern="$3" data-tag-index="2_1" data-time="" data-username="" data-userid="">50</named-content><named-content id="30a2e269-2d34-4948-9b5f-a2c8cd5b562d" data-cid="30a2e269-2d34-4948-9b5f-a2c8cd5b562d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣and' to ' and'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="UNT" data-offset="169" data-match="of ≥50 and" data-replace=" and" data-pattern=" $6" data-tag-index="2_1" data-track-change=" and" data-time="" data-username="" data-userid=""> and</named-content> <named-content id="d19989e3-76ff-42e8-8f08-65a1355bfb07" data-cid="d19989e3-76ff-42e8-8f08-65a1355bfb07" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣≤' to '≤'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="173" data-match=" ≤70%" data-replace="≤" data-pattern="$2" data-tag-index="2_2" data-track-change=" ≤" data-time="" data-username="" data-userid="">≤</named-content><named-content data-cid="1555285385" id="d67ef2d8-ab56-4a6e-97cf-df016d24f80c" content-type="del cts-3" specific-use="1555285647162" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 7:47am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555285647162"> </named-content><named-content id="42477d82-3d61-4bff-bff7-374773ef7dd0" data-cid="42477d82-3d61-4bff-bff7-374773ef7dd0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="177" data-match="70%" data-replace="70" data-pattern="$3" data-tag-index="2_2" data-time="" data-username="" data-userid="">70</named-content><named-content data-cid="1555285386" id="169a54f7-dff2-468a-9166-87130645a958" content-type="del cts-3" specific-use="1555285648103" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 7:47am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555285648103"> </named-content><named-content id="34595ed0-894f-45f3-9e0a-6f6531d906e8" data-cid="34595ed0-894f-45f3-9e0a-6f6531d906e8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="179" data-match="70%" data-replace="%" data-pattern="%" data-tag-index="2_4" data-time="" data-username="" data-userid="">%</named-content> predicted) and heightened cardiovascular risk in a <named-content id="296190ba-2155-4185-a228-9d019f812f97" data-cid="296190ba-2155-4185-a228-9d019f812f97" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="HYPPRE" data-track-detail="" data-tag-desc="HYPPRE" data-tag-type="HYPPRE" data-offset="232" data-match="sub-" data-pattern="" data-tag-index="2_6" data-time="" data-username="" data-userid="">sub<named-content data-cid="1555285387" id="adf1d620-cd1b-43bb-8e23-921722b7bb2c" content-type="del cts-3" specific-use="1555285650487" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 7:47am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555285650487">-</named-content></named-content>study of the <named-content data-cid="1555285388" id="33743f05-cc67-4f17-a1a7-67a297600246" content-type="ins cts-3" specific-use="1555285662094" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 7:47am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555285662094">Study to Understand Mortality and MorbidITy</named-content><named-content data-cid="1555285389" id="658a1630-af5d-4e2c-8918-00977b60d4f4" content-type="del cts-3" specific-use="1555285665702" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 7:47am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555285665702">SUMMIT</named-content> trial.</p><title data-level="2" data-head-type="bold" id="3cc3a2c0-ee86-459a-925f-b56b4bb58661">Methods</title><p data-head-type="bold" id="2167c0fc-e28b-4b7f-a2bb-6322303ed167">Participants were randomised to daily inhalations of placebo, vilanterol 25 <named-content id="225716ea-3996-4fd9-a582-019e05a92b50" data-cid="1555285702151" content-type="ins cts-1" specific-use="1555285702151" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 7:48am" data-track-detail="" data-username="Ariel (COPYEDITOR)" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-time="1555285702151">µ</named-content><named-content data-cid="1555285390" id="71b1ed5f-a882-454a-9d91-937650cdaf3c" content-type="del cts-3" specific-use="1555285704770" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 7:48am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555285704770">mc</named-content>g (<named-content id="59d987c4-2c27-402e-a56e-7b7826af3091" data-cid="59d987c4-2c27-402e-a56e-7b7826af3091" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ABBR" data-track-detail="" data-tag-desc="ABBR" data-tag-type="ABBR" data-offset="81" data-match=" (VI)" data-pattern="" data-tag-index="3_1" data-time="" data-username="" data-userid="">VI</named-content>), fluticasone furoate 100 <named-content data-cid="1555285392" id="d23194ad-3192-4b19-b4d1-1e5fa7fa27bb" content-type="ins cts-3" specific-use="1555285709230" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 7:48am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555285709230">µ</named-content><named-content data-cid="1555285393" id="78e25b3f-006c-4437-bec3-866e5d38821b" content-type="del cts-3" specific-use="1555285710515" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 7:48am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555285710515">mc</named-content>g (<named-content id="044d766b-9a7c-4496-9680-43468a6c9b77" data-cid="044d766b-9a7c-4496-9680-43468a6c9b77" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ABBR" data-track-detail="" data-tag-desc="ABBR" data-tag-type="ABBR" data-offset="115" data-match=" (FF)" data-pattern="" data-tag-index="3_2" data-time="" data-username="" data-userid="">FF</named-content>) or their combination (VI 25/FF 100) and followed quarterly until <named-content id="97530e29-68ea-4bab-a7bb-690d223b1ea6" data-cid="97530e29-68ea-4bab-a7bb-690d223b1ea6" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="184" data-match="1000" data-replace="1000" data-pattern="1000" data-tag-index="3_3" data-time="" data-username="" data-userid="">1000</named-content> deaths in the overall 16 485 participants occurred. Biomarker blood samples were available from <named-content id="d981fbc4-14f0-4cbd-a209-20f2e12948c8" data-cid="d981fbc4-14f0-4cbd-a209-20f2e12948c8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="285" data-match="1673" data-replace="1673" data-pattern="1673" data-tag-index="3_4" data-time="" data-username="" data-userid="">1673</named-content> <named-content id="baa6e709-7a3d-41f6-951d-73143ac78dfe" data-cid="baa6e709-7a3d-41f6-951d-73143ac78dfe" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="290" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="3_5" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content>. The FEV<sub id="b38d7aa7-dfb5-478f-a4c2-fc9cbc16ca4f">1</sub> decline (mL/year), COPD exacerbations, hospitalisations and death were determined. Associations between biomarker levels and outcomes were adjusted by age and gender.</p><title data-level="2" data-head-type="bold" id="8a4e1f7b-0a17-4193-8f56-f545204e0360">Results</title><p data-head-type="bold" id="fa1b21e7-e6aa-4519-9984-258e876ae3cb">Systemic levels of CC-16, CRP, sRAGE, SPD and fibrinogen did not relate to baseline FEV<sub id="b34e66b2-c977-4a8f-bec1-403f1a2bf799">1</sub>, FEV<sub id="475b4813-2b9b-484d-9e47-87175740446b">1</sub> decline, exacerbations or hospitalisations. Fibrinogen and CRP were related to mortality over a median follow-up of <named-content id="d3262080-7bb7-45f5-b034-e98f8c80e442" data-cid="d3262080-7bb7-45f5-b034-e98f8c80e442" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="211" data-match="2.3 years" data-replace="2.3" data-pattern="$1" data-tag-index="4_2" data-time="" data-username="" data-userid="">2.3</named-content> <named-content id="f4b10882-29c8-4a4e-b7d3-735f60037192" data-cid="f4b10882-29c8-4a4e-b7d3-735f60037192" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="214" data-match="2.3 years" data-replace=" years" data-pattern=" $2" data-tag-index="4_2" data-time="" data-username="" data-userid="">years</named-content>. Only the CC-16 changed with study therapy (VI, FF and FF/VI, <named-content id="c957466c-22ce-4dcb-9c76-5a206796ac8a" data-cid="c957466c-22ce-4dcb-9c76-5a206796ac8a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'p' to 'p'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="283" data-match="p&amp;lt;0.01" data-replace="&lt;i&gt;p&lt;/i&gt;" data-pattern="$1" data-tag-index="4_1" data-function="lowercase,removeItalics" data-track-change="p" data-time="" data-username="" data-userid="">p</named-content><named-content data-cid="1555285396" id="cf16e21d-83e3-4b60-8d43-87a40f65aab9" content-type="del cts-3" specific-use="1555285747918" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 7:49am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555285747918"> </named-content><named-content id="3a0370f0-b2d0-4f71-b15f-a4759fb423da" data-cid="3a0370f0-b2d0-4f71-b15f-a4759fb423da" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="284" data-match="p&amp;lt;0.01" data-replace="&lt;" data-pattern="$2" data-tag-index="4_1" data-time="" data-username="" data-userid="">&lt;</named-content><named-content data-cid="1555285395" id="005f2d1b-30c2-47cd-bb2c-9475499e26c5" content-type="del cts-3" specific-use="1555285747403" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 7:49am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555285747403"> </named-content><named-content id="1be35f1c-68e0-4e13-b3b6-cb72cf803e70" data-cid="1be35f1c-68e0-4e13-b3b6-cb72cf803e70" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="285" data-match="p&amp;lt;0.01" data-replace="0.01" data-pattern="$3" data-tag-index="4_1" data-time="" data-username="" data-userid="">0.01</named-content>) at <named-content id="72f12b84-852a-492c-abf1-9d7a7eb5832d" data-cid="72f12b84-852a-492c-abf1-9d7a7eb5832d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="294" data-match="3 months" data-replace="3" data-pattern="$1" data-tag-index="4_3" data-time="" data-username="" data-userid="">3</named-content> <named-content id="ea597765-5a89-4995-873f-962d0721f8e7" data-cid="ea597765-5a89-4995-873f-962d0721f8e7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="295" data-match="3 months" data-replace=" months" data-pattern=" $2" data-tag-index="4_3" data-time="" data-username="" data-userid="">months</named-content>.</p><title data-level="2" data-head-type="bold" id="46dc5319-7253-4b4f-a405-b78466d9335e">Conclusions</title><p id="2ba86791-9bfc-4ba2-8d25-7fa302902d67" data-head-type="bold">In COPD, systemic levels of CC-16, CRP, sRAGE, SPD and fibrinogen were not associated with FEV<sub id="d53ec39e-455d-41bc-967e-7484d66e3330">1</sub> decline, exacerbations or hospitalisations. These results cast doubts about the clinical usefulness of the systemic levels of these proteins as surrogate markers of these <named-content data-class="jrnlQueryRef" id="39aac88c-d4b5-46a7-a803-694266d3df16" data-message="{'funcToCall': 'highlightQuery'}" data-event="click" data-topic="action" data-channel="query" specific-use="start" content-type="jrnlQueryRef" data-query-type="action" data-query-for="author" data-query-ref="true" data-type="start" rid="3f76056f-962e-4661-bef0-a521276b642e" data-query-from="typesetter" data-replied="true"/>COPD<named-content data-class="jrnlQueryRef" id="80c62c77-0b2d-4dee-ab1d-dd66c2f1bfe6" specific-use="end" content-type="jrnlQueryRef" data-type="end" rid="3f76056f-962e-4661-bef0-a521276b642e" data-replied="true"/> outcomes. The study confirms that CRP and fibrinogen are associated with increased risk of death in <named-content id="383d98bf-926a-4bb8-a4f1-59a4f416a1a0" data-cid="383d98bf-926a-4bb8-a4f1-59a4f416a1a0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-time="" data-username="" data-userid="" data-tag-index="5_1" data-pattern="$1" data-match="patients" data-offset="372" data-tag-type="HIGH" data-tag-desc="HIGH" data-replace="patients" data-function="addTrackChanges">patients</named-content> with COPD.</p><title data-level="2" data-head-type="bold" id="69d6e64d-d9e1-49f7-b114-787a0340ce6d"><named-content data-cid="1555285431" id="f63da3c6-43a3-466d-9bfc-233802980373" content-type="ins cts-3" specific-use="1555286365593" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 7:59am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555286365593">Trial registration <named-content rid="a8f5a716-f979-45e9-a596-198800020681" data-class="jrnlQueryRef" data-type="start" data-query-ref="true" data-query-for="typesetter" data-query-from="copyeditor" data-channel="query" data-topic="action" data-event="click" data-message="{'funcToCall': 'highlightQuery'}" data-query-type="action" id="a1986f3a-1507-4020-9531-7f4ef507d842" content-type="jrnlQueryRef" specific-use="start" data-replied="true"/>number<named-content rid="a8f5a716-f979-45e9-a596-198800020681" data-class="jrnlQueryRef" data-type="end" id="199840f2-4490-4be7-b9ae-f95acb41b230" content-type="jrnlQueryRef" specific-use="end" data-replied="true"/></named-content></title><p data-head-type="bold" id="ace42851-fa79-4d0e-94de-a2bd815f56af"><named-content data-cid="1555285456" id="9450cc63-962e-47fc-86ca-541c1e6fc073" content-type="ins cts-3" specific-use="1555286369197" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 7:59am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555286369197"><ext-link xlink:href="NCT01313676" data-class="jrnlClinicalTrial" id="84c0f60f-4657-4d58-b77b-acf263b1822f" ext-link-type="clintrialgov" data-result-type="none" specific-use="clinicaltrial none">NCT01313676</ext-link>.</named-content></p> </abstract><kwd-group section="front" node-xpath="article-meta" next-xpath="funding-group" id="670d6e21-33bf-43ce-bfba-ee381ed9e897"> <kwd data-class="jrnlKeyword" id="988997cd-2f72-4aae-a24d-189f4d3b4a8e">chronic obstructive pulmonary disease</kwd> <kwd data-class="jrnlKeyword" id="77dc3ea6-e0cc-41b4-b271-c76d5f886ff9">mortality</kwd> <kwd data-class="jrnlKeyword" id="ba0fdd1b-025d-4bfe-bb1c-fa671c5172f9">biomarkers</kwd> <kwd data-title="Inserted by Bartolome R Celli (AUTHOR) - Apr 15 2019 10:16am" data-class="jrnlKeyword" id="a4473b64-3221-490c-8e72-8646713b5b5d" data-time="1555337770692" data-username="Bartolome R Celli (AUTHOR)" data-userid="author 2376147574" data-cid="1555337770694" data-track="ins">Lung function decline</kwd></kwd-group><funding-group specific-use="FundRef" id="0c66a199-d700-4af7-b50b-31cc793c2a59"><award-group id="fund1" data-id="fund1"><funding-source id="ff9a8d98-a403-4c6c-be3a-e80c9ca1a10f"><institution-wrap id="197b60ad-b31b-436d-a68b-510fd032979e"><institution id="39ec6a5e-f0ee-4a69-bb22-bc38ee12b2b5">GlaxoSmithKline plc.</institution></institution-wrap></funding-source></award-group><funding-statement data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'addDataTempSelector', 'param' : {'component' : 'jrnlFN'}}" data-ele-type="funding-statement" fn-type="funding" data-label="Funding" data-track="ins" data-cid="1555313353376" data-username="Gowtham Ram (TYPESETTER)" data-userid="typesetter gowthamram" data-time="1555313353376" data-title="Inserted by Gowtham Ram (TYPESETTER) - Apr 15 2019 12:59pm" id="118b1f86-06ba-444d-a13c-bb07f4f475a6">This work was supported by GlaxoSmithKline plc.</funding-statement></funding-group><custom-meta-group id="8dfd99bd-f5d1-4fa1-a640-4930c9567b93"><custom-meta id="e123e3e5-2b5d-46fc-8294-373a4703bb13"><meta-name id="b87417d5-8bc7-4987-853e-58f517144c95">Copy editing requirement</meta-name><meta-value id="b1fbb771-0db4-47ab-bc93-1502d9d49460">2</meta-value></custom-meta><custom-meta id="deacda27-e74c-4f77-973f-0bcb1052af02"><meta-name id="911e39b4-efd2-43f4-8832-85948cd274c7">Author requirement</meta-name><meta-value id="fed4f204-0ec1-432c-993c-c0ec9352bb41">2</meta-value></custom-meta><custom-meta id="8a651d77-17d8-45cc-8b6f-0cb6769249a9"><meta-name id="2ed35db3-69a7-4361-9351-5a9dc4ac2a99">payment method</meta-name><meta-value holdtype="Holdatstart" id="25d22bde-29f5-451c-9f39-289a5117ea9d">RightsLink</meta-value></custom-meta><custom-meta id="e68fd2ed-b81d-49a8-83a3-014220e5098c"><meta-name id="b2b5b376-7bb8-4765-920f-286799d8b722">license type</meta-name><meta-value id="e733caf7-639b-4ff4-8994-4a93189c455c">CC-BY-NC</meta-value></custom-meta><custom-meta id="051bd45d-12da-4e9e-8362-5283f94dc833"><meta-name id="21969c6d-7c0e-4676-a4b3-9e58bd572538">Spelling language</meta-name><meta-value id="e0504a1a-40d8-4cae-864a-a95db6092a94">en-GB</meta-value></custom-meta><custom-meta specific-use="hold" data-title="hold" data-type="processed" id="a47bf11b-3de9-48f8-b2a7-d0a3a445ea76"><meta-name id="3d6ae505-f325-4612-9166-991d3f07651a">Pre-editing</meta-name><meta-value id="f6fa7a48-4ca1-4a75-90ae-303838123f11"><user-name id="c6c5690f-2795-4a7f-a616-e9596cd08181">Workflow</user-name><date-time id="c06fdf52-5b16-4600-8bec-da8acf1e39d4">2019-04-09 04:45:32</date-time><reason id="98012ebb-20d8-4968-a995-fa6b881ddc98">Payment Method has hold start</reason></meta-value></custom-meta><custom-meta id="e2cd89c2-3126-4e43-a77b-740e43bba41f"><meta-name id="4aaeec57-7574-4e8d-be5b-7c9231d5c076">payment received</meta-name><meta-value id="50ad7222-9503-495b-a30f-7695411c25b9">true</meta-value></custom-meta><custom-meta specific-use="query" id="1555068417015" section="article-meta" node-xpath="custom-meta-group" xlink:type="action" data-type="action" data-replied="true"><meta-value id="d0558a3a-bbc3-4b35-bda3-897057563672"><named-content xlink:title="Exeter Pre-editing" specific-use="Apr 12 2019 (16:57)" content-type="Author" alt="preeditor" id="2f5d7055-6f36-4810-95f5-641e86585c0c">Corrections at this stage should be limited to those that are essential. Extensive corrections will delay the time to publication and may also have to be approved by the Editor. Changes can not be made after the article has published online. Please acknowledge that you have read this message.</named-content><named-content xlink:title="Bartolome R Celli (AUTHOR)" specific-use="Apr 15 2019 (10:12)" content-type="reply" alt="author" id="11407e71-62ca-4164-a8f3-d205f26318d8">Acknowledged</named-content></meta-value></custom-meta><custom-meta specific-use="query" id="1555068417016" section="article-meta" node-xpath="custom-meta-group" xlink:type="action" data-type="action" data-replied="true"><meta-value id="b55e7a43-fdc2-4bd7-a59d-aa6525199ad3"><named-content xlink:title="Exeter Pre-editing" specific-use="Apr 12 2019 (16:57)" content-type="Author" alt="preeditor" id="e2ac08dc-df7e-492e-865d-c0a8c4c13a86">Please check all author names are spelt correctly, and that affiliations and correspondence details are accurate. Please confirm that these are correct.</named-content><named-content xlink:title="Bartolome R Celli (AUTHOR)" specific-use="Apr 15 2019 (10:17)" content-type="reply" alt="author" id="d0c2be33-bed4-47c1-a91c-c1fab2d631d4">OK as it is</named-content></meta-value></custom-meta><custom-meta specific-use="query" id="1ba46b07-a8fe-4ca3-ae6a-676fd45f22c8" section="article-meta" node-xpath="custom-meta-group" xlink:type="action" data-type="action" data-replied="true"><meta-value id="33f1b612-c383-4034-9561-174af8cc5682"><named-content xlink:title="Manoj (BMJ)" specific-use="Apr 26 2019 12:20 PM" content-type="Typesetter" alt="publisher" id="ccf33b7e-5bf1-4b4c-a3c8-5d9b97c4cf0d">Please add the key message and other details of first page as per the attached file.</named-content><named-content xlink:title="Renganath (TYPESETTER)" specific-use="Apr 27 2019 (10:35)" content-type="reply" alt="typesetter" id="4d035910-29fe-4d03-a309-8b28646bd880">This has been added.<div data-type="file" data-file-name="Key Messages Celli.docx" id="7fa0702a-e2a3-4ac3-a680-1893741c4534"><p data-class="note-file" src="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/ca71550c-195c-48f4-b331-884a42c25b2f.docx" id="98969c53-c7a6-4f88-9ad4-f88651d27674">Key Messages Celli.docx</p></div></named-content></meta-value></custom-meta><custom-meta specific-use="query" id="3f76056f-962e-4661-bef0-a521276b642e" section="article-meta" node-xpath="custom-meta-group" xlink:type="action" data-type="action" data-replied="true"><meta-value id="f4aa3a26-be52-489f-bacc-2b08d2c22e64"><named-content xlink:title="Gowtham Ram (TYPESETTER)" specific-use="Apr 15 2019 1:04 PM" content-type="Author" alt="typesetter" id="cfc96a09-d78b-4503-8cc7-78f7b5a9c0f3">As per style key message is mandatory for this aticle. please check and mane the necessary changes.</named-content><named-content xlink:title="Bartolome R Celli (AUTHOR)" specific-use="Apr 15 2019 (10:16)" content-type="reply" alt="author" id="5044035c-4e94-4fa7-ad41-9cbb3dddb34a">Added one more</named-content></meta-value></custom-meta><custom-meta specific-use="query" id="7e7651ab-9dfe-4547-8a1c-0b4eeafc6ba2" section="article-meta" node-xpath="custom-meta-group" xlink:type="action" data-type="action" data-replied="true"><meta-value id="a03a7358-5c56-48fb-89b9-60fa214efeb3"><named-content xlink:title="Ariel (COPYEDITOR)" specific-use="Apr 15 2019 7:45 AM" content-type="Author" alt="copyeditor" id="f343946a-a001-4ab3-945a-706373c2e557">Please provide the department (if any) for affiliations 5, 6, 7 and 8.</named-content><named-content xlink:title="Bartolome R Celli (AUTHOR)" specific-use="Apr 15 2019 (10:15)" content-type="reply" alt="author" id="bd6a4a5f-8ef1-4f60-b110-348a7b64e977">The only one needing corrections is # 8. This should read "Department of Medicine"</named-content></meta-value></custom-meta><custom-meta specific-use="query" id="6d97e74a-5804-45f6-866c-aaaedc8b541d" section="article-meta" node-xpath="custom-meta-group" xlink:type="action" data-type="action" data-replied="true"><meta-value id="839f8a40-024c-44fa-bf9b-4663d86b422e"><named-content xlink:title="Ariel (COPYEDITOR)" specific-use="Apr 15 2019 7:58 AM" content-type="Author" alt="copyeditor" id="2c467544-169a-45e4-ba95-e3090f2d50f0">'The study was approved by local ethics committees and was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines.' This text has been removed as this has been set as Ethics approval statement. Is this OK?</named-content><named-content xlink:title="Bartolome R Celli (AUTHOR)" specific-use="Apr 15 2019 (10:19)" content-type="reply" alt="author" id="282ccef7-6df2-4c6d-94e9-4c7d3b80c3be">It is OKas it is</named-content></meta-value></custom-meta><custom-meta specific-use="query" id="49f14994-10e5-4bc2-b917-72d26075ee9c" section="article-meta" node-xpath="custom-meta-group" xlink:type="action" data-type="action" data-replied="true"><meta-value id="f7212702-b440-41fb-8cc0-b0189da6ae65"><named-content xlink:title="Ariel (COPYEDITOR)" specific-use="Apr 15 2019 7:59 AM" content-type="Author" alt="copyeditor" id="761a29a5-8cee-4fb2-8bf8-a23831a493ee">'as NCT01313676': This text has been removed as this has been set as Trial registration number. Is this OK?</named-content><named-content xlink:title="Bartolome R Celli (AUTHOR)" specific-use="Apr 15 2019 (10:18)" content-type="reply" alt="author" id="988efb1c-78af-41c9-bcc9-c4522ff35791">It is OK</named-content></meta-value></custom-meta><custom-meta specific-use="query" id="a8f5a716-f979-45e9-a596-198800020681" section="article-meta" node-xpath="custom-meta-group" xlink:type="action" data-type="action" data-replied="true"><meta-value id="a106b8c4-062a-4314-9c4e-73bb5fb30bb9"><named-content xlink:title="Ariel (COPYEDITOR)" specific-use="Apr 15 2019 7:59 AM" content-type="Typesetter" alt="copyeditor" id="7ff5f0bf-f233-43af-98bd-a1d4baf201f9">Please set this correctly.</named-content><named-content xlink:title="Gowtham Ram (TYPESETTER)" specific-use="Apr 15 2019 (12:59)" content-type="reply" alt="typesetter" id="c487fa91-fbca-46ad-b983-34f5490b96fe">ok</named-content></meta-value></custom-meta><custom-meta specific-use="query" id="e454f372-614c-4b94-9f3c-5e5c1f9da1d3" section="article-meta" node-xpath="custom-meta-group" xlink:type="action" data-type="action" data-replied="true"><meta-value id="cc4e2c52-2f3f-4a27-a93f-a484d37b0e73"><named-content xlink:title="Ariel (COPYEDITOR)" specific-use="Apr 15 2019 8:03 AM" content-type="Author" alt="copyeditor" id="745f33a5-ef10-4054-980b-02f1b9496b79">'The published primary results...' Please check and confirm if this sentence is correct.</named-content><named-content xlink:title="Bartolome R Celli (AUTHOR)" specific-use="Apr 15 2019 (10:19)" content-type="reply" alt="author" id="b328388b-3372-4477-bdde-da25de013387">OK as it is</named-content></meta-value></custom-meta><custom-meta specific-use="query" id="8a35aa60-1ad3-49af-9bcf-26e7ab9bffa7" section="article-meta" node-xpath="custom-meta-group" xlink:type="action" data-type="action" data-replied="true"><meta-value id="35ebd1d3-2b5a-4786-a79f-d4ee5953b532"><named-content xlink:title="Ariel (COPYEDITOR)" specific-use="Apr 15 2019 8:59 AM" content-type="Typesetter" alt="copyeditor" id="047c3994-2737-4e96-ac73-65aed092a58a">'<named-content data-cid="1555068417014" id="49a79aa8-6306-44d4-a3ed-a869b86a590f" content-type="ins cts-1" specific-use="1555068417000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1555068417000" data-reason="truecase"> </named-content><bold id="5ff1591e-8f78-49b2-b9da-d4d6fe61b515"><sup id="63a0a773-c29a-492e-b4a2-63d22e3371ba">___</sup> Low <sup id="b59c1cc8-72c8-4132-bc05-f61c15a12a02">___</sup> Middle <sup id="880ac8a1-fc65-4411-ae1a-58b38c788c51">___</sup> High': Please check this footnote.</bold></named-content><named-content xlink:title="Gowtham Ram (TYPESETTER)" specific-use="Apr 15 2019 (13:02)" content-type="reply" alt="typesetter" id="23cb1038-89f0-40d5-aa4c-a0028583b8c4">ok</named-content></meta-value></custom-meta><custom-meta specific-use="query" id="1555068417017" section="article-meta" node-xpath="custom-meta-group" xlink:type="action" data-type="action" data-replied="true"><meta-value id="ff0fc679-1ef9-43d2-855a-40f21da3183a"><named-content xlink:title="Exeter Pre-editing" specific-use="Apr 12 2019 (16:57)" content-type="Author" alt="preeditor" id="a027c1e3-1555-42b9-afd6-c7d5161b066e">Please confirm that the section headings are correct.</named-content><named-content xlink:title="Bartolome R Celli (AUTHOR)" specific-use="Apr 15 2019 (10:18)" content-type="reply" alt="author" id="a4a6bc31-6325-416b-87a5-04f91931eb46">OK as it is</named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="1d5e7efb-1237-48a9-ae86-020755467c8a" xlink:title="c5b7739d-1c3a-4064-ba1c-c5e119723b26" xlink:actuate="0b0ea00d-3c02-4ab4-9a81-09db426c9c05" xlink:role="typesetter" xlink:href="9161d6e0-16c4-47ae-82a8-ec29899c3147"><meta-value><named-content specific-use="historyContent" data-title="" id="9f319708-1919-42fe-aa4e-2244b655d989"><named-content specific-use="change-person" data-title="" id="af85bd06-5e1f-455a-a987-2d0efa4a1d09">Usha</named-content> <named-content specific-use="" data-title="" id="3d086d5b-c1b7-4a3c-bfa3-e9e78f6e44f5">inserted</named-content> <named-content specific-use="newVal" data-title="" id="cbe3e4c5-cb13-43cd-8b89-438b7f3baf44">04052019</named-content> <named-content specific-use="" data-title="" id="937edb69-a26d-497b-8544-6140e63e3c8d"> in ppub field on</named-content> <named-content specific-use="change-time" data-title="" id="b3f7e051-d325-4870-a35d-033b8dcfd4dd">4 May 2019 8:56 AM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="bb2ba863-f61b-478b-a30b-ce7d92756120" xlink:title="c5b7739d-1c3a-4064-ba1c-c5e119723b26" xlink:actuate="0b0ea00d-3c02-4ab4-9a81-09db426c9c05" xlink:role="typesetter" xlink:href="5345d947-2cf3-45bf-8ede-e61ef9dddeb9"><meta-value><named-content specific-use="historyContent" data-title="" id="4239f069-6bca-46ca-b07b-608f432050ab"><named-content specific-use="change-person" data-title="" id="54252db8-1eaf-4dc4-92c7-3c56d8f3b413">Usha</named-content> <named-content specific-use="" data-title="" id="a8e7e1e7-0dbf-444d-aad7-4049a965cd77">inserted</named-content> <named-content specific-use="newVal" data-title="" id="92d4cbf6-d38d-41bf-9f16-cd9593ae716f">04052019</named-content> <named-content specific-use="" data-title="" id="d6277aee-0920-4486-a634-2c2f0fc88235"> in epub field on</named-content> <named-content specific-use="change-time" data-title="" id="bc8fbd81-e2f3-4897-898a-2890b24c1c33">4 May 2019 8:56 AM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="962e02a5-d63e-4fca-a1ca-86063d1a4a3b" xlink:title="ad679c21-4e16-4982-8999-b7ca5830d5b0" xlink:actuate="0b0ea00d-3c02-4ab4-9a81-09db426c9c05" xlink:role="typesetter" xlink:href="ad679c21-4e16-4982-8999-b7ca5830d5b0"><meta-value><named-content specific-use="historyContent" data-title="" id="1a68bc57-b982-4e92-88a0-e79305c6d6f4"><named-content specific-use="change-person" data-title="" id="e0973f57-6abf-4bd6-89d7-bedb99cd0a4c">Usha</named-content> <named-content specific-use="" data-title="" id="7d30b554-86d9-451b-8261-fc224aa2b32e">changed</named-content> <named-content specific-use="oldVal" data-title="Randomised controlled trial" id="afc6b653-6a2a-45ae-9aee-86b583e28249">Randomised controlled trial</named-content> <named-content specific-use="" data-title="" id="967fa875-d631-45ba-855f-6d938d95c411">to</named-content> <named-content specific-use="newVal" data-title="&lt;span class=”deletedNode”&gt;+ Add Section head&lt;/span&gt;" id="1108e800-fa15-4328-a790-e8f8f4039f1e"><named-content specific-use="deletedNode" data-title="" id="c137ce68-38be-4336-a2ab-cb20c2e6519d">+ Add Section head</named-content></named-content> <named-content specific-use="" data-title="" id="d4ab70ac-f277-4699-953d-14a1df20206c"> on</named-content> <named-content specific-use="change-time" data-title="" id="016794af-6dc1-483a-8ac5-b9305cd18ed1">4 May 2019 8:55 AM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="6aeb1479-e596-4ab4-97ce-293f81206deb" xlink:title="pubData" xlink:actuate="0b0ea00d-3c02-4ab4-9a81-09db426c9c05" xlink:role="typesetter" xlink:href="23e0e19b-3fd8-4eff-a1f3-ed0f629da297"><meta-value id="4f09122c-1aaa-4e2e-adff-46b4cb2c8728"><named-content specific-use="historyContent" data-title="" id="007a75ef-b793-4c32-a2d7-5dd4639c9b8d"><named-content specific-use="change-person" data-title="" id="571846ee-0f19-4490-9dc6-f3e84a470148">Usha</named-content> <named-content specific-use="" data-title="" id="f307bbca-e7a1-4115-964c-c69c1c849c19">inserted</named-content> <named-content specific-use="newVal" data-title="" id="bf86715a-1126-47f4-99b5-acd4836f3047">1</named-content> <named-content specific-use="" data-title="" id="5f618d41-f938-4b14-9fdf-20fb2697f71a"> in Issue field on</named-content> <named-content specific-use="change-time" data-title="" id="60317d76-f363-4394-a2d3-63e0bc117a1f">3 May 2019 7:29 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="d9d91a18-9c13-4e6d-b47e-04f5761e157a" xlink:title="pubData" xlink:actuate="0b0ea00d-3c02-4ab4-9a81-09db426c9c05" xlink:role="typesetter" xlink:href="411a05be-8fc5-4cc6-a232-73129d51ca6f"><meta-value id="35ec3450-eccf-4c04-af74-bb64711c6800"><named-content specific-use="historyContent" data-title="" id="446d5ec9-910a-4da3-bdc0-171a98f231af"><named-content specific-use="change-person" data-title="" id="e69c107d-3808-43f7-bd6f-775ea566f148">Usha</named-content> <named-content specific-use="" data-title="" id="e0692ce3-07fb-4934-9db7-f631bf349191">changed</named-content> <named-content specific-use="oldVal" data-title="" id="e1e141bc-9bf9-4ef9-a724-f458fee3c857">0</named-content> <named-content specific-use="" data-title="" id="5086d669-fe5e-4164-bcd1-165df9e98ab4">to</named-content> <named-content specific-use="newVal" data-title="" id="883072cd-5ddf-4cf0-a388-87e52be48296">6</named-content> <named-content specific-use="" data-title="" id="47d496f2-a657-4adf-b65d-d89274306bcd"> in Volume field on</named-content> <named-content specific-use="change-time" data-title="" id="bd9e99db-3234-4648-824f-64dc41901d6d">3 May 2019 7:29 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="43d9fcdd-c8af-4741-962e-f7004c182643" xlink:title="c7164c56-52f9-4a34-9bc7-aec4131011d4" xlink:actuate="ab536488-13fd-4e4f-857d-d52a866c90cc" xlink:role="typesetter" xlink:href="a60a1fab-9690-4bb1-8ba1-f98b172c57ff"><meta-value id="5a55ff1c-9f12-4aee-b054-bb512ddfe24a"><named-content specific-use="historyContent" data-title="" id="5c68d913-79f8-43db-8d5a-591c367cfdde"><named-content specific-use="change-person" data-title="" id="6163a8bf-4096-4004-9f13-1fb96259207c">Renganath</named-content> <named-content specific-use="" data-title="" id="6d36f633-f8ab-4c59-88f1-aba07d0ac8bf">inserted</named-content> <named-content specific-use="newVal" data-title="The SUMMIT study was an event-driven design and as such not all patients were followed over a period of several years.An assumption was made that a few (or possibly only one) biomarkers would be valid for all COPD patients. Given the heterogeneity of patients with COPD, this assumption may not be right." id="e0be5d06-d844-4b9a-a85c-05b97e33305d">The SUMMIT study was an event-driven design and as such not all patients were followed over a period of several years.An assumption was made that a few (or possibly only one) biomarkers would be valid for all COPD patients. Given the heterogeneity of patients with COPD, this assumption may not be right.</named-content> <named-content specific-use="" data-title="" id="25deb5bf-e505-477d-839c-eb89dd212864"> in Box text field on</named-content> <named-content specific-use="change-time" data-title="" id="63ed4971-0d35-4fca-aa62-e4f8325782e4">27 Apr 2019 10:24 AM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="09cae4b9-933f-4328-a65b-50bf3513f382" xlink:title="c7164c56-52f9-4a34-9bc7-aec4131011d4" xlink:actuate="ab536488-13fd-4e4f-857d-d52a866c90cc" xlink:role="typesetter" xlink:href="dd72e5d0-c598-454a-8814-a16506e6fce5"><meta-value id="658362f8-d590-4333-960d-ca90207a0b0a"><named-content specific-use="historyContent" data-title="" id="b8b2a576-c223-467d-9ca5-dd829b803a5f"><named-content specific-use="change-person" data-title="" id="ef6f99f4-7160-4e85-a053-ad0a1bcb5ca8">Renganath</named-content> <named-content specific-use="" data-title="" id="a68f413c-da04-4722-9db2-f9025017f86d">changed</named-content> <named-content specific-use="oldVal" data-title="" id="b95b062c-5aa3-400d-9cf2-ca24d00b8f3f">Uncited Box 3.</named-content> <named-content specific-use="" data-title="" id="c67806ec-34b0-4c05-8b92-e89325c0b554">to</named-content> <named-content specific-use="newVal" data-title="Uncited Box 3.Limitations" id="63cc856d-2b61-46c4-9b4e-60dc24dc48e8">Uncited Box 3.Limitations</named-content> <named-content specific-use="" data-title="" id="d685121a-9299-4aa6-8f3a-98c7d953bf50"> in Caption field on</named-content> <named-content specific-use="change-time" data-title="" id="9e5aff8a-affc-4264-bda5-49dc18001cc9">27 Apr 2019 10:24 AM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="cfc71a64-5798-481d-bf97-6d2056804368" xlink:title="65e60b1b-fe16-41c0-82b9-7d487b94952f" xlink:actuate="ab536488-13fd-4e4f-857d-d52a866c90cc" xlink:role="typesetter" xlink:href="5cb330fb-9b1c-4fdb-8673-0ed9d9eab220"><meta-value id="5051958b-8868-4135-a1b1-4ed77d72a067"><named-content specific-use="historyContent" data-title="" id="2aed6a64-427e-45a5-ad95-e409b2362c1b"><named-content specific-use="change-person" data-title="" id="21996ecb-79cc-49ef-9e49-eab7f0d42954">Renganath</named-content> <named-content specific-use="" data-title="" id="64941d6e-40f3-4a17-951d-6ffb517b44a0">inserted</named-content> <named-content specific-use="newVal" data-title="The relatively large sample size and multi-centre nature of the study overcome the usual limitations of smaller trials conducted in a single center. The patients included had a careful clinical, functional and biological characterization. In addition, the study had a prospective design, significant follow-up time and a clinical adjudicating committee that validated the outcomes.The selections of biomarkers was based on previous studies suggesting a relationship between those proteins and outcomes." id="4efb9f01-2a9c-4565-b0ea-b7c0e1aaf115">The relatively large sample size and multi-centre nature of the study overcome the usual limitations of smaller trials conducted in a single center. The patients included had a careful clinical, functional and biological characterization. In addition, the study had a prospective design, significant follow-up time and a clinical adjudicating committee that validated the outcomes.The selections of biomarkers was based on previous studies suggesting a relationship between those proteins and outcomes.</named-content> <named-content specific-use="" data-title="" id="91139909-0da2-497a-8492-8149ac371ecf"> in Box text field on</named-content> <named-content specific-use="change-time" data-title="" id="58712e9c-4b34-4dd8-b323-505beb6309c8">27 Apr 2019 10:23 AM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="4d34eae0-6aa7-4f22-b5cf-f883fb819ea9" xlink:title="65e60b1b-fe16-41c0-82b9-7d487b94952f" xlink:actuate="ab536488-13fd-4e4f-857d-d52a866c90cc" xlink:role="typesetter" xlink:href="a845ab96-d4a0-49de-962a-95007335097b"><meta-value id="6f35d692-c5ad-4b50-8332-49a689494ee2"><named-content specific-use="historyContent" data-title="" id="a4899aa5-a5ff-4c1b-874e-23c5f9e0027b"><named-content specific-use="change-person" data-title="" id="50ede30b-aaa7-4df2-9de7-6d690a24713b">Renganath</named-content> <named-content specific-use="" data-title="" id="0392f298-847b-49c4-8925-b66998f42313">changed</named-content> <named-content specific-use="oldVal" data-title="" id="96169c90-ec6a-41a7-bd23-35849bfa63ff">Uncited Box 2.</named-content> <named-content specific-use="" data-title="" id="1fff6d76-99af-485f-b7af-03b227f751fa">to</named-content> <named-content specific-use="newVal" data-title="Uncited Box 2.Strengths" id="43347abb-8f8d-4cac-b014-90b678d1f1b5">Uncited Box 2.Strengths</named-content> <named-content specific-use="" data-title="" id="b3eeb6c7-510c-4d8a-9564-1a26bb8b514e"> in Caption field on</named-content> <named-content specific-use="change-time" data-title="" id="30359296-9e64-4d74-82f6-4c499bf631c5">27 Apr 2019 10:23 AM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="c9cc92c5-398e-41f0-8200-6db878c6553f" xlink:title="1e7b4410-d7b9-411f-bc4c-599b01e1a84a" xlink:actuate="ab536488-13fd-4e4f-857d-d52a866c90cc" xlink:role="typesetter" xlink:href="e001d630-6eef-4c60-84f2-bba2ebf39b20"><meta-value id="9c20ee6d-e5e7-46ef-b147-0acd325b6964"><named-content specific-use="historyContent" data-title="" id="626e40fb-9268-43e2-8bfc-f4fbb01c7d33"><named-content specific-use="change-person" data-title="" id="397fb27d-68bf-43df-b9f4-779f04b00e89">Renganath</named-content> <named-content specific-use="" data-title="" id="a5c58501-7d32-406c-8d2a-c4113c397ea2">inserted</named-content> <named-content specific-use="newVal" data-title="There is intense interest in discovering systemic biomarkers that may relate to important patient related outcomes (PRO) in patients with COPD.Using data and biological samples prospectively collected in the Study to Understand Mortality and MorbidITy (SUMMIT) study in 1,673 COPD patients with heightened cardiovascular risk the systemic levels of C-reactive protein (CRP), fibrinogen, surfactant protein-D (SPD), soluble receptor of glycation end-product (sRAGE) and club cell protein 16 (CC16) were related to rate of decline of the forced expiratory volume in the 1st second (FEV1), exacerbations, hospitalizations and mortality.We found no relationship between serum levels of these 5 biomarkers and rate of FEV1 decline (ml/year) and COPD exacerbations and hospitalizations. The serum levels of CRP and fibrinogen, but not sRAGE, SPD or CC16 were related to increased risk of death. These results cast doubts about the clinical usefulness of the systemic levels of these proteins as surrogate markers of COPD related outcomes." id="968ca34a-1fb5-4682-865c-c1c50fd408f4">There is intense interest in discovering systemic biomarkers that may relate to important patient related outcomes (PRO) in patients with COPD.Using data and biological samples prospectively collected in the Study to Understand Mortality and MorbidITy (SUMMIT) study in 1,673 COPD patients with heightened cardiovascular risk the systemic levels of C-reactive protein (CRP), fibrinogen, surfactant protein-D (SPD), soluble receptor of glycation end-product (sRAGE) and club cell protein 16 (CC16) were related to rate of decline of the forced expiratory volume in the 1st second (FEV1), exacerbations, hospitalizations and mortality.We found no relationship between serum levels of these 5 biomarkers and rate of FEV1 decline (ml/year) and COPD exacerbations and hospitalizations. The serum levels of CRP and fibrinogen, but not sRAGE, SPD or CC16 were related to increased risk of death. These results cast doubts about the clinical usefulness of the systemic levels of these proteins as surrogate markers of COPD related outcomes.</named-content> <named-content specific-use="" data-title="" id="835812ad-d4bb-4557-94ab-33bc84a85455"> in Box text field on</named-content> <named-content specific-use="change-time" data-title="" id="68615f6c-e2a4-4dfe-ad97-c3a44ae9af93">27 Apr 2019 10:23 AM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="8f75d4fc-8214-4dea-87e5-2027bcc168d1" xlink:title="1e7b4410-d7b9-411f-bc4c-599b01e1a84a" xlink:actuate="ab536488-13fd-4e4f-857d-d52a866c90cc" xlink:role="typesetter" xlink:href="d2ea855b-3073-4176-9423-586d448fee60"><meta-value id="1bd9284e-fd2f-461c-9c06-a17b435e5e4d"><named-content specific-use="historyContent" data-title="" id="5218f643-8286-42c6-aaee-003dcfc2d0a8"><named-content specific-use="change-person" data-title="" id="eee24ee9-10fb-4493-8293-2780db246bbc">Renganath</named-content> <named-content specific-use="" data-title="" id="7f81e59a-a875-449f-9113-8ee249641e6b">changed</named-content> <named-content specific-use="oldVal" data-title="" id="7546b8e5-c44c-458f-a998-ffc7c8f3eaf5">Uncited Box 1.</named-content> <named-content specific-use="" data-title="" id="6af81b29-6ff7-40f4-ad5b-a48a0407272f">to</named-content> <named-content specific-use="newVal" data-title="Uncited Box 1.Key messages" id="ac0e20a3-59ae-410f-8d26-cf9e19a11af2">Uncited Box 1.Key messages</named-content> <named-content specific-use="" data-title="" id="76922223-7c83-4a16-a21a-4789649b6699"> in Caption field on</named-content> <named-content specific-use="change-time" data-title="" id="bf63ac49-3d83-4051-a5f5-00ae811947f9">27 Apr 2019 10:23 AM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="61ab16d9-bc44-4b00-aa06-5304a33e1995" xlink:title="aff9" xlink:actuate="11c88b3b-aedf-4d66-bc9e-7d4334bc2b06" xlink:role="publisher" xlink:href="e8007d34-c9e0-4c8e-95c9-e2fc68d42828"><meta-value id="9a2f4b8c-345f-4aa1-9bb4-aa0186b7ebe4"><named-content specific-use="historyContent" data-title="" id="86a4a3d6-503c-43f2-90e1-bf66c0fa8756"><named-content specific-use="change-person" data-title="" id="07be7688-0f51-4711-bc24-b8e309cf07fe">Manoj</named-content> <named-content specific-use="" data-title="" id="d7cd6bcb-9e9f-4208-b430-ed731290e0cd">inserted</named-content> <named-content specific-use="newVal" data-title="Department of Medicine" id="dd7c7264-50fb-40d0-8de9-3ccf3d6251f7">Department of Medicine</named-content> <named-content specific-use="" data-title="" id="e5f9b261-ad8e-424c-bca2-0e802354bc52"> in Department field on</named-content> <named-content specific-use="change-time" data-title="" id="213f8ee7-9af3-4f83-ac72-3b091b70183a">17 Apr 2019 4:27 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="593745ca-5bc4-4b0b-9a11-ba670ab7073a" xlink:title="a4473b64-3221-490c-8e72-8646713b5b5d" xlink:actuate="2376147574" xlink:role="author" xlink:href="a4473b64-3221-490c-8e72-8646713b5b5d"><meta-value id="e1ae2374-4d3d-4546-bcd4-c15e097c009a"><named-content specific-use="historyContent" data-title="" id="ca12319a-9131-4acc-910b-edef4869c2cb"><named-content specific-use="change-person" data-title="" id="5d67f932-f825-4965-a405-3905bbf2b056">Bartolome R Celli</named-content> <named-content specific-use="" data-title="" id="932aca84-4141-4657-8867-ba0b760afbb4">inserted</named-content> <named-content specific-use="newVal" data-title="Lung function decline" id="1ee1940a-f789-40fb-8fbf-3da39b6b5340">Lung function decline</named-content> <named-content specific-use="" data-title="" id="cdfcb905-e57e-4c8c-8802-4fe37c764e40"> on</named-content> <named-content specific-use="change-time" data-title="" id="f3db1b20-a946-4cf0-a93a-a59b7feec9d2">15 Apr 2019 10:16 AM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="dc4bab94-aca4-496f-b4ba-6164694f7d11" xlink:title="BLK_F3" xlink:actuate="gowthamram" xlink:role="typesetter" xlink:href="0d0354a9-00ed-4cc0-a9b2-8ff1c8a83890"><meta-value id="5bb9cbe9-5891-46df-a2b8-b34e5cf88142"><named-content specific-use="historyContent" data-title="" id="c518e75f-f78c-4a74-8f0d-4dc59b251012"><p id="8a66b701-2c93-409f-8948-f3c8f65d4005"><named-content specific-use="change-person" data-title="" id="78ed7c08-1e6c-4310-bf5a-f83ee1167a8d">Gowtham Ram</named-content> <named-content specific-use="" data-title="" id="298cff04-5aa6-421a-bf2b-20d94904a2ed">changed image on</named-content> <named-content specific-use="change-time" data-title="" id="cf8b6353-bab4-4778-ba28-bd5dbe03eb01">15 Apr 2019 2:31 PM</named-content></p><p data-class="imageContainer" id="353c5a0b-b10f-47e6-9de0-aa66ec220e0c"><a href="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/d79f4586-4ce1-4e21-a2af-0eb68b62cb3f.jpg.JPEG" data-title="Click to view the image" target="_blank" id="b4c5d432-780d-440c-8a5c-3490ab4d18ba"><graphic xlink:href="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/d79f4586-4ce1-4e21-a2af-0eb68b62cb3f.jpg.JPEG" id="168e4f2b-ee19-4123-89a1-7f6d3ba6f337"/></a> <named-content specific-use="material-icons" data-title="" id="3b12eb62-e180-43b3-b1ff-eed601684679">arrow_forward</named-content> <a href="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/ebe52246-04a8-41a8-97ea-ecaff969ba77.tiff.JPEG" data-title="Click to view the image" target="_blank" id="ca08178f-0f3c-4575-b44c-26af89a60ba7"><graphic xlink:href="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/ebe52246-04a8-41a8-97ea-ecaff969ba77.tiff.JPEG" id="19abf27a-625c-4f32-8125-f42bfa124f8b"/></a></p><p data-class="hisComment" id="4e3f80c8-7486-4c69-9bbc-778899545598">123</p></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="a78d64d0-c5c7-4d90-af95-93c1e8250a52" xlink:title="BLK_F2" xlink:actuate="gowthamram" xlink:role="typesetter" xlink:href="913fe95a-b553-4b2f-a2ff-a923b18cc8cb"><meta-value id="765e3a09-77c8-4571-9276-1b6dffce7bee"><named-content specific-use="historyContent" data-title="" id="9885aec3-99d8-424d-be15-ef66aa868d1d"><p id="0694c934-caae-4594-a3df-cb7fa033a496"><named-content specific-use="change-person" data-title="" id="bc425b9b-6b26-4332-b0ce-024cc0eb70f2">Gowtham Ram</named-content> <named-content specific-use="" data-title="" id="a698b6b9-4420-4cb5-9dea-f64667b13365">changed image on</named-content> <named-content specific-use="change-time" data-title="" id="c7bba7ac-40a9-473c-8a5b-53ebd16c74d2">15 Apr 2019 2:31 PM</named-content></p><p data-class="imageContainer" id="f0d34784-9060-4002-b71f-44edd633b6c8"><a href="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/2b5bf100-b0f7-4209-bf0b-f70b3bffa73b.jpg.JPEG" data-title="Click to view the image" target="_blank" id="cfb45f80-802c-4652-a527-633debc69f97"><graphic xlink:href="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/2b5bf100-b0f7-4209-bf0b-f70b3bffa73b.jpg.JPEG" id="be034a66-b68b-459f-8196-e89d005c06a3"/></a> <named-content specific-use="material-icons" data-title="" id="f9a33c77-62fa-4331-82fb-ef93023aa719">arrow_forward</named-content> <a href="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/0941b357-dd92-4b69-833f-ed631c16d821.tiff.JPEG" data-title="Click to view the image" target="_blank" id="6ba8631b-b010-428f-b6c9-35322ea286aa"><graphic xlink:href="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/0941b357-dd92-4b69-833f-ed631c16d821.tiff.JPEG" id="dcf31d56-915a-4d89-a232-8f99f69fa36a"/></a></p><p data-class="hisComment" id="bfed46c2-7213-432f-ae1d-54bdd8407e65">23</p></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="49afe2bc-162e-43ae-86c4-89e1a26dfaa3" xlink:title="BLK_F1" xlink:actuate="gowthamram" xlink:role="typesetter" xlink:href="5021f723-e412-4aaf-b8e2-e8dfbb521a44"><meta-value id="2b91b08b-020b-4f0f-bf99-9cd8af20b392"><named-content specific-use="historyContent" data-title="" id="5d58768d-822f-4f78-ac1b-497c2567aa4f"><p id="c7f24c52-76ff-4949-95a1-1fb69ee82b37"><named-content specific-use="change-person" data-title="" id="59a49c24-5160-476e-8d16-964cba0a75b1">Gowtham Ram</named-content> <named-content specific-use="" data-title="" id="26fbb628-e596-4a3e-9d50-686d69c6d42e">changed image on</named-content> <named-content specific-use="change-time" data-title="" id="688bf09b-8dd5-4773-bfc1-05a6341eacf8">15 Apr 2019 2:30 PM</named-content></p><p data-class="imageContainer" id="c4e04e3d-b7bb-47e5-a9f5-28f5cae42f2f"><a href="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/c5b38804-1a3f-47af-9ccd-65b03d34eadd.jpg.JPEG" data-title="Click to view the image" target="_blank" id="419a9972-3bc0-472e-b11f-ebbc70aa0e22"><graphic xlink:href="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/c5b38804-1a3f-47af-9ccd-65b03d34eadd.jpg.JPEG" id="5d9c33e8-88fa-4b5d-a0fe-05a60591b4d7"/></a> <named-content specific-use="material-icons" data-title="" id="a6fa804c-fe65-44c0-87d7-62af8b58fc0a">arrow_forward</named-content> <a href="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/4cd6e9ad-bb6f-45ba-90a3-31f52ba2c388.tiff.JPEG" data-title="Click to view the image" target="_blank" id="7154e50e-6e7e-4c8e-8b81-5cd07a0849d7"><graphic xlink:href="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/4cd6e9ad-bb6f-45ba-90a3-31f52ba2c388.tiff.JPEG" id="be1a1ae0-0bbf-470c-964d-8fd7017fa131"/></a></p><p data-class="hisComment" id="17bec9bc-6404-4074-a0a7-420274e78779">546</p></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="6a8a8b54-473a-48c9-bf5d-7791d791a7c2" xlink:title="aff12" xlink:actuate="gowthamram" xlink:role="typesetter" xlink:href="24854b74-99c7-463f-a8e8-d3c70424378a"><meta-value id="14f63429-ff06-43c2-a9ac-2668408b4523"><named-content specific-use="historyContent" data-title="" id="ea2318f0-ea5c-4630-91d4-8479254e8773"><named-content specific-use="change-person" data-title="" id="1e7f133c-2dbf-48e4-b0b3-d6c3295e2609">Gowtham Ram</named-content> <named-content specific-use="" data-title="" id="e9b8e500-bd91-48a4-86c6-138a0453c03f">deleted</named-content> <named-content specific-use="oldVal" data-title="Greater Manchester" id="be7af3f0-c4b3-4177-b8d2-77ab7ea83c20">Greater Manchester</named-content> <named-content specific-use="" data-title="" id="23b88f0e-b0c4-45a6-9bb4-5b9ef887e67c"> in State field on</named-content> <named-content specific-use="change-time" data-title="" id="e61fbdc6-0168-4044-8dad-8af97b0e3bd2">15 Apr 2019 2:27 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="c4c130f2-05d2-46b0-8ded-1d82ef62ed94" xlink:title="author-33503242" xlink:actuate="gowthamram" xlink:role="typesetter" xlink:href="b02983b4-9d4b-411e-a440-f70fd566a92e"><meta-value id="a1d39f87-d012-40ae-89a3-baef0db444f7"><named-content specific-use="historyContent" data-title="" id="4a1ecb5f-0d6a-4c10-8497-e89c79b3138b"><named-content specific-use="change-person" data-title="" id="0e96c376-cdca-44ca-9e6c-a390cfbb6a6e">Gowtham Ram</named-content> <named-content specific-use="" data-title="" id="710cd6b5-5b1f-4aef-9a33-ac4c9a872351">inserted</named-content> <named-content specific-use="newVal" data-title="†Temple University School of Medicine, Pennsylvania, Philadelphia, United States" id="23668ff7-d3df-4fab-bb94-b746b8472f7b">†Temple University School of Medicine, Pennsylvania, Philadelphia, United States</named-content> <named-content specific-use="" data-title="" id="129a8271-a219-4d71-adfb-9699a2c8e861">in Present address on</named-content> <named-content specific-use="change-time" data-title="" id="8ccdca09-49e5-47c6-b907-c339447dbab0">15 Apr 2019 2:26 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="32d7444d-a3a7-4d72-9ab0-80d8bd2d224d" xlink:title="BLK_F3" xlink:actuate="gowthamram" xlink:role="typesetter" xlink:href="2e1a0a35-3cc3-4661-8358-d449343fe8ea"><meta-value id="bf2aee28-d463-4f4c-b409-4c67ea27e086"><named-content specific-use="historyContent" data-title="" id="67e1c31b-80d3-4301-ace0-ebb90130fee1"><p id="9fb8b79d-680c-4fe4-867d-e04a44dc8cfb"><named-content specific-use="change-person" data-title="" id="3d32ac7c-8387-42da-bd9c-751d06e631d9">Gowtham Ram</named-content> <named-content specific-use="" data-title="" id="0e1883ba-ee73-46ee-b6b2-1e4c90db9daa">changed image on</named-content> <named-content specific-use="change-time" data-title="" id="8202606a-30b3-46ca-973a-cee7d34c49d7">15 Apr 2019 2:22 PM</named-content></p><p data-class="imageContainer" id="c79b72ac-65cc-48bf-9abd-0808d97d3611"><a href="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/0aa95a11-fb19-464b-9864-248ff6fb61dd.tif.JPEG" data-title="Click to view the image" target="_blank" id="cdf17621-005e-4067-a90d-cf7ea2c038a5"><graphic xlink:href="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/0aa95a11-fb19-464b-9864-248ff6fb61dd.tif.JPEG" id="e29ce338-101f-4d12-a23d-00458cd46d4f"/></a> <named-content specific-use="material-icons" data-title="" id="b22a204f-0c1d-4839-b5e8-cad9ab3881ae">arrow_forward</named-content> <a href="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/d79f4586-4ce1-4e21-a2af-0eb68b62cb3f.jpg.JPEG" data-title="Click to view the image" target="_blank" id="ae3cf2fb-1bcf-4ff1-a123-dd957524e9dd"><graphic xlink:href="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/d79f4586-4ce1-4e21-a2af-0eb68b62cb3f.jpg.JPEG" id="b146fec6-c460-445f-8bc3-79764dae0a76"/></a></p><p data-class="hisComment" id="4b5a4efe-9f5d-45a5-a84b-750607d1a5cd">852</p></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="bc274962-d26b-444b-9c7c-0c8737cb0218" xlink:title="BLK_F2" xlink:actuate="gowthamram" xlink:role="typesetter" xlink:href="30e36039-62f2-4b18-b4c2-23e66db252de"><meta-value id="474d0455-5326-45ab-b01c-e665abd7ac98"><named-content specific-use="historyContent" data-title="" id="45669725-dd82-4ac5-8e06-b97c28dbbce5"><p id="3bc2c4c4-bee2-4f7d-972d-733d0af7bc49"><named-content specific-use="change-person" data-title="" id="f1107d0c-7dda-4d31-be5b-c0f40a8d8d5a">Gowtham Ram</named-content> <named-content specific-use="" data-title="" id="589f5995-5b1f-45a8-aa42-137baa09c640">changed image on</named-content> <named-content specific-use="change-time" data-title="" id="887f20e3-5874-4287-9b56-c554cdca5c24">15 Apr 2019 2:22 PM</named-content></p><p data-class="imageContainer" id="7db4ba8c-4b0f-45eb-8e94-bdee83e84091"><a href="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/38061bf3-7c39-4c8b-870d-4b4d2a5a3223.tif.JPEG" data-title="Click to view the image" target="_blank" id="5c0a1a87-dd85-4d9a-b6b9-7bf61408116b"><graphic xlink:href="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/38061bf3-7c39-4c8b-870d-4b4d2a5a3223.tif.JPEG" id="855889cc-a537-4888-a6b4-ad0f909cf138"/></a> <named-content specific-use="material-icons" data-title="" id="3bae348a-6d8c-4dc3-96d5-9c2c1412a68a">arrow_forward</named-content> <a href="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/2b5bf100-b0f7-4209-bf0b-f70b3bffa73b.jpg.JPEG" data-title="Click to view the image" target="_blank" id="a090eb11-3ede-4f73-a8d5-61596b33a079"><graphic xlink:href="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/2b5bf100-b0f7-4209-bf0b-f70b3bffa73b.jpg.JPEG" id="c088bfa2-b73f-46f8-adf7-bbfd14c5af4a"/></a></p><p data-class="hisComment" id="dc5f2720-28ad-46e6-a560-e43700ae9453">3</p></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="ef78aadb-2f24-4a53-96d4-07618b169f34" xlink:title="BLK_F1" xlink:actuate="gowthamram" xlink:role="typesetter" xlink:href="205e4a5a-a2a8-48d7-b1e8-1319b08ccfab"><meta-value id="97ec830f-b700-4d22-8279-807feee21874"><named-content specific-use="historyContent" data-title="" id="723f696e-8375-4c6d-8630-fe588eaddf8d"><p id="71767eb5-a566-4268-b060-60c0c2980728"><named-content specific-use="change-person" data-title="" id="d36fd59c-267c-4a74-8960-59859070a75c">Gowtham Ram</named-content> <named-content specific-use="" data-title="" id="dd87265a-7165-4dfb-bc68-88db66bfac5c">changed image on</named-content> <named-content specific-use="change-time" data-title="" id="4cc30477-dfa5-42f1-a8f0-c13394213b40">15 Apr 2019 2:21 PM</named-content></p><p data-class="imageContainer" id="9548799f-7cd0-40f6-b068-567e3eb30c8c"><a href="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/938c2ba8-9c71-4eee-8def-f169447c31df.tif.JPEG" data-title="Click to view the image" target="_blank" id="e4856868-f6d5-44a9-8a10-e09b6f2bb436"><graphic xlink:href="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/938c2ba8-9c71-4eee-8def-f169447c31df.tif.JPEG" id="ac936f85-a09c-4613-b94a-ff26bc6cf316"/></a> <named-content specific-use="material-icons" data-title="" id="bdf45043-b23d-4ffc-8553-19c5fe4eeb37">arrow_forward</named-content> <a href="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/c5b38804-1a3f-47af-9ccd-65b03d34eadd.jpg.JPEG" data-title="Click to view the image" target="_blank" id="56623173-6825-4492-ad31-529d0b97b064"><graphic xlink:href="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/c5b38804-1a3f-47af-9ccd-65b03d34eadd.jpg.JPEG" id="b803f032-6869-4e46-a58a-abbe48ff84d8"/></a></p><p data-class="hisComment" id="d0589d93-7273-4ba9-ad4f-571d385df01c">7</p></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="697240e8-473b-48df-9496-03edcba6753b" xlink:title="BLK_F3" xlink:actuate="gowthamram" xlink:role="typesetter" xlink:href="bed9255c-8bb2-481f-89b0-e2d7be73c853"><meta-value id="7ffd94ed-b29e-446d-876c-c3c1067766c5"><named-content specific-use="historyContent" data-title="" id="5ad9c048-a8c9-4ac6-8d74-8f4b9e90f0c5"><p id="b671c7ee-6359-4e86-92a0-6d1c7482d47d"><named-content specific-use="change-person" data-title="" id="d2af9748-0d2c-4785-aa7c-db9aab6a02e2">Gowtham Ram</named-content> <named-content specific-use="" data-title="" id="5adf2583-73b4-46f0-85ce-21b8b4486c79">changed image on</named-content> <named-content specific-use="change-time" data-title="" id="f62f17cd-831d-446d-9f87-e602f3f26963">15 Apr 2019 1:11 PM</named-content></p><p data-class="imageContainer" id="26228264-945a-48f7-8f9e-65978b11c98d"><a href="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/SUMMIT_biomarker_Fig3_29MAR2019.jpg.JPEG" data-title="Click to view the image" target="_blank" id="0eea4581-1452-4f09-8833-a0f7f138dd0f"><graphic xlink:href="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/SUMMIT_biomarker_Fig3_29MAR2019.jpg.JPEG" id="f7178596-24cf-4777-bdb6-8b76f9024d34"/></a> <named-content specific-use="material-icons" data-title="" id="b198def1-3d7e-4e27-af5b-5d5110b4dfe2">arrow_forward</named-content> <a href="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/0aa95a11-fb19-464b-9864-248ff6fb61dd.tif.JPEG" data-title="Click to view the image" target="_blank" id="38bf5bc8-6e0d-4dc3-b139-29a20915504a"><graphic xlink:href="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/0aa95a11-fb19-464b-9864-248ff6fb61dd.tif.JPEG" id="646e043c-c4fe-49b5-893e-c9d7ed231c22"/></a></p><p data-class="hisComment" id="d22b0660-17a4-43fe-a19c-0771384f32cb">8</p></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="8218b9be-b664-4ff7-9a3f-e9d2d21bb93c" xlink:title="BLK_F2" xlink:actuate="gowthamram" xlink:role="typesetter" xlink:href="f3e6c7c7-4d60-439c-b520-9a9ecd07c916"><meta-value id="2c579735-db09-4f36-89c7-2326617560cc"><named-content specific-use="historyContent" data-title="" id="50318da5-a5d9-4cf4-a432-349153dfd1bc"><p id="eb13de7b-96a3-4ba9-bb5e-06bc2f3bb73f"><named-content specific-use="change-person" data-title="" id="b0230c2a-4ff7-45e2-9325-4747b4bad3eb">Gowtham Ram</named-content> <named-content specific-use="" data-title="" id="1bc0d0a4-e24e-4e12-b8b2-e873a1e6f6d2">changed image on</named-content> <named-content specific-use="change-time" data-title="" id="c44030f9-42c7-4f47-a94d-24f3fc5b0288">15 Apr 2019 1:11 PM</named-content></p><p data-class="imageContainer" id="4348db3b-8897-45c4-8f1a-ad5919d749dd"><a href="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/SUMMIT_biomarker_Fig2_29MAR2019.jpg.JPEG" data-title="Click to view the image" target="_blank" id="07d9fa63-6683-4d4a-869c-ecd6eefd1394"><graphic xlink:href="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/SUMMIT_biomarker_Fig2_29MAR2019.jpg.JPEG" id="2694ec24-d3de-4417-80b7-2fa696403734"/></a> <named-content specific-use="material-icons" data-title="" id="55ea9dc3-3cba-4dff-85d1-ff4aeafbe4fd">arrow_forward</named-content> <a href="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/38061bf3-7c39-4c8b-870d-4b4d2a5a3223.tif.JPEG" data-title="Click to view the image" target="_blank" id="6a5f9f4f-f901-486e-9dfa-60948c9f480b"><graphic xlink:href="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/38061bf3-7c39-4c8b-870d-4b4d2a5a3223.tif.JPEG" id="010921b5-6cd3-4080-9e81-c2a916be3bb2"/></a></p><p data-class="hisComment" id="0609a8cb-2a74-41e3-9b72-43e4308f173d">8</p></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="38a80f79-f992-46a3-a7c5-07812203def6" xlink:title="BLK_F1" xlink:actuate="gowthamram" xlink:role="typesetter" xlink:href="e2fe3d81-aca1-4885-ba12-cbf7efdabf0c"><meta-value id="ba039659-903f-47ab-9733-4ac64f600706"><named-content specific-use="historyContent" data-title="" id="269f1103-f2e2-4a17-b9f0-f436f0a034f4"><p id="eb70a8b4-2b2f-4418-a828-816ac7961c6a"><named-content specific-use="change-person" data-title="" id="cf821f0c-d851-477b-9703-a0ccb5216739">Gowtham Ram</named-content> <named-content specific-use="" data-title="" id="9d599119-02ac-42b3-8be4-70058e0ed14f">changed image on</named-content> <named-content specific-use="change-time" data-title="" id="cb6d1f6b-1ae4-4876-8da6-a7ea6e657656">15 Apr 2019 1:11 PM</named-content></p><p data-class="imageContainer" id="e64f49b4-5303-471d-81f3-5911dd02775c"><a href="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/SUMMIT_biomarker_Fig1_29MAR2019.jpg.JPEG" data-title="Click to view the image" target="_blank" id="d1f918ed-3965-45cc-a085-ab5930ef5632"><graphic xlink:href="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/SUMMIT_biomarker_Fig1_29MAR2019.jpg.JPEG" id="4f758a46-964f-46db-881f-20f5c59ee8e2"/></a> <named-content specific-use="material-icons" data-title="" id="4059f369-2d72-474f-9a3d-494e79974872">arrow_forward</named-content> <a href="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/938c2ba8-9c71-4eee-8def-f169447c31df.tif.JPEG" data-title="Click to view the image" target="_blank" id="d2c268a7-03e6-4d45-bc91-8f150187f08f"><graphic xlink:href="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/938c2ba8-9c71-4eee-8def-f169447c31df.tif.JPEG" id="bfb2661d-a4f4-4231-97c1-0a752d255d22"/></a></p><p data-class="hisComment" id="bcb6094a-d7eb-43a7-b451-1ecc90040ffe">1</p></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="0e137b1d-8ea1-4cee-bf7d-bb6ed22ad7ac" xlink:title="fn3" xlink:actuate="ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" xlink:role="copyeditor" xlink:href="fn3"><meta-value id="b19a730e-2cd6-4d25-b1f3-6a55463a8d24"><named-content specific-use="historyContent" data-title="" id="f5e87a00-0fb4-4c36-9d21-e89c8b2ce148"><named-content specific-use="change-person" data-title="" id="bcaea15d-108a-4631-8ade-a0bd8958c2f2">Ariel</named-content> <named-content specific-use="" data-title="" id="a274ee2e-6e2e-4c36-b164-ec01532dd7c3">changed</named-content> <named-content specific-use="oldVal" data-title="Information on GSK’s data sharing commitments and requesting access to anonymized individual participant data and associated documents can be found at www.clinicalstudydatarequest.com" id="cb2ae357-e4ce-4e1a-a313-07d793b54b7b">Information on GSK’s data sharing commitments and requesting access to anonymized individual participant data and associated documents can be found at www.clinicalstudydatarequest.com</named-content> <named-content specific-use="" data-title="" id="3de087d4-09fb-47d5-b801-27bca48758d6">to</named-content> <named-content specific-use="newVal" data-title="Information on GSK’s data sharing commitments and requesting access to anonymised individual participant data and associated documents can be found at www.clinicalstudydatarequest.com" id="cfb3d717-ad83-4c26-8600-49e5e7889204">Information on GSK’s data sharing commitments and requesting access to anonymised individual participant data and associated documents can be found at www.clinicalstudydatarequest.com</named-content> <named-content specific-use="" data-title="" id="59b3b55e-24e8-4a37-8699-e5906863fdc0"> in Content field on</named-content> <named-content specific-use="change-time" data-title="" id="1c8fd959-cffd-45db-81b4-586b583f9159">15 Apr 2019 9:13 AM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="63fcd1e3-d7d2-4e35-9031-3289847147e1" xlink:title="5c814365-f2c8-4081-8517-91993fb54d7c" xlink:actuate="ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" xlink:role="copyeditor" xlink:href="5c814365-f2c8-4081-8517-91993fb54d7c"><meta-value id="200c2633-f2ff-4abe-b8bc-347459761aed"><named-content specific-use="historyContent" data-title="" id="19d73845-5959-4390-bfeb-d62d6ca89cc8"><named-content specific-use="change-person" data-title="" id="b89bbea2-d74d-4de9-929c-3794743aeea9">Ariel</named-content> <named-content specific-use="" data-title="" id="ed7a206c-b9c6-49dc-ac02-acb6c473c205">changed</named-content> <named-content specific-use="oldVal" data-title="All patients provided written informed consent. The study was approved by local ethics committees and was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines. Members of the Steering Committee Jørgen Vestbo (co-chair, UK), Robert Brook (USA), Peter Calverley (UK), Bartolome Celli (USA), Fernando Martinez (USA), David Newby (UK), Courtney Crim, (co-chair, GlaxoSmithKline plc, USA), Julie Anderson (GlaxoSmithKline plc, UK), Julie Yates (GlaxoSmithKline plc, USA). Members of the Independent Data Monitoring Committee Peter Lange (chair, Denmark), Richard Kay (UK), Mark Dransfield (USA), Sanjay Rajagopalan (USA). Members of the Clinical Endpoint Committee Robert Wise (chair, USA), Dennis Niewoehner (USA), Camilo Gomez (USA), Sheldon Madger (Canada), Martin Denvir (UK), Pierre Amarenco (France)." id="a1dcda75-1af6-4c92-be11-8a03f185bc75">All patients provided written informed consent. The study was approved by local ethics committees and was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines. Members of the Steering Committee Jørgen Vestbo (co-chair, UK), Robert Brook (USA), Peter Calverley (UK), Bartolome Celli (USA), Fernando Martinez (USA), David Newby (UK), Courtney Crim, (co-chair, GlaxoSmithKline plc, USA), Julie Anderson (GlaxoSmithKline plc, UK), Julie Yates (GlaxoSmithKline plc, USA). Members of the Independent Data Monitoring Committee Peter Lange (chair, Denmark), Richard Kay (UK), Mark Dransfield (USA), Sanjay Rajagopalan (USA). Members of the Clinical Endpoint Committee Robert Wise (chair, USA), Dennis Niewoehner (USA), Camilo Gomez (USA), Sheldon Madger (Canada), Martin Denvir (UK), Pierre Amarenco (France).</named-content> <named-content specific-use="" data-title="" id="52f8fab2-95ab-4c9b-b289-1fa8b8b02bcb">to</named-content> <named-content specific-use="newVal" data-title="All patients provided written informed consent. The study was approved by local ethics committees and was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines. Members of the Steering Committee Jørgen Vestbo (cochair, UK), Robert Brook (USA), Peter Calverley (UK), Bartolome Celli (USA), Fernando Martinez (USA), David Newby (UK), Courtney Crim, (cochair, GlaxoSmithKline plc, USA), Julie Anderson (GlaxoSmithKline plc, UK) and Julie Yates (GlaxoSmithKline plc, USA). Members of the Independent Data Monitoring Committee Peter Lange (chair, Denmark), Richard Kay (UK), Mark Dransfield (USA) and Sanjay Rajagopalan (USA). Members of the Clinical Endpoint Committee Robert Wise (chair, USA), Dennis Niewoehner (USA), Camilo Gomez (USA), Sheldon Madger (Canada), Martin Denvir (UK) and Pierre Amarenco (France)." id="00f541c5-3529-40cc-b8fe-72de93705b22">All patients provided written informed consent. The study was approved by local ethics committees and was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines. Members of the Steering Committee Jørgen Vestbo (cochair, UK), Robert Brook (USA), Peter Calverley (UK), Bartolome Celli (USA), Fernando Martinez (USA), David Newby (UK), Courtney Crim, (cochair, GlaxoSmithKline plc, USA), Julie Anderson (GlaxoSmithKline plc, UK) and Julie Yates (GlaxoSmithKline plc, USA). Members of the Independent Data Monitoring Committee Peter Lange (chair, Denmark), Richard Kay (UK), Mark Dransfield (USA) and Sanjay Rajagopalan (USA). Members of the Clinical Endpoint Committee Robert Wise (chair, USA), Dennis Niewoehner (USA), Camilo Gomez (USA), Sheldon Madger (Canada), Martin Denvir (UK) and Pierre Amarenco (France).</named-content> <named-content specific-use="" data-title="" id="47c9caca-5fa5-49ee-803b-7468a4108539"> in Content field on</named-content> <named-content specific-use="change-time" data-title="" id="af6f9df5-e9eb-45e6-a7bf-f18ad947a6e2">15 Apr 2019 9:13 AM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="055182a6-2aea-478d-81b7-58132beb0f68" xlink:title="fn2" xlink:actuate="ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" xlink:role="copyeditor" xlink:href="fn2"><meta-value id="ad2d90f0-21d2-4a9c-b2f3-1cf3fcbb0b81"><named-content specific-use="historyContent" data-title="" id="faa93f6c-f9d6-426f-9734-3b6716c629fc"><named-content specific-use="change-person" data-title="" id="f8dc1c0c-2cd8-45f9-9a4b-bf76bd245712">Ariel</named-content> <named-content specific-use="" data-title="" id="0cf23035-6a9d-46b7-b01f-db6166d8cf9b">changed</named-content> <named-content specific-use="oldVal" data-title="Study design: BC, JAA, RB, PMAC, CC, IJD, FJM, DN, JY and JV. Data collection: JAA, CC, NJC and JY. Database search: N/A. Data analysis/interpretation: BC, JAA, RB, PMAC, NJC, CC, IJD, VK, FJM, AM, DN, JY and JV. Writing/reviewing of the manuscript: BC, JAA, RB, PMAC, NJC, CC, IJD, VK, FJM, AM, DN, JY and JV. Final approval of the manuscript: All." id="a104678e-3110-43d3-9ea9-eb5990b63a57">Study design: BC, JAA, RB, PMAC, CC, IJD, FJM, DN, JY and JV. Data collection: JAA, CC, NJC and JY. Database search: N/A. Data analysis/interpretation: BC, JAA, RB, PMAC, NJC, CC, IJD, VK, FJM, AM, DN, JY and JV. Writing/reviewing of the manuscript: BC, JAA, RB, PMAC, NJC, CC, IJD, VK, FJM, AM, DN, JY and JV. Final approval of the manuscript: All.</named-content> <named-content specific-use="" data-title="" id="2dc0872e-5958-4029-a0d3-aaef3bc32f7f">to</named-content> <named-content specific-use="newVal" data-title="Study design: BCR, JAA, RB, PC, CC, ID, FJM, DEN, JY and JV. Data collection: JAA, CC, NJC and JY. Database search: N/A. Data analysis/interpretation: BCR, JAA, RB, PC, NJC, CC, ID, VK, FJM, AM, DEN, JY and JV. Writing/reviewing of the manuscript: BCR, JAA, RB, PC, NJC, CC, ID, VK, FJM, AM, DEN, JY and JV. Final approval of the manuscript: all authors." id="e48ff958-77da-4b08-9eec-3d3d197affec">Study design: BCR, JAA, RB, PC, CC, ID, FJM, DEN, JY and JV. Data collection: JAA, CC, NJC and JY. Database search: N/A. Data analysis/interpretation: BCR, JAA, RB, PC, NJC, CC, ID, VK, FJM, AM, DEN, JY and JV. Writing/reviewing of the manuscript: BCR, JAA, RB, PC, NJC, CC, ID, VK, FJM, AM, DEN, JY and JV. Final approval of the manuscript: all authors.</named-content> <named-content specific-use="" data-title="" id="e551354e-5e71-4906-9af9-112caccebacc"> in Content field on</named-content> <named-content specific-use="change-time" data-title="" id="790da433-5398-4fb7-8b3e-ca2bf2fc2ba8">15 Apr 2019 9:11 AM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="9ec10347-8b80-4c4f-ad53-f08f53e4f6f3" xlink:title="71a07ef3-25da-4ea0-8107-2f61444b0f79" xlink:actuate="ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" xlink:role="copyeditor" xlink:href="71a07ef3-25da-4ea0-8107-2f61444b0f79"><meta-value id="af8978f2-c49f-447f-b251-2e1ba54165be"><named-content specific-use="historyContent" data-title="" id="ba3e398f-884f-489b-bd1f-0f4bdf718023"><named-content specific-use="change-person" data-title="" id="ec8cf772-891c-4d25-9080-13bf04332fbb">Ariel</named-content> <named-content specific-use="" data-title="" id="5f89b4d4-5217-496d-8aa2-60400becf9df">changed</named-content> <named-content specific-use="oldVal" data-title="Editorial assistance was provided by Matthew Hallam, MSc, and Carol A. Richter, PhD, at Gardiner-Caldwell Communications (Macclesfield), and was funded by GlaxoSmithKline plc." id="e7e3c5a9-97d6-4e34-b137-bf355f94fef4">Editorial assistance was provided by Matthew Hallam, MSc, and Carol A. Richter, PhD, at Gardiner-Caldwell Communications (Macclesfield), and was funded by GlaxoSmithKline plc.</named-content> <named-content specific-use="" data-title="" id="dc86d798-3926-40e3-9d88-b5aad81f4fbd">to</named-content> <named-content specific-use="newVal" data-title="Editorial assistance was provided by Matthew Hallam, MSc, and Carol A Richter, PhD, at Gardiner-Caldwell Communications (Macclesfield) and was funded by GlaxoSmithKline plc." id="6319a427-b5be-4327-9029-894c899d21e6">Editorial assistance was provided by Matthew Hallam, MSc, and Carol A Richter, PhD, at Gardiner-Caldwell Communications (Macclesfield) and was funded by GlaxoSmithKline plc.</named-content> <named-content specific-use="" data-title="" id="d3323a9a-bf66-47a3-bec1-f27132df422f"> in Content field on</named-content> <named-content specific-use="change-time" data-title="" id="4a76b4a7-95e9-4754-9662-517ff419458f">15 Apr 2019 9:10 AM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="632acf0a-e2c7-4d1a-8d5d-b51bf1f2ab75" xlink:title="aff10" xlink:actuate="ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" xlink:role="copyeditor" xlink:href="890794c0-cd9e-400f-90fc-66bd8fd682b5"><meta-value id="ca2007d4-75b4-4faa-89bd-a56e909e0d26"><named-content specific-use="historyContent" data-title="" id="4ee089f0-4f9c-4d24-b87d-3bc03c21e0f2"><named-content specific-use="change-person" data-title="" id="3b2e94e0-c144-4df7-85ca-df7e27957dab">Ariel</named-content> <named-content specific-use="" data-title="" id="3d5ca419-afa6-4a55-b9e1-3f7157039d84">changed</named-content> <named-content specific-use="oldVal" data-title="" id="b924109f-961b-4a2d-818b-9afbd8e8e436">New York</named-content> <named-content specific-use="" data-title="" id="3ba2d0ff-e503-4d0b-b18f-fe48c07c5910">to</named-content> <named-content specific-use="newVal" data-title="" id="075aa7c6-4128-470a-8111-86f4180db159">New York City</named-content> <named-content specific-use="" data-title="" id="50f21d33-8147-44f8-8b43-08ce781eb0f5"> in City field on</named-content> <named-content specific-use="change-time" data-title="" id="164aa93d-84da-4d30-874f-db8cab468c32">15 Apr 2019 7:46 AM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="da705ca7-5722-4087-9252-4347bb02e715" xlink:title="aff1" xlink:actuate="ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" xlink:role="copyeditor" xlink:href="e8648c51-f964-4d2c-b481-bbe2b96dc324"><meta-value id="f5838c2b-8623-44a4-99ec-9431deb0e8a8"><named-content specific-use="historyContent" data-title="" id="2d16528a-5ce7-4c4d-9115-61c0ef25c57d"><named-content specific-use="change-person" data-title="" id="fde4b4af-10f3-431f-94ba-208747a24475">Ariel</named-content> <named-content specific-use="" data-title="" id="2614d41e-3e7c-478c-8716-e080126dfba9">changed</named-content> <named-content specific-use="oldVal" data-title="" id="9c554aa3-e7b6-4a18-a013-25ade93f4a91">Michigan</named-content> <named-content specific-use="" data-title="" id="62b53e3a-75bc-4330-86c4-dea4d75980b1">to</named-content> <named-content specific-use="newVal" data-title="" id="9ea88ba3-e389-4f54-9ceb-b6315d934117">Massachusetts</named-content> <named-content specific-use="" data-title="" id="6d02a648-f0d1-4560-a4be-03d0793bf3f7"> in State field on</named-content> <named-content specific-use="change-time" data-title="" id="1eda5ada-85c7-46ef-890c-e043e81cf80a">15 Apr 2019 7:45 AM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="d7878003-1107-413c-a951-388c5e3446dc" xlink:title="aff6" xlink:actuate="gowthamram" xlink:role="preeditor" xlink:href="11c3984e-3dca-4e20-b954-05e95bc27c71"><meta-value id="ebd89b5e-b82b-4aca-a3f8-1fd11b68c138"><named-content specific-use="historyContent" data-title="" id="b740cc97-d78f-4345-b239-2e6c1b29fe8a"><named-content specific-use="change-person" data-title="" id="22ff257b-14d6-4509-b69f-be1c9caad189">Gowtham Ram</named-content> <named-content specific-use="" data-title="" id="dc3c25f4-4476-4b1b-b114-df9910508dc2">changed</named-content> <named-content specific-use="oldVal" data-title="" id="d91d4532-2826-4440-bfac-64ea30d03f96">Veramed Ltd.</named-content> <named-content specific-use="" data-title="" id="055e84fa-9770-4f48-8526-934579ab7fe3">to</named-content> <named-content specific-use="newVal" data-title="" id="e124436a-dd1b-4c57-8218-76267e071970">Veramed Ltd</named-content> <named-content specific-use="" data-title="" id="bddda3c3-0226-4205-a1e0-9d6d5110af7c"> in Institution field on</named-content> <named-content specific-use="change-time" data-title="" id="6c690d0d-c269-4447-a24c-8be9860d99db">12 Apr 2019 5:46 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="e91a31fb-fc5e-4472-8bd5-dbe2c309b515" xlink:title="author-65005347" xlink:actuate="gowthamram" xlink:role="preeditor" xlink:href="6807cfb0-5c7c-4169-9228-7ea6d37d6b23"><meta-value id="86250ee2-af87-48c3-b385-ffc19482d63b"><named-content specific-use="historyContent" data-title="" id="c6669307-512e-452b-809b-1d7041385b3c"><named-content specific-use="change-person" data-title="" id="9cc60d1b-e160-4003-94f1-4d1a61cabc3a">Gowtham Ram</named-content> <named-content specific-use="" data-title="" id="b2917263-309d-45df-8ba4-9ad921206bf9">inserted</named-content> <named-content specific-use="newVal" data-title="Veramed Ltd., Twickenham, UK" id="19bc46d4-32d0-4714-9fd4-4322434a1c50">Veramed Ltd., Twickenham, UK</named-content> <named-content specific-use="" data-title="" id="7b0c58cc-a38e-45d1-bbe4-292dfb69841e">in Affiliations on</named-content> <named-content specific-use="change-time" data-title="" id="af6ae7d1-9863-4ea3-8d44-4f386035fb0d">12 Apr 2019 5:45 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="1ab7a218-5897-4b11-91cf-fa9d6448fafd" xlink:title="aff6" xlink:actuate="gowthamram" xlink:role="preeditor" xlink:href="a4e0f060-c02e-4f0f-a811-111e7b879353"><meta-value id="02167211-9b6c-439c-abd1-36e6174b5bcf"><named-content specific-use="historyContent" data-title="" id="2c00fd90-db28-4730-85b9-c00d6378c08b"><named-content specific-use="change-person" data-title="" id="e69fee0a-8ae0-4e37-8080-18d89cad86ec">Gowtham Ram</named-content> <named-content specific-use="" data-title="" id="9f915fee-6efa-4f93-b259-7fa3278daf76">deleted</named-content> <named-content specific-use="oldVal" data-title="Veramed Ltd., Twickenham, UK" id="b0ad6d5e-d0d1-4078-8a96-f6731456c112">Veramed Ltd., Twickenham, UK</named-content> <named-content specific-use="" data-title="" id="ebd1bd2f-5f61-4b1e-99f1-ed49df2dc732"> in State field on</named-content> <named-content specific-use="change-time" data-title="" id="dd81123f-e201-443c-a8d6-7eb17c9ff22e">12 Apr 2019 5:45 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="d6c54621-2888-4db7-9f36-20a97850d598" xlink:title="fn3" xlink:actuate="gowthamram" xlink:role="preeditor" xlink:href="fn3"><meta-value id="d5a28b74-51e8-4084-a80b-4287fe2937cf"><named-content specific-use="historyContent" data-title="" id="d401ddea-f05d-40f5-b330-536639784f7a"><named-content specific-use="change-person" data-title="" id="7ffc3761-866e-4c95-b76a-8097bd901411">Gowtham Ram</named-content> <named-content specific-use="" data-title="" id="ccdfe44b-b700-4c5b-b784-66c961dee62c">changed</named-content> <named-content specific-use="oldVal" data-title="All data relevant to the study are included in the article or uploaded as supplementary information." id="4e824f41-3efc-4eba-96a1-cb7d997a898f">All data relevant to the study are included in the article or uploaded as supplementary information.</named-content> <named-content specific-use="" data-title="" id="e18b8099-6c07-4812-bc7b-a95e70a08fa7">to</named-content> <named-content specific-use="newVal" data-title="Information on GSK’s data sharing commitments and requesting access to anonymized individual participant data and associated documents can be found at www.clinicalstudydatarequest.com" id="e4edb4db-92ae-4dd3-95bf-ac148f2d50e0">Information on GSK’s data sharing commitments and requesting access to anonymized individual participant data and associated documents can be found at www.clinicalstudydatarequest.com</named-content> <named-content specific-use="" data-title="" id="bb315763-017f-4739-9062-5df9efbc6f20"> in Content field on</named-content> <named-content specific-use="change-time" data-title="" id="5e1d8951-1a99-44ab-be4a-b5fd2bf13292">12 Apr 2019 5:18 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="02c31958-88f5-42a3-b922-1018fe691444" xlink:title="5c814365-f2c8-4081-8517-91993fb54d7c" xlink:actuate="gowthamram" xlink:role="preeditor" xlink:href="5c814365-f2c8-4081-8517-91993fb54d7c"><meta-value id="664474dc-539c-468a-b0d8-ea62aa9e4981"><named-content specific-use="historyContent" data-title="" id="6542e950-3cb0-4260-bc54-68fbbfda23c7"><named-content specific-use="change-person" data-title="" id="810b1d28-f37d-4752-b6d6-462f5ff35bba">Gowtham Ram</named-content> <named-content specific-use="" data-title="" id="9df5cdce-9333-479e-8b28-6f911a0742b2">changed</named-content> <named-content specific-use="oldVal" data-title="All patients provided written informed consent. The study was approved by local ethics committees and was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines." id="767751db-a53d-4c13-899c-cfaeadb6f70e">All patients provided written informed consent. The study was approved by local ethics committees and was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines.</named-content> <named-content specific-use="" data-title="" id="5ef0fb4d-db54-451b-922f-aaf0077285d2">to</named-content> <named-content specific-use="newVal" data-title="All patients provided written informed consent. The study was approved by local ethics committees and was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines. Members of the Steering Committee Jørgen Vestbo (co-chair, UK), Robert Brook (USA), Peter Calverley (UK), Bartolome Celli (USA), Fernando Martinez (USA), David Newby (UK), Courtney Crim, (co-chair, GlaxoSmithKline plc, USA), Julie Anderson (GlaxoSmithKline plc, UK), Julie Yates (GlaxoSmithKline plc, USA). Members of the Independent Data Monitoring Committee Peter Lange (chair, Denmark), Richard Kay (UK), Mark Dransfield (USA), Sanjay Rajagopalan (USA). Members of the Clinical Endpoint Committee Robert Wise (chair, USA), Dennis Niewoehner (USA), Camilo Gomez (USA), Sheldon Madger (Canada), Martin Denvir (UK), Pierre Amarenco (France)." id="e36d2b10-2649-4943-bd0a-b76d63057b63">All patients provided written informed consent. The study was approved by local ethics committees and was conducted in accordance with the Declaration of Helsinki and Good Clinical Practice guidelines. Members of the Steering Committee Jørgen Vestbo (co-chair, UK), Robert Brook (USA), Peter Calverley (UK), Bartolome Celli (USA), Fernando Martinez (USA), David Newby (UK), Courtney Crim, (co-chair, GlaxoSmithKline plc, USA), Julie Anderson (GlaxoSmithKline plc, UK), Julie Yates (GlaxoSmithKline plc, USA). Members of the Independent Data Monitoring Committee Peter Lange (chair, Denmark), Richard Kay (UK), Mark Dransfield (USA), Sanjay Rajagopalan (USA). Members of the Clinical Endpoint Committee Robert Wise (chair, USA), Dennis Niewoehner (USA), Camilo Gomez (USA), Sheldon Madger (Canada), Martin Denvir (UK), Pierre Amarenco (France).</named-content> <named-content specific-use="" data-title="" id="230b2651-b1d2-4589-8338-f9f43a725492"> in Content field on</named-content> <named-content specific-use="change-time" data-title="" id="9adead45-2042-4205-8e04-73ad38ad8dd0">12 Apr 2019 5:17 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="da82cc73-5e91-4402-a180-7ed5a6f16d49" xlink:title="fn1" xlink:actuate="gowthamram" xlink:role="preeditor" xlink:href="fn1"><meta-value id="fca8a58e-3835-42df-a446-af4bd614d2c8"><named-content specific-use="historyContent" data-title="" id="1cf70136-fe6f-4115-8507-41fa25a0cded"><named-content specific-use="change-person" data-title="" id="680b6962-1548-4891-a005-b24479119a25">Gowtham Ram</named-content> <named-content specific-use="" data-title="" id="f54f7c1e-2451-4828-970d-e2d3161e38b3">changed</named-content> <named-content specific-use="oldVal" data-title="Additional material is published online only. To view please visit the journal online (http://dx.doi.org/10.1136/bmjresp-2019-000431)" id="38a09fd1-e648-4a98-94f3-4228746b098e">Additional material is published online only. To view please visit the journal online (http://dx.doi.org/10.1136/bmjresp-2019-000431)</named-content> <named-content specific-use="" data-title="" id="1abd568c-ffb0-42d5-92fc-14b249eda248">to</named-content> <named-content specific-use="newVal" data-title="Additional material is published online only. To view please visit the journal online (http://dx.doi.org/10.1136/bmjresp-2019-000431)." id="398219cc-44d3-482b-aac1-90ca0da73fe5">Additional material is published online only. To view please visit the journal online (http://dx.doi.org/10.1136/bmjresp-2019-000431).</named-content> <named-content specific-use="" data-title="" id="e876fa85-9703-4e54-8787-89d7e0c2fd2f"> in Content field on</named-content> <named-content specific-use="change-time" data-title="" id="650610cf-6803-42a1-a62a-c119dcf17310">12 Apr 2019 5:17 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="925b9403-0ea8-4a68-815d-7b8e4c58ba6f" xlink:title="pubData" xlink:actuate="gowthamram" xlink:role="preeditor" xlink:href="411a05be-8fc5-4cc6-a232-73129d51ca6f"><meta-value id="089b1e16-487e-4afd-98f2-f736a6757d70"><named-content specific-use="historyContent" data-title="" id="21d49255-97fc-406a-b418-b54e24519da5"><named-content specific-use="change-person" data-title="" id="d85d8cf6-710e-45f6-b1b4-419e0df3d468">Gowtham Ram</named-content> <named-content specific-use="" data-title="" id="9ef71422-5e40-4922-bd3f-685809913845">inserted</named-content> <named-content specific-use="newVal" data-title="" id="1b2e0e6d-9023-452d-8dbc-a4c7fe66cc92">0</named-content> <named-content specific-use="" data-title="" id="f97449d3-1fab-499e-a637-f56171def612"> in Volume field on</named-content> <named-content specific-use="change-time" data-title="" id="bf539fc3-e8ae-4dd2-9e1b-532720840299">12 Apr 2019 5:15 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="84853a93-0833-4ddb-805d-bb4158f9b4a2" xlink:title="author-33503242" xlink:actuate="gowthamram" xlink:role="preeditor" xlink:href="5b3b59d4-e22d-4f33-bc9d-5e756eeb4a0a"><meta-value id="d36be20b-2141-46c0-8278-095ce3ef4ee8"><named-content specific-use="historyContent" data-title="" id="2aa01edb-9b60-4961-94a8-5cc2c87b656f"><named-content specific-use="change-person" data-title="" id="385e9b39-8dd7-4f36-85d8-83aa34dd701d">Gowtham Ram</named-content> <named-content specific-use="newVal" data-title="" id="ca7f07ac-eb8f-4432-95e6-e8215fb460c3">checked</named-content> <named-content specific-use="" data-title="" id="3ca8bc01-bee4-4784-a690-fd6bd5367f27">Corresponding on</named-content> <named-content specific-use="change-time" data-title="" id="6e5efc77-ebb8-4ed6-a8c1-46bafe15d456">12 Apr 2019 5:15 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" id="62573c45-cd93-461a-9532-244bfbaf22f0" xlink:title="author-33503242" xlink:actuate="gowthamram" xlink:role="preeditor" xlink:href="a2a07f58-0b12-453b-8843-6cfcaca18787"><meta-value id="a5c63a6d-a512-4aad-80f8-d98e1e6dfc82"><named-content specific-use="historyContent" data-title="" id="989ed93a-c0f6-4134-b3ad-e8b5f9f296c0"><named-content specific-use="change-person" data-title="" id="256f9cbb-113d-4414-8d0c-48505ace7a7d">Gowtham Ram</named-content> <named-content specific-use="newVal" data-title="" id="ceecf648-57c8-444f-a062-f83bc1d6a681">unchecked</named-content> <named-content specific-use="" data-title="" id="59d95333-f76e-4ecc-9c4b-5c05c298f7f6">Corresponding on</named-content> <named-content specific-use="change-time" data-title="" id="f8bbc42d-365e-4c09-9973-395e006bbe3c">12 Apr 2019 5:15 PM</named-content></named-content></meta-value></custom-meta><custom-meta id="85bf5c2a-616f-4f85-b55e-1a62868e796a"><meta-name id="d0c6e643-934a-4c68-9ac0-ebe144cda013">Copyediting_user_level</meta-name><meta-value id="2d6b1812-da90-4211-a200-e31b91fee826">expert</meta-value></custom-meta></custom-meta-group><counts id="3a586ef1-afa3-4ad2-985b-ddaf3b44d26a"><fig-count count="3"/><table-count count="2"/><equation-count count="0"/><ref-count count="43"/><page-count count="7.5"/><word-count count="6303"/></counts></article-meta></front><body id="b3070c90-7fa9-4625-895d-dc36e0329d31"><title data-level="1" data-class="jrnlDeleted" old-class="jrnlHead1" id="b65d0b20-a0a4-4411-81ec-909ad8a3c250" data-role="typesetter"><named-content rid="1555068417017" data-class="jrnlQueryRef" data-type="start" id="e4f4d6b8-32c0-47a6-83f3-8003da04a388" data-message="{'funcToCall': 'highlightQuery'}" data-event="click" data-topic="action" data-channel="query" specific-use="start" content-type="jrnlQueryRef" data-query-type="action" data-query-for="author" data-query-ref="true" data-replied="true"/><named-content data-cid="1556341827" id="934598ef-2c1c-4c28-85b9-bcf3b7909d76" content-type="del cts-5" specific-use="1556341855439" xlink:title="Renganath (TYPESETTER)" alt="typesetter ab536488-13fd-4e4f-857d-d52a866c90cc" data-title="Deleted by Renganath (TYPESETTER) - Apr 27 2019 10:40am" data-track-detail="" data-userid="typesetter ab536488-13fd-4e4f-857d-d52a866c90cc" data-username="Renganath (TYPESETTER)" data-time="1556341855439">in</named-content></title><title data-level="1" data-class="jrnlDeleted" old-class="jrnlHead1" id="faf89b14-e5da-4b0e-8904-2f9c825dcb03" data-role="typesetter"><xref id="2558a92e-8f0e-4e92-b677-f051eaf5083f" ref-type="box" rid="B1" data-citation-string=" B1 " data-cite-type="delete" data-track="del" data-cid="1556340886745" data-username="Renganath (TYPESETTER)" data-userid="typesetter ab536488-13fd-4e4f-857d-d52a866c90cc" data-time="1556340886744">Box 1<xref id="9d4494f4-3517-4af7-be14-d49542a86bb9" ref-type="box" rid="B1 B2" data-citation-string=" B1 B2 " data-track="ins" data-cid="1556340847370" data-username="Renganath (TYPESETTER)" data-userid="typesetter ab536488-13fd-4e4f-857d-d52a866c90cc" data-time="1556340847370">Boxes 1; 2<xref id="954f10b8-8367-4e85-992b-0a7daf318e9d" ref-type="box" rid="B1 B2 B3" data-citation-string=" B1 B2 B3 " data-track="ins" data-cid="1556340876763" data-username="Renganath (TYPESETTER)" data-userid="typesetter ab536488-13fd-4e4f-857d-d52a866c90cc" data-time="1556340876763">Boxes 1–3</xref></xref></xref><break id="579e7e95-d9f3-4065-a2c5-398cbec20d26"/></title><boxed-text data-id="BLK_B1" insert-citation="true" data-new-float="true" id="1e7b4410-d7b9-411f-bc4c-599b01e1a84a" data-uncited="true"><caption id="4dcded90-63c2-498a-b8e9-b299ad803ad3"><title data-id="B1" id="d2ea855b-3073-4176-9423-586d448fee60">Key messages</title></caption><list id="b9dce66a-5acd-4070-9208-d83255e4964b" list-content="ul" list-type="disc"><list-item id="924d239f-af16-4f3f-b44e-f80352d00a86"><p id="e001d630-6eef-4c60-84f2-bba2ebf39b20">There is intense interest in discovering systemic biomarkers that may relate to important patient related outcomes (PRO) in patients with COPD.</p></list-item><list-item id="882df63b-3d26-4362-9948-484904b53f4d"><p id="909a804c-9fea-4203-aee8-30e14702e85b">Using data and biological samples prospectively collected in the Study to Understand Mortality and MorbidITy (SUMMIT) study in 1,673 COPD patients with heightened cardiovascular risk the systemic levels of C-reactive protein (CRP), fibrinogen, surfactant protein-D (SPD), soluble receptor of glycation end-product (sRAGE) and club cell protein 16 (CC16) were related to rate of decline of the forced expiratory volume in the 1st second (FEV1), exacerbations, hospitalizations and mortality.</p></list-item><list-item id="4e5e0127-99e5-44e1-a8a5-e7823935765e"><p id="21f8f186-2cf8-456e-afce-b7f2d9d0468c">We found no relationship between serum levels of these 5 biomarkers and rate of FEV1 decline (ml/year) and COPD exacerbations and hospitalizations. The serum levels of CRP and fibrinogen, but not sRAGE, SPD or CC16 were related to increased risk of death. These results cast doubts about the clinical usefulness of the systemic levels of these proteins as surrogate markers of COPD related outcomes.</p></list-item></list></boxed-text><boxed-text data-id="BLK_B2" insert-citation="true" data-new-float="true" id="65e60b1b-fe16-41c0-82b9-7d487b94952f"><caption id="634bb5ce-4e11-45fc-8bef-e55d6ceff3c6"><title data-id="B2" id="a845ab96-d4a0-49de-962a-95007335097b">Strengths</title></caption><list id="6ed614c1-bf2f-4bb8-b91f-09d0244b5d90" list-content="ul" list-type="disc"><list-item id="447c5405-19fc-4c2d-8cfe-8f5fa7804537"><p id="5cb330fb-9b1c-4fdb-8673-0ed9d9eab220">The relatively large sample size and multi-centre nature of the study overcome the usual limitations of smaller trials conducted in a single center.</p></list-item><list-item id="2116ef81-844f-4601-a282-46e544a02d20"><p id="2317a110-8856-4170-8264-8745d2607360">The patients included had a careful clinical, functional and biological characterization. In addition, the study had a prospective design, significant follow-up time and a clinical adjudicating committee that validated the outcomes.</p></list-item><list-item id="5bcf9039-8ab8-45ab-b65a-bf32f9de5915"><p id="b187b573-9fbc-4127-ab02-a18ec5fb1cb1">The selections of biomarkers was based on previous studies suggesting a relationship between those proteins and outcomes.</p></list-item></list></boxed-text><boxed-text data-id="BLK_B3" insert-citation="true" data-new-float="true" id="c7164c56-52f9-4a34-9bc7-aec4131011d4"><caption id="4e373174-5732-4cd9-bcb0-791701d9af48"><title data-id="B3" id="dd72e5d0-c598-454a-8814-a16506e6fce5">Limitations</title></caption><list id="359fc5e7-f35f-4270-b266-8673c1f14869" list-content="ul" list-type="disc"><list-item id="6465b425-229b-4887-b39d-71091a672c4d"><p id="a60a1fab-9690-4bb1-8ba1-f98b172c57ff">The SUMMIT study was an event-driven design and as such not all patients were followed over a period of several years.</p></list-item><list-item id="8de96c7a-8dbc-4603-92b5-4e0a7645697f"><p id="3c834fcd-0ff7-479d-8b7f-e56ae3212b7e">An assumption was made that a few (or possibly only one) biomarkers would be valid for all COPD patients. Given the heterogeneity of patients with COPD, this assumption may not be right.</p></list-item></list></boxed-text><title data-level="1" data-class="jrnlHead1" id="e39dd6b3-a43b-4f60-8d39-34aacfa3d170">Introduction</title><p data-class="jrnlSecPara" id="e29e45d4-81d6-44b4-a1e5-9e1ed4bc288b"><named-content rid="1ba46b07-a8fe-4ca3-ae6a-676fd45f22c8" data-class="jrnlQueryRef" data-type="start" data-query-ref="true" data-query-for="typesetter" data-query-from="publisher" data-channel="query" data-topic="action" data-event="click" data-message="{'funcToCall': 'highlightQuery'}" data-query-type="action" id="7f917be5-68b8-433c-a1fd-4108a02f4ffe" content-type="jrnlQueryRef" specific-use="start" data-replied="true"/>Chronic obstructive pulmonary disease (<named-content id="55bf6708-96ae-4cb7-9f96-429370a4464c" data-cid="55bf6708-96ae-4cb7-9f96-429370a4464c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ABBR" data-track-detail="" data-tag-desc="ABBR" data-tag-type="ABBR" data-offset="39" data-match=" (COPD)" data-pattern="" data-tag-index="7_4" data-time="" data-username="" data-userid="">COPD</named-content>) is an important cause of morbidity and mortality worldwide.<xref id="265c8ec3-2ad2-4b0f-befa-a5e4dbced5f1" ref-type="bibr" rid="R1" data-citation-string=" R1 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="105" data-match="1" data-pattern="" data-tag-index="7_1" data-track-change="1"><sup id="8d1116d4-aee8-4648-87a6-49d642c141c0">1</sup></xref> Accurate prediction of outcomes such as rate of lung function decline, exacerbations, <named-content data-cid="1555068417000" id="116922d6-7100-4669-904e-1961f32d08ea" content-type="del cts-1" specific-use="1555068417000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1555068417000">health care</named-content><named-content data-cid="1555068417000" id="f25977b4-65bd-412e-970c-aa0f690784f7" content-type="ins cts-1" specific-use="1555068417000" xlink:title="Exeter" alt="preediting" data-title="changed from 'health␣care' to 'healthcare'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="194" data-match="health care" data-replace="healthcare" data-pattern="healthcare" data-tag-index="7_5" data-function="addTrackChanges" data-track-change="health care" data-userid="preediting" data-username="Exeter" data-time="1555068417000">healthcare</named-content> utilisation of resources and risk of death are important because it helps identify <named-content id="b1e28c0a-2165-462f-a858-47b4454b4dc2" data-cid="b1e28c0a-2165-462f-a858-47b4454b4dc2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="289" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="7_6" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> in whom the implementation of therapeutic measures could improve those outcomes.<xref id="e6d4e297-20f4-474c-a871-36ac4dd5e53c" ref-type="bibr" rid="R2" data-citation-string=" R2 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="379" data-match="2" data-pattern="" data-tag-index="7_2" data-track-change="2"><sup id="28c99167-de4e-4575-8019-dce13c5a3e17">2</sup></xref> COPD is also a complex and heterogeneous disease at the genetic, cellular and molecular level, and therefore<named-content data-cid="1555285399" id="2dbdea74-e3a7-4563-94d2-d170dd9bac13" content-type="ins cts-3" specific-use="1555285857154" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 7:50am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555285857154">,</named-content> it is likely that the use of biomarkers that reflect diverse pathobiological pathways could help assess multiple dimensions of disease progression that could be modulated with specific therapeutic agents.<xref id="925ac6ba-606c-4dcf-86a2-f5278f5ce419" ref-type="bibr" rid="R3" data-citation-string=" R3 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="696" data-match="3" data-pattern="" data-tag-index="7_3" data-track-change="3"><sup id="17e26e8e-4200-4491-9a97-135f6bdf0c7e">3</sup></xref></p><p data-class="jrnlSecPara" id="19340943-5f7a-4a59-b053-06c7433beb1a">Several systemic biomarkers, including C<named-content data-cid="1555285400" id="2a31a4b1-d5ca-4cff-a8a6-6288fb373932" content-type="del cts-3" specific-use="1555285863182" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 7:51am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555285863182">-</named-content><named-content data-cid="1555285401" id="62cc43a0-386c-4d35-b2f6-ff75fe221f41" content-type="ins cts-3" specific-use="1555285863520" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 7:51am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555285863520"> </named-content>reactive protein (<named-content id="74c18d74-50bb-441f-9368-b6cb79eeb7aa" data-cid="74c18d74-50bb-441f-9368-b6cb79eeb7aa" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ABBR" data-track-detail="" data-tag-desc="ABBR" data-tag-type="ABBR" data-offset="59" data-match=" (CRP)" data-pattern="" data-tag-index="8_12" data-time="" data-username="" data-userid="">CRP</named-content>), fibrinogen and surfactant protein D (<named-content id="1db023d6-56a5-41c7-9613-41d0217d13b8" data-cid="1db023d6-56a5-41c7-9613-41d0217d13b8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ABBR" data-track-detail="" data-tag-desc="ABBR" data-tag-type="ABBR" data-offset="102" data-match=" (SPD)" data-pattern="" data-tag-index="8_13" data-time="" data-username="" data-userid="">SPD</named-content>) have been associated with increased risk of death in <named-content id="eebc85b4-a057-4e86-995f-71aa976e7a65" data-cid="eebc85b4-a057-4e86-995f-71aa976e7a65" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="160" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="8_18" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> with COPD.<xref id="3526f255-b8e0-4d3b-a0b3-ee37a8373046" ref-type="bibr" rid="R4 R5 R6 R7 R8" data-citation-string=" R4 R5 R6 R7 R8 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="180" data-match="4-8" data-pattern="" data-tag-index="8_1" data-track-change="4-8"><sup id="5834cc48-f75d-451f-9266-08ffc1ff0019">4–8</sup></xref> However, their relationship to other outcomes such as rate of decline of the forced expiratory volume in <named-content id="29361f87-7b89-4fc1-8736-e60acd8b16ff" data-cid="29361f87-7b89-4fc1-8736-e60acd8b16ff" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="290" data-match="1 s" data-replace="1" data-pattern="$1" data-tag-index="8_11" data-time="" data-username="" data-userid="">1</named-content><named-content id="51995ec0-1d98-4ca4-8913-720bcb30c1d5" data-cid="51995ec0-1d98-4ca4-8913-720bcb30c1d5" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣s' to ' s'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="291" data-match="1 s" data-replace=" s" data-pattern=" s" data-tag-index="8_11" data-track-change=" s" data-time="" data-username="" data-userid=""> s</named-content> (FEV<sub id="d4110794-5aed-4d95-bbd1-b06535746cfa">1</sub>) of a forced expiratory manoeuvre, exacerbations and hospitalisations remains unclear.<xref id="ebe19d3b-6fa0-4b63-8ce5-f4d54ffc39f9" ref-type="bibr" rid="R9 R10" data-citation-string=" R9 R10 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="387" data-match="9,10" data-pattern="" data-tag-index="8_2" data-track-change="9,10"><sup id="761d1d5a-ab10-4795-b87d-7508fb76de36">9 10</sup></xref> The serum concentration of club cell protein 16 (CC-16) was inversely related to rate of FEV<sub id="b759c984-219e-46f9-911c-e1ecc997594f">1</sub> decline in observational studies,<xref id="7072b150-d7da-4e17-a2aa-5dd26ea63f8d" ref-type="bibr" rid="R11" data-citation-string=" R11 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="521" data-match="11" data-pattern="" data-tag-index="8_3" data-track-change="11"><sup id="a0dbc929-9254-42f5-9050-644ed5ce8701">11</sup></xref> in pharmacological trials of <named-content id="cf8b929a-5c18-4de5-8e4c-a0cda5892da1" data-cid="cf8b929a-5c18-4de5-8e4c-a0cda5892da1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="554" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="8_19" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> with COPD<xref id="d9a2853b-f034-4a86-a589-261985cef969" ref-type="bibr" rid="R12" data-citation-string=" R12 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="573" data-match="12" data-pattern="" data-tag-index="8_4" data-track-change="12"><sup id="bb55a613-a86f-4969-893d-1a77cee76470">12</sup></xref> and in smokers without clinical airflow limitation.<xref id="cb39ae44-8274-4d56-84dd-af50115a9798" ref-type="bibr" rid="R13" data-citation-string=" R13 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="629" data-match="13" data-pattern="" data-tag-index="8_5" data-track-change="13"><sup id="9f651310-c862-4865-8376-687ffb416f76">13</sup></xref> The serum levels of <named-content data-cid="1555285637" id="14495f19-802c-4614-aebb-37e504a355cc" content-type="ins cts-3" specific-use="1555291061434" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 9:17am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291061434">soluble receptor of activated glycogen end-product</named-content><named-content data-cid="1555285638" id="651870cd-e2d8-4381-8f1d-36e06f6a3f1a" content-type="del cts-3" specific-use="1555291064500" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:17am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291064500">soluble receptor of glycation end-product</named-content> (<named-content id="b5462469-c098-4f9a-b63c-ed5f2785ede3" data-cid="b5462469-c098-4f9a-b63c-ed5f2785ede3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ABBR" data-track-detail="" data-tag-desc="ABBR" data-tag-type="ABBR" data-offset="696" data-match=" (sRAGE)" data-pattern="" data-tag-index="8_14" data-time="" data-username="" data-userid="">sRAGE</named-content>) relate inversely to progression of emphysema,<xref id="01b30a4a-f387-423b-97d4-c7a9247e857c" ref-type="bibr" rid="R14" data-citation-string=" R14 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="749" data-match="14" data-pattern="" data-tag-index="8_6" data-track-change="14"><sup id="ba4281e8-f4d4-4766-b442-0a03bbfdb680">14</sup></xref> as determined by serially repeated <named-content data-cid="1555068417002" id="2bee4c60-83e2-457c-98cb-07178a5ad6ed" content-type="del cts-1" specific-use="1555068417000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1555068417000">computerised tomography (CT)</named-content><named-content data-cid="1555068417002" id="4c072ecf-4485-49eb-97ce-dbf4636242c2" content-type="ins cts-1" specific-use="1555068417000" xlink:title="Exeter" alt="preediting" data-title="changed from 'computerised␣tomography␣(CT)' to 'CT'" data-track-detail="" data-tag-desc="ABBRV" data-tag-type="ABBRV" data-offset="788" data-match="computerised tomography (CT)" data-replace="CT" data-pattern="CT" data-tag-index="8_17" data-function="addTrackChanges" data-track-change="computerised tomography (CT)" data-userid="preediting" data-username="Exeter" data-time="1555068417000">CT</named-content> of the lungs. In addition, genome<named-content data-cid="1555285402" id="a8662485-def3-47dd-9af1-a4df8843e954" content-type="del cts-3" specific-use="1555285930587" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 7:52am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555285930587"> </named-content><named-content data-cid="1555285403" id="59c42bdd-f443-4a4e-b0da-3bb294b99f2e" content-type="ins cts-3" specific-use="1555285930856" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 7:52am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555285930856">-</named-content>wide association studies (<named-content id="f786e74f-4ced-401f-9dc7-c0b809dbcb23" data-cid="f786e74f-4ced-401f-9dc7-c0b809dbcb23" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ABBR" data-track-detail="" data-tag-desc="ABBR" data-tag-type="ABBR" data-offset="877" data-match=" (GWAS)" data-pattern="" data-tag-index="8_16" data-time="" data-username="" data-userid="">GWAS</named-content>) do support the increased prevalence of single nucleotide polymorphisms associated to the RAGE,<xref id="9731d617-63d1-47d9-8541-1d6035352328" ref-type="bibr" rid="R15" data-citation-string=" R15 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="977" data-match="15" data-pattern="" data-tag-index="8_7" data-track-change="15"><sup id="68738345-42ba-48fe-8647-14dcbcf79195">15</sup></xref> SPD and CC-16 genes.<xref id="073aad43-b009-4868-94be-b21a1d65691a" ref-type="bibr" rid="R16" data-citation-string=" R16 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="1003" data-match="16" data-pattern="" data-tag-index="8_8" data-track-change="16"><sup id="b4a71cab-080b-4d72-a4f8-d660aebdd426">16</sup></xref> Importantly, the systemic baseline levels of troponin determined in the <named-content id="70acac8a-a7f7-4f8b-9e9e-0ae22195c36e" data-cid="70acac8a-a7f7-4f8b-9e9e-0ae22195c36e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="1079" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="8_20" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> participating in the biomarker component of the <named-content data-cid="1555285404" id="afbd3cfc-e231-4b53-adca-75208ec4892c" content-type="ins cts-3" specific-use="1555285975970" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 7:52am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555285975970">Study to Understand Mortality and MorbidITy (</named-content>SUMMIT<named-content data-cid="1555285409" id="bde510f8-04ee-414b-b6db-398f10dc504d" content-type="ins cts-3" specific-use="1555285980266" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 7:53am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555285980266">)</named-content> trial were highly predictive of subsequent cardiovascular<named-content data-cid="1555285709" id="de84f941-251f-4773-a704-2e880019ad12" content-type="ins cts-3" specific-use="1555291399381" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 9:23am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291399381"> (CV)</named-content> events and death in this cohort.<xref id="704f3ce0-aa6a-4b34-86ca-e9f2c90c6bc1" ref-type="bibr" rid="R17" data-citation-string=" R17 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="1234" data-match="17" data-pattern="" data-tag-index="8_9" data-track-change="17"><sup id="d364f89c-e863-472c-a55a-6f828beb616b">17</sup></xref></p><p data-class="jrnlSecPara" id="c14b55b3-9b5c-4c88-aa98-3118381c9259">Based on these findings, we hypothesised that the serum levels of one or more of CC-16, CRP, sRAGE, SPD and fibrinogen would relate to the following outcomes: rate of FEV<sub id="e892b5c7-9ea4-468b-8008-14a6401a134a">1</sub> decline, exacerbations of COPD, hospitalisations due to these episodes and the risk of death in <named-content id="1c588e8d-0a79-4d85-96cb-2348ba1cd68c" data-cid="1c588e8d-0a79-4d85-96cb-2348ba1cd68c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="268" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="9_3" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> with COPD. We tested this hypothesis using data and biological samples prospectively collected in the subset of <named-content id="08483b9a-1bda-40f2-9d2e-b1ee347b5332" data-cid="08483b9a-1bda-40f2-9d2e-b1ee347b5332" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="389" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="9_4" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> recruited in the USA who participated in the <named-content data-cid="1555285410" id="1b22f0ad-fded-418e-84ef-aa0f237ef1cd" content-type="del cts-3" specific-use="1555286005380" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 7:53am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555286005380">Study to Understand Mortality and MorbidITy (</named-content><named-content id="b5b2a271-2028-4b55-a6f3-b05824356826" data-cid="b5b2a271-2028-4b55-a6f3-b05824356826" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ABBR" data-track-detail="" data-tag-desc="ABBR" data-tag-type="ABBR" data-offset="488" data-match=" (SUMMIT)" data-pattern="" data-tag-index="9_2" data-time="" data-username="" data-userid="">SUMMIT</named-content><named-content data-cid="1555285411" id="c3dd749a-cedc-4e93-a81c-34b79da278fd" content-type="del cts-3" specific-use="1555286006992" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 7:53am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555286006992">)</named-content> study. SUMMIT was an event-driven study that assessed the efficacy and safety of inhaled corticosteroids<named-content data-cid="1555285653" id="c05558d9-55f4-4b70-82d1-96b0ca99bccd" content-type="ins cts-3" specific-use="1555291122808" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 9:18am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291122808"> (ICSs)</named-content> and long-acting beta agonists<named-content data-cid="1555285639" id="30d0f7f0-04dc-499f-b759-a9e3ac4c1926" content-type="ins cts-3" specific-use="1555291100523" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 9:18am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291100523"> (LABA)</named-content> in COPD <named-content id="ce9320c7-3a5b-4513-b60b-7e9952779212" data-cid="ce9320c7-3a5b-4513-b60b-7e9952779212" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="639" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="9_5" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> with heightened <named-content data-cid="1555285714" id="25b34a64-3f86-4cfa-b013-c51feb58a23c" content-type="del cts-3" specific-use="1555291402630" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:23am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291402630">cardiovascular</named-content><named-content data-cid="1555285715" id="a12b6ef6-ffaf-4283-b42f-3d6593602fa6" content-type="ins cts-3" specific-use="1555291402675" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 9:23am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291402675">CV</named-content> risk. In the subset of <named-content id="373aebfb-fc20-46b7-b167-d1aea88fd6de" data-cid="373aebfb-fc20-46b7-b167-d1aea88fd6de" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="702" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="9_6" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content>, serum samples were taken at baseline and <named-content id="b41ffc26-0ac3-4ab5-820d-a5d0ddb04ad7" data-cid="b41ffc26-0ac3-4ab5-820d-a5d0ddb04ad7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="753" data-match="3 months" data-replace="3" data-pattern="$1" data-tag-index="9_1" data-time="" data-username="" data-userid="">3</named-content><named-content id="f3ebda6f-fddd-4f45-b9ce-aa525f7dc963" data-cid="f3ebda6f-fddd-4f45-b9ce-aa525f7dc963" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="754" data-match="3 months" data-replace=" months" data-pattern=" $2" data-tag-index="9_1" data-time="" data-username="" data-userid=""> months</named-content> after randomisation, enabling us to also test whether pharmacotherapy modulated the serum levels of these biomarkers.</p><title data-level="1" data-class="jrnlHead1" id="75e70a7c-abfc-4b23-91f2-2a23dbb77583">Methods</title><title data-level="2" data-class="jrnlHead2" id="acf61d65-5f5b-42b3-a5dd-0f1ba30b45aa">Study design and study population</title><p data-class="jrnlSecPara" id="f9c13281-f820-40cf-8366-8c77bee22d7d">SUMMIT was a prospective, multi<named-content id="4ebc168d-c109-403a-8409-f214baae4031" data-cid="1555285412" content-type="del cts-3" specific-use="1555286022455" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 7:53am" data-track-detail="" data-time="1555286022455" data-username="Ariel (COPYEDITOR)" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c">-</named-content>centre, international randomised controlled trial to determine whether treatment with the inhaled <named-content id="26189d56-afd3-4e07-b88c-4c2f6f2da412" data-cid="1555285646" content-type="del cts-3" specific-use="1555291105110" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:18am" data-track-detail="" data-time="1555291105110" data-username="Ariel (COPYEDITOR)" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c">long-acting beta agonist (</named-content><named-content id="7859e239-8c9c-4071-a011-3a57578efd7c" data-cid="7859e239-8c9c-4071-a011-3a57578efd7c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ABBR" data-track-detail="" data-time="" data-username="" data-userid="" data-tag-index="10_16" data-pattern="" data-match=" (LABA)" data-offset="156" data-tag-type="ABBR" data-tag-desc="ABBR">LABA</named-content><named-content id="a8d0d129-b15f-4204-b847-282c9edf4aa1" data-cid="1555285647" content-type="del cts-3" specific-use="1555291106312" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:18am" data-track-detail="" data-time="1555291106312" data-username="Ariel (COPYEDITOR)" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c">)</named-content> vilanterol<named-content id="a806af10-c98c-4eaf-a6f8-05be1b77c37a" data-cid="1555285685" content-type="ins cts-3" specific-use="1555291218917" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 9:20am" data-track-detail="" data-time="1555291218917" data-username="Ariel (COPYEDITOR)" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c"> (VI)</named-content>, the <named-content id="a8cd1ecf-1fee-42e8-af47-87dcb6cba31e" data-cid="1555285660" content-type="del cts-3" specific-use="1555291130610" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:18am" data-track-detail="" data-time="1555291130610" data-username="Ariel (COPYEDITOR)" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c">inhaled corticosteroid (</named-content><named-content id="12521995-0443-4580-b64e-5b0d02770ef7" data-cid="12521995-0443-4580-b64e-5b0d02770ef7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ABBR" data-track-detail="" data-time="" data-username="" data-userid="" data-tag-index="10_17" data-pattern="" data-match=" (ICS)" data-offset="202" data-tag-type="ABBR" data-tag-desc="ABBR">ICS</named-content><named-content id="2f054840-3ee9-46ae-bd80-8f764084b0af" data-cid="1555285661" content-type="del cts-3" specific-use="1555291131827" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:18am" data-track-detail="" data-time="1555291131827" data-username="Ariel (COPYEDITOR)" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c">)</named-content> fluticasone furoate<named-content id="e231a2c4-727b-4ff8-ab93-5077a85fd73a" data-cid="1555285670" content-type="ins cts-3" specific-use="1555291170685" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 9:19am" data-track-detail="" data-time="1555291170685" data-username="Ariel (COPYEDITOR)" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c"> (FF)</named-content> or both in combination could improve clinical outcomes in <named-content id="a474b2c8-17da-4930-8335-69ccd57b70d8" data-cid="a474b2c8-17da-4930-8335-69ccd57b70d8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-time="" data-username="" data-userid="" data-tag-index="10_20" data-pattern="$1" data-match="patients" data-offset="285" data-tag-type="HIGH" data-tag-desc="HIGH" data-replace="patients" data-function="addTrackChanges">patients</named-content> with moderate COPD and increased <named-content id="b81b7c2e-8647-4c7e-a15f-58f0dc801bdf" data-cid="1555285719" content-type="del cts-3" specific-use="1555291405327" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:23am" data-track-detail="" data-time="1555291405327" data-username="Ariel (COPYEDITOR)" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c">cardiovascular</named-content><named-content id="1fd71134-a4d5-48d1-8561-b650759df2d4" data-cid="1555285720" content-type="ins cts-3" specific-use="1555291405373" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 9:23am" data-track-detail="" data-time="1555291405373" data-username="Ariel (COPYEDITOR)" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c">CV</named-content> risk. Details regarding study design and its primary results have been previously published.<xref id="34e21060-d9ab-4a95-8422-1fda69b75c58" ref-type="bibr" rid="R18 R19" data-tag-index="10_1" data-pattern="" data-match="18,19" data-offset="435" data-tag-type="BIBREF" data-tag-desc="BIBREF" data-track-change="18,19" data-citation-string=" R18 R19 "><sup id="c11f55d9-32f9-4158-a3f9-93df8e73d73c">18 19</sup></xref> In brief, participants included former or current smokers (<named-content id="c21964c5-9634-4103-9e17-27808184709d" data-cid="c21964c5-9634-4103-9e17-27808184709d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-time="" data-username="" data-userid="" data-tag-index="10_3" data-pattern="$2" data-match="≥10" data-offset="501" data-tag-type="OPR" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-replace="≥">≥</named-content><named-content id="4e2c7ed1-fbe7-4e93-8189-050a1d03c1f8" data-cid="4e2c7ed1-fbe7-4e93-8189-050a1d03c1f8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-time="" data-username="" data-userid="" data-tag-index="10_3" data-pattern="$3" data-match="≥10" data-offset="504" data-tag-type="VAL" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-replace="10">10</named-content> pack-years) between 40 and <named-content id="9f1fc2d8-3773-4be9-bb37-0fc64c99a72f" data-cid="9f1fc2d8-3773-4be9-bb37-0fc64c99a72f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-time="" data-username="" data-userid="" data-tag-index="10_9" data-pattern="$1" data-match="80 years" data-offset="534" data-tag-type="VAL" data-tag-desc="VAL,UNT" data-replace="80">80</named-content><named-content id="7951a88c-2add-4001-81bb-e4eb6761af5d" data-cid="7951a88c-2add-4001-81bb-e4eb6761af5d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-time="" data-username="" data-userid="" data-tag-index="10_9" data-pattern=" $2" data-match="80 years" data-offset="536" data-tag-type="UNT" data-tag-desc="VAL,UNT" data-replace=" years"> years</named-content> of age, with a history of COPD and a post<named-content id="3aa5be51-184a-4634-9786-0168fb43639d" data-cid="1555285413" content-type="del cts-3" specific-use="1555286057109" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 7:54am" data-track-detail="" data-time="1555286057109" data-username="Ariel (COPYEDITOR)" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c">-</named-content>bronchodilator FEV<sub id="9649b7d0-20c0-4e5e-9fca-3faaf5ff59ec">1</sub> to <named-content id="6b378e22-c67b-4f46-9081-9327fe5f7881" data-cid="6b378e22-c67b-4f46-9081-9327fe5f7881" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'forced vital capacity' to 'forced vital capacity'" data-track-detail="" data-time="" data-username="" data-userid="" data-tag-index="10_21" data-pattern="$1" data-match="forced vital capacity" data-offset="608" data-tag-type="HIGH" data-tag-desc="HIGH" data-replace="forced vital capacity" data-function="addTrackChanges">forced vital capacity</named-content><named-content id="406bef28-2de6-46cf-9c31-a575dc558d99" data-cid="406bef28-2de6-46cf-9c31-a575dc558d99" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣≤' to '⍽≤'" data-track-detail="" data-time="" data-username="" data-userid="" data-tag-index="10_4" data-pattern=" $2" data-match="capacity ≤0.70 and" data-offset="629" data-tag-type="OPR" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-replace=" ≤" data-track-change=" ≤"> ≤</named-content><named-content id="64767b67-be20-4306-8950-c6b97b642e21" data-cid="64767b67-be20-4306-8950-c6b97b642e21" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-time="" data-username="" data-userid="" data-tag-index="10_4" data-pattern="$3" data-match="capacity ≤0.70 and" data-offset="633" data-tag-type="VAL" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-replace="0.70">0.70</named-content><named-content id="ecbe38c5-9cf5-479f-985c-5a832d33be39" data-cid="ecbe38c5-9cf5-479f-985c-5a832d33be39" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣and' to ' and'" data-track-detail="" data-time="" data-username="" data-userid="" data-tag-index="10_4" data-pattern=" $6" data-match="capacity ≤0.70 and" data-offset="637" data-tag-type="UNT" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-replace=" and" data-track-change=" and"> and</named-content> an FEV<sub id="0f573f70-6180-4c1a-856f-b1498e3136d6">1</sub><named-content id="5480b7f2-a632-432f-9188-5b49e2c4c340" data-cid="5480b7f2-a632-432f-9188-5b49e2c4c340" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣≥' to '⍽≥'" data-track-detail="" data-time="" data-username="" data-userid="" data-tag-index="10_5" data-pattern=" $2" data-match="FEV1 ≥50% and" data-offset="649" data-tag-type="OPR" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-replace=" ≥" data-track-change=" ≥"> ≥</named-content><named-content id="3f3aa389-320b-4f0f-b1cd-acf3ce342203" data-cid="3f3aa389-320b-4f0f-b1cd-acf3ce342203" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-time="" data-username="" data-userid="" data-tag-index="10_5" data-pattern="$3" data-match="50%" data-offset="653" data-tag-type="VAL" data-tag-desc="VAL,UNT" data-replace="50">50</named-content><named-content id="10621f8e-ea5a-48ba-97f6-a41933aade34" data-cid="10621f8e-ea5a-48ba-97f6-a41933aade34" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-time="" data-username="" data-userid="" data-tag-index="10_10" data-pattern="%" data-match="50%" data-offset="655" data-tag-type="UNT" data-tag-desc="VAL,UNT" data-replace="%">%</named-content><named-content id="0a541587-e787-4974-8e82-aa49057cf8a9" data-cid="0a541587-e787-4974-8e82-aa49057cf8a9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣and' to ' and'" data-track-detail="" data-time="" data-username="" data-userid="" data-tag-index="10_5" data-pattern=" $6" data-match="FEV1 ≥50% and" data-offset="656" data-tag-type="UNT" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-replace=" and" data-track-change=" and"> and<named-content id="ec2c505c-f2cf-4d07-9d7a-b39e5c5b330e" data-cid="1555285414" content-type="ins cts-3" specific-use="1555286063302" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 7:54am" data-track-detail="" data-time="1555286063302" data-username="Ariel (COPYEDITOR)" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c"> </named-content></named-content><named-content id="8bfcad22-5bcd-4f8b-8e0c-4812097ffcbf" data-cid="8bfcad22-5bcd-4f8b-8e0c-4812097ffcbf" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣≤' to '≤'" data-track-detail="" data-time="" data-username="" data-userid="" data-tag-index="10_6" data-pattern="$2" data-match=" ≤70% of" data-offset="660" data-tag-type="OPR" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-replace="≤" data-track-change=" ≤">≤</named-content><named-content id="9e96bc22-8299-4539-bc91-b4b30927a649" data-cid="9e96bc22-8299-4539-bc91-b4b30927a649" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-time="" data-username="" data-userid="" data-tag-index="10_6" data-pattern="$3" data-match="70%" data-offset="664" data-tag-type="VAL" data-tag-desc="VAL,UNT" data-replace="70">70</named-content><named-content id="f5fd1bd9-2c11-4f7c-ace6-b5623255642a" data-cid="f5fd1bd9-2c11-4f7c-ace6-b5623255642a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-time="" data-username="" data-userid="" data-tag-index="10_11" data-pattern="%" data-match="70%" data-offset="666" data-tag-type="UNT" data-tag-desc="VAL,UNT" data-replace="%">%</named-content> of predicted. They had a score<named-content id="06fd0bbf-5dc4-4210-a913-a2b26e9d2009" data-cid="06fd0bbf-5dc4-4210-a913-a2b26e9d2009" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣≥' to '⍽≥'" data-track-detail="" data-time="" data-username="" data-userid="" data-tag-index="10_7" data-pattern=" $2" data-match="score ≥2 on" data-offset="698" data-tag-type="OPR" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-replace=" ≥" data-track-change=" ≥"> ≥</named-content><named-content id="5e16f661-2f6c-4d51-93c8-a1f5148317a6" data-cid="5e16f661-2f6c-4d51-93c8-a1f5148317a6" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="SNUM" data-track-detail="" data-time="" data-username="" data-userid="" data-tag-index="10_7" data-pattern="" data-match="score ≥2 on" data-offset="702" data-tag-type="SNUM" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT">2</named-content> on the modified Medical Research Council dyspnoea scale. <named-content id="b1dc8797-0337-46e7-a8e7-edcf3644e7bb" data-cid="b1dc8797-0337-46e7-a8e7-edcf3644e7bb" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'Patients' to 'Patients'" data-track-detail="" data-time="" data-username="" data-userid="" data-tag-index="10_22" data-pattern="$1" data-match="Patients" data-offset="761" data-tag-type="HIGH" data-tag-desc="HIGH" data-replace="Patients" data-function="addTrackChanges">Patients</named-content> were additionally required to have a history, or be at increased risk, of <named-content id="d3340164-7911-4951-b4ba-8ff7cfa3262a" data-cid="1555285722" content-type="del cts-3" specific-use="1555291407474" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:23am" data-track-detail="" data-time="1555291407474" data-username="Ariel (COPYEDITOR)" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c">cardiovascular</named-content><named-content id="ba0ff4a5-5e6e-420e-96d1-85d064e50567" data-cid="1555285723" content-type="ins cts-3" specific-use="1555291407524" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 9:23am" data-track-detail="" data-time="1555291407524" data-username="Ariel (COPYEDITOR)" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c">CV</named-content> disease defined as coronary artery or peripheral arterial disease, prior stroke or myocardial infarction, or diabetes mellitus with target organ disease. <named-content id="94104c8c-67b5-4229-a06e-54c4d259a766" data-cid="94104c8c-67b5-4229-a06e-54c4d259a766" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'Patients' to 'Patients'" data-track-detail="" data-time="" data-username="" data-userid="" data-tag-index="10_23" data-pattern="$1" data-match="Patients" data-offset="1013" data-tag-type="HIGH" data-tag-desc="HIGH" data-replace="Patients" data-function="addTrackChanges">Patients</named-content> were also included if they had increased <named-content id="c54ffc11-0ce9-4fe7-8de4-7ad511ecc7f3" data-cid="1555285727" content-type="del cts-3" specific-use="1555291410122" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:23am" data-track-detail="" data-time="1555291410122" data-username="Ariel (COPYEDITOR)" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c">cardiovascular</named-content><named-content id="4a6f195a-8c94-41d2-9a05-02952eb6a8ff" data-cid="1555285728" content-type="ins cts-3" specific-use="1555291410169" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 9:23am" data-track-detail="" data-time="1555291410169" data-username="Ariel (COPYEDITOR)" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c">CV</named-content> risk defined as being<named-content id="d5d2f9b3-75cc-4277-aa9e-f0b0d8ee76ce" data-cid="d5d2f9b3-75cc-4277-aa9e-f0b0d8ee76ce" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣≥' to '⍽≥'" data-track-detail="" data-time="" data-username="" data-userid="" data-tag-index="10_8" data-pattern=" $2" data-match="being ≥60 years" data-offset="1099" data-tag-type="OPR" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-replace=" ≥" data-track-change=" ≥"> ≥</named-content><named-content id="0f4d880e-4a9b-4dfb-8397-87f602f33fb0" data-cid="0f4d880e-4a9b-4dfb-8397-87f602f33fb0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-time="" data-username="" data-userid="" data-tag-index="10_8" data-pattern="$1" data-match="being ≥60 years" data-offset="1103" data-tag-type="VAL" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-replace="60">60</named-content><named-content id="2d875285-198e-4f18-b89b-a618220d2803" data-cid="2d875285-198e-4f18-b89b-a618220d2803" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-time="" data-username="" data-userid="" data-tag-index="10_8" data-pattern=" $2" data-match="being ≥60 years" data-offset="1105" data-tag-type="UNT" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-replace=" years"> years</named-content> and receiving medications for two or more of the following: hypercholesterolaemia, hypertension, diabetes mellitus or peripheral vascular disease. While <named-content id="8cb477cd-4624-409e-a934-1c2c08ba38d1" data-cid="1555285662" content-type="del cts-3" specific-use="1555291133913" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:18am" data-track-detail="" data-time="1555291133913" data-username="Ariel (COPYEDITOR)" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c">inhaled corticosteroid</named-content><named-content id="02a65e59-9ec5-4bbd-9ae3-9b96d08d566b" data-cid="1555285663" content-type="ins cts-3" specific-use="1555291133960" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 9:18am" data-track-detail="" data-time="1555291133960" data-username="Ariel (COPYEDITOR)" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c">ICS</named-content>s and <named-content id="94fc91a8-29d2-4dd2-ae11-1d1e4a98e667" data-cid="1555285648" content-type="del cts-3" specific-use="1555291108325" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:18am" data-track-detail="" data-time="1555291108325" data-username="Ariel (COPYEDITOR)" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c">long-acting beta agonist</named-content><named-content id="54a27b3f-e81f-432a-a9fd-a4befe5181c0" data-cid="1555285649" content-type="ins cts-3" specific-use="1555291108374" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 9:18am" data-track-detail="" data-time="1555291108374" data-username="Ariel (COPYEDITOR)" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c">LABA</named-content> treatments were discontinued before study entry, other COPD medications were permitted during the trial. Participants were randomly allocated to one of four treatments: placebo, <named-content id="065464e6-abbd-4d21-9000-2f53cfa8e61a" data-cid="1555285675" content-type="del cts-3" specific-use="1555291177876" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:19am" data-track-detail="" data-time="1555291177876" data-username="Ariel (COPYEDITOR)" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c">fluticasone furoate</named-content><named-content id="4b70a1dd-df83-4ee6-959c-4d16b89550b5" data-cid="1555285676" content-type="ins cts-3" specific-use="1555291177925" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 9:19am" data-track-detail="" data-time="1555291177925" data-username="Ariel (COPYEDITOR)" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c">FF</named-content> (<named-content id="39d735b3-71f7-403a-80cf-93d74500d179" data-cid="1555285415" content-type="del cts-3" specific-use="1555286119430" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 7:55am" data-track-detail="" data-time="1555286119430" data-username="Ariel (COPYEDITOR)" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c">FF,</named-content><named-content id="f22ac08c-c915-45d5-808b-41dcd37b1631" data-cid="1555285678" content-type="del cts-3" specific-use="1555291179828" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:19am" data-track-detail="" data-time="1555291179828" data-username="Ariel (COPYEDITOR)" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c"> </named-content><named-content id="f96f04fd-e53d-4674-af5b-44e7829fa11d" data-cid="f96f04fd-e53d-4674-af5b-44e7829fa11d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-time="" data-username="" data-userid="" data-tag-index="10_13" data-pattern="$1" data-match="100 μg" data-offset="1521" data-tag-type="VAL" data-tag-desc="VAL,UNT" data-replace="100">100</named-content><named-content id="f184b105-5acb-48d1-a89d-fd10219358a3" data-cid="f184b105-5acb-48d1-a89d-fd10219358a3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣μg' to ' µg'" data-track-detail="" data-time="" data-username="" data-userid="" data-tag-index="10_13" data-pattern=" $2" data-match="100 μg" data-offset="1524" data-tag-type="UNT" data-tag-desc="VAL,UNT" data-replace=" &amp;#x00B5;g" data-track-change=" μg"> µg</named-content>), <named-content id="0bae4abe-3dd2-4942-b686-e65942a8575c" data-cid="1555285690" content-type="del cts-3" specific-use="1555291225871" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:20am" data-track-detail="" data-time="1555291225871" data-username="Ariel (COPYEDITOR)" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c">vilanterol</named-content><named-content id="62a84da1-8a49-4aae-b66f-b43234851803" data-cid="1555285691" content-type="ins cts-3" specific-use="1555291225920" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 9:20am" data-track-detail="" data-time="1555291225920" data-username="Ariel (COPYEDITOR)" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c">VI</named-content> <named-content id="d098548d-a4a2-48f6-ab38-bc9093f91696" data-cid="1555285698" content-type="ins cts-3" specific-use="1555291231781" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 9:20am" data-track-detail="" data-time="1555291231781" data-username="Ariel (COPYEDITOR)" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c">(</named-content><named-content id="42899d9d-44cb-4502-8ab9-586db1523a7f" data-cid="42899d9d-44cb-4502-8ab9-586db1523a7f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-time="" data-username="" data-userid="" data-tag-index="10_14" data-pattern="$1" data-match="25 μg" data-offset="1547" data-tag-type="VAL" data-tag-desc="VAL,UNT" data-replace="25">25</named-content><named-content id="2d0dac45-c476-4c05-be67-3690ce450e23" data-cid="2d0dac45-c476-4c05-be67-3690ce450e23" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣μg' to ' µg'" data-track-detail="" data-time="" data-username="" data-userid="" data-tag-index="10_14" data-pattern=" $2" data-match="25 μg" data-offset="1549" data-tag-type="UNT" data-tag-desc="VAL,UNT" data-replace=" &amp;#x00B5;g" data-track-change=" μg"> µg</named-content>) or their combination (FF/VI, <named-content id="51047a55-78d3-4bdc-9f70-8fa0f2b001ae" data-cid="51047a55-78d3-4bdc-9f70-8fa0f2b001ae" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-time="" data-username="" data-userid="" data-tag-index="10_15" data-pattern="$1" data-match="100/25 μg" data-offset="1584" data-tag-type="VAL" data-tag-desc="VAL,UNT" data-replace="100/25">100/25</named-content><named-content id="a2ca902d-a10a-4199-9e9c-71ef0884f487" data-cid="a2ca902d-a10a-4199-9e9c-71ef0884f487" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣μg' to ' µg'" data-track-detail="" data-time="" data-username="" data-userid="" data-tag-index="10_15" data-pattern=" $2" data-match="100/25 μg" data-offset="1590" data-tag-type="UNT" data-tag-desc="VAL,UNT" data-replace=" &amp;#x00B5;g" data-track-change=" μg"> µg</named-content>) inhaled once daily as a dry powder. Of the total of 16 485 <named-content id="c7182bb4-29c9-4b2c-ba24-8d45d91e03a7" data-cid="c7182bb4-29c9-4b2c-ba24-8d45d91e03a7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-time="" data-username="" data-userid="" data-tag-index="10_24" data-pattern="$1" data-match="patients" data-offset="1655" data-tag-type="HIGH" data-tag-desc="HIGH" data-replace="patients" data-function="addTrackChanges">patients</named-content> <named-content id="62e8cb60-7824-4931-9a25-cb019bcad799" data-cid="1555285419" content-type="ins cts-3" specific-use="1555286157371" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 7:55am" data-track-detail="" data-time="1555286157371" data-username="Ariel (COPYEDITOR)" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c">who</named-content><named-content id="f3b33469-2b8e-472f-ba8b-d57d43018fe9" data-cid="1555285426" content-type="del cts-3" specific-use="1555286161289" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 7:56am" data-track-detail="" data-time="1555286161289" data-username="Ariel (COPYEDITOR)" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c">that</named-content> participated in SUMMIT, 1673 of those enrolled in the USA had blood samples analysed for this biomarker <named-content id="d1c11ec8-1f02-4e14-a497-1c811226365d" data-cid="d1c11ec8-1f02-4e14-a497-1c811226365d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="HYPPRE" data-track-detail="" data-time="" data-username="" data-userid="" data-tag-index="10_27" data-pattern="" data-match="sub-" data-offset="1773" data-tag-type="HYPPRE" data-tag-desc="HYPPRE">sub<named-content id="27b38fe4-c43d-48c7-b3cf-9511422aabf7" data-cid="1555285427" content-type="del cts-3" specific-use="1555286165621" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 7:56am" data-track-detail="" data-time="1555286165621" data-username="Ariel (COPYEDITOR)" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c">-</named-content></named-content>study. All <named-content id="f1d50d35-3e73-4a13-824b-5094c117f954" data-cid="f1d50d35-3e73-4a13-824b-5094c117f954" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-time="" data-username="" data-userid="" data-tag-index="10_25" data-pattern="$1" data-match="patients" data-offset="1788" data-tag-type="HIGH" data-tag-desc="HIGH" data-replace="patients" data-function="addTrackChanges">patients</named-content> provided written informed <named-content data-class="jrnlQueryRef" id="bed021f4-4ab3-4532-b926-882526982dd5" data-message="{'funcToCall': 'highlightQuery'}" data-event="click" data-topic="action" data-channel="query" specific-use="start" content-type="jrnlQueryRef" data-query-type="action" data-query-for="author" data-query-ref="true" data-type="start" rid="49f14994-10e5-4bc2-b917-72d26075ee9c" data-query-from="copyeditor" data-replied="true"/>consent<named-content data-class="jrnlQueryRef" id="24f7ca1d-05cc-48d2-8dbb-1e6f24f33c7a" specific-use="end" content-type="jrnlQueryRef" data-type="end" rid="49f14994-10e5-4bc2-b917-72d26075ee9c" data-replied="true"/>.<named-content id="3600a775-4422-4ea9-87c9-62114d78a2e8" data-cid="1555285428" content-type="del cts-3" specific-use="1555286227221" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 7:57am" data-track-detail="" data-time="1555286227221" data-username="Ariel (COPYEDITOR)" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c"> The study was approved by local ethics committees and was conducted in accordance with the </named-content><named-content id="dfc29d1a-e66d-46a6-9098-c2c81be6bef1" data-cid="dfc29d1a-e66d-46a6-9098-c2c81be6bef1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'Declaration of Helsinki' to 'Declaration of Helsinki'" data-track-detail="" data-time="" data-username="" data-userid="" data-tag-index="10_26" data-pattern="$1" data-match="Declaration of Helsinki" data-offset="1923" data-tag-type="HIGH" data-tag-desc="HIGH" data-replace="Declaration of Helsinki" data-function="addTrackChanges"><named-content id="6ba5b67d-367a-4dff-ae2e-9854ce2a39db" data-cid="1555285428" content-type="del cts-3" specific-use="1555286227221" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 7:57am" data-track-detail="" data-time="1555286227221" data-username="Ariel (COPYEDITOR)" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c">Declaration of Helsinki</named-content></named-content><named-content id="75d6446e-cea0-42b5-8920-e5bea3d253e2" data-cid="1555285428" content-type="del cts-3" specific-use="1555286227221" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 7:57am" data-track-detail="" data-time="1555286227221" data-username="Ariel (COPYEDITOR)" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c"> and Good Clinical Practice guidelines. </named-content><named-content id="ebedcc54-fd5f-49f8-96e1-e96183653d20" data-cid="1555285429" content-type="ins cts-3" specific-use="1555286230190" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 7:57am" data-track-detail="" data-time="1555286230190" data-username="Ariel (COPYEDITOR)" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c"> </named-content><named-content data-class="jrnlQueryRef" id="d5a865c8-32f5-45fc-9c5e-6b6815f2c594" data-message="{'funcToCall': 'highlightQuery'}" data-event="click" data-topic="action" data-channel="query" specific-use="start" content-type="jrnlQueryRef" data-query-type="action" data-query-for="author" data-query-ref="true" data-type="start" rid="6d97e74a-5804-45f6-866c-aaaedc8b541d" data-query-from="copyeditor" data-replied="true"/>The<named-content data-class="jrnlQueryRef" id="81ec26b4-65a6-4be7-bc4c-6a4703cdc264" specific-use="end" content-type="jrnlQueryRef" data-type="end" rid="6d97e74a-5804-45f6-866c-aaaedc8b541d" data-replied="true"/> study is registered on <named-content id="0cca8563-a934-43a4-9b0e-c81d7213d0a7" data-cid="1555285754" content-type="del cts-3" specific-use="1555291641799" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:27am" data-track-detail="" data-time="1555291641799" data-username="Ariel (COPYEDITOR)" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c">c</named-content><named-content id="e60bc2e8-f238-413e-a2a3-aa3edb0a7836" data-cid="1555285755" content-type="ins cts-3" specific-use="1555291642191" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 9:27am" data-track-detail="" data-time="1555291642191" data-username="Ariel (COPYEDITOR)" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c">C</named-content>linical<named-content id="7179a961-2342-4511-bccb-127084d3e962" data-cid="1555285756" content-type="del cts-3" specific-use="1555291643999" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:27am" data-track-detail="" data-time="1555291643999" data-username="Ariel (COPYEDITOR)" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c">t</named-content><named-content id="d5888125-c31f-4735-8ec4-7eecbac59fb1" data-cid="1555285757" content-type="ins cts-3" specific-use="1555291644442" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 9:27am" data-track-detail="" data-time="1555291644442" data-username="Ariel (COPYEDITOR)" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c">T</named-content>rials.gov<named-content id="2f182a6a-3a2e-4ed5-b751-5de9ac584527" data-cid="1555285430" content-type="del cts-3" specific-use="1555286298287" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 7:58am" data-track-detail="" data-time="1555286298287" data-username="Ariel (COPYEDITOR)" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c"> as NCT01313676</named-content>.</p><title data-level="2" data-class="jrnlHead2" id="678b21bc-972b-4781-a37b-cef9fb0d8923">Patient and public involvement</title><p data-class="jrnlSecPara" id="999e6a77-53de-4e88-87e0-63ba6e580b0e"><named-content content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'Patients' to 'Patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="0" data-match="Patients" data-replace="Patients" data-pattern="$1" data-tag-index="11_1" data-function="addTrackChanges" id="12b2b5a5-4033-4f82-85b7-3962551337d5">Patients</named-content> were not involved in the design, conduct or interpretation of the study.</p><title data-level="2" data-class="jrnlHead2" id="f57dbe8b-c076-41c1-a62b-6be2ccc37495">Measurements and endpoints</title><p data-class="jrnlSecPara" id="4dd8a15d-2187-4e07-bd7f-f7ec828267ab">On-treatment spirometry was performed following the European Respiratory Society<named-content data-cid="1555285705" id="5b77d10f-d1dd-4d42-9d34-fc2c1eb5ab8c" content-type="del cts-3" specific-use="1555291317820" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:21am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291317820"> (</named-content><named-content id="05e47f36-5d26-4356-ba7d-e2db164e2554" data-cid="05e47f36-5d26-4356-ba7d-e2db164e2554" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ABBR" data-track-detail="" data-tag-desc="ABBR" data-tag-type="ABBR" data-offset="82" data-match=" (ERS)" data-pattern="" data-tag-index="12_3" data-time="" data-username="" data-userid=""><named-content data-cid="1555285705" id="38eabfb7-bac7-4dec-8afe-32cc449c5f50" content-type="del cts-3" specific-use="1555291317820" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:21am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291317820">ERS</named-content></named-content><named-content data-cid="1555285705" id="b6da063f-5d73-442a-bd4b-dd12bd050906" content-type="del cts-3" specific-use="1555291317820" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:21am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291317820">)</named-content>/<named-content data-cid="1555285461" id="ebe18a3c-b6c6-49b9-ab4d-90149d061b2b" content-type="del cts-3" specific-use="1555286453489" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 8:00am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555286453489"> </named-content>American Thoracic Society<named-content data-cid="1555285706" id="482e856a-affa-443d-b0cb-c10506eec4ee" content-type="del cts-3" specific-use="1555291328601" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:22am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291328601"> (</named-content><named-content id="ec8f1511-621a-4fcc-9eeb-33dbe231f167" data-cid="ec8f1511-621a-4fcc-9eeb-33dbe231f167" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ABBR" data-track-detail="" data-tag-desc="ABBR" data-tag-type="ABBR" data-offset="115" data-match=" (ATS)" data-pattern="" data-tag-index="12_4" data-time="" data-username="" data-userid=""><named-content data-cid="1555285706" id="6034081d-e54d-4708-8003-c0cba4042766" content-type="del cts-3" specific-use="1555291328601" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:22am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291328601">ATS</named-content></named-content><named-content data-cid="1555285706" id="e71288b8-14af-40b0-b270-97f5ece39897" content-type="del cts-3" specific-use="1555291328601" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:22am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291328601">)</named-content> guidelines. Spirometric reference values were those of National Health and Nutrition Examination Survey<named-content data-cid="1555285707" id="5afba13a-0970-4c81-aa31-524c4fac79ea" content-type="del cts-3" specific-use="1555291339322" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:22am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291339322"> (</named-content><named-content id="6ce9a187-bfe3-472e-9480-d3f68d66de23" data-cid="6ce9a187-bfe3-472e-9480-d3f68d66de23" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ABBR" data-track-detail="" data-tag-desc="ABBR" data-tag-type="ABBR" data-offset="225" data-match=" (NHANES)" data-pattern="" data-tag-index="12_5" data-time="" data-username="" data-userid=""><named-content data-cid="1555285707" id="32b8228c-ecbf-4a76-aa4b-db18055d552c" content-type="del cts-3" specific-use="1555291339322" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:22am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291339322">NHANES</named-content></named-content><named-content data-cid="1555285707" id="ed0609b6-08ab-494a-a59d-fd8ca8e36ede" content-type="del cts-3" specific-use="1555291339322" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:22am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291339322">)</named-content>.<xref id="8cb9365b-3486-40fc-abbe-82623e6d4da4" ref-type="bibr" rid="R20" data-citation-string=" R20 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="234" data-match="20" data-pattern="" data-tag-index="12_1" data-track-change="20"><sup id="d456d881-deed-4afc-9acb-e31016ff36b3">20</sup></xref> On-treatment COPD exacerbations requiring treatment with antibiotics and/or oral corticosteroids<named-content data-cid="1555285462" id="20f7fcd7-f623-4b47-8326-f591c6f74a2a" content-type="del cts-3" specific-use="1555286468898" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 8:01am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555286468898">,</named-content> were recorded as moderate exacerbations<named-content data-cid="1555285463" id="ddce65c1-f0bb-4f47-a4a7-637e2ae18a39" content-type="ins cts-3" specific-use="1555286473260" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 8:01am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555286473260">,</named-content> and those requiring hospitalisation were recorded as severe. On-<named-content data-cid="1555285464" id="76d37f2e-a9b1-4b18-abba-78c7f3c47e84" content-type="ins cts-3" specific-use="1555286475470" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 8:01am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555286475470">treatment</named-content> and post-treatment deaths were adjudicated for cause by an endpoint committee.<xref id="b7c2be75-09b6-4114-951e-9666e2b6baaf" ref-type="bibr" rid="R19" data-citation-string=" R19 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="520" data-match="19" data-pattern="" data-tag-index="12_2" data-track-change="19"><sup id="7d0b5360-e556-43d1-96fd-e1258a49d0e4">19</sup></xref></p><title data-level="2" data-class="jrnlHead2" id="4f7d8a34-e2aa-4a0c-96c7-75bb28a210df">Biomarkers</title><p data-class="jrnlSecPara" id="cc90012b-9737-4749-a95d-6c499b343cca">Blood samples were collected at baseline and <named-content id="94a38721-8b1f-4b87-866d-05dcc3331731" data-cid="94a38721-8b1f-4b87-866d-05dcc3331731" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="45" data-match="3 months" data-replace="3" data-pattern="$1" data-tag-index="13_2" data-time="" data-username="" data-userid="">3</named-content><named-content id="5ede6117-01be-4278-a578-bdb46c8fe878" data-cid="5ede6117-01be-4278-a578-bdb46c8fe878" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="46" data-match="3 months" data-replace=" months" data-pattern=" $2" data-tag-index="13_2" data-time="" data-username="" data-userid=""> months</named-content> post<named-content data-cid="1555285473" id="7b41ff31-1243-44e6-9983-4733af460048" content-type="del cts-3" specific-use="1555286481200" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 8:01am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555286481200">-</named-content>randomisation. Samples were stored at –<named-content id="d00d1c57-6ce9-4fa6-af4a-6a077da0dce5" data-cid="d00d1c57-6ce9-4fa6-af4a-6a077da0dce5" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="100" data-match="80°C" data-replace="80" data-pattern="$1" data-tag-index="13_3" data-time="" data-username="" data-userid="">80</named-content><named-content id="da9ca350-005e-46e8-871b-cf147c05c890" data-cid="da9ca350-005e-46e8-871b-cf147c05c890" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="102" data-match="80°C" data-replace="°C" data-pattern="°C" data-tag-index="13_3" data-time="" data-username="" data-userid="">°C</named-content> until analysed. SPD, CC-16 and sRAGE were measured in serum samples. Fibrinogen and CRP (high<named-content data-cid="1555285474" id="a029b734-5965-49d4-a896-937846e4bbbb" content-type="del cts-3" specific-use="1555286488743" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 8:01am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555286488743"> </named-content><named-content data-cid="1555285475" id="9e97fc4e-eac1-420b-b995-14a42b589c9d" content-type="ins cts-3" specific-use="1555286489014" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 8:01am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555286489014">-</named-content>sensitivity methods) were measured in plasma samples. All protein biomarkers were measured by validated immunoassays. Concentrations below lower limit of detection (<named-content id="6a71f125-df3a-4faa-8162-c3fd6e444126" data-cid="6a71f125-df3a-4faa-8162-c3fd6e444126" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ABBR" data-track-detail="" data-tag-desc="ABBR" data-tag-type="ABBR" data-offset="365" data-match=" (LLD)" data-pattern="" data-tag-index="13_4" data-time="" data-username="" data-userid="">LLD</named-content>) were imputed to ½<named-content id="4bd3a388-78c7-421e-9c2f-c2295fc94aa3" data-cid="4bd3a388-78c7-421e-9c2f-c2295fc94aa3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣×␣' to '×'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="388" data-match=" × LLD" data-replace="×" data-pattern="$2" data-tag-index="13_1" data-track-change=" × " data-time="" data-username="" data-userid="">×</named-content>LLD.</p><title data-level="2" data-class="jrnlHead2" id="e01dbff6-1ea0-4f67-ab5d-b57a240e232a">Statistical analysis</title><p data-class="jrnlSecPara" id="c4c5b638-e43e-452e-9b8e-e20a6a5904e3">To examine the effect of treatment on the change in biomarker concentrations between baseline and <named-content id="01c01471-1ba8-44b9-96a4-e4daac16f530" data-cid="01c01471-1ba8-44b9-96a4-e4daac16f530" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="98" data-match="3 months" data-replace="3" data-pattern="$1" data-tag-index="14_1" data-time="" data-username="" data-userid="">3</named-content><named-content id="19c31fe2-93ed-4f25-af2f-6349c651eccb" data-cid="19c31fe2-93ed-4f25-af2f-6349c651eccb" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="99" data-match="3 months" data-replace=" months" data-pattern=" $2" data-tag-index="14_1" data-time="" data-username="" data-userid=""> months</named-content>, analyses of covariance<named-content data-cid="1555285510" id="87fc540f-fbaf-4b01-a111-cdf4554d0c2d" content-type="del cts-3" specific-use="1555286679461" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 8:04am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555286679461"> (</named-content><named-content id="7b92a6de-83f1-4607-983b-556ce0d02a23" data-cid="7b92a6de-83f1-4607-983b-556ce0d02a23" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ABBR" data-track-detail="" data-tag-desc="ABBR" data-tag-type="ABBR" data-offset="132" data-match=" (ANCOVAs)" data-pattern="" data-tag-index="14_2" data-time="" data-username="" data-userid=""><named-content data-cid="1555285510" id="03faaf18-03d8-4b6d-a749-dd6123a2facd" content-type="del cts-3" specific-use="1555286679461" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 8:04am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555286679461">ANCOVAs</named-content></named-content><named-content data-cid="1555285510" id="eef914cd-715e-4aca-b839-ce74c832457e" content-type="del cts-3" specific-use="1555286679461" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 8:04am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555286679461">)</named-content> were performed using the covariates of baseline biomarker concentration, age and gender. As all biomarkers except fibrinogen had positively skewed distributions, these were log transformed<named-content data-cid="1555285476" id="feaad6b5-bcbe-4ffe-bd2d-99204c95fbff" content-type="ins cts-3" specific-use="1555286525368" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 8:02am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555286525368">,</named-content> and the changes were expressed as ratios, and geometric means presented rather than arithmetic means.</p><p data-class="jrnlSecPara" id="c91acd9e-2192-4ea8-b1b7-98af893c82ce">The biomarker concentrations were divided into groups according to tertiles at baseline and are presented in <named-content data-cid="1555394565767" id="dadd61af-2ea6-4795-8a87-6e0dabcd0de8" content-type="del cts-1" specific-use="1555068439000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1555068439000">supplementary table 1</named-content><named-content data-cid="1555394565767" id="9e7be5fb-224f-4bfc-9fd0-c91387524407" content-type="ins cts-1" specific-use="1555068439000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1555068439000"><xref id="30bf3a93-8ab3-417b-8b90-2b6667feae5c" ref-type="supplementary-material" rid="SP1" data-citation-string=" SP1 " data-mark-cited="SP1">online supplementary table 1</xref></named-content>. To explore whether the biomarker concentrations affected rate of decline in FEV<sub id="de60b94d-5e78-475d-83a3-304ddfddaa6e">1</sub>, random coefficients models were fitted with terms of age, gender, baseline FEV<sub id="2c5c41a0-6f21-4294-863a-099915faec2b">1</sub>, time, treatment, treatment by time, baseline biomarker tertile groups and baseline biomarker tertile groups by time, with subjects fitted as a random effect. Associations between baseline biomarker tertile groups and endpoints including all-cause mortality, <named-content data-cid="1555285730" id="3af5a925-35f4-433a-ba5d-b269f9fb29af" content-type="del cts-3" specific-use="1555291412458" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:23am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291412458">cardiovascular</named-content><named-content data-cid="1555285731" id="68655f79-458b-40be-8c48-42bb1220707e" content-type="ins cts-3" specific-use="1555291412506" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 9:23am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291412506">CV</named-content> death, moderate or severe exacerbations and severe exacerbations were modelled using Cox proportional hazards including terms for age, gender and study treatment<named-content data-cid="1555285477" id="6ed7bd01-b7a6-4a67-b7e5-e6e70ef6ec94" content-type="del cts-3" specific-use="1555286552536" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 8:02am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555286552536">,</named-content> and also previous exacerbation history for the exacerbation endpoints.</p><p data-class="jrnlSecPara" id="d6cbf5a1-6fd2-4bdc-b390-08b2ce23c726">Correlations between variables of interest were explored using Pearson’s correlation coefficient.</p><p data-class="jrnlSecPara" id="b5772378-da23-43ba-af38-ae7353628643">Two-sided tests were performed <named-content data-cid="1555285478" id="307e8ea2-aeb0-4007-b4b5-3735aa6b195b" content-type="styrm cts-3" specific-use="1555286558607" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Italic Removed by Ariel (COPYEDITOR) - Apr 15 2019 8:02am" data-track-detail="" data-format-command="italic" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555286558607" data-track-hint="Italic Removed">post hoc</named-content> at the 0.05 level of significance, using SAS <named-content data-cid="1555285481" id="646f84ab-299b-4779-97d8-06aa36883288" content-type="ins cts-3" specific-use="1555286562646" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 8:02am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555286562646">V.</named-content>9.4. All p values are nominal, as no adjustment was made for multiple comparisons.</p><title data-level="1" data-class="jrnlHead1" id="e905db23-13f1-45dc-98fd-f0fd7c52217e">Results</title><title data-level="2" data-class="jrnlHead2" id="565ddb4c-bcd3-42fa-afba-2af875639d10">Clinical data</title><p data-class="jrnlSecPara" id="5663aff2-945f-4056-be76-34e0ec26f2c2"><named-content data-class="jrnlQueryRef" id="04b9dbbc-9fdd-4917-a33e-dfebc2340faa" data-message="{'funcToCall': 'highlightQuery'}" data-event="click" data-topic="action" data-channel="query" specific-use="start" content-type="jrnlQueryRef" data-query-type="action" data-query-for="author" data-query-ref="true" data-type="start" rid="e454f372-614c-4b94-9f3c-5e5c1f9da1d3" data-query-from="copyeditor" data-replied="true"/>The<named-content data-class="jrnlQueryRef" id="ee4e1227-ed46-4279-9bdf-57881819c06e" specific-use="end" content-type="jrnlQueryRef" data-type="end" rid="e454f372-614c-4b94-9f3c-5e5c1f9da1d3" data-replied="true"/> published primary results of SUMMIT showed that there was no effect of any of the therapies on mortality, the primary outcome.<xref id="eb4e80c4-6f66-4d33-b943-db1378166920" ref-type="bibr" rid="R19" data-tag-index="18_2" data-pattern="" data-match="19" data-offset="131" data-tag-type="BIBREF" data-tag-desc="BIBREF" data-track-change="19" data-citation-string=" R19 "><sup id="2d2a339b-5db1-4f75-8dbc-f70a806c8a5f">19</sup></xref> The <named-content id="f49a0cfa-efee-4cf4-ac26-70cb3230631f" data-cid="1555285483" content-type="ins cts-3" specific-use="1555286624365" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 8:03am" data-track-detail="" data-time="1555286624365" data-username="Ariel (COPYEDITOR)" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c"><span id="0e18e98d-dee0-48f5-b4e3-d73dc5d126d2"><span id="788ebbf8-5c07-41fe-92a6-a0401222f382">Consolidated Standards of Reporting Trials</span></span></named-content><named-content id="4c4b4694-7beb-4c41-8992-eb721cbd07c7" data-cid="1555285508" content-type="del cts-3" specific-use="1555286656409" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 8:04am" data-track-detail="" data-time="1555286656409" data-username="Ariel (COPYEDITOR)" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c">CONSORT</named-content> diagram of the SUMMIT systemic biomarker <named-content id="dddf31d0-0724-40db-b787-62b04705dcdd" data-cid="dddf31d0-0724-40db-b787-62b04705dcdd" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="HYPPRE" data-track-detail="" data-time="" data-username="" data-userid="" data-tag-index="18_6" data-pattern="" data-match="sub-" data-offset="188" data-tag-type="HYPPRE" data-tag-desc="HYPPRE">sub<named-content id="d4b59258-4b40-493c-9063-df816933b42c" data-cid="1555285509" content-type="del cts-3" specific-use="1555286658953" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 8:04am" data-track-detail="" data-time="1555286658953" data-username="Ariel (COPYEDITOR)" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c">-</named-content></named-content>study enrolled in the USA is shown in <xref id="a4a3f614-49a6-4cbe-9d1a-9323ef004120" ref-type="fig" rid="F1" data-tag-index="18_1" data-pattern="" data-match="figure 1" data-offset="230" data-tag-type="FIGTBLREF" data-tag-desc="FIGTBLREF" data-citation-string=" F1 " data-anchor="true">figure 1</xref>. Of the 16 485 worldwide <named-content id="4ce93272-b2d8-4633-8ff1-410d92bff15f" data-cid="4ce93272-b2d8-4633-8ff1-410d92bff15f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-time="" data-username="" data-userid="" data-tag-index="18_5" data-pattern="$1" data-match="patients" data-offset="264" data-tag-type="HIGH" data-tag-desc="HIGH" data-replace="patients" data-function="addTrackChanges">patients</named-content> participating in SUMMIT, 1673 recruited in the USA had biomarker data at baseline.</p><fig id="BLK_F1" data-id="BLK_F1" data-stream-name="a_F1" data-edited-node="true" data-float-percent="70" position="float" fig-type="figure"><label id="40daf4f1-8c46-423c-919c-3148c471963d">Figure 1</label><caption id="53da1907-f1fb-4746-964b-74513061926b"><title id="F1" data-id="F1"><named-content data-cid="1555285484" id="6d762601-bb98-440a-8aec-3e30518b52dd" content-type="del cts-3" specific-use="1555286629951" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 8:03am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555286629951">Consort</named-content><named-content data-cid="1555285485" id="d8896672-bc23-4bb8-ab07-39e99db9e75e" content-type="ins cts-3" specific-use="1555286629999" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 8:03am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555286629999">CONSORT</named-content> diagram of the <named-content id="f5f7bbb4-e3e5-420a-ae47-4a88c5e50f70" data-cid="f5f7bbb4-e3e5-420a-ae47-4a88c5e50f70" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="32" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="196_2" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content><named-content data-cid="1555068417012" id="af033818-c5b3-44f5-8e10-7b048571809c" content-type="del cts-1" specific-use="1555068417000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1555068417000" data-reason="truecase"> included in the systemic biomarker study completed only in the United States, as part of the SUMMIT international trial. CC-16, club cell protein 16; CRP, C-reactive protein; SPD, surfactant protein D; sRAGE, soluble receptor of activated glycogen end-product.</named-content><named-content data-cid="1555068417012" id="3db7c43c-24d0-4fc7-90a2-e0f3b599c9ad" content-type="ins cts-1" specific-use="1555068417000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1555068417000" data-reason="truecase"> included in the systemic biomarker study completed only in the U<named-content data-cid="1555285511" id="507da96a-1d2e-4b7a-981f-b019c045e0f0" content-type="ins cts-3" specific-use="1555287086649" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 8:11am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555287086649">SA</named-content><named-content data-cid="1555285513" id="64a360ac-aa0c-4eb1-9046-84fdb1be082e" content-type="del cts-3" specific-use="1555287088703" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 8:11am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555287088703">nited States</named-content>, as part of the S<named-content data-cid="1555285514" id="30c58a56-1b00-4042-a2e9-f8e46e1c1e01" content-type="ins cts-3" specific-use="1555287093559" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 8:11am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555287093559">UMMIT</named-content><named-content data-cid="1555285519" id="dd80ecb0-49a4-48e8-9960-e6df8d418899" content-type="del cts-3" specific-use="1555287097155" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 8:11am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555287097155">ummit</named-content> international trial. CC-16, <named-content data-cid="1555285520" id="bf9b4314-181c-44b6-85a2-0fb78affcc5f" content-type="del cts-3" specific-use="1555287102003" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 8:11am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555287102003">C</named-content><named-content data-cid="1555285521" id="761eb9c9-b58c-4a9f-8dec-0c4694513b09" content-type="ins cts-3" specific-use="1555287102584" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 8:11am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555287102584">c</named-content>lub cell protein 16; <named-content data-cid="1555285494" id="3bf3d352-8015-47e7-ab2f-21fe6980573f" content-type="ins cts-3" specific-use="1555286640171" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 8:04am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555286640171">CONSORT, <named-content data-cid="1555285503" id="ff02bb4a-c6b5-4adf-97c6-d90687f67054" content-type="ins cts-3" specific-use="1555286641786" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 8:04am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555286641786"><span id="2437b04b-1e31-40ec-81ee-c4193cf70f85"><span id="e918dd24-5ac6-4449-bb1c-772af7210029">Consolidated Standards of Reporting Trials</span></span>; </named-content></named-content>CRP, C<named-content data-cid="1555285506" id="ece59331-5427-4cfc-a30a-c9b24b5dd416" content-type="del cts-3" specific-use="1555286645376" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 8:04am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555286645376">-</named-content><named-content data-cid="1555285507" id="06d10f8f-b675-41c3-afa7-350de85e8b68" content-type="ins cts-3" specific-use="1555286645534" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 8:04am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555286645534"> </named-content>reactive protein; SPD, surfactant protein D; sRAGE, soluble receptor of activated glycogen end-product.</named-content></title></caption><graphic xlink:href="" id="7912aba1-6258-4117-97e8-4824c543ecdd" data-alt-src="" data-primary-extension="" data-old-src="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/SUMMIT_biomarker_Fig1_29MAR2019.jpg.JPEG" data-track="del"/><graphic xlink:href="" id="e2fe3d81-aca1-4885-ba12-cbf7efdabf0c" data-alt-src="" data-primary-extension="tif" data-original-name="F001" data-filesize="202KB" data-colorspace="sRGB" data-geometry="1415x729+0+0" data-track="del" data-cid="1555314088860" data-username="Gowtham Ram (TYPESETTER)" data-userid="typesetter gowthamram" data-time="1555314088860" data-title="Inserted by Gowtham Ram (TYPESETTER) - Apr 15 2019 1:11pm" data-old-src="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/938c2ba8-9c71-4eee-8def-f169447c31df.tif.JPEG"/><graphic xlink:href="" id="205e4a5a-a2a8-48d7-b1e8-1319b08ccfab" data-alt-src="" data-primary-extension="jpg" data-original-name="Fig1" data-filesize="194KB" data-colorspace="sRGB" data-geometry="1509x792+0+0" data-track="del" data-cid="1555318311740" data-username="Gowtham Ram (TYPESETTER)" data-userid="typesetter gowthamram" data-time="1555318311740" data-title="Inserted by Gowtham Ram (TYPESETTER) - Apr 15 2019 2:21pm" data-old-src="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/c5b38804-1a3f-47af-9ccd-65b03d34eadd.jpg.JPEG"/><graphic xlink:href="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/4cd6e9ad-bb6f-45ba-90a3-31f52ba2c388.tiff.JPEG" id="5021f723-e412-4aaf-b8e2-e8dfbb521a44" data-alt-src="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/4cd6e9ad-bb6f-45ba-90a3-31f52ba2c388.tiff.JPEG" data-primary-extension="tiff" data-original-name="Fig1" data-filesize="126KB" data-colorspace="sRGB" data-geometry="1509x792+0+0" data-track="ins" data-cid="1555318816076" data-username="Gowtham Ram (TYPESETTER)" data-userid="typesetter gowthamram" data-time="1555318816076" data-title="Inserted by Gowtham Ram (TYPESETTER) - Apr 15 2019 2:30pm"/></fig><p data-class="jrnlSecPara" id="38415a15-37f9-4266-b686-71560c942931">The clinical characteristics of the <named-content id="b1453461-4cc3-4984-b486-83cdee775a8e" data-cid="b1453461-4cc3-4984-b486-83cdee775a8e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="36" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="19_12" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> included in the study and those from the general SUMMIT population are shown in <xref id="620d8192-15d1-4ffa-a5af-20ef698c1447" ref-type="table" rid="T1" data-citation-string=" T1 " data-tag-desc="FIGTBLREF" data-tag-type="FIGTBLREF" data-offset="125" data-match="table 1" data-pattern="" data-tag-index="19_1" data-anchor="true">table 1</xref>. Most characteristics were similar in both groups, except for the biomarker population having more females, higher body mass index<named-content data-cid="1555285708" id="550f318f-0c6c-4c11-acd9-a9c350b17553" content-type="del cts-3" specific-use="1555291373797" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:22am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291373797"> (</named-content><named-content id="c7ed9653-8fdb-4079-9d4f-7d0fd18bbc36" data-cid="c7ed9653-8fdb-4079-9d4f-7d0fd18bbc36" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ABBR" data-track-detail="" data-tag-desc="ABBR" data-tag-type="ABBR" data-offset="265" data-match=" (BMI)" data-pattern="" data-tag-index="19_9" data-time="" data-username="" data-userid=""><named-content data-cid="1555285708" id="321d8535-4617-40ba-848e-d4de73ec0cee" content-type="del cts-3" specific-use="1555291373797" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:22am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291373797">BMI</named-content></named-content><named-content data-cid="1555285708" id="14e1c07e-d86e-4404-9875-a836d15cf584" content-type="del cts-3" specific-use="1555291373797" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:22am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291373797">)</named-content>, fewer COPD exacerbations in the year prior to the study and some differences in <named-content data-cid="1555285733" id="523a86f9-fb63-4199-ba82-5be20b03f4b2" content-type="del cts-3" specific-use="1555291415272" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:23am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291415272">cardiovascular (</named-content><named-content id="02c4bacc-3071-43b9-a50f-5b0d462dacd9" data-cid="02c4bacc-3071-43b9-a50f-5b0d462dacd9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ABBR" data-track-detail="" data-tag-desc="ABBR" data-tag-type="ABBR" data-offset="367" data-match=" (CV)" data-pattern="" data-tag-index="19_10" data-time="" data-username="" data-userid="">CV</named-content><named-content data-cid="1555285734" id="3ee9c81a-e4ba-468e-9742-6bc2684ecf84" content-type="del cts-3" specific-use="1555291416070" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:23am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291416070">)</named-content> history and CV therapy. In the biomarker <named-content id="f5eb58cc-fb0c-4c88-8061-41b76b14a4fe" data-cid="f5eb58cc-fb0c-4c88-8061-41b76b14a4fe" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="HYPPRE" data-track-detail="" data-tag-desc="HYPPRE" data-tag-type="HYPPRE" data-offset="412" data-match="sub-" data-pattern="" data-tag-index="19_15" data-time="" data-username="" data-userid="">sub<named-content data-cid="1555285522" id="be008806-ed3e-49a7-ac4d-4b8036df5584" content-type="del cts-3" specific-use="1555287180035" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 8:13am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555287180035">-</named-content></named-content>study, the average age was <named-content id="5aa0edb4-ff6d-467d-970b-c1f7b1498f43" data-cid="5aa0edb4-ff6d-467d-970b-c1f7b1498f43" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="443" data-match="66 years" data-replace="66" data-pattern="$1" data-tag-index="19_2" data-time="" data-username="" data-userid="">66</named-content><named-content id="5391b19b-7258-479e-8b9f-d90c31754a2a" data-cid="5391b19b-7258-479e-8b9f-d90c31754a2a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="445" data-match="66 years" data-replace=" years" data-pattern=" $2" data-tag-index="19_2" data-time="" data-username="" data-userid=""> years</named-content>, <named-content id="4308ab29-e805-4051-9883-6848e73820a7" data-cid="4308ab29-e805-4051-9883-6848e73820a7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="453" data-match="62%" data-replace="62" data-pattern="$1" data-tag-index="19_3" data-time="" data-username="" data-userid="">62</named-content><named-content id="570d7c81-8732-47c5-8785-4d40fb1ccef7" data-cid="570d7c81-8732-47c5-8785-4d40fb1ccef7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="455" data-match="62%" data-replace="%" data-pattern="%" data-tag-index="19_3" data-time="" data-username="" data-userid="">%</named-content> of the <named-content id="d003493c-2011-4b8a-8a91-a03d44dd2192" data-cid="d003493c-2011-4b8a-8a91-a03d44dd2192" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="464" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="19_13" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> were male and <named-content id="5b15e3e8-9178-4762-8a3b-605045dc7600" data-cid="5b15e3e8-9178-4762-8a3b-605045dc7600" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="487" data-match="49%" data-replace="49" data-pattern="$1" data-tag-index="19_4" data-time="" data-username="" data-userid="">49</named-content><named-content id="9b666f3b-c352-480d-9d0e-27d3159195a8" data-cid="9b666f3b-c352-480d-9d0e-27d3159195a8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="489" data-match="49%" data-replace="%" data-pattern="%" data-tag-index="19_4" data-time="" data-username="" data-userid="">%</named-content> were smoking at the time of enrolment. By design<named-content data-cid="1555285523" id="48aa8dba-576a-4ff7-a8f2-8815442d715a" content-type="ins cts-3" specific-use="1555287186445" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 8:13am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555287186445">,</named-content> they had moderate airflow limitation by the Global Initiative for Chronic Obstructive Lung Disease (<named-content id="9b0003c1-bf0e-4c11-b1c6-329b778b33c1" data-cid="9b0003c1-bf0e-4c11-b1c6-329b778b33c1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ABBR" data-track-detail="" data-tag-desc="ABBR" data-tag-type="ABBR" data-offset="640" data-match=" (GOLD)" data-pattern="" data-tag-index="19_11" data-time="" data-username="" data-userid="">GOLD</named-content>) criteria (FEV<sub id="fa3fc4dc-88c2-4916-8c7f-f4cf8785cd55">1</sub> <named-content id="84c7205c-1cda-4066-b886-e055e0677334" data-cid="84c7205c-1cda-4066-b886-e055e0677334" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="661" data-match="60%" data-replace="60" data-pattern="$1" data-tag-index="19_5" data-time="" data-username="" data-userid="">60</named-content><named-content id="00f6861f-59ad-427e-8892-40c33a85ef16" data-cid="00f6861f-59ad-427e-8892-40c33a85ef16" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="663" data-match="60%" data-replace="%" data-pattern="%" data-tag-index="19_5" data-time="" data-username="" data-userid="">%</named-content> predicted) and had significant <named-content data-cid="1555285735" id="df1cef63-20a1-4a9e-b768-cd6902ef0c1f" content-type="del cts-3" specific-use="1555291417444" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:23am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291417444">cardiovascular</named-content><named-content data-cid="1555285736" id="382d0876-717f-4d69-8dbc-f6fe906794bd" content-type="ins cts-3" specific-use="1555291417492" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 9:23am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291417492">CV</named-content> disease or risk. <named-content id="b0cef81e-e8c6-4681-8222-46fa056f08a7" data-cid="b0cef81e-e8c6-4681-8222-46fa056f08a7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'Patients' to 'Patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="728" data-match="Patients" data-replace="Patients" data-pattern="$1" data-tag-index="19_14" data-function="addTrackChanges" data-time="" data-username="" data-userid="">Patients</named-content> were followed for mortality for a median of <named-content id="232b5323-2bc3-4f63-a6d8-97685bfda839" data-cid="232b5323-2bc3-4f63-a6d8-97685bfda839" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="781" data-match="2 years" data-replace="2" data-pattern="$1" data-tag-index="19_6" data-time="" data-username="" data-userid="">2</named-content><named-content id="e63d05be-d656-4215-bc51-6e0a0152d7f9" data-cid="e63d05be-d656-4215-bc51-6e0a0152d7f9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="782" data-match="2 years" data-replace=" years" data-pattern=" $2" data-tag-index="19_6" data-time="" data-username="" data-userid=""> years</named-content> and <named-content id="eea46e95-6bbb-4ae7-ac36-1b8c292805a0" data-cid="eea46e95-6bbb-4ae7-ac36-1b8c292805a0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="793" data-match="3 months" data-replace="3" data-pattern="$1" data-tag-index="19_7" data-time="" data-username="" data-userid="">3</named-content><named-content id="6424d957-0bc1-48f7-83a8-938498d04372" data-cid="6424d957-0bc1-48f7-83a8-938498d04372" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="794" data-match="3 months" data-replace=" months" data-pattern=" $2" data-tag-index="19_7" data-time="" data-username="" data-userid=""> months</named-content> and for all on-treatment endpoints for a median of <named-content id="9776cda4-aacd-450b-8730-227052c6502b" data-cid="9776cda4-aacd-450b-8730-227052c6502b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="853" data-match="18 months" data-replace="18" data-pattern="$1" data-tag-index="19_8" data-time="" data-username="" data-userid="">18</named-content><named-content id="16cbae93-ccdf-475a-85a6-76a4cd01a4f2" data-cid="16cbae93-ccdf-475a-85a6-76a4cd01a4f2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="855" data-match="18 months" data-replace=" months" data-pattern=" $2" data-tag-index="19_8" data-time="" data-username="" data-userid=""> months</named-content> and an average of <named-content data-cid="1555285524" id="b07aa66a-e5fa-4634-9d64-309b70853004" content-type="del cts-3" specific-use="1555287199805" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 8:13am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555287199805">7</named-content><named-content data-cid="1555285525" id="cdf3ee4f-ba5c-4ea9-b15a-eef1d623dc88" content-type="ins cts-3" specific-use="1555287199888" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 8:13am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555287199888">seven</named-content> spirometric measurements over this time.</p><table-wrap id="BLK_T1" data-id="BLK_T1" data-stream-name="a_T1" position="float"><label id="0232d256-db85-45cc-9f60-710747f0b637">Table 1</label><caption id="f6a57166-d619-4c98-a9cf-386e9d5dc36b"><title id="T1" data-head-type="bold" data-id="T1">Demographic characteristics of the <named-content id="7e231f9e-ce6c-4d2e-ae26-aead69024da8" data-cid="7e231f9e-ce6c-4d2e-ae26-aead69024da8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="43" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="20_2" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> included in the biomarker <named-content id="e4466d64-e9b1-42e7-8552-bca1ee2dbd0d" data-cid="e4466d64-e9b1-42e7-8552-bca1ee2dbd0d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="HYPPRE" data-track-detail="" data-tag-desc="HYPPRE" data-tag-type="HYPPRE" data-offset="78" data-match="sub-" data-pattern="" data-tag-index="20_3" data-time="" data-username="" data-userid="">sub<named-content data-cid="1555285530" id="be3ea745-404b-4fde-8f9e-10bd226d4b79" content-type="del cts-3" specific-use="1555287204168" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 8:13am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555287204168">-</named-content></named-content>study conducted in the USA and that of the worldwide participants</title></caption><table data-col-count="3" data-caption-link="T1" data-col-widths-px="139.388,53,54" data-table-type="singleColumn" id="495820c6-b73f-4580-8c76-b519934579ac" data-old-attributes="&quot;data-font-size&quot;:&quot;undefined&quot;;&quot;data-col-widths-px&quot;:&quot;115.12933333333,62.129333333333,69.129333333333&quot;" data-changed-attributes="data-font-size" data-font-size="8px"><thead id="d53f787d-6594-4962-a4a1-9360d35628a8" data-old-attributes="&quot;data-font-size&quot;:&quot;undefined&quot;;" data-changed-attributes="data-font-size" data-font-size="8px"><tr data-col-count="3" id="1da5a723-5752-4802-831d-940141bea51f"><td data-original-space="1" data-original-border="border:none;border-top:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" valign="bottom" id="e96bf7b5-acb6-49f4-b210-aaf1e0332dc0" data-old-attributes=""><p id="4c3ebdae-44e2-4cf6-bfb4-f037f7e231d7" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"/></td><td data-class="" data-original-border="border:none;border-top:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" valign="bottom" id="e8cc84a3-ccb9-4aef-8993-c7c85e8df864" data-old-attributes=""><p id="5b9e43e4-1096-4f70-a9f6-38aec19c3ca7" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Biomarker <named-content id="4bc52f46-c438-442c-9642-98306eb46f69" data-cid="4bc52f46-c438-442c-9642-98306eb46f69" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="HYPPRE" data-track-detail="" data-tag-desc="HYPPRE" data-tag-type="HYPPRE" data-offset="10" data-match="sub-" data-pattern="" data-tag-index="21_1" data-time="" data-username="" data-userid="">sub<named-content data-cid="1555285531" id="f42cde77-c600-4048-9ea2-a6d9902e209f" content-type="del cts-3" specific-use="1555287207720" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 8:13am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555287207720">-</named-content></named-content>study</p></td><td data-class="" data-original-border="border:none;border-top:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" valign="bottom" id="68b32c4b-6277-40af-a29b-a8292f6f7f7a" data-old-attributes=""><p id="a349ac52-c91a-4617-9943-ae1fe586b667" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">SUMMIT population</p></td></tr></thead><tbody id="391c2b91-a9ca-4156-9b18-ab0feae13a47" data-old-attributes="&quot;data-font-size&quot;:&quot;undefined&quot;;" data-changed-attributes="data-font-size" data-font-size="8px"><tr data-col-count="3" data-fill="true" id="3017be9c-5c1b-4fbf-b6be-9e65effb6372"><td data-original-space="1" data-original-border="border:none;border-bottom:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" valign="top" id="d33b84f9-a563-47ad-8642-0c80eacecc8d" data-old-attributes=""><p id="71f03a40-5141-4b1d-844a-b572aa0ceb3a" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-bottom: 3.0pt; margin-top: 0cm;"/></td><td data-original-border="border:none;border-bottom:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" valign="top" id="f8fd5ba1-8300-4bab-af53-fc7d9cfb5928" data-old-attributes=""><p id="cdd6d94c-9116-422d-ab45-8c4c053c0b62" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-bottom: 3.0pt; margin-top: 0cm;"><named-content id="271a928a-e3b0-4995-b81d-23185913db7b" data-cid="271a928a-e3b0-4995-b81d-23185913db7b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'n' to 'n'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="0" data-match="n=1673" data-replace="n" data-pattern="$1" data-tag-index="23_1" data-function="lowercase,removeItalics" data-time="" data-username="" data-userid="">n</named-content><named-content id="215b5913-8b4d-41e1-90cd-bac7ee411ed0" data-cid="215b5913-8b4d-41e1-90cd-bac7ee411ed0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="1" data-match="n=1673" data-replace="=" data-pattern="$2" data-tag-index="23_1" data-time="" data-username="" data-userid="">=</named-content><named-content id="4b7a9aa9-c861-4bb8-b3f3-a72f2133bc7f" data-cid="4b7a9aa9-c861-4bb8-b3f3-a72f2133bc7f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="2" data-match="n=1673" data-replace="1673" data-pattern="1673" data-tag-index="23_1" data-time="" data-username="" data-userid="">1673</named-content></p></td><td data-original-border="border:none;border-bottom:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" valign="top" id="c7a02996-fe73-4da8-8c3b-24918471440c" data-old-attributes=""><p id="b17fe721-8b3b-4ed0-9ec4-331eee6af8fb" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-bottom: 3.0pt; margin-top: 0cm;"><named-content id="3f3f2d2b-876a-4d69-baae-67601397bf6a" data-cid="3f3f2d2b-876a-4d69-baae-67601397bf6a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'n' to 'n'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="0" data-match="n=16 485" data-replace="n" data-pattern="$1" data-tag-index="24_1" data-function="lowercase,removeItalics" data-time="" data-username="" data-userid="">n</named-content><named-content id="bec463d1-7feb-45aa-ace3-ec3d166f4289" data-cid="bec463d1-7feb-45aa-ace3-ec3d166f4289" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="1" data-match="n=16 485" data-replace="=" data-pattern="$2" data-tag-index="24_1" data-time="" data-username="" data-userid="">=</named-content><named-content id="4b5addf2-30ff-4979-bd9e-897affaad20d" data-cid="4b5addf2-30ff-4979-bd9e-897affaad20d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="2" data-match="n=16 485" data-replace="16 485" data-pattern="$3" data-tag-index="24_1" data-time="" data-username="" data-userid="">16 485</named-content></p></td></tr><tr data-col-count="3" id="2a83a75b-e35c-482b-93a8-6a24e4ba28cf"><td data-class="" data-original-border="border:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" valign="top" id="505ed6d6-a9d9-4192-8b5f-8aa81c6e5f46" data-old-attributes=""><p id="5a625938-4540-49aa-9d91-bbd358212788" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1555069313" id="075f2ca0-514b-49c0-ad57-8dce4fe6050d" content-type="styrm cts-2" specific-use="1555070023151" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Bold Removed by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:23pm" data-track-detail="" data-format-command="bold" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070023151" data-track-hint="Bold Removed">Age, years</named-content></p></td><td data-original-border="border:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" valign="top" id="5691c15b-b516-4161-a439-91a1e35bf749" data-old-attributes=""><p id="dfec5f9b-0e9e-4bb0-9bc8-43a0d819680d" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="64efbfa6-1dbb-4719-9609-ed6433834341" data-cid="64efbfa6-1dbb-4719-9609-ed6433834341" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="66 (8)" data-replace="66" data-pattern="$1" data-tag-index="26_1" data-time="" data-username="" data-userid="">66</named-content><named-content id="8eed6699-0482-4a98-a756-1c8bb738e070" data-cid="8eed6699-0482-4a98-a756-1c8bb738e070" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="2" data-match="66 (8)" data-replace=" (8)" data-pattern=" $2" data-tag-index="26_1" data-time="" data-username="" data-userid=""> (8)</named-content></p></td><td data-original-border="border:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" valign="top" id="2a823864-8ee7-4ce3-8f52-85ee3449fae8" data-old-attributes=""><p id="45f840b7-39ad-4fd6-b45b-26852366c6bc" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="a4524834-8561-45f3-8cc9-2304b810c42e" data-cid="a4524834-8561-45f3-8cc9-2304b810c42e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="65 (8)" data-replace="65" data-pattern="$1" data-tag-index="27_1" data-time="" data-username="" data-userid="">65</named-content><named-content id="502c7ca2-ac32-449e-9d6d-b1c2fcc2b8e4" data-cid="502c7ca2-ac32-449e-9d6d-b1c2fcc2b8e4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="2" data-match="65 (8)" data-replace=" (8)" data-pattern=" $2" data-tag-index="27_1" data-time="" data-username="" data-userid=""> (8)</named-content></p></td></tr><tr data-col-count="3" data-fill="true" id="b0fecf7e-7c13-4e16-8c64-6ff0b1c8196e"><td data-class="" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" valign="top" id="39681c25-cf22-4573-b63a-80502f435ed3" data-old-attributes=""><p id="017bf7ee-e238-4a70-8d37-8f35e7a359cf" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1555069314" id="0876fdd0-d7bf-447b-9df4-9555468e8c5d" content-type="styrm cts-2" specific-use="1555070024518" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Bold Removed by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:23pm" data-track-detail="" data-format-command="bold" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070024518" data-track-hint="Bold Removed">Women</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" valign="top" id="4b4dc6e8-2773-4434-a231-4b0cf4466e88" data-old-attributes=""><p id="b278f58d-0687-4fa9-b36f-4a5880efe10f" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="f164a997-55ac-4cd4-ae48-81c09b81aa9a" data-cid="f164a997-55ac-4cd4-ae48-81c09b81aa9a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="635 (38%)" data-replace="635" data-pattern="$1" data-tag-index="29_1" data-time="" data-username="" data-userid="">635</named-content><named-content id="a9a97997-4428-47fa-8e31-76239d7bf5a3" data-cid="a9a97997-4428-47fa-8e31-76239d7bf5a3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="635 (38%)" data-replace=" (38%)" data-pattern=" $2" data-tag-index="29_1" data-time="" data-username="" data-userid=""> (38%)</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" valign="top" id="96130b9b-9b8b-4483-b921-1112abe76361" data-old-attributes=""><p id="3f0f927a-2a84-446b-9340-d069b427b3b9" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="eca5fd1e-8d67-4aa1-86e3-93a72441f21d" data-cid="eca5fd1e-8d67-4aa1-86e3-93a72441f21d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="0" data-match="4196" data-replace="4196" data-pattern="4196" data-tag-index="30_2" data-time="" data-username="" data-userid="">4196</named-content><named-content id="9f7bad17-4292-4087-bd56-e89239e4d4d4" data-cid="9f7bad17-4292-4087-bd56-e89239e4d4d4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="4196 (25%)" data-replace=" (25%)" data-pattern=" $2" data-tag-index="30_1" data-time="" data-username="" data-userid=""> (25%)</named-content></p></td></tr><tr data-col-count="3" id="dbbd2e04-be12-46e2-983f-b3aff7ca321b"><td data-class="" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" valign="top" id="09743644-4428-4312-a6dd-1520f7238790" data-old-attributes=""><p id="8ab880b0-7d53-41e0-a16a-79661c0e44e0" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1555069315" id="8268a3b4-d700-49de-b003-3919ef1fa017" content-type="styrm cts-2" specific-use="1555070025816" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Bold Removed by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:23pm" data-track-detail="" data-format-command="bold" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070025816" data-track-hint="Bold Removed">BMI, kg/m</named-content><sup id="7e2d81a4-7243-48f3-a526-df867288e2af"><named-content data-cid="1555069315" id="bcf2c1c9-1899-46cb-bcc8-97225b444f33" content-type="styrm cts-2" specific-use="1555070025816" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Bold Removed by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:23pm" data-track-detail="" data-format-command="Bold" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070025816" data-track-hint="Bold Removed">2</named-content></sup></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" valign="top" id="91b442b4-b91c-4e0f-bec1-0e10c2d06e84" data-old-attributes=""><p id="4b4db1f9-e1da-48bc-8e95-e9786b87582c" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="2ea875fc-dbef-439b-9378-3a2a567c1872" data-cid="2ea875fc-dbef-439b-9378-3a2a567c1872" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="31 (7)" data-replace="31" data-pattern="$1" data-tag-index="32_1" data-time="" data-username="" data-userid="">31</named-content><named-content id="58d0eb0a-3750-40f2-b539-020a7ced936b" data-cid="58d0eb0a-3750-40f2-b539-020a7ced936b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="2" data-match="31 (7)" data-replace=" (7)" data-pattern=" $2" data-tag-index="32_1" data-time="" data-username="" data-userid=""> (7)</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" valign="top" id="e3bfca8b-668e-4aee-a98c-7d2fc004641d" data-old-attributes=""><p id="81dfe680-987e-4d36-aaf9-629c6686aa10" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="addb1c75-dcb3-4a9b-8add-babdef558b41" data-cid="addb1c75-dcb3-4a9b-8add-babdef558b41" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="28 (6)" data-replace="28" data-pattern="$1" data-tag-index="33_1" data-time="" data-username="" data-userid="">28</named-content><named-content id="bade2ce4-3358-4b04-a642-f22785caf668" data-cid="bade2ce4-3358-4b04-a642-f22785caf668" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="2" data-match="28 (6)" data-replace=" (6)" data-pattern=" $2" data-tag-index="33_1" data-time="" data-username="" data-userid=""> (6)</named-content></p></td></tr><tr data-col-count="3" data-fill="true" id="96a0a611-43f2-4831-8042-7b975260d81b"><td data-class="" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" valign="top" id="2c593268-189c-428a-92e7-ffeb78a985c7" data-old-attributes=""><p id="7e2e7c2e-fd9d-4330-a9a7-393af6ea1a11" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1555069316" id="5860c212-7ee6-44a3-b2d5-f5838bbca22c" content-type="styrm cts-2" specific-use="1555070027077" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Bold Removed by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:23pm" data-track-detail="" data-format-command="bold" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070027077" data-track-hint="Bold Removed">Smoking status</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" valign="top" id="60d528f4-ad24-4129-9f86-c92539819712" data-old-attributes=""><p id="448f9272-dfbf-494c-a97e-0d0cb703da72"/></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" valign="top" id="50fcd286-9a35-4391-97db-6142c09596fa" data-old-attributes=""><p id="990eabf4-640e-4a89-9adc-a51a7ef2e867"/></td></tr><tr data-col-count="3" id="3f999019-db56-4bd8-9d93-3b47a956f2ff"><td data-class="" data-original-space="4" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" valign="top" id="40cca1ac-3638-4bc4-bc65-e9fdee2ffe4d" data-old-attributes=""><p id="0e1652d5-5bba-421f-bf74-9f0de29043f4" data-original-margin=" margin-left: 14.2pt; margin-right: 0cm; margin-top: 0cm;"> <named-content data-cid="1555069317" id="e6153aaa-6327-456d-9af5-0de413581379" content-type="styrm cts-2" specific-use="1555070028099" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Bold Removed by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:23pm" data-track-detail="" data-format-command="bold" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070028099" data-track-hint="Bold Removed">Current smoker</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" valign="top" id="84d59bd4-2d4c-400b-83f6-8ba7b0fc811e" data-old-attributes=""><p id="544e7775-58b3-4d91-aaf9-022f8455392b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="a7203937-db4c-4ce6-8f8a-9879b194e1c8" data-cid="a7203937-db4c-4ce6-8f8a-9879b194e1c8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="828 (49%)" data-replace="828" data-pattern="$1" data-tag-index="36_1" data-time="" data-username="" data-userid="">828</named-content><named-content id="54d0a142-295c-49db-9382-5f10fcd159a5" data-cid="54d0a142-295c-49db-9382-5f10fcd159a5" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="828 (49%)" data-replace=" (49%)" data-pattern=" $2" data-tag-index="36_1" data-time="" data-username="" data-userid=""> (49%)</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" valign="top" id="4c2467e4-12fc-4aba-bfcf-c4533671e369" data-old-attributes=""><p id="fc6ae50b-2f92-47e2-83b3-3ae3cdaf95ab" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="dc77ce9e-ecd2-49be-82ff-6f4d9f6b26ee" data-cid="dc77ce9e-ecd2-49be-82ff-6f4d9f6b26ee" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="0" data-match="7678" data-replace="7678" data-pattern="7678" data-tag-index="37_2" data-time="" data-username="" data-userid="">7678</named-content><named-content id="8e8538b2-3d48-49ac-8e6f-e1f6d81bfbec" data-cid="8e8538b2-3d48-49ac-8e6f-e1f6d81bfbec" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="7678 (47%)" data-replace=" (47%)" data-pattern=" $2" data-tag-index="37_1" data-time="" data-username="" data-userid=""> (47%)</named-content></p></td></tr><tr data-col-count="3" data-fill="true" id="3d162895-a1ad-4ad7-84c0-0990804846bd"><td data-class="" data-original-space="4" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" valign="top" id="34bc938d-b8df-4e5e-998a-f6b33135f4f2" data-old-attributes=""><p id="2dcb0543-d64f-4a25-a496-767e11c6be63" data-original-margin=" margin-left: 14.2pt; margin-right: 0cm; margin-top: 0cm;"> Smoking<named-content data-cid="1555285532" id="54285fcb-23d6-414b-9062-1fb9ae656038" content-type="del cts-3" specific-use="1555287252325" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 8:14am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555287252325">-</named-content><named-content data-cid="1555285533" id="f347cb16-e2c1-43de-8bb4-14baa310ad6d" content-type="ins cts-3" specific-use="1555287252599" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 8:14am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555287252599"> </named-content>history (pack-years)</p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" valign="top" id="197defd5-aa4b-4cdd-89c9-a7f424152b2b" data-old-attributes=""><p id="555e3e38-74ee-435c-b495-7851471d09f9" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="6811c2c8-665e-4882-a4dc-09d62557bd4a" data-cid="6811c2c8-665e-4882-a4dc-09d62557bd4a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="52 (29)" data-replace="52" data-pattern="$1" data-tag-index="39_1" data-time="" data-username="" data-userid="">52</named-content><named-content id="f5c4ccef-0cb5-471c-add4-860eff7905a2" data-cid="f5c4ccef-0cb5-471c-add4-860eff7905a2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="2" data-match="52 (29)" data-replace=" (29)" data-pattern=" $2" data-tag-index="39_1" data-time="" data-username="" data-userid=""> (29)</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" valign="top" id="04fdfd2e-a865-4cc8-ab8a-2e1c1c10ed2f" data-old-attributes=""><p id="c922ba8e-27bb-44f6-bdf6-2570368b5662" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="2a0f847f-d981-4fbc-8260-59acc7fb9ef9" data-cid="2a0f847f-d981-4fbc-8260-59acc7fb9ef9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="41 (24)" data-replace="41" data-pattern="$1" data-tag-index="40_1" data-time="" data-username="" data-userid="">41</named-content><named-content id="0ab538cf-64e4-4cc2-be1b-2c901d70b1ef" data-cid="0ab538cf-64e4-4cc2-be1b-2c901d70b1ef" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="2" data-match="41 (24)" data-replace=" (24)" data-pattern=" $2" data-tag-index="40_1" data-time="" data-username="" data-userid=""> (24)</named-content></p></td></tr><tr data-col-count="3" id="d1e080d9-fcdb-44e9-8881-cedb275b6b67"><td data-class="" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" valign="top" id="c9797547-1c7c-4967-8218-15d05eb3a0e8" data-old-attributes=""><p id="eb3a53c0-d072-43dd-adee-cd267a536db8" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1555069319" id="421ada5e-3b69-4066-b75c-1cf0ed101195" content-type="styrm cts-2" specific-use="1555070031881" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Bold Removed by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:23pm" data-track-detail="" data-format-command="bold" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070031881" data-track-hint="Bold Removed">Respiratory status</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" valign="top" id="60366026-7d86-469b-9d9b-f9f1b2077fc5" data-old-attributes=""><p id="060a0709-6ce3-4867-a24f-c663ae9dc96f"/></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" valign="top" id="09d863ee-dcd8-438d-aadf-6687ce3b838f" data-old-attributes=""><p id="a9a8f27d-80c1-4fe6-aca9-790f8674a750"/></td></tr><tr data-col-count="3" data-fill="true" id="9cc67803-f636-4eba-8616-b15802966a1d"><td data-class="" data-original-space="4" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" valign="top" id="b9fd3a8f-19e8-4793-afe7-a89d5057ce9f" data-old-attributes=""><p id="824ca1d1-f50e-48d6-9b50-ea95f88db742" data-original-margin=" margin-left: 14.2pt; margin-right: 0cm; margin-top: 0cm;"> Post<named-content data-cid="1555285534" id="938df97c-b710-4b18-b893-9dacf416a2d0" content-type="del cts-3" specific-use="1555287254623" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 8:14am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555287254623">-</named-content>bronchodilator FEV<sub id="add1c43b-a469-42f2-972c-e32d93fe8ddd">1</sub> (L)</p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" valign="top" id="de8be235-81ca-4d21-bbd8-a0206c8cd4e7" data-old-attributes=""><p id="3125a2d1-c65a-4cb6-883d-5eb4965378ec" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="bd404059-0e44-441a-88aa-5a8512f2cef4" data-cid="bd404059-0e44-441a-88aa-5a8512f2cef4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1.7 (0.4)" data-replace="1.7" data-pattern="$1" data-tag-index="43_1" data-time="" data-username="" data-userid="">1.7</named-content><named-content id="3f20ce4f-68fd-4f1e-b1fb-2f9aba30f4af" data-cid="3f20ce4f-68fd-4f1e-b1fb-2f9aba30f4af" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="1.7 (0.4)" data-replace=" (0.4)" data-pattern=" $2" data-tag-index="43_1" data-time="" data-username="" data-userid=""> (0.4)</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" valign="top" id="ead8de08-258f-4497-8ecb-d64e6f5a57dc" data-old-attributes=""><p id="9030d327-e942-4e85-9183-a9ecb9e84954" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="61278af3-e30d-44f8-aaa1-f5dff0eaa64f" data-cid="61278af3-e30d-44f8-aaa1-f5dff0eaa64f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1.7 (0.4)" data-replace="1.7" data-pattern="$1" data-tag-index="44_1" data-time="" data-username="" data-userid="">1.7</named-content><named-content id="4eded88a-f2a7-486b-8669-f5169c5fa727" data-cid="4eded88a-f2a7-486b-8669-f5169c5fa727" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="1.7 (0.4)" data-replace=" (0.4)" data-pattern=" $2" data-tag-index="44_1" data-time="" data-username="" data-userid=""> (0.4)</named-content></p></td></tr><tr data-col-count="3" id="efc72db3-1eac-475c-9cfb-ba47e1e7a4e6"><td data-class="" data-original-space="4" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" valign="top" id="e977c4cf-727d-433a-ba2a-5eb292cf260a" data-old-attributes=""><p id="58646275-b320-4285-80d8-1530d8103779" data-original-margin=" margin-left: 14.2pt; margin-right: 0cm; margin-top: 0cm;"> Predicted post<named-content data-cid="1555285535" id="4def274a-20d3-416f-aedf-9d3d63ca6af9" content-type="del cts-3" specific-use="1555287256441" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 8:14am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555287256441">-</named-content>bronchodilator FEV<sub id="bfd9f3ea-3596-4c4a-a62f-f55aa1fb0cf1">1</sub> (%)</p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" valign="top" id="11450266-4317-40c0-8765-ef1195297341" data-old-attributes=""><p id="25f861e4-4fd2-4197-ad96-1a6a06c99a81" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="299b0530-8814-4693-a706-298a49ca29f1" data-cid="299b0530-8814-4693-a706-298a49ca29f1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="59 (7)" data-replace="59" data-pattern="$1" data-tag-index="46_1" data-time="" data-username="" data-userid="">59</named-content><named-content id="8c5ffffe-c25a-49ef-8021-ccc4c1bcb1f6" data-cid="8c5ffffe-c25a-49ef-8021-ccc4c1bcb1f6" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="2" data-match="59 (7)" data-replace=" (7)" data-pattern=" $2" data-tag-index="46_1" data-time="" data-username="" data-userid=""> (7)</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" valign="top" id="84d17f53-68d5-4b39-b4f1-be48552aceed" data-old-attributes=""><p id="73c42934-efc2-4bef-a3d2-718bf1992599" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="2ec41470-14b8-4212-9c9e-7fd555522592" data-cid="2ec41470-14b8-4212-9c9e-7fd555522592" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="60 (6)" data-replace="60" data-pattern="$1" data-tag-index="47_1" data-time="" data-username="" data-userid="">60</named-content><named-content id="50061e90-cf74-4203-be13-305f13a11bf2" data-cid="50061e90-cf74-4203-be13-305f13a11bf2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="2" data-match="60 (6)" data-replace=" (6)" data-pattern=" $2" data-tag-index="47_1" data-time="" data-username="" data-userid=""> (6)</named-content></p></td></tr><tr data-col-count="3" data-fill="true" id="ae1ee500-db49-4c2e-b3e8-1597211267a5"><td data-class="" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" valign="top" id="76d96f39-982a-41bb-9b6e-0f021ddf8128" data-old-attributes=""><p id="7325e550-3ff6-4608-8179-e566ef708492" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1555069326" id="7adb5243-8792-431e-937c-de4b109ae984" content-type="styrm cts-2" specific-use="1555070040028" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Bold Removed by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:24pm" data-track-detail="" data-format-command="bold" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070040028" data-track-hint="Bold Removed">Exacerbations in </named-content><named-content id="67a16ef8-2ae9-4ccc-ac60-358985867f01" data-cid="67a16ef8-2ae9-4ccc-ac60-358985867f01" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="17" data-match="12 months" data-replace="12" data-pattern="$1" data-tag-index="48_1" data-time="" data-username="" data-userid=""><named-content data-cid="1555069326" id="b9f42e80-3357-4759-98ab-37254e200c4d" content-type="styrm cts-2" specific-use="1555070040028" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Bold Removed by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:24pm" data-track-detail="" data-format-command="Bold" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070040028" data-track-hint="Bold Removed">12</named-content></named-content><named-content id="694447ce-529b-4f75-86cb-8ded24ce21f3" data-cid="694447ce-529b-4f75-86cb-8ded24ce21f3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="19" data-match="12 months" data-replace=" months" data-pattern=" $2" data-tag-index="48_1" data-time="" data-username="" data-userid=""><named-content data-cid="1555069326" id="b9bc466c-cab4-447e-ab28-83f330a0dfd8" content-type="styrm cts-2" specific-use="1555070040028" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Bold Removed by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:24pm" data-track-detail="" data-format-command="Bold" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070040028" data-track-hint="Bold Removed"> months</named-content></named-content><named-content data-cid="1555069326" id="eb649273-726a-42eb-93e7-f0a69ab1b2d9" content-type="styrm cts-2" specific-use="1555070040028" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Bold Removed by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:24pm" data-track-detail="" data-format-command="Bold" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070040028" data-track-hint="Bold Removed"> before study</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" valign="top" id="aab652d2-4aa9-4b8f-a3e1-e050aca4179d" data-old-attributes=""><p id="f8458914-1e41-4fc6-8165-232702b20ea5"/></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" valign="top" id="bbac7ab9-4eb5-400c-9236-d1a83e1510f2" data-old-attributes=""><p id="48394b18-e33d-4250-9673-c8e660503813"/></td></tr><tr data-col-count="3" id="b8e50771-1d21-4503-b139-6e0a6e581830"><td data-class="" data-original-space="4" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" valign="top" id="94d79799-0627-40f2-9526-77ed443f1a02" data-old-attributes=""><p id="9cdf614c-2578-4b1f-820d-33a4dc9b9476" data-original-margin=" margin-left: 14.2pt; margin-right: 0cm; margin-top: 0cm;"> <named-content data-cid="1555069327" id="2c55dbc7-f8bc-46b5-bee8-da0211fa2ae4" content-type="styrm cts-2" specific-use="1555070041995" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Bold Removed by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:24pm" data-track-detail="" data-format-command="bold" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070041995" data-track-hint="Bold Removed">0</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" valign="top" id="24e75cc8-6936-4714-af0e-87488ac8f5c6" data-old-attributes=""><p id="2b20e1b4-f0f2-4f30-954a-de82c1aa84a8" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="037ff193-52d0-4578-9a02-673c12984411" data-cid="037ff193-52d0-4578-9a02-673c12984411" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="0" data-match="1215" data-replace="1215" data-pattern="1215" data-tag-index="49_2" data-time="" data-username="" data-userid="">1215</named-content><named-content id="ef2c3333-86a1-4a49-bbb9-dc653b7a8868" data-cid="ef2c3333-86a1-4a49-bbb9-dc653b7a8868" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="1215 (73%)" data-replace=" (73%)" data-pattern=" $2" data-tag-index="49_1" data-time="" data-username="" data-userid=""> (73%)</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" valign="top" id="5cba83d8-398d-4bda-b05f-6b59317c2765" data-old-attributes=""><p id="0e8f477b-8462-4b0b-aa7a-616debd9a0bd" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">10 <named-content id="85b4c8c4-1f17-4d32-8456-87e8a286edeb" data-cid="85b4c8c4-1f17-4d32-8456-87e8a286edeb" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="3" data-match="021 (61%)" data-replace="021" data-pattern="$1" data-tag-index="50_1" data-time="" data-username="" data-userid="">021</named-content><named-content id="8e7db2c4-c996-41ef-b527-1a479543986f" data-cid="8e7db2c4-c996-41ef-b527-1a479543986f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="6" data-match="021 (61%)" data-replace=" (61%)" data-pattern=" $2" data-tag-index="50_1" data-time="" data-username="" data-userid=""> (61%)</named-content></p></td></tr><tr data-col-count="3" data-fill="true" id="37512ee6-b7e6-433e-896c-da4052313155"><td data-class="" data-original-space="4" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" valign="top" id="93d8780a-2546-468d-9f3e-71ae80a505c8" data-old-attributes=""><p id="1b7ae764-721f-4392-a160-ba5f0a8b297a" data-original-margin=" margin-left: 14.2pt; margin-right: 0cm; margin-top: 0cm;"> <named-content data-cid="1555069328" id="29d03405-351a-4c94-8687-5062dae333b2" content-type="styrm cts-2" specific-use="1555070043323" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Bold Removed by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:24pm" data-track-detail="" data-format-command="bold" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070043323" data-track-hint="Bold Removed">1</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" valign="top" id="515ee23d-4007-492c-b3bc-5c7abf4a5e62" data-old-attributes=""><p id="e220a02d-5098-4eaa-aabb-5a20b0b556fa" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="6dd16006-c06d-48d9-b23b-bf299ca80e07" data-cid="6dd16006-c06d-48d9-b23b-bf299ca80e07" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="290 (17%)" data-replace="290" data-pattern="$1" data-tag-index="51_1" data-time="" data-username="" data-userid="">290</named-content><named-content id="86b708f7-a5a5-4789-a590-a0a66aaac02b" data-cid="86b708f7-a5a5-4789-a590-a0a66aaac02b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="290 (17%)" data-replace=" (17%)" data-pattern=" $2" data-tag-index="51_1" data-time="" data-username="" data-userid=""> (17%)</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" valign="top" id="967e5ccd-e291-4f38-97ee-9deb73a95239" data-old-attributes=""><p id="e38b0177-f86b-4a02-8713-fb4e17992014" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="ca59f39e-7de1-40e2-9ad5-457b3795b4e3" data-cid="ca59f39e-7de1-40e2-9ad5-457b3795b4e3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="0" data-match="4020" data-replace="4020" data-pattern="4020" data-tag-index="52_2" data-time="" data-username="" data-userid="">4020</named-content><named-content id="dbdbac99-5a75-44ac-930e-169b27d281c2" data-cid="dbdbac99-5a75-44ac-930e-169b27d281c2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="4020 (24%)" data-replace=" (24%)" data-pattern=" $2" data-tag-index="52_1" data-time="" data-username="" data-userid=""> (24%)</named-content></p></td></tr><tr data-col-count="3" id="5e433fab-d71a-40bb-9d2b-c7d233ec231a"><td data-class="" data-original-space="4" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" valign="top" id="d5c49727-ed63-44f9-a6ac-6a7bb55dc552" data-old-attributes=""><p id="d8303e90-ce6c-4cbc-a82f-b8be1f72672a" data-original-margin=" margin-left: 14.2pt; margin-right: 0cm; margin-top: 0cm;"> <named-content data-cid="1555069329" id="71123a5e-5423-4a79-9e3f-f2ddbce4d4cf" content-type="styrm cts-2" specific-use="1555070044585" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Bold Removed by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:24pm" data-track-detail="" data-format-command="bold" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070044585" data-track-hint="Bold Removed">2+</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" valign="top" id="52f6f9e5-2657-4243-b2b6-81d19ceda728" data-old-attributes=""><p id="4fb8f50c-1aab-420f-8f0d-cce99735888c" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="5fa2e32c-9015-4680-a690-c6914187077b" data-cid="5fa2e32c-9015-4680-a690-c6914187077b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="168 (10%)" data-replace="168" data-pattern="$1" data-tag-index="53_1" data-time="" data-username="" data-userid="">168</named-content><named-content id="dda97a52-d67b-4a00-9048-262dd0b0a1cf" data-cid="dda97a52-d67b-4a00-9048-262dd0b0a1cf" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="168 (10%)" data-replace=" (10%)" data-pattern=" $2" data-tag-index="53_1" data-time="" data-username="" data-userid=""> (10%)</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" valign="top" id="26bd39ea-2b3f-4fca-a6ee-bf42157d5c32" data-old-attributes=""><p id="8cae90c3-686c-4a0a-9c02-2d033663fe3b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="cee80dc2-3d6b-41d6-8a3e-257fa475fe69" data-cid="cee80dc2-3d6b-41d6-8a3e-257fa475fe69" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="0" data-match="2444" data-replace="2444" data-pattern="2444" data-tag-index="54_2" data-time="" data-username="" data-userid="">2444</named-content><named-content id="3b447d9f-4302-4133-bdc8-017b2d091ebd" data-cid="3b447d9f-4302-4133-bdc8-017b2d091ebd" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="2444 (15%)" data-replace=" (15%)" data-pattern=" $2" data-tag-index="54_1" data-time="" data-username="" data-userid=""> (15%)</named-content></p></td></tr><tr data-col-count="3" data-fill="true" id="975e3dff-5cfe-422e-af4d-567ae37f4ed7"><td data-class="" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" valign="top" id="f01e4563-f2bf-4999-92de-9d822ce77f45" data-old-attributes=""><p id="e40cc22e-c966-4df5-85b9-d8b66d3c107e" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1555069330" id="6a83a444-bcd8-40d7-90d1-e36ee33bca6b" content-type="styrm cts-2" specific-use="1555070045772" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Bold Removed by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:24pm" data-track-detail="" data-format-command="bold" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070045772" data-track-hint="Bold Removed">Cardiovascular inclusion criteria</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" valign="top" id="7dbe3e3c-1b46-4d45-bf03-ab5391e69335" data-old-attributes=""><p id="1a61b406-c9ce-4725-aefc-52bc20b32a59"/></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" valign="top" id="859555c2-96b9-4338-9daa-804128f39418" data-old-attributes=""><p id="3dfcc3fc-2ef1-4865-8336-5787092cc659"/></td></tr><tr data-col-count="3" id="8f2ef698-2382-4b87-9b62-0884a12f3e25"><td data-class="" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" valign="top" id="6917041f-e8c6-4c0e-8409-1b13e0660cfb" data-old-attributes=""><p id="b90852f9-b610-4995-9c57-a4c5f5813dad" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1555069331" id="355cdb1d-3423-497f-88de-4854d6e1a226" content-type="styrm cts-2" specific-use="1555070046982" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Bold Removed by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:24pm" data-track-detail="" data-format-command="bold" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070046982" data-track-hint="Bold Removed">Manifest disease</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" valign="top" id="2c7c4437-3e7e-44a5-baad-0b0687815001" data-old-attributes=""><p id="865ca705-8374-4c7b-99aa-23f86ee02b29"/></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" valign="top" id="d46da979-13d3-455a-bd59-1a12e471c3c8" data-old-attributes=""><p id="8d94854a-f027-462a-80c0-3ee94e115af2"/></td></tr><tr data-col-count="3" data-fill="true" id="4bd5ccd6-d4ce-429c-8247-9ad0d43faefe"><td data-class="" data-original-space="4" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" valign="top" id="67ca36f4-f152-4d92-88f2-bc60d8df8d9f" data-old-attributes=""><p id="a1aef02d-cfe6-4b30-be83-9a2246798101" data-original-margin=" margin-left: 14.2pt; margin-right: 0cm; margin-top: 0cm;"> <named-content data-cid="1555069332" id="b46b6b64-e68e-422f-80bb-aba00be3466c" content-type="styrm cts-2" specific-use="1555070048262" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Bold Removed by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:24pm" data-track-detail="" data-format-command="bold" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070048262" data-track-hint="Bold Removed">Coronary artery disease</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" valign="top" id="1daaf0a5-1aee-4493-886f-c53a3ee09d6f" data-old-attributes=""><p id="53504b2e-51e8-4ab2-9cd3-7490c90b4653" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="c33496e5-9409-4a8f-9707-f8786990215b" data-cid="c33496e5-9409-4a8f-9707-f8786990215b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="818 (49%)" data-replace="818" data-pattern="$1" data-tag-index="58_1" data-time="" data-username="" data-userid="">818</named-content><named-content id="29dbfc30-05de-48a0-929c-e53d34a9546a" data-cid="29dbfc30-05de-48a0-929c-e53d34a9546a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="818 (49%)" data-replace=" (49%)" data-pattern=" $2" data-tag-index="58_1" data-time="" data-username="" data-userid=""> (49%)</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" valign="top" id="9bddf781-c210-4384-93a2-7fc567ac700e" data-old-attributes=""><p id="a14a0dea-318c-4fbd-8e89-d86815a410e0" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="1eaa2d1d-88e0-4945-8bfc-7114997849fd" data-cid="1eaa2d1d-88e0-4945-8bfc-7114997849fd" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="0" data-match="8379" data-replace="8379" data-pattern="8379" data-tag-index="59_2" data-time="" data-username="" data-userid="">8379</named-content><named-content id="d465d71a-eee3-40e4-afb9-a7d4f6079343" data-cid="d465d71a-eee3-40e4-afb9-a7d4f6079343" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="8379 (51%)" data-replace=" (51%)" data-pattern=" $2" data-tag-index="59_1" data-time="" data-username="" data-userid=""> (51%)</named-content></p></td></tr><tr data-col-count="3" id="154d108e-f538-4a46-aebc-8f27ec77647f"><td data-class="" data-original-space="4" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" valign="top" id="b63a0e0f-3c5b-4701-a3b7-35b568785bae" data-old-attributes=""><p id="3b471e77-caee-41b0-afd5-31d35b29f561" data-original-margin=" margin-left: 14.2pt; margin-right: 0cm; margin-top: 0cm;"> <named-content data-cid="1555069333" id="b0b96978-d305-4bf6-91cd-92d5260b725e" content-type="styrm cts-2" specific-use="1555070049535" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Bold Removed by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:24pm" data-track-detail="" data-format-command="bold" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070049535" data-track-hint="Bold Removed">Peripheral arterial disease</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" valign="top" id="3805e4b9-2bb3-4be2-afed-c7ce19b8bf22" data-old-attributes=""><p id="a1bdc66a-9599-4384-a205-238564a587c0" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="b88b2c77-859c-4546-abb9-231eaff157dd" data-cid="b88b2c77-859c-4546-abb9-231eaff157dd" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="384 (23%)" data-replace="384" data-pattern="$1" data-tag-index="61_1" data-time="" data-username="" data-userid="">384</named-content><named-content id="adcc924c-9a46-48bc-a77d-86e998fee2e1" data-cid="adcc924c-9a46-48bc-a77d-86e998fee2e1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="384 (23%)" data-replace=" (23%)" data-pattern=" $2" data-tag-index="61_1" data-time="" data-username="" data-userid=""> (23%)</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" valign="top" id="0b91185e-7bcd-404f-9463-698244d551ae" data-old-attributes=""><p id="9361f5c4-eaef-406e-80ac-15daa8a4b19a" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="7425a6e2-4041-4c73-a75e-378cfc2b54f8" data-cid="7425a6e2-4041-4c73-a75e-378cfc2b54f8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="0" data-match="3145" data-replace="3145" data-pattern="3145" data-tag-index="62_2" data-time="" data-username="" data-userid="">3145</named-content><named-content id="6e66eb25-49e0-4d76-954e-3e5460b1bdfe" data-cid="6e66eb25-49e0-4d76-954e-3e5460b1bdfe" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="3145 (19%)" data-replace=" (19%)" data-pattern=" $2" data-tag-index="62_1" data-time="" data-username="" data-userid=""> (19%)</named-content></p></td></tr><tr data-col-count="3" data-fill="true" id="3b49ea69-6a71-4783-a5f5-bad387eec6de"><td data-class="" data-original-space="4" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" valign="top" id="0182d7fa-2b79-4cbe-a173-803228383012" data-old-attributes=""><p id="364e7a5b-436a-479f-a833-383933d7fccd" data-original-margin=" margin-left: 14.2pt; margin-right: 0cm; margin-top: 0cm;"> <named-content data-cid="1555069334" id="758e6a1f-8802-4b76-bfbd-7362eafef426" content-type="styrm cts-2" specific-use="1555070050717" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Bold Removed by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:24pm" data-track-detail="" data-format-command="bold" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070050717" data-track-hint="Bold Removed">Previous stroke</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" valign="top" id="fe2edd54-e935-46b7-81b8-2816a516f8be" data-old-attributes=""><p id="0856e40f-a256-4da3-99da-2dc5a86a60be" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="05ff64ce-06bd-4197-9fc1-e6c5a41639ad" data-cid="05ff64ce-06bd-4197-9fc1-e6c5a41639ad" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="172 (10%)" data-replace="172" data-pattern="$1" data-tag-index="64_1" data-time="" data-username="" data-userid="">172</named-content><named-content id="4d71f4b2-7e0b-45db-a39b-2aebce8f6b31" data-cid="4d71f4b2-7e0b-45db-a39b-2aebce8f6b31" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="172 (10%)" data-replace=" (10%)" data-pattern=" $2" data-tag-index="64_1" data-time="" data-username="" data-userid=""> (10%)</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" valign="top" id="b1cbf924-3acd-4184-868d-144bc72db640" data-old-attributes=""><p id="57778ce3-e64e-4830-8623-18488086aa9f" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="8cc57623-7fbf-4d37-9493-535444f26770" data-cid="8cc57623-7fbf-4d37-9493-535444f26770" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="0" data-match="1595" data-replace="1595" data-pattern="1595" data-tag-index="65_2" data-time="" data-username="" data-userid="">1595</named-content><named-content id="b0ea9c20-10a4-4d3c-a4f9-9fde0484f466" data-cid="b0ea9c20-10a4-4d3c-a4f9-9fde0484f466" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="1595 (10%)" data-replace=" (10%)" data-pattern=" $2" data-tag-index="65_1" data-time="" data-username="" data-userid=""> (10%)</named-content></p></td></tr><tr data-col-count="3" id="ee698ee8-96f1-43f2-91ac-6010c343f7d1"><td data-class="" data-original-space="4" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" valign="top" id="b521be66-c436-4bc4-aac7-c0e4ff6ebfcd" data-old-attributes=""><p id="2a736351-b496-4533-8ac0-02fa19be167e" data-original-margin=" margin-left: 14.2pt; margin-right: 0cm; margin-top: 0cm;"> <named-content data-cid="1555069335" id="e44c5468-748d-4d73-aa7e-3462f828b801" content-type="styrm cts-2" specific-use="1555070052045" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Bold Removed by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:24pm" data-track-detail="" data-format-command="bold" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070052045" data-track-hint="Bold Removed">Previous myocardial infarction</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" valign="top" id="63285fb8-eb97-445e-9ffb-d2471cc2dcae" data-old-attributes=""><p id="d583bfc8-4db2-4d7a-b206-c46ce12419bc" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="cf68c2a5-c00d-435f-9f1e-76daa42a74b6" data-cid="cf68c2a5-c00d-435f-9f1e-76daa42a74b6" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="413 (25%)" data-replace="413" data-pattern="$1" data-tag-index="67_1" data-time="" data-username="" data-userid="">413</named-content><named-content id="3cde8444-2cba-45b6-80bf-05bb71d7f8e9" data-cid="3cde8444-2cba-45b6-80bf-05bb71d7f8e9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="413 (25%)" data-replace=" (25%)" data-pattern=" $2" data-tag-index="67_1" data-time="" data-username="" data-userid=""> (25%)</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" valign="top" id="4e0d3cbc-e3f3-4fa2-a6b5-c17016ddeb44" data-old-attributes=""><p id="ca92a7e5-7f41-478e-8013-accd2e0762cc" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="0ad4ffb1-985a-4075-b15a-7cc774d397df" data-cid="0ad4ffb1-985a-4075-b15a-7cc774d397df" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="0" data-match="2774" data-replace="2774" data-pattern="2774" data-tag-index="68_2" data-time="" data-username="" data-userid="">2774</named-content><named-content id="ee887173-db4e-4880-9f09-1ccc01c0698c" data-cid="ee887173-db4e-4880-9f09-1ccc01c0698c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="2774 (17%)" data-replace=" (17%)" data-pattern=" $2" data-tag-index="68_1" data-time="" data-username="" data-userid=""> (17%)</named-content></p></td></tr><tr data-col-count="3" data-fill="true" id="f18bf978-aff9-4139-8a09-4fdfd254a9a4"><td data-class="" data-original-space="4" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" valign="top" id="3ba4f0c3-0307-4ce9-b3c2-7321647146fc" data-old-attributes=""><p id="57b7d488-0f87-4c70-a871-8470a5f065be" data-original-margin=" margin-left: 14.2pt; margin-right: 0cm; margin-top: 0cm;"> <named-content data-cid="1555069336" id="236e0bf2-2c8a-4425-a9b4-30f603d95fbc" content-type="styrm cts-2" specific-use="1555070053468" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Bold Removed by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:24pm" data-track-detail="" data-format-command="bold" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070053468" data-track-hint="Bold Removed">Diabetes with target organ disease</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" valign="top" id="c4bc90fe-5705-4fd8-92ea-e74c0a3b2a2a" data-old-attributes=""><p id="c4e6fd3f-08bc-4e4f-8fa2-d4055ca388e6" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="91cdbeb2-83eb-432f-98f6-7c23ae24e901" data-cid="91cdbeb2-83eb-432f-98f6-7c23ae24e901" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="226 (14%)" data-replace="226" data-pattern="$1" data-tag-index="70_1" data-time="" data-username="" data-userid="">226</named-content><named-content id="fa5baa56-e2b9-4c81-b1d3-7aa64ec5b5c6" data-cid="fa5baa56-e2b9-4c81-b1d3-7aa64ec5b5c6" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="226 (14%)" data-replace=" (14%)" data-pattern=" $2" data-tag-index="70_1" data-time="" data-username="" data-userid=""> (14%)</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" valign="top" id="1e6c57fe-e4ed-45ca-a570-c1ead740cf6f" data-old-attributes=""><p id="328c6072-1424-4d36-8c3f-2dffead1199a" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="b3e31b2f-6bf3-44db-9b46-8bbbae7f4abf" data-cid="b3e31b2f-6bf3-44db-9b46-8bbbae7f4abf" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="0" data-match="1503" data-replace="1503" data-pattern="1503" data-tag-index="71_2" data-time="" data-username="" data-userid="">1503</named-content><named-content id="1aebf845-7e5f-4ec8-a6ec-2c2cda3424d2" data-cid="1aebf845-7e5f-4ec8-a6ec-2c2cda3424d2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="1503 (9%)" data-replace=" (9%)" data-pattern=" $2" data-tag-index="71_1" data-time="" data-username="" data-userid=""> (9%)</named-content></p></td></tr><tr data-col-count="3" id="9238c104-b4f7-4867-884a-42f43cf862b0"><td data-class="" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" valign="top" id="4f20846e-6abc-4f8a-b913-b118616d7db9" data-old-attributes=""><p id="e6bac132-00ec-43da-91b0-97177faed034" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1555069337" id="3aafeeb1-ec76-4470-be61-1c11ac479d1b" content-type="styrm cts-2" specific-use="1555070054735" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Bold Removed by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:24pm" data-track-detail="" data-format-command="bold" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070054735" data-track-hint="Bold Removed">At risk</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" valign="top" id="a14e3ffd-aecc-4928-bf51-569a4d4c2807" data-old-attributes=""><p id="c12371d3-5521-477e-969a-4cf16400aa8f"/></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" valign="top" id="a39f30fd-de0c-4419-b18d-6de83f345fa7" data-old-attributes=""><p id="4693c13f-0208-4014-a6d7-95422e168680"/></td></tr><tr data-col-count="3" data-fill="true" id="04a6bc28-7a8d-4645-8a19-0385988b72d4"><td data-class="" data-original-space="4" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" valign="top" id="6d2cb171-ee49-470a-a4ae-3140c4c1a3f4" data-old-attributes=""><p id="9ca76942-2621-4e90-b53d-3c59355a120b" data-original-margin=" margin-left: 14.2pt; margin-right: 0cm; margin-top: 0cm;"> <named-content data-cid="1555069338" id="b6ec1a5e-0ae4-40bf-bc8b-e6682588b55d" content-type="styrm cts-2" specific-use="1555070056051" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Bold Removed by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:24pm" data-track-detail="" data-format-command="bold" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070056051" data-track-hint="Bold Removed">Hypercholesterolaemia</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" valign="top" id="ace76eba-dca6-4369-836f-b25717610b27" data-old-attributes=""><p id="bff0ec26-8051-435a-8c5c-de1e5ba33d14" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="34ab35b7-3202-4a23-a887-2ac76ead8c26" data-cid="34ab35b7-3202-4a23-a887-2ac76ead8c26" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="0" data-match="1072" data-replace="1072" data-pattern="1072" data-tag-index="74_2" data-time="" data-username="" data-userid="">1072</named-content><named-content id="e752605f-f5d6-43e6-a1d9-5508a24b1c08" data-cid="e752605f-f5d6-43e6-a1d9-5508a24b1c08" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="1072 (64%)" data-replace=" (64%)" data-pattern=" $2" data-tag-index="74_1" data-time="" data-username="" data-userid=""> (64%)</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" valign="top" id="2c86732c-7dba-46dd-b48b-9733be04d390" data-old-attributes=""><p id="95422fa6-2946-45c7-bf1e-78562d53f11a" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="9c3ae719-96e6-4161-8c2a-1b1917c3b537" data-cid="9c3ae719-96e6-4161-8c2a-1b1917c3b537" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="0" data-match="8479" data-replace="8479" data-pattern="8479" data-tag-index="75_2" data-time="" data-username="" data-userid="">8479</named-content><named-content id="dc5a9b23-7898-4264-a883-c5cd8789df67" data-cid="dc5a9b23-7898-4264-a883-c5cd8789df67" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="8479 (51%)" data-replace=" (51%)" data-pattern=" $2" data-tag-index="75_1" data-time="" data-username="" data-userid=""> (51%)</named-content></p></td></tr><tr data-col-count="3" id="c4a9043d-1273-40a0-bd71-4ead019a6db3"><td data-class="" data-original-space="4" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" valign="top" id="60905313-4c26-49fb-855f-4261aa482775" data-old-attributes=""><p id="1fa4466b-d29b-4091-9a7d-849008587beb" data-original-margin=" margin-left: 14.2pt; margin-right: 0cm; margin-top: 0cm;"> <named-content data-cid="1555069339" id="deed429b-a630-4f53-91cf-061da5a42b6f" content-type="styrm cts-2" specific-use="1555070057268" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Bold Removed by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:24pm" data-track-detail="" data-format-command="bold" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070057268" data-track-hint="Bold Removed">Hypertension</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" valign="top" id="01e1b316-5648-4b3b-b53f-9e1c48425f79" data-old-attributes=""><p id="479c1bda-7a97-4826-9f1b-5304dff13306" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="bf930b5d-8f8f-4f4e-be80-a720d43f819b" data-cid="bf930b5d-8f8f-4f4e-be80-a720d43f819b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="0" data-match="1166" data-replace="1166" data-pattern="1166" data-tag-index="77_2" data-time="" data-username="" data-userid="">1166</named-content><named-content id="02903335-6941-4400-b5d9-3510ff04d331" data-cid="02903335-6941-4400-b5d9-3510ff04d331" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="1166 (70%)" data-replace=" (70%)" data-pattern=" $2" data-tag-index="77_1" data-time="" data-username="" data-userid=""> (70%)</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" valign="top" id="19872be3-a9ce-4a2a-9efd-453314fec93e" data-old-attributes=""><p id="014b50c7-6f9a-4127-85d3-c0fc9c86b5ea" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">11 <named-content id="8a1db20e-4d4d-471e-96d8-12da65133bc3" data-cid="8a1db20e-4d4d-471e-96d8-12da65133bc3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="3" data-match="478 (70%)" data-replace="478" data-pattern="$1" data-tag-index="78_1" data-time="" data-username="" data-userid="">478</named-content><named-content id="2a4b154a-999a-4e84-b127-f6acb3c88642" data-cid="2a4b154a-999a-4e84-b127-f6acb3c88642" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="6" data-match="478 (70%)" data-replace=" (70%)" data-pattern=" $2" data-tag-index="78_1" data-time="" data-username="" data-userid=""> (70%)</named-content></p></td></tr><tr data-col-count="3" data-fill="true" id="5a803119-62b9-4cdb-86b8-8ebd23106130"><td data-class="" data-original-space="4" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" valign="top" id="dfd0fe8d-5c97-47b3-8f18-822839e85fa8" data-old-attributes=""><p id="2ea8bdb8-b6a0-4918-b2e3-828747b93e28" data-original-margin=" margin-left: 14.2pt; margin-right: 0cm; margin-top: 0cm;"> <named-content data-cid="1555069340" id="38958c51-3867-4444-a849-aaae583acdd6" content-type="styrm cts-2" specific-use="1555070058500" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Bold Removed by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:24pm" data-track-detail="" data-format-command="bold" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070058500" data-track-hint="Bold Removed">Diabetes mellitus</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" valign="top" id="debdfc0c-3f7e-42ad-ae1f-f3962300a6b5" data-old-attributes=""><p id="8a098177-4cd7-43bd-8ef1-9d3feaa8f34d" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="918c04c0-8b73-4be0-b26f-9943544cd20a" data-cid="918c04c0-8b73-4be0-b26f-9943544cd20a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="447 (27%)" data-replace="447" data-pattern="$1" data-tag-index="80_1" data-time="" data-username="" data-userid="">447</named-content><named-content id="6117cefd-ea1d-44ba-82da-5815a4d3d49a" data-cid="6117cefd-ea1d-44ba-82da-5815a4d3d49a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="447 (27%)" data-replace=" (27%)" data-pattern=" $2" data-tag-index="80_1" data-time="" data-username="" data-userid=""> (27%)</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" valign="top" id="94049d5b-2f9c-4f3e-b6ee-88b27d500fd2" data-old-attributes=""><p id="96a96aad-d052-4bc3-bbdc-fd3cd1fb5e11" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="486e1445-fadc-4fef-bbde-52670e0251c8" data-cid="486e1445-fadc-4fef-bbde-52670e0251c8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="0" data-match="3480" data-replace="3480" data-pattern="3480" data-tag-index="81_2" data-time="" data-username="" data-userid="">3480</named-content><named-content id="fc93e34d-f518-4d7c-96a2-dd28ca0b8efc" data-cid="fc93e34d-f518-4d7c-96a2-dd28ca0b8efc" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="3480 (21%)" data-replace=" (21%)" data-pattern=" $2" data-tag-index="81_1" data-time="" data-username="" data-userid=""> (21%)</named-content></p></td></tr><tr data-col-count="3" id="f837c5af-b452-45fe-a8df-59f9ca451233"><td data-class="" data-original-space="4" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" valign="top" id="082deae8-80a1-4dd5-9557-8a95233bd53f" data-old-attributes=""><p id="61fee004-0325-42fa-b1d5-bc6ffa0fdd27" data-original-margin=" margin-left: 14.2pt; margin-right: 0cm; margin-top: 0cm;"> <named-content data-cid="1555069341" id="3e50ac66-22a6-4fd3-9eb1-da3507cd9514" content-type="styrm cts-2" specific-use="1555070059627" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Bold Removed by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:24pm" data-track-detail="" data-format-command="bold" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070059627" data-track-hint="Bold Removed">Peripheral arterial disease</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" valign="top" id="78c9430c-7db6-4c4e-8651-950df29e47eb" data-old-attributes=""><p id="390899db-9a95-4def-a86b-d589710e3cd2" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="04f2a0ff-2d4f-4b09-ac18-a52d9da535e8" data-cid="04f2a0ff-2d4f-4b09-ac18-a52d9da535e8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="106 (6%)" data-replace="106" data-pattern="$1" data-tag-index="83_1" data-time="" data-username="" data-userid="">106</named-content><named-content id="8fa66998-188c-4329-ab1d-a386e650517d" data-cid="8fa66998-188c-4329-ab1d-a386e650517d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="106 (6%)" data-replace=" (6%)" data-pattern=" $2" data-tag-index="83_1" data-time="" data-username="" data-userid=""> (6%)</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" valign="top" id="19afec79-5e3a-4304-982b-0b3f9891c901" data-old-attributes=""><p id="ad073175-6854-4891-97f4-74cf8b420e7e" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="0dedf307-a2a3-4a32-ac00-3bcf3bf385e7" data-cid="0dedf307-a2a3-4a32-ac00-3bcf3bf385e7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="0" data-match="1154" data-replace="1154" data-pattern="1154" data-tag-index="84_2" data-time="" data-username="" data-userid="">1154</named-content><named-content id="4e3ad1de-31dd-4a76-84bf-ccce781f85b7" data-cid="4e3ad1de-31dd-4a76-84bf-ccce781f85b7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="1154 (7%)" data-replace=" (7%)" data-pattern=" $2" data-tag-index="84_1" data-time="" data-username="" data-userid=""> (7%)</named-content></p></td></tr><tr data-col-count="3" data-fill="true" id="fa8b5c7d-91d9-43e8-8381-53fc5e936d28"><td data-class="" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" valign="top" id="b3c7f446-5763-4303-8b53-1e0a9021aa89" data-old-attributes=""><p id="61714435-26c8-4038-8f76-200dbf089116" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1555069342" id="4e15a1a7-8dba-449e-8cb1-962fa0da1a97" content-type="styrm cts-2" specific-use="1555070061532" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Bold Removed by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:24pm" data-track-detail="" data-format-command="bold" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070061532" data-track-hint="Bold Removed">Concomitant medications</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" valign="top" id="052e6bad-e9c6-46b7-ac8d-f6628843329d" data-old-attributes=""><p id="56eb21ed-f7da-4575-b393-d5640e91aafa"/></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" valign="top" id="9fbcd007-5946-4c53-9bbb-9518789f9cf7" data-old-attributes=""><p id="577546df-3130-4e7d-96cf-c4dec91914bd"/></td></tr><tr data-col-count="3" id="f411daab-04bd-47d2-8709-f08e349a7321"><td data-class="" data-original-space="4" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" valign="top" id="5ea9d1a0-b9ad-4889-a445-7a4a84f15123" data-old-attributes=""><p id="ff7c0087-83f7-479a-bf6a-cce8c5844399" data-original-margin=" margin-left: 14.2pt; margin-right: 0cm; margin-top: 0cm;"> <named-content data-cid="1555069343" id="1d40188a-ae6a-45d2-b750-98c0f1dc7564" content-type="styrm cts-2" specific-use="1555070062981" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Bold Removed by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:24pm" data-track-detail="" data-format-command="bold" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070062981" data-track-hint="Bold Removed">Antiplatelet</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" valign="top" id="fc135b03-cccd-42c0-8590-6b3bff5cb2df" data-old-attributes=""><p id="d71ee359-85be-4457-b16b-89df440d58fd" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="6df2a44f-5955-4819-a865-29c8f6d5eedf" data-cid="6df2a44f-5955-4819-a865-29c8f6d5eedf" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="0" data-match="1081" data-replace="1081" data-pattern="1081" data-tag-index="87_2" data-time="" data-username="" data-userid="">1081</named-content><named-content id="2b9243bb-b916-4cf0-8111-86766f2757c4" data-cid="2b9243bb-b916-4cf0-8111-86766f2757c4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="1081 (65%)" data-replace=" (65%)" data-pattern=" $2" data-tag-index="87_1" data-time="" data-username="" data-userid=""> (65%)</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" valign="top" id="507ab447-307f-4204-a550-96a201e6566b" data-old-attributes=""><p id="cc701a95-422c-4ca2-9033-e9fa47689df2" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="2dcc831a-eb6f-490b-9a62-51d8a3654de2" data-cid="2dcc831a-eb6f-490b-9a62-51d8a3654de2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="0" data-match="8517" data-replace="8517" data-pattern="8517" data-tag-index="88_2" data-time="" data-username="" data-userid="">8517</named-content><named-content id="853afb22-7b1b-4e3a-a2eb-766d63558d7f" data-cid="853afb22-7b1b-4e3a-a2eb-766d63558d7f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="8517 (52%)" data-replace=" (52%)" data-pattern=" $2" data-tag-index="88_1" data-time="" data-username="" data-userid=""> (52%)</named-content></p></td></tr><tr data-col-count="3" data-fill="true" id="b201fa42-651c-4415-99b1-880a4df54c34"><td data-class="" data-original-space="4" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" valign="top" id="c2b645d8-aaa1-4940-aba6-bd3397808ef5" data-old-attributes=""><p id="65c70249-7fd6-4cc9-bc1a-e8b17aa62516" data-original-margin=" margin-left: 14.2pt; margin-right: 0cm; margin-top: 0cm;"> <named-content data-cid="1555069344" id="12a04e3c-4dee-4da1-9748-8b2015080195" content-type="styrm cts-2" specific-use="1555070064217" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Bold Removed by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:24pm" data-track-detail="" data-format-command="bold" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070064217" data-track-hint="Bold Removed">Beta-blocker</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" valign="top" id="f30a8bff-f04b-4c80-a40e-3c649bf9d2e9" data-old-attributes=""><p id="49413f6f-1bec-4ce4-93f1-ef38233a8eaa" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="064240d9-eb82-4efc-b67a-2c34c9d47af0" data-cid="064240d9-eb82-4efc-b67a-2c34c9d47af0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="787 (47%)" data-replace="787" data-pattern="$1" data-tag-index="90_1" data-time="" data-username="" data-userid="">787</named-content><named-content id="128ac228-6c67-4725-9791-16da1ae5c097" data-cid="128ac228-6c67-4725-9791-16da1ae5c097" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="787 (47%)" data-replace=" (47%)" data-pattern=" $2" data-tag-index="90_1" data-time="" data-username="" data-userid=""> (47%)</named-content></p></td><td data-class="" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" valign="top" id="3559f55b-1ef1-4e47-a4ca-0d85a6274074" data-old-attributes=""><p id="ccb1e3f0-4c2e-4817-bd89-48ad10b53865" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="541881bf-2f24-4ca2-ba44-de1c42808822" data-cid="541881bf-2f24-4ca2-ba44-de1c42808822" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="0" data-match="5667" data-replace="5667" data-pattern="5667" data-tag-index="91_2" data-time="" data-username="" data-userid="">5667</named-content><named-content id="7c5f026e-b77c-4bfe-9483-bd1499d5bf65" data-cid="7c5f026e-b77c-4bfe-9483-bd1499d5bf65" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="5667 (34%)" data-replace=" (34%)" data-pattern=" $2" data-tag-index="91_1" data-time="" data-username="" data-userid=""> (34%)</named-content></p></td></tr><tr data-col-count="3" id="7990fadb-5142-45da-adc3-564e40987d3f"><td data-class="" data-original-space="4" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" valign="top" id="b438e2be-d484-4cb4-8feb-4ff001292fa3" data-old-attributes=""><p id="670628ca-cafe-4089-8833-f9c82f89980c" data-original-margin=" margin-left: 14.2pt; margin-right: 0cm; margin-top: 0cm;"> <named-content data-cid="1555069345" id="019f94ab-2265-4be1-8782-5676770a6de0" content-type="styrm cts-2" specific-use="1555070065633" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Bold Removed by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:24pm" data-track-detail="" data-format-command="bold" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070065633" data-track-hint="Bold Removed">ACE inhibitor</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" valign="top" id="21d52f2c-d2f7-4250-bc6f-7d5f3c2ed5b5" data-old-attributes=""><p id="91b16e98-c45d-464d-9ded-d1dfb5c817cf" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="67156b1a-5002-450c-8218-cb4d194d0ca5" data-cid="67156b1a-5002-450c-8218-cb4d194d0ca5" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="779 (47%)" data-replace="779" data-pattern="$1" data-tag-index="93_1" data-time="" data-username="" data-userid="">779</named-content><named-content id="6cd7c696-68fc-45eb-8725-8ffd620c1108" data-cid="6cd7c696-68fc-45eb-8725-8ffd620c1108" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="779 (47%)" data-replace=" (47%)" data-pattern=" $2" data-tag-index="93_1" data-time="" data-username="" data-userid=""> (47%)</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" valign="top" id="e1b014a1-6a43-4a19-b58c-028371bd351c" data-old-attributes=""><p id="790aa8d5-1bd4-46e0-9db6-408fea94bf1b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="59da7d08-2617-42d3-98df-4831c1650288" data-cid="59da7d08-2617-42d3-98df-4831c1650288" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="0" data-match="7655" data-replace="7655" data-pattern="7655" data-tag-index="94_2" data-time="" data-username="" data-userid="">7655</named-content><named-content id="ebc3dfb6-51fa-45b3-9f65-fb9f29102e28" data-cid="ebc3dfb6-51fa-45b3-9f65-fb9f29102e28" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="7655 (46%)" data-replace=" (46%)" data-pattern=" $2" data-tag-index="94_1" data-time="" data-username="" data-userid=""> (46%)</named-content></p></td></tr><tr data-col-count="3" data-fill="true" id="d7a71b96-09b0-4ec3-a7a7-c8bce25e888b"><td data-class="" data-original-space="4" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" valign="top" id="0c61df3b-d790-4753-8e55-21bfb10ea403" data-old-attributes=""><p id="dc75712a-f0ec-4c73-9a00-2ef325963380" data-original-margin=" margin-left: 14.2pt; margin-right: 0cm; margin-top: 0cm;"> <named-content data-cid="1555069346" id="669bc05f-d10d-4b9b-b0a9-cf8a2eacbf94" content-type="styrm cts-2" specific-use="1555070066903" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Bold Removed by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:24pm" data-track-detail="" data-format-command="bold" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070066903" data-track-hint="Bold Removed">Statin</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" valign="top" id="162d4ad1-1896-42e2-a522-ce2807a94249" data-old-attributes=""><p id="f7deb305-08ba-426e-912b-5ad6a150a789" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="cd9f1f27-f1be-40d6-b58c-a0e8a1b1794d" data-cid="cd9f1f27-f1be-40d6-b58c-a0e8a1b1794d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="0" data-match="1263" data-replace="1263" data-pattern="1263" data-tag-index="96_2" data-time="" data-username="" data-userid="">1263</named-content><named-content id="e93ed59f-2694-43c3-8094-97599b07b547" data-cid="e93ed59f-2694-43c3-8094-97599b07b547" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="1263 (75%)" data-replace=" (75%)" data-pattern=" $2" data-tag-index="96_1" data-time="" data-username="" data-userid=""> (75%)</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" valign="top" id="bda4227c-990a-44b4-8906-f88552022a73" data-old-attributes=""><p id="369d89a4-a38a-4f84-ac12-1feae40a7c02" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">10 <named-content id="45e4e0f9-8473-4712-a0bc-54ed52ff81e9" data-cid="45e4e0f9-8473-4712-a0bc-54ed52ff81e9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="3" data-match="721 (65%)" data-replace="721" data-pattern="$1" data-tag-index="97_1" data-time="" data-username="" data-userid="">721</named-content><named-content id="bfb5927c-770a-4bdc-a58b-d2a53c83be93" data-cid="bfb5927c-770a-4bdc-a58b-d2a53c83be93" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="6" data-match="721 (65%)" data-replace=" (65%)" data-pattern=" $2" data-tag-index="97_1" data-time="" data-username="" data-userid=""> (65%)</named-content></p></td></tr><tr data-col-count="3" id="d3ef41f5-3d62-420d-b8a3-e261ea64b39f"><td data-class="" data-original-space="4" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" valign="top" id="8ad1c6d4-9d68-437f-b8c3-6596cb86c39c" data-old-attributes=""><p id="ac646274-11aa-481d-a0c0-d65825f9cfd2" data-original-margin=" margin-left: 14.2pt; margin-right: 0cm; margin-top: 0cm;"> <named-content data-cid="1555069347" id="dedf7147-485d-4dc0-b0fa-401f8c4642a9" content-type="styrm cts-2" specific-use="1555070068522" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Bold Removed by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:24pm" data-track-detail="" data-format-command="bold" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070068522" data-track-hint="Bold Removed">Long-acting muscarinic antagonist</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" valign="top" id="a9fb833b-bd0c-47e9-baaf-78e702d81bf0" data-old-attributes=""><p id="27dedb91-213c-4474-8cbd-9203dab31aed" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="167f3b79-0db5-438b-8edc-45a8e652af77" data-cid="167f3b79-0db5-438b-8edc-45a8e652af77" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="168 (10%)" data-replace="168" data-pattern="$1" data-tag-index="99_1" data-time="" data-username="" data-userid="">168</named-content><named-content id="713c77b5-35a4-441d-9e32-612e64606d63" data-cid="713c77b5-35a4-441d-9e32-612e64606d63" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="168 (10%)" data-replace=" (10%)" data-pattern=" $2" data-tag-index="99_1" data-time="" data-username="" data-userid=""> (10%)</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" valign="top" id="53fb8c6a-85bd-4111-b669-bcea282c5671" data-old-attributes=""><p id="0c12155f-758e-431b-ba51-813702e5d00f" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="306f96ed-df9f-4b42-9692-9a8b9cb85ea0" data-cid="306f96ed-df9f-4b42-9692-9a8b9cb85ea0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="818 (5%)" data-replace="818" data-pattern="$1" data-tag-index="100_1" data-time="" data-username="" data-userid="">818</named-content><named-content id="8d0005cb-16ec-4b64-90c7-8c8a05018264" data-cid="8d0005cb-16ec-4b64-90c7-8c8a05018264" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="818 (5%)" data-replace=" (5%)" data-pattern=" $2" data-tag-index="100_1" data-time="" data-username="" data-userid=""> (5%)</named-content></p></td></tr><tr data-col-count="3" data-fill="true" id="56dcd39a-9b90-4440-a846-34ac84fa1ef6"><td data-class="" data-original-space="4" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" valign="top" id="9d0b4749-b299-4eb4-bcff-7f15c82e9d0a" data-old-attributes=""><p id="13e08fd4-6259-498e-81e0-6fbc895b5d9a" data-original-margin=" margin-left: 14.2pt; margin-right: 0cm; margin-top: 0cm;"> Xanthine (including theophylline)</p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" valign="top" id="e72972cd-21a6-4057-a7a9-65499449be07" data-old-attributes=""><p id="29da4ced-1ca8-46ea-9201-7e8964ad620b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="0e049f61-5060-4965-9663-b7b916a10b06" data-cid="0e049f61-5060-4965-9663-b7b916a10b06" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="78 (5%)" data-replace="78" data-pattern="$1" data-tag-index="102_1" data-time="" data-username="" data-userid="">78</named-content><named-content id="31919d91-a0a7-4f5b-ab77-6e9d29460d07" data-cid="31919d91-a0a7-4f5b-ab77-6e9d29460d07" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="2" data-match="78 (5%)" data-replace=" (5%)" data-pattern=" $2" data-tag-index="102_1" data-time="" data-username="" data-userid=""> (5%)</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" valign="top" id="b0357f50-60c4-4ff9-b543-3096969b02a2" data-old-attributes=""><p id="29c607c0-7eac-44ff-9fa8-27d02de37581" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="5a79eff8-3db2-44fe-af2f-5d552de8ff62" data-cid="5a79eff8-3db2-44fe-af2f-5d552de8ff62" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="0" data-match="3719" data-replace="3719" data-pattern="3719" data-tag-index="103_2" data-time="" data-username="" data-userid="">3719</named-content><named-content id="204f4cb6-6bf0-41e7-8846-0bd7c0091ab7" data-cid="204f4cb6-6bf0-41e7-8846-0bd7c0091ab7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="3719 (23%)" data-replace=" (23%)" data-pattern=" $2" data-tag-index="103_1" data-time="" data-username="" data-userid=""> (23%)</named-content></p></td></tr><tr data-col-count="3" id="88217562-1b0d-4208-b1af-9adf8d8907bd"><td data-class="" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" valign="top" id="c9ac2958-a247-4522-b077-e5b980f3e9dd" data-old-attributes=""><p id="09a8c14e-e210-418f-9270-17d480e1f25a" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1555069349" id="8ef2812c-c8c4-4225-8255-516dda6835f6" content-type="styrm cts-2" specific-use="1555070071779" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Bold Removed by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:24pm" data-track-detail="" data-format-command="bold" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070071779" data-track-hint="Bold Removed">Treatment allocation</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" valign="top" id="1268a232-23aa-48f9-a36a-cfb9e3acb1c4" data-old-attributes=""><p id="8f5812f3-8bf5-491b-be83-b4c6f0911591"/></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" valign="top" id="e1029b86-f66a-4a28-9fe8-205ef4d1bb5c" data-old-attributes=""><p id="ee1073a4-3092-4fd6-ab74-d74c0d5be1f3"/></td></tr><tr data-col-count="3" data-fill="true" id="ade12735-372c-49df-be5f-2de4dcebd908"><td data-class="" data-original-space="4" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" valign="top" id="c8096c3a-28d9-4aab-95b8-eba743625136" data-old-attributes=""><p id="58a22424-6690-4901-8676-db4fc964626f" data-original-margin=" margin-left: 14.2pt; margin-right: 0cm; margin-top: 0cm;"> <named-content data-cid="1555069350" id="2a119edf-0ba8-4802-90e7-19c6e635cdb4" content-type="styrm cts-2" specific-use="1555070075136" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Bold Removed by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:24pm" data-track-detail="" data-format-command="bold" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070075136" data-track-hint="Bold Removed">Placebo</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" valign="top" id="5d358374-5350-476e-9a6f-2694817b2814" data-old-attributes=""><p id="c6482fa3-a8d5-4c9e-9689-fe2b3151d987" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="acba1c2f-8f4e-4842-9831-a3c5d7345bdd" data-cid="acba1c2f-8f4e-4842-9831-a3c5d7345bdd" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="439 (26%)" data-replace="439" data-pattern="$1" data-tag-index="106_1" data-time="" data-username="" data-userid="">439</named-content><named-content id="3ebf97fe-20da-433f-8a52-53b0cab5eaf9" data-cid="3ebf97fe-20da-433f-8a52-53b0cab5eaf9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="439 (26%)" data-replace=" (26%)" data-pattern=" $2" data-tag-index="106_1" data-time="" data-username="" data-userid=""> (26%)</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" valign="top" id="bc2cdc74-8b6c-4e37-a8ee-ae780004fe1b" data-old-attributes=""><p id="de7f7933-21f4-44ff-9539-c9fda49c5270" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="c6fb30c6-aa0e-4585-8c93-fc2136608bbe" data-cid="c6fb30c6-aa0e-4585-8c93-fc2136608bbe" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="0" data-match="4111" data-replace="4111" data-pattern="4111" data-tag-index="107_2" data-time="" data-username="" data-userid="">4111</named-content><named-content id="15f77f5b-db08-4e39-934a-b8ac9c7e0309" data-cid="15f77f5b-db08-4e39-934a-b8ac9c7e0309" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="4111 (25%)" data-replace=" (25%)" data-pattern=" $2" data-tag-index="107_1" data-time="" data-username="" data-userid=""> (25%)</named-content></p></td></tr><tr data-col-count="3" id="6e9720c3-b873-460c-a791-31f9a79e063b"><td data-class="" data-original-space="4" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" valign="top" id="073748b1-0f62-4c8f-a671-f6aef8f45274" data-old-attributes=""><p id="aca6b042-d957-401c-a368-0e5d61aee29c" data-original-margin=" margin-left: 14.2pt; margin-right: 0cm; margin-top: 0cm;"> <named-content data-cid="1555069351" id="4acbb141-984b-42cc-b3a6-3e5508e530db" content-type="styrm cts-2" specific-use="1555070076585" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Bold Removed by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:24pm" data-track-detail="" data-format-command="bold" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070076585" data-track-hint="Bold Removed">Fluticasone furoate</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" valign="top" id="0a46e782-9de7-43dc-99b5-4c419b97e1a1" data-old-attributes=""><p id="d648f189-6628-49a7-a034-5c31e5a39feb" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="dbab5dfc-92ab-4940-837c-0ef443ffc4d7" data-cid="dbab5dfc-92ab-4940-837c-0ef443ffc4d7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="415 (25%)" data-replace="415" data-pattern="$1" data-tag-index="109_1" data-time="" data-username="" data-userid="">415</named-content><named-content id="8c5c9de5-ebc8-4309-892e-d4744521afbf" data-cid="8c5c9de5-ebc8-4309-892e-d4744521afbf" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="415 (25%)" data-replace=" (25%)" data-pattern=" $2" data-tag-index="109_1" data-time="" data-username="" data-userid=""> (25%)</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" valign="top" id="9c701fd8-0627-4aca-8275-cd25f33c6f00" data-old-attributes=""><p id="65d05bc2-5eae-4e9f-8bd4-34d6ec8e5410" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="9ba29047-c54f-4d46-97f6-e64e20c2e28b" data-cid="9ba29047-c54f-4d46-97f6-e64e20c2e28b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="0" data-match="4135" data-replace="4135" data-pattern="4135" data-tag-index="110_2" data-time="" data-username="" data-userid="">4135</named-content><named-content id="f2794607-b0fa-4c4d-95a1-5ba2a17c82ea" data-cid="f2794607-b0fa-4c4d-95a1-5ba2a17c82ea" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="4135 (25%)" data-replace=" (25%)" data-pattern=" $2" data-tag-index="110_1" data-time="" data-username="" data-userid=""> (25%)</named-content></p></td></tr><tr data-col-count="3" data-fill="true" id="e4b9a235-5402-4001-b17d-e66bc8276a41"><td data-class="" data-original-space="4" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" valign="top" id="477c6e1a-a8e9-44ea-af67-54f0ec56a9f9" data-old-attributes=""><p id="17243999-a66b-4b84-a5f0-2991c324632c" data-original-margin=" margin-left: 14.2pt; margin-right: 0cm; margin-top: 0cm;"> <named-content data-cid="1555069352" id="8e65f160-c930-4b86-8fb0-fe71493c4953" content-type="styrm cts-2" specific-use="1555070077963" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Bold Removed by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:24pm" data-track-detail="" data-format-command="bold" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070077963" data-track-hint="Bold Removed">Vilanterol</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" valign="top" id="3a5e3a1e-1da7-4001-b43c-24bbd7453b00" data-old-attributes=""><p id="fc7fb983-1492-4b5f-b5dc-31ad4cd05658" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="fc428418-8ee9-4618-a05a-d701270237ac" data-cid="fc428418-8ee9-4618-a05a-d701270237ac" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="416 (25%)" data-replace="416" data-pattern="$1" data-tag-index="112_1" data-time="" data-username="" data-userid="">416</named-content><named-content id="64d6b2f7-44a3-4a48-8ccd-439be652359d" data-cid="64d6b2f7-44a3-4a48-8ccd-439be652359d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="416 (25%)" data-replace=" (25%)" data-pattern=" $2" data-tag-index="112_1" data-time="" data-username="" data-userid=""> (25%)</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" valign="top" id="afe06cb9-a174-41a0-a899-6235a1191f12" data-old-attributes=""><p id="7d07f4d7-3b54-4bde-8e31-de54ad40ce85" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="94ecb872-fdf6-4ef3-803c-6e3ea06db641" data-cid="94ecb872-fdf6-4ef3-803c-6e3ea06db641" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="0" data-match="4118" data-replace="4118" data-pattern="4118" data-tag-index="113_2" data-time="" data-username="" data-userid="">4118</named-content><named-content id="b439d149-dd2b-435e-a25c-a26d57d120c5" data-cid="b439d149-dd2b-435e-a25c-a26d57d120c5" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="4118 (25%)" data-replace=" (25%)" data-pattern=" $2" data-tag-index="113_1" data-time="" data-username="" data-userid=""> (25%)</named-content></p></td></tr><tr data-col-count="3" id="c670e3ac-3307-4b4c-a66f-e1726909da22"><td data-class="" data-original-space="4" data-original-border="border:none;border-bottom:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" valign="top" id="879fecd4-97f0-4506-8fec-d11f18894a1c" data-old-attributes=""><p id="f5efec91-03f2-4506-a6d5-f61e30a8e26b" data-original-margin=" margin-left: 14.2pt; margin-right: 0cm; margin-top: 0cm;"> <named-content data-cid="1555069353" id="f63b2256-c8bb-4759-9b30-e3ee24adf13c" content-type="styrm cts-2" specific-use="1555070079172" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Bold Removed by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:24pm" data-track-detail="" data-format-command="bold" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070079172" data-track-hint="Bold Removed">Combination therapy</named-content></p></td><td data-original-border="border:none;border-bottom:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" valign="top" id="4f3edbe0-b931-45ff-84c2-114cf3644fa4" data-old-attributes=""><p id="4feafd32-3cdf-4cc1-9384-48a7b2cde11b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="f10725f1-eeda-4876-946d-559b45a3f49a" data-cid="f10725f1-eeda-4876-946d-559b45a3f49a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="403 (24%)" data-replace="403" data-pattern="$1" data-tag-index="115_1" data-time="" data-username="" data-userid="">403</named-content><named-content id="9f28d451-da5d-4fa2-9afe-93a8d3033589" data-cid="9f28d451-da5d-4fa2-9afe-93a8d3033589" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="403 (24%)" data-replace=" (24%)" data-pattern=" $2" data-tag-index="115_1" data-time="" data-username="" data-userid=""> (24%)</named-content></p></td><td data-original-border="border:none;border-bottom:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" valign="top" id="76652b5b-1244-4bcf-b940-7b01040487a8" data-old-attributes=""><p id="2860be18-afdc-438a-90c8-9b26613fc711" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="05a5e840-feb3-4b4e-a9aa-b4daa43c5b80" data-cid="05a5e840-feb3-4b4e-a9aa-b4daa43c5b80" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="0" data-match="4121" data-replace="4121" data-pattern="4121" data-tag-index="116_2" data-time="" data-username="" data-userid="">4121</named-content><named-content id="db35e4d2-8937-4666-86ee-1a38e59bd312" data-cid="db35e4d2-8937-4666-86ee-1a38e59bd312" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="4121 (25%)" data-replace=" (25%)" data-pattern=" $2" data-tag-index="116_1" data-time="" data-username="" data-userid=""> (25%)</named-content></p></td></tr></tbody></table><table-wrap-foot id="0b5231d4-154b-46fe-a54d-9258704fffec"><fn data-class="jrnlTblFoot" data-id="T1_FN1" fn-type="general" id="T1_FN1"><p id="3bb6b556-634f-4ec0-997d-7852cf7644b1">Continuous variables are mean (<named-content id="d605a673-4705-46ab-862e-ace2a20e94c7" data-cid="d605a673-4705-46ab-862e-ace2a20e94c7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'SD' to 'SD'" data-track-detail="" data-tag-desc="ABBRV" data-tag-type="ABBRV" data-offset="31" data-match="SD" data-replace="SD" data-pattern="SD" data-tag-index="117_2" data-function="addTrackChanges" data-time="" data-username="" data-userid="">SD</named-content>); categorical variables are n and (%).</p></fn><fn data-class="jrnlTblFoot" data-id="T1_FN2" fn-type="abbrev" id="T1_FN2" data-def-list="true"><p id="e373a4ab-86fd-4870-a989-12698eaa6d56"><def-list id="43272cea-ce18-4ae3-a414-027027adb1d5"><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" id="496faf0b-3881-42c3-abca-4ca3608ed728" data-track="del" data-cid="1555287232402" data-username="Ariel (COPYEDITOR)" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-time="1555287232402" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 8:13am"><term data-class="jrnlAbbrevTerm" data-tag-desc="DEFITEM,DEFSEP,DEFITEM,DEFEND" data-title="DEFITEM" data-tag-type="DEFITEM" data-offset="0" data-match="ACE, angiotensin converting enzyme;" data-pattern="" data-tag-index="" id="cc3806fc-af31-4aa7-af4f-e932f209de5b">ACE</term><named-content id="262354b0-7a55-4b6c-be06-c15fb55a78a3" data-cid="262354b0-7a55-4b6c-be06-c15fb55a78a3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="DEFSEP" data-track-detail="" data-tag-desc="DEFITEM,DEFSEP,DEFITEM,DEFEND" data-tag-type="DEFSEP" data-offset="3" data-match="ACE, angiotensin converting enzyme;" data-pattern="" data-tag-index="" data-time="" data-username="" data-userid="">, </named-content><def data-class="jrnlFootDefinition" data-tag-desc="DEFITEM,DEFSEP,DEFITEM,DEFEND" data-title="DEFITEM" data-tag-type="DEFITEM" data-offset="5" data-match="ACE, angiotensin converting enzyme;" data-pattern="" data-tag-index="" id="2dd0f224-ecae-4155-9345-0b9749f21ad1"><p id="faed28b8-a690-413d-9801-4c5a07ecc24f">angiotensin converting enzyme</p></def><named-content id="911331dd-0370-484a-aafd-4e7a78278233" data-cid="911331dd-0370-484a-aafd-4e7a78278233" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="DEFEND" data-track-detail="" data-tag-desc="DEFITEM,DEFSEP,DEFITEM,DEFEND" data-tag-type="DEFEND" data-offset="34" data-match="ACE, angiotensin converting enzyme;" data-pattern="" data-tag-index="" data-time="" data-username="" data-userid="">;</named-content></def-item><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" id="93364af9-6dca-45b0-a7cd-30d40988441a"><term data-class="jrnlAbbrevTerm" data-tag-desc="DEFITEM,DEFSEP,DEFITEM,DEFEND" data-title="DEFITEM" data-tag-type="DEFITEM" data-offset="36" data-match="BMI, body mass index;" data-pattern="" data-tag-index="" id="4385e75a-ebf4-4483-978f-fc86cdf70cfe">BMI</term><named-content id="a24dbadf-d804-4c4e-928f-8e2f33853024" data-cid="a24dbadf-d804-4c4e-928f-8e2f33853024" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="DEFSEP" data-track-detail="" data-tag-desc="DEFITEM,DEFSEP,DEFITEM,DEFEND" data-tag-type="DEFSEP" data-offset="39" data-match="BMI, body mass index;" data-pattern="" data-tag-index="" data-time="" data-username="" data-userid="">, </named-content><def data-class="jrnlFootDefinition" data-tag-desc="DEFITEM,DEFSEP,DEFITEM,DEFEND" data-title="DEFITEM" data-tag-type="DEFITEM" data-offset="41" data-match="BMI, body mass index;" data-pattern="" data-tag-index="" id="ea06fef1-3cf2-48ce-8a7a-b36e0d6c2e60"><p id="afff3e57-4c76-4319-9afd-b7f5b080c57a">body mass index</p></def><named-content id="79b3ddc4-8636-41ff-b6ac-3d96b7f60ba6" data-cid="79b3ddc4-8636-41ff-b6ac-3d96b7f60ba6" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="DEFEND" data-track-detail="" data-tag-desc="DEFITEM,DEFSEP,DEFITEM,DEFEND" data-tag-type="DEFEND" data-offset="56" data-match="BMI, body mass index;" data-pattern="" data-tag-index="" data-time="" data-username="" data-userid="">;</named-content></def-item><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" id="525996e7-9231-438b-99ae-d6c91807adee"> <term data-class="jrnlAbbrevTerm" data-tag-desc="DEFITEM,DEFSEP,DEFITEM,DEFEND" data-title="DEFITEM" data-tag-type="DEFITEM" data-offset="58" data-match="FEV1, forced expiratory volume in 1 s;" data-pattern="" data-tag-index="" id="3dfa7fee-58fe-4628-a541-f389d0cb5144">FEV<sub id="00638115-5fa3-44f1-a493-18231e11d394">1</sub></term><named-content id="01397df0-edee-45f1-b067-eef188587a68" data-cid="01397df0-edee-45f1-b067-eef188587a68" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="DEFSEP" data-track-detail="" data-tag-desc="DEFITEM,DEFSEP,DEFITEM,DEFEND" data-tag-type="DEFSEP" data-offset="62" data-match="FEV1, forced expiratory volume in 1 s;" data-pattern="" data-tag-index="" data-time="" data-username="" data-userid="">, </named-content><def data-class="jrnlFootDefinition" data-tag-desc="DEFITEM,DEFSEP,DEFITEM,DEFEND" data-title="DEFITEM" data-tag-type="DEFITEM" data-offset="64" data-match="FEV1, forced expiratory volume in 1 s;" data-pattern="" data-tag-index="" id="eb05b80c-0aae-4ec1-af68-d7998c122f96"><p id="f4026737-4fb9-44a6-8692-311764c74347">forced expiratory volume in <named-content id="4516e255-9341-4046-ae3b-c26a658c9827" data-cid="4516e255-9341-4046-ae3b-c26a658c9827" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="92" data-match="1 s" data-replace="1" data-pattern="$1" data-tag-index="118_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="b1fd2bb1-3acd-4d38-81b6-27c96a6c13be" data-cid="b1fd2bb1-3acd-4d38-81b6-27c96a6c13be" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣s' to ' s'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="93" data-match="1 s" data-replace=" s" data-pattern=" s" data-tag-index="118_1" data-track-change=" s" data-time="" data-username="" data-userid=""> s</named-content></p></def><named-content id="61627d0e-0753-4e99-b22d-22c5bbcd53a9" data-cid="61627d0e-0753-4e99-b22d-22c5bbcd53a9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="DEFEND" data-track-detail="" data-tag-desc="DEFITEM,DEFSEP,DEFITEM,DEFEND" data-tag-type="DEFEND" data-offset="97" data-match="FEV1, forced expiratory volume in 1 s;" data-pattern="" data-tag-index="" data-time="" data-username="" data-userid="">;</named-content></def-item><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" id="b28fbdf2-9145-434e-b31b-e3fd8337f9ea" data-track="del" data-cid="1555287238075" data-username="Ariel (COPYEDITOR)" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-time="1555287238075" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 8:13am"> <term data-class="jrnlAbbrevTerm" data-tag-desc="DEFITEM,DEFSEP,DEFITEM,DEFEND" data-title="DEFITEM" data-tag-type="DEFITEM" data-offset="99" data-match="SD, standard deviation" data-pattern="" data-tag-index="" id="70517694-72c7-44a7-83ea-c3aee10a04b9"><named-content id="dabad1ed-4990-444a-964a-1bdca00aff4b" data-cid="dabad1ed-4990-444a-964a-1bdca00aff4b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'SD' to 'SD'" data-track-detail="" data-tag-desc="ABBRV" data-tag-type="ABBRV" data-offset="97" data-match="SD" data-replace="SD" data-pattern="SD" data-tag-index="118_2" data-function="addTrackChanges" data-time="" data-username="" data-userid="">SD</named-content></term><named-content id="4ea18bc5-2c5a-49d2-af3b-b1dfbd9aa9dd" data-cid="4ea18bc5-2c5a-49d2-af3b-b1dfbd9aa9dd" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="DEFSEP" data-track-detail="" data-tag-desc="DEFITEM,DEFSEP,DEFITEM,DEFEND" data-tag-type="DEFSEP" data-offset="101" data-match="SD, standard deviation" data-pattern="" data-tag-index="" data-time="" data-username="" data-userid="">, </named-content><def data-class="jrnlFootDefinition" data-tag-desc="DEFITEM,DEFSEP,DEFITEM,DEFEND" data-title="DEFITEM" data-tag-type="DEFITEM" data-offset="103" data-match="SD, standard deviation" data-pattern="" data-tag-index="" id="fe17f1fc-f2cc-4736-9e54-27f23a5cfc90"><p id="16f35f39-c52b-41d2-a7c6-2a41e0cf39a1">standard deviation</p></def>; </def-item><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="23e91562-6c9e-40cb-815f-08ecd9185b31" fn-type="abbrev" data-id="T1_FN3"><term data-class="jrnlAbbrevTerm" id="3fc11dd4-f016-4d47-aa4c-7f327d4dd0cf">SUMMIT</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="e6da7471-5512-4c41-a4e1-646a376de558"><p id="78a2b27f-9154-4ebf-be2d-dc64d98fb76c">Study to Understand Mortality and MorbidITy</p></def>.</def-item></def-list></p></fn></table-wrap-foot></table-wrap><title data-level="2" data-class="jrnlHead2" id="ee6206b1-75a9-4dbd-b80e-415f212207d2">Effect of treatment on biomarker concentration at 3 months</title><p data-class="jrnlSecPara" id="b664774b-93bd-4504-b359-a97a11e9b841">Inhaled <named-content data-cid="1555285699" id="0d619386-7d25-4217-b526-912a2b85d0cc" content-type="del cts-3" specific-use="1555291235077" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:20am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291235077">vilanterol</named-content><named-content data-cid="1555285700" id="12169b2d-79e0-488e-8330-c0a5435448b9" content-type="ins cts-3" specific-use="1555291235133" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 9:20am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291235133">VI</named-content>, <named-content data-cid="1555285679" id="98db4088-8394-4b03-a0bd-74efb34cfc9e" content-type="del cts-3" specific-use="1555291198545" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:19am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291198545">fluticasone furoate</named-content><named-content data-cid="1555285680" id="cdb323c7-b302-47c6-954a-76cd89537999" content-type="ins cts-3" specific-use="1555291198601" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 9:19am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291198601">FF</named-content> and the combination resulted in a <named-content id="0d936578-4fa3-403d-9e00-767b7115bdba" data-cid="0d936578-4fa3-403d-9e00-767b7115bdba" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PRE" data-track-detail="" data-tag-desc="APP,PRE,PREP,RNG,SUF,SREP,UNT" data-tag-type="PRE" data-offset="74" data-match="6%–9% reduction" data-replace="6" data-pattern="$2" data-tag-index="119_5" data-time="" data-username="" data-userid="">6</named-content><named-content id="e6d0aa2b-95ba-4234-bf3a-5126e477f325" data-cid="e6d0aa2b-95ba-4234-bf3a-5126e477f325" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PREP" data-track-detail="" data-tag-desc="APP,PRE,PREP,RNG,SUF,SREP,UNT" data-tag-type="PREP" data-offset="75" data-match="6%–9% reduction" data-replace="%" data-pattern="$3" data-tag-index="119_5" data-time="" data-username="" data-userid="">%</named-content><named-content id="9c5e917a-db2d-4438-98d4-5a01b7531e79" data-cid="9c5e917a-db2d-4438-98d4-5a01b7531e79" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNG" data-track-detail="" data-tag-desc="APP,PRE,PREP,RNG,SUF,SREP,UNT" data-tag-type="RNG" data-offset="76" data-match="6%–9% reduction" data-replace="–" data-pattern="–" data-tag-index="119_5" data-time="" data-username="" data-userid="">–</named-content><named-content id="e0ec1953-9ef4-409e-97f0-985db5a5b44f" data-cid="e0ec1953-9ef4-409e-97f0-985db5a5b44f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="APP,PRE,PREP,RNG,SUF,SREP,UNT" data-tag-type="VAL" data-offset="79" data-match="6%–9% reduction" data-replace="9" data-pattern="$1" data-tag-index="119_5" data-time="" data-username="" data-userid="">9</named-content><named-content id="516f48cc-7ed1-43de-bf57-d84ce377d88b" data-cid="516f48cc-7ed1-43de-bf57-d84ce377d88b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="APP,PRE,PREP,RNG,SUF,SREP,UNT" data-tag-type="UNT" data-offset="80" data-match="6%–9% reduction" data-replace="%" data-pattern="%" data-tag-index="119_5" data-time="" data-username="" data-userid="">%</named-content><named-content id="35b8c5ce-d86c-4b32-9bab-830a8a3111cd" data-cid="35b8c5ce-d86c-4b32-9bab-830a8a3111cd" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="APP,PRE,PREP,RNG,SUF,SREP,UNT" data-tag-type="UNT" data-offset="81" data-match="6%–9% reduction" data-replace=" reduction" data-pattern=" $7" data-tag-index="119_5" data-time="" data-username="" data-userid=""> reduction</named-content> in CC-16 serum levels as is shown in <named-content data-cid="1555394565768" id="6dea84bb-a977-4772-92dd-33a815132177" content-type="del cts-1" specific-use="1555068439000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1555068439000">supplementary table 2</named-content><named-content data-cid="1555394565768" id="e9135c90-3982-4a80-8d02-57fcd4f1e50a" content-type="ins cts-1" specific-use="1555068439000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1555068439000"><xref id="6c088a3b-dad7-480f-8892-144bee31344d" ref-type="supplementary-material" rid="SP1" data-citation-string=" SP1 " data-mark-cited="SP1">online supplementary table 2</xref></named-content> (<named-content id="6e2017c6-134b-4083-8f25-e548b9b3200b" data-cid="6e2017c6-134b-4083-8f25-e548b9b3200b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'p' to 'p'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="152" data-match="p&amp;lt;0.01 for" data-replace="&lt;i&gt;p&lt;/i&gt;" data-pattern="$1" data-tag-index="119_6" data-function="lowercase,removeItalics" data-track-change="p" data-time="" data-username="" data-userid="">p</named-content><named-content id="76cdf473-38e8-466f-a6de-f27bda301d9c" data-cid="76cdf473-38e8-466f-a6de-f27bda301d9c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="153" data-match="p&amp;lt;0.01 for" data-replace="&lt;" data-pattern="$2" data-tag-index="119_6" data-time="" data-username="" data-userid="">&lt;</named-content><named-content id="53e09762-0a08-45cf-ac82-81177061fc7c" data-cid="53e09762-0a08-45cf-ac82-81177061fc7c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="154" data-match="p&amp;lt;0.01 for" data-replace="0.01" data-pattern="$3" data-tag-index="119_6" data-time="" data-username="" data-userid="">0.01</named-content> for all three compared with placebo). However, there was no effect of the inhaled therapy on systemic levels of CRP, sRAGE, SPD and fibrinogen when compared with placebo (<named-content data-cid="1555394565769" id="b5c14fdc-931a-44fb-8412-35cd68046f20" content-type="del cts-1" specific-use="1555068439000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1555068439000">supplementary table 3</named-content><named-content data-cid="1555394565769" id="6b5be08c-d7ac-4caf-82a4-433999f3731d" content-type="ins cts-1" specific-use="1555068439000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1555068439000"><xref id="e1602787-5d7a-444a-bf82-9975b425fb00" ref-type="supplementary-material" rid="SP1" data-citation-string=" SP1 " data-mark-cited="SP1">online supplementary table 3</xref></named-content>).</p><title data-level="2" data-class="jrnlHead2" id="d3ed644c-e2e8-4334-82a3-5a72d2c4747a">Baseline biomarker data and outcomes</title><p data-class="jrnlSecPara" id="21667322-dd0b-4ae0-b6db-26f9ab84204b">There was no relationship between baseline levels of CC-16, CRP, sRAGE, SPD and fibrinogen and baseline FEV<sub id="ef92b30b-8b44-4057-857e-09a6eff1db2b">1</sub> expressed as % of predicted normal value (<xref ref-type="fig" rid="F2" data-tag-desc="FIGTBLREF" data-tag-type="FIGTBLREF" data-offset="151" data-match="figure 2" data-pattern="" data-tag-index="120_1" data-citation-string=" F2 " data-anchor="true" id="18fa0634-155e-4bc0-9503-343faec5feae">figure 2</xref>). The rate of decline in FEV<sub id="7f9117a9-cace-4985-8b84-827fad27e34b">1</sub> was not different between the baseline tertile groups for any of the biomarkers (<xref ref-type="table" rid="T2" data-tag-desc="FIGTBLREF" data-tag-type="FIGTBLREF" data-offset="271" data-match="table 2" data-pattern="" data-tag-index="120_2" data-citation-string=" T2 " data-anchor="true" id="988bcf2f-bb9d-4303-b023-3066a9d38f07">table 2</xref>). There was no association between any of the biomarker concentrations and the risk of a moderate or severe COPD exacerbation (<named-content data-cid="1555394565770" content-type="del cts-1" specific-use="1555068439000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1555068439000" id="70054cea-fff1-46d7-9d01-5554b2bb6d5e">supplementary figure 1</named-content><named-content data-cid="1555394565770" content-type="ins cts-1" specific-use="1555068439000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1555068439000" id="8662421e-bf7e-4f38-8bab-7d4c56f439df"><xref ref-type="supplementary-material" rid="SP1" data-citation-string=" SP1 " data-mark-cited="SP1" id="685d585d-9af4-4011-af07-6f575dd8faa2">online supplementary figure 1</xref></named-content>) or a hospitalised exacerbation (<named-content data-cid="1555394565771" content-type="del cts-1" specific-use="1555068439000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1555068439000" id="15b9ecac-e802-4145-b7e9-c404a12ebe4e">supplementary figure 2</named-content><named-content data-cid="1555394565771" content-type="ins cts-1" specific-use="1555068439000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1555068439000" id="48e08534-4f6f-4fdd-9687-a391b87d1e35"><xref ref-type="supplementary-material" rid="SP1" data-citation-string=" SP1 " data-mark-cited="SP1" id="fbd2f8a9-5bc7-4e7d-bede-6e8e569a2f3d">online supplementary figure 2</xref></named-content>).</p><table-wrap id="BLK_T2" data-id="BLK_T2" data-stream-name="a_T2" position="float"><label id="2c9e9af1-9a7c-4632-951b-d165025869b1">Table 2</label><caption id="ab9a80cb-5184-489d-9c62-d8edab38980b"><title id="T2" data-head-type="bold" data-id="T2">Rate of FEV<sub id="0d1ad580-ead6-453a-8d4d-be91de80aae7">1</sub> decline (mL/year) by systemic biomarker tertile groups</title></caption><table data-col-count="5" data-caption-link="T2" data-col-widths-px="79,141,96,95,100.276" data-table-type="doubleColumn" id="47573372-4333-4e09-82f1-115a0767cf61" data-old-attributes="&quot;data-col-widths-px&quot;:&quot;67.569,156.569,101.569,101.569,84&quot;;" data-changed-attributes="data-col-widths-px"><thead id="3f1d4eda-eb2f-4f79-8e4e-ff60a91c348a"><tr data-col-count="5" id="e9965bde-8b18-4c97-a062-142c4b6726dc"><td rowspan="2" data-original-space="1" data-original-border="border-top:solid windowtext 1.0pt; border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" valign="bottom" id="2530f2a5-e797-48ab-9bb7-25edfca3148b" data-old-attributes=""><p id="5ad53a85-4965-4a95-a0b9-3ac689b29cfe" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"/></td><td rowspan="2" data-original-border="border-top:solid windowtext 1.0pt; border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" valign="bottom" id="0c1596ec-8bf5-4caf-a990-48fa2035eccc" data-old-attributes=""><p id="11657ede-2bea-4766-a8cc-e41a4779d7b6" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Number of <named-content id="f1386e34-91ee-42d6-b20b-847771378b7b" data-cid="f1386e34-91ee-42d6-b20b-847771378b7b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="10" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="122_1" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> in analysis<xref id="20e07908-debb-444f-8b43-c54f39395add" ref-type="table-fn" rid="T2_FN2" data-citation-string="T2_FN2"><named-content data-cid="1555068417004" id="d889f512-81c6-441b-83ca-c8a622a965ab" content-type="del" specific-use="1555068417000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1555068417000">*</named-content><named-content data-cid="1555068417005" id="1e619c9c-bde0-4576-bb0b-e4742f0e493d" content-type="ins cts-1" specific-use="1555068417000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1555068417000">*</named-content></xref></p></td><td data-original-border="border-top:solid windowtext 1.0pt; border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" valign="bottom" id="b2b72748-f285-4c4d-82c8-75b524917288" data-old-attributes=""><p id="f36cdba6-3e3f-41b9-ac70-5f3a7d9714f6">Lowest tertile group</p></td><td data-original-border="border-top:solid windowtext 1.0pt; border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" valign="bottom" id="9d003c93-0e58-4923-b0e9-620689c8f6cd" data-old-attributes=""><p id="96482707-4314-4ebe-9f7b-96ab9b59a717">Middle tertile group</p></td><td data-original-border="border-top:solid windowtext 1.0pt; border-left:none;border-bottom:solid windowtext 1.0pt;border-right:none;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" valign="bottom" id="dcf67a59-1ec8-49e6-b708-e1cce24e4a70" data-old-attributes=""><p id="7e026a39-1c56-4e92-80e7-7cb1b25f4e1e">Highest tertile group</p></td></tr><tr data-col-count="5" id="cc347b59-5d81-41ec-82b6-c14a0dbaffe7"><td data-class="" colspan="3" data-original-border="border:none; border-bottom:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" valign="bottom" id="fe48ac61-b1d2-463e-bc4f-f7b574fc1482" data-old-attributes=""><p id="420a51ce-b989-49a2-beac-154e6d060c85" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Mean rate of decline (mL/year) (<named-content id="fd4daf8c-9dac-48c2-a25b-f28db71a94d7" data-cid="fd4daf8c-9dac-48c2-a25b-f28db71a94d7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'SE' to 'SE'" data-track-detail="" data-tag-desc="ABBRV" data-tag-type="ABBRV" data-offset="32" data-match="SE" data-replace="SE" data-pattern="SE" data-tag-index="126_2" data-function="addTrackChanges" data-time="" data-username="" data-userid="">SE</named-content>)</p></td></tr></thead><tbody id="8a35e2a3-3226-4f9a-bc0e-44dbc22f287a"><tr data-col-count="5" id="9afc8697-631a-4695-bf60-a24c9f644bfd" data-fill="true"><td data-class="" data-original-border="border:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" valign="top" id="ccde1d7a-c9e8-4894-a8c4-941448fa94fd" data-old-attributes=""><p id="b09d4bbe-dfee-44a6-85cd-560d7c015640" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1555069354" id="0d6c026f-e851-48b6-9dde-a7989acbd611" content-type="styrm cts-2" specific-use="1555070200036" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Bold Removed by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:26pm" data-track-detail="" data-format-command="bold" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070200036" data-track-hint="Bold Removed">CRP</named-content><xref id="ae8a7b2e-bc39-46da-bd25-9a6326949fb5" ref-type="table-fn" rid="T2_FN3" data-citation-string="T2_FN3"><named-content data-cid="1555068417006" id="588432f6-e97b-483a-9066-8192f00024c7" content-type="del" specific-use="1555068417000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1555068417000">†</named-content><named-content data-cid="1555068417007" id="3b17dc26-d008-4e66-b391-e018c4acfb35" content-type="ins cts-1" specific-use="1555068417000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1555068417000">†</named-content></xref></p></td><td data-class="" data-original-border="border:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" data-auto-align="true" data-left-indent="0" valign="top" id="c8fd43c9-5484-4601-9061-5079ed7079af" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-left-indent&quot;:&quot;0&quot;;&quot;data-auto-align&quot;:&quot;true&quot;" data-changed-attributes="align" align="left"><p id="c15bc422-3616-4e3b-a5a3-3a509ee10ca6" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="dad8c0f7-bc70-4277-83de-11451d879b6b" data-cid="dad8c0f7-bc70-4277-83de-11451d879b6b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="0" data-match="1462" data-replace="1462" data-pattern="1462" data-tag-index="128_1" data-time="" data-username="" data-userid="">1462</named-content></p></td><td data-original-border="border:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" data-auto-align="true" data-left-indent="0" data-align="decimal" valign="top" id="0d98f7d0-4390-443e-bc43-ce5eea0bbede" data-old-attributes=""><p id="d876181b-69af-4805-af08-79b8daf3f4c7" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">–38 (7)</p></td><td data-original-border="border:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" data-auto-align="true" data-left-indent="0" data-align="decimal" valign="top" id="e2aed17e-d210-4bdc-b6d4-60ed8e2ca6eb" data-old-attributes=""><p id="df42a5c1-d758-4550-9b46-8d3146a57f50" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">–40 (7)</p></td><td data-original-border="border:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" data-auto-align="true" data-left-indent="0" data-align="decimal" valign="top" id="6374d5b1-4151-4959-a749-21718b4d9856" data-old-attributes=""><p id="ef035323-80e6-45b0-9f38-8fb34b7bae22" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">–33 (7)</p></td></tr><tr data-col-count="5" id="fe508be0-2ca2-4c3f-8718-29f673f1c13c"><td data-class="" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" valign="top" id="e022778e-834a-4251-aaad-2b91b9fad5fa" data-old-attributes=""><p id="246b3389-b4dd-4df7-911d-a97eacf3b4c5" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1555069355" id="b383618d-6ae3-42ec-b69b-936d9882bc89" content-type="styrm cts-2" specific-use="1555070201617" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Bold Removed by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:26pm" data-track-detail="" data-format-command="bold" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070201617" data-track-hint="Bold Removed">sRAGE</named-content><xref id="56733b42-4e82-49dd-b6f0-e1af3b1fca04" ref-type="table-fn" rid="T2_FN3" data-citation-string="T2_FN3"><named-content data-cid="1555068417007" id="1739a87b-f4bc-4527-87c4-08a0f42ab113" content-type="del" specific-use="1555068417000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1555068417000">†</named-content><named-content data-cid="1555068417008" id="2465b80e-6579-4a09-90e0-e13ed57af70f" content-type="ins cts-1" specific-use="1555068417000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1555068417000">†</named-content></xref></p></td><td data-class="" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" data-auto-align="true" data-left-indent="0" valign="top" id="b7db5ce2-908d-4d9b-bee0-c35a721015af" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-left-indent&quot;:&quot;0&quot;;&quot;data-auto-align&quot;:&quot;true&quot;" data-changed-attributes="align" align="left"><p id="d12c6a01-cc43-4fa9-a63e-69fa2c9f74d7" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="f02db87c-be9f-4faa-bd81-809fb3bacc2e" data-cid="f02db87c-be9f-4faa-bd81-809fb3bacc2e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="0" data-match="1454" data-replace="1454" data-pattern="1454" data-tag-index="133_1" data-time="" data-username="" data-userid="">1454</named-content></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" data-auto-align="true" data-left-indent="0" data-align="decimal" valign="top" id="a5f2d992-105d-4f5a-8d48-d8671f9da571" data-old-attributes=""><p id="f90d95a9-53a7-4958-a865-f1eaf511a153" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">–37 (7)</p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" data-auto-align="true" data-left-indent="0" data-align="decimal" valign="top" id="db48208c-023c-40cd-b082-2e9d4b55394f" data-old-attributes=""><p id="fe7df768-ff23-4e85-aa53-c4dd7bcdd0d1" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">–37 (7)</p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" data-auto-align="true" data-left-indent="0" data-align="decimal" valign="top" id="7f6d332e-de39-44a9-adc5-49a8afcaef1e" data-old-attributes=""><p id="6176d728-9f82-4728-b2cb-e315f2621347" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">–36 (7)</p></td></tr><tr data-col-count="5" id="b32cc230-bbfa-4957-a492-ed4e60e4cd10" data-fill="true"><td data-class="" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" valign="top" id="e3f45f53-b7a4-43ae-9ad6-688ea09e2870" data-old-attributes=""><p id="d5ccb832-3226-4cd1-8eff-581dc8e7b1ec" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1555069356" id="6c790261-9746-4d6a-b51d-974ff57bd8a3" content-type="styrm cts-2" specific-use="1555070202894" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Bold Removed by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:26pm" data-track-detail="" data-format-command="bold" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070202894" data-track-hint="Bold Removed">SPD</named-content><xref id="5483effc-9d6c-44af-bd45-582ca6eedf41" ref-type="table-fn" rid="T2_FN3" data-citation-string="T2_FN3"><named-content data-cid="1555068417008" id="406b6f37-edec-402c-8da9-61883c7c010f" content-type="del" specific-use="1555068417000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1555068417000">†</named-content><named-content data-cid="1555068417009" id="b7789264-f8b2-45a5-b272-9efd739ed270" content-type="ins cts-1" specific-use="1555068417000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1555068417000">†</named-content></xref></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" data-auto-align="true" data-left-indent="0" valign="top" id="2bf353ed-b47d-4ef7-8c73-426f809faaa8" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-left-indent&quot;:&quot;0&quot;;&quot;data-auto-align&quot;:&quot;true&quot;" data-changed-attributes="align" align="left"><p id="b770016e-8ffc-438c-bfd3-bf63dfb0bb1e" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="d582c19a-1437-465e-b740-78216dc6d0a1" data-cid="d582c19a-1437-465e-b740-78216dc6d0a1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="0" data-match="1461" data-replace="1461" data-pattern="1461" data-tag-index="138_1" data-time="" data-username="" data-userid="">1461</named-content></p></td><td data-class="" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" data-auto-align="true" data-left-indent="0" data-align="decimal" valign="top" id="8ab70417-af16-4863-b1c5-23704c8c7cd7" data-old-attributes=""><p id="654cb734-b294-445f-a48c-c802e2dcb967" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">–30 (7)</p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" data-auto-align="true" data-left-indent="0" data-align="decimal" valign="top" id="2c8b4970-5e49-4315-8729-6bb061606a58" data-old-attributes=""><p id="fe3086bd-496e-49b7-8e5e-d83509fa3a4a" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">–33 (7)</p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" data-auto-align="true" data-left-indent="0" data-align="decimal" valign="top" id="b2c6785e-01e7-40fb-b1b3-3eb4725ba471" data-old-attributes=""><p id="5dc9adfa-c7eb-4dc7-b7c8-72b9b7d9405f" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">–48 (7)</p></td></tr><tr data-col-count="5" id="ccf893d0-1fc5-4d47-a75d-8b9c4f25cb85"><td data-class="" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" valign="top" id="162cff4d-d6e6-44d0-a883-6aca20380068" data-old-attributes=""><p id="93f08e3a-1beb-4a35-b39e-41ca3559b219" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1555069357" id="1039e673-5c77-46de-9f26-5a5b7cbb468d" content-type="styrm cts-2" specific-use="1555070204384" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Bold Removed by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:26pm" data-track-detail="" data-format-command="bold" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070204384" data-track-hint="Bold Removed">Fibrinogen</named-content><xref id="f0385cdf-ceda-4993-878c-bd483f9d71a2" ref-type="table-fn" rid="T2_FN3" data-citation-string="T2_FN3"><named-content data-cid="1555068417009" id="75a77ec1-c353-41ca-a99b-be2aa1f86f1e" content-type="del" specific-use="1555068417000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1555068417000">†</named-content><named-content data-cid="1555068417010" id="99b6e843-2c29-4432-9880-732a93a4ed53" content-type="ins cts-1" specific-use="1555068417000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1555068417000">†</named-content></xref></p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" data-auto-align="true" data-left-indent="0" valign="top" id="dc1ea501-a653-4e61-bdb7-977e26800b1a" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-left-indent&quot;:&quot;0&quot;;&quot;data-auto-align&quot;:&quot;true&quot;" data-changed-attributes="align" align="left"><p id="977f7785-b963-433a-a400-64c323b511f7" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="090923aa-770a-44c6-899a-a6bcc00a2248" data-cid="090923aa-770a-44c6-899a-a6bcc00a2248" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="0" data-match="1410" data-replace="1410" data-pattern="1410" data-tag-index="143_1" data-time="" data-username="" data-userid="">1410</named-content></p></td><td data-class="" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" data-auto-align="true" data-left-indent="0" data-align="decimal" valign="top" id="94ded446-9dea-4f50-ae08-45c35664e33d" data-old-attributes=""><p id="6567507b-ffa0-43d4-b4ad-63458e4af282" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">–39 (7)</p></td><td data-class="" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" data-auto-align="true" data-left-indent="0" data-align="decimal" valign="top" id="00bfd0a7-5cee-4b43-90d3-7fe82cf337e0" data-old-attributes=""><p id="ac03a21b-ab86-4266-a51f-7fd2d017570c" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">–35 (7)</p></td><td data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" data-auto-align="true" data-left-indent="0" data-align="decimal" valign="top" id="223d341a-68a0-4bb1-9a3c-9edce247e7f1" data-old-attributes=""><p id="e35ad848-8ad3-4382-ace4-b9638f17ccc3" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">–37 (8)</p></td></tr><tr id="8867bf4d-9683-4af0-aa6a-fa0f194265c5" data-fill="true"><td data-class="" id="243a53ec-0ac4-440c-8c3f-54d9793d3bd1" valign="top" data-col-index="1" data-old-attributes=""><p id="5c2efaf3-95c8-4fad-b20c-f69f98da114c"><named-content data-cid="1555069365" id="9331990d-a52e-447e-a03a-72cc41ae86e8" content-type="ins cts-2" specific-use="1555070233030" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Inserted by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:27pm" data-track-detail="" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070233030"><span id="efff652b-bb54-497b-a0e5-ec504e633481"><named-content data-cid="1555285759" id="f8d6f8e7-4e4d-4771-8d44-67e31a7c2233" content-type="styrm cts-3" specific-use="1555291677962" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Bold Removed by Ariel (COPYEDITOR) - Apr 15 2019 9:27am" data-track-detail="" data-format-command="bold" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291677962" data-track-hint="Bold Removed"><named-content data-cid="1555285760" id="a6d480bd-2a7c-4d70-8dd2-2af75fd893b8" content-type="styrm cts-3" specific-use="1555291684609" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Bold Removed by Ariel (COPYEDITOR) - Apr 15 2019 9:28am" data-track-detail="" data-format-command="bold" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291684609" data-track-hint="Bold Removed"><named-content data-cid="1555285761" id="180c4df3-4ec0-4942-8349-9fec5f28c77f" content-type="styrm cts-3" specific-use="1555291686568" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Bold Removed by Ariel (COPYEDITOR) - Apr 15 2019 9:28am" data-track-detail="" data-format-command="bold" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291686568" data-track-hint="Bold Removed"><named-content data-cid="1555285762" id="1d9c6513-60ae-4758-98b5-8c5b83febb96" content-type="styrm cts-3" specific-use="1555291690193" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Bold Removed by Ariel (COPYEDITOR) - Apr 15 2019 9:28am" data-track-detail="" data-format-command="bold" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291690193" data-track-hint="Bold Removed"><named-content data-cid="1555285763" id="bb33c1e1-0aeb-4db5-9511-b1e9895eefd6" content-type="styrm cts-3" specific-use="1555291697666" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Bold Removed by Ariel (COPYEDITOR) - Apr 15 2019 9:28am" data-track-detail="" data-format-command="bold" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291697666" data-track-hint="Bold Removed"><named-content data-cid="1555285764" id="292596b6-e56d-4e4e-9342-48f0927629fc" content-type="styrm cts-3" specific-use="1555291701428" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Bold Removed by Ariel (COPYEDITOR) - Apr 15 2019 9:28am" data-track-detail="" data-format-command="bold" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291701428" data-track-hint="Bold Removed"><bold id="e13d8456-2414-4378-9995-5293be731c60">CC-16</bold></named-content></named-content></named-content></named-content></named-content></named-content></span><span id="c1ee78b7-f472-492f-9597-a364569a6740"><named-content data-cid="1555285758" id="4196d017-9be4-49cf-b140-528811134a3a" content-type="styrm cts-3" specific-use="1555291675312" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Bold Removed by Ariel (COPYEDITOR) - Apr 15 2019 9:27am" data-track-detail="" data-format-command="bold" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291675312" data-track-hint="Bold Removed"><named-content data-cid="1555285759" id="c40554eb-8cb4-4cd7-a185-d2edeef2f9bd" content-type="styrm cts-3" specific-use="1555291677962" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Bold Removed by Ariel (COPYEDITOR) - Apr 15 2019 9:27am" data-track-detail="" data-format-command="Bold" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291677962" data-track-hint="Bold Removed"><named-content data-cid="1555285761" id="75d3c928-0cd9-4ba2-99c2-08aaa8bf86dc" content-type="styrm cts-3" specific-use="1555291686568" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Bold Removed by Ariel (COPYEDITOR) - Apr 15 2019 9:28am" data-track-detail="" data-format-command="Bold" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291686568" data-track-hint="Bold Removed"><named-content data-cid="1555285764" id="7e6aa64a-a934-4a5a-addc-671f4a513136" content-type="styrm cts-3" specific-use="1555291701428" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Bold Removed by Ariel (COPYEDITOR) - Apr 15 2019 9:28am" data-track-detail="" data-format-command="Bold" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291701428" data-track-hint="Bold Removed">‡</named-content></named-content></named-content></named-content></span></named-content></p></td><td data-class="" id="7504fdcc-372e-4f11-9100-33878c9bea9a" valign="top" data-col-index="2" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;" data-changed-attributes="align" align="left"><p id="c7b81fcf-ebe2-497b-a1ac-ee3dbc0d29fe" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"/></td><td data-class="" id="4aa990d9-5600-4b7d-8aea-21e8b81bf3d6" valign="top" data-col-index="3" data-old-attributes=""><p id="cb3713f0-9cfe-4a13-8525-82f582d9ca48"/></td><td data-class="" id="92ba3d85-61e2-44cf-a83c-983f03f26ff9" valign="top" data-col-index="4" data-old-attributes=""><p id="36cfa5d7-d2c7-4783-a250-82fd8ce4a9dc"/></td><td id="c741d336-f05b-4423-b52e-607ccb680185" valign="top" data-col-index="5" data-old-attributes=""><p id="2441e12f-9707-4f93-917b-b9915afddd53"/></td></tr><tr data-col-count="5" id="9469fabe-2287-45c2-a2de-836e242b5637"><td data-class="" data-original-border="border:none;border-bottom:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" valign="top" id="4b2f6e80-1ad4-4fbd-b16a-050a1cb039dd" data-old-attributes=""><p id="a5179617-912d-4a7f-ada2-15bf853b814c"> <named-content data-cid="1555069358" id="e51241c2-f0a5-465a-9665-c5502323ac39" content-type="styrm cts-2" specific-use="1555070206764" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Bold Removed by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:26pm" data-track-detail="" data-format-command="bold" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070206764" data-track-hint="Bold Removed"><named-content data-cid="1555069363" id="b2a01c69-2649-40f1-9113-47c7595046e8" content-type="del cts-2" specific-use="1555070230536" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Deleted by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:27pm" data-track-detail="" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070230536">CC-16</named-content></named-content><bold id="e3a7fb86-35cb-47bf-a91f-cdec751958ec"><xref id="f2f2d0ee-89dd-47ac-bbd0-1311bbad9d7b" ref-type="table-fn" rid="T2_FN4" data-citation-string="T2_FN4" data-track="del" data-cid="1555070238055" data-username="Gowtham Ram (PREEDITOR)" data-userid="preeditor gowthamram" data-time="1555070238055"><named-content data-cid="1555068417011" id="e365d870-8d89-4373-b3a1-df9310306e75" content-type="del" specific-use="1555068417000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1555068417000">‡</named-content><named-content data-cid="1555068417012" id="99e19348-a2e1-412f-9ab3-bc113363185d" content-type="ins cts-1" specific-use="1555068417000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1555068417000">‡</named-content></xref></bold></p><p id="52dab903-e56c-437c-97c5-f09a0427dda0"> <named-content data-cid="1555070616" id="c3ac4bc7-15a8-4ce9-b97c-1ddd7e07edb6" content-type="del cts-2" specific-use="1555071312329" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Deleted by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:45pm" data-track-detail="" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555071312329"> </named-content><named-content data-cid="1555069359" id="18d582ce-76d2-482c-bcdc-05cd735ee604" content-type="styrm cts-2" specific-use="1555070208348" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Bold Removed by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:26pm" data-track-detail="" data-format-command="bold" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070208348" data-track-hint="Bold Removed">Placebo</named-content></p><p id="ba043415-1a9c-4285-9e32-9d12d04f135f"> <named-content data-cid="1555070617" id="523ea775-951d-4f38-ae45-d97829547280" content-type="del cts-2" specific-use="1555071313445" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Deleted by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:45pm" data-track-detail="" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555071313445"> </named-content><named-content data-cid="1555069360" id="6f351daf-58df-47ac-9849-888aa4887a6c" content-type="styrm cts-2" specific-use="1555070210752" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Bold Removed by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:26pm" data-track-detail="" data-format-command="bold" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070210752" data-track-hint="Bold Removed">FF 100</named-content></p><p id="fb53db4c-dfea-489f-aaf8-dcfb984a2d12" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"> <named-content data-cid="1555070618" id="f33d2490-7f4c-44c2-ab31-5db5e85ece7a" content-type="del cts-2" specific-use="1555071314236" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Deleted by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:45pm" data-track-detail="" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555071314236"> </named-content><named-content data-cid="1555069361" id="bed9c282-5c0f-44d5-8426-8bdeffec0cf4" content-type="styrm cts-2" specific-use="1555070212128" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Bold Removed by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:26pm" data-track-detail="" data-format-command="bold" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070212128" data-track-hint="Bold Removed">VI 25</named-content></p><p id="64ef7f44-230a-41fb-a755-928d33433e87" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"> <named-content data-cid="1555070619" id="cc1f9719-7f8e-4de3-ae2b-2fe1fc78b395" content-type="del cts-2" specific-use="1555071314969" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Deleted by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:45pm" data-track-detail="" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555071314969"> </named-content><named-content data-cid="1555069362" id="80cba967-7321-4aa5-860c-f9930953e15b" content-type="styrm cts-2" specific-use="1555070217470" xlink:title="Gowtham Ram (PREEDITOR)" alt="preeditor gowthamram" data-title="Bold Removed by Gowtham Ram (PREEDITOR) - Apr 12 2019 5:26pm" data-track-detail="" data-format-command="bold" data-userid="preeditor gowthamram" data-username="Gowtham Ram (PREEDITOR)" data-time="1555070217470" data-track-hint="Bold Removed">FF/VI 100/25</named-content></p></td><td data-class="" data-original-space="1" data-original-border="border:none;border-bottom:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" data-auto-align="true" data-left-indent="20.015625" valign="top" id="f81c17df-fd82-49b2-ad51-8309d2c18e59" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-left-indent&quot;:&quot;20.015625&quot;;&quot;data-auto-align&quot;:&quot;true&quot;" data-changed-attributes="align" align="left"><p id="d746648f-8923-4029-a0c0-6a615efd6eba" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align">371</p><p id="f0d1880a-7f40-43af-a403-807500ff48b5" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align">365</p><p id="cbb0b392-da64-4e21-9e1b-6419f3c5e1ea" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align">362</p><p id="846dd1db-fc84-48ce-a53b-8a295b47c928" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align">363</p></td><td data-class="" data-original-space="1" data-original-border="border:none;border-bottom:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" data-auto-align="true" data-left-indent="5" data-align="decimal" valign="top" id="ad0b4abf-ec69-4538-9261-4515c00b119f" data-old-attributes=""><p id="6c0748a7-0857-44f8-bec0-64d0898f5a5b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-original-alignment=" text-align: center;"/><p data-class="jrnlSecPara" id="b7982df5-6d20-4774-9862-853a25a12537" contenteditable="true"><named-content id="a0a0c1b2-ddb0-44af-bebe-eae7cde94f5f" data-cid="a0a0c1b2-ddb0-44af-bebe-eae7cde94f5f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="HYPTOMIN" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="HYPTOMIN" data-offset="0" data-match="-33" data-replace="−" data-pattern="−" data-tag-index="156_2" data-time="" data-username="" data-userid=""><named-content id="1f3e319d-661e-4015-a373-2f82b3411503" data-cid="1f3e319d-661e-4015-a373-2f82b3411503" content-type="del cts-1" specific-use="" xlink:title="" alt="" data-title="" data-track-detail="" data-time="" data-username="" data-userid="">-</named-content></named-content><named-content id="7680e567-ba78-40cb-bee9-87b8106c0563" data-cid="7680e567-ba78-40cb-bee9-87b8106c0563" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="VAL" data-offset="1" data-match="-33" data-replace="33" data-pattern="$2" data-tag-index="156_2" data-time="" data-username="" data-userid="">33</named-content> (15)</p><p data-class="jrnlSecPara" id="0d5569fb-489f-418e-be1a-2483540bcb43" contenteditable="true"><named-content id="c77d9170-c9d5-4a74-b303-2b16862cdaa8" data-cid="c77d9170-c9d5-4a74-b303-2b16862cdaa8" content-type="del cts-1" specific-use="" xlink:title="" alt="" data-title="" data-track-detail="" data-time="" data-username="" data-userid=""> <named-content id="7384c6a7-1c3b-42e1-8762-8a4198938c62" data-cid="7384c6a7-1c3b-42e1-8762-8a4198938c62" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '−'" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="HYPTOMIN" data-offset="1" data-match="-32" data-replace="−" data-pattern="−" data-tag-index="157_2" data-track-change="-" data-time="" data-username="" data-userid="">−</named-content></named-content><named-content id="072c6469-93d9-45a6-9762-d155c45306a3" data-cid="072c6469-93d9-45a6-9762-d155c45306a3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="VAL" data-offset="2" data-match="-32" data-replace="32" data-pattern="$2" data-tag-index="157_2" data-time="" data-username="" data-userid="">32</named-content> (15)</p><p data-class="jrnlSecPara" id="266b129b-f061-4743-a592-f530fbdbdc6a" contenteditable="true"><named-content id="37748d7a-44ad-466b-bcbb-75ad8cb2b965" data-cid="37748d7a-44ad-466b-bcbb-75ad8cb2b965" content-type="del cts-1" specific-use="" xlink:title="" alt="" data-title="" data-track-detail="" data-time="" data-username="" data-userid=""> <named-content id="7a6fb85b-f4fb-41c6-8f4b-910253f4d65f" data-cid="7a6fb85b-f4fb-41c6-8f4b-910253f4d65f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '−'" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="HYPTOMIN" data-offset="1" data-match="-62" data-replace="−" data-pattern="−" data-tag-index="158_2" data-track-change="-" data-time="" data-username="" data-userid="">−</named-content></named-content><named-content id="37d710be-7aa9-43ba-8514-2efe25b7edfb" data-cid="37d710be-7aa9-43ba-8514-2efe25b7edfb" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="VAL" data-offset="2" data-match="-62" data-replace="62" data-pattern="$2" data-tag-index="158_2" data-time="" data-username="" data-userid="">62</named-content> (15)</p><p data-class="jrnlSecPara" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" id="33c59a11-d46d-4ecf-8795-91dc30a26c47" contenteditable="true"><named-content id="41815858-bdf8-4094-b9b5-190999ac0d92" data-cid="41815858-bdf8-4094-b9b5-190999ac0d92" content-type="del cts-1" specific-use="" xlink:title="" alt="" data-title="" data-track-detail="" data-time="" data-username="" data-userid=""> <named-content id="01d2050a-c267-41ed-be19-bef34838469a" data-cid="01d2050a-c267-41ed-be19-bef34838469a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '−'" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="HYPTOMIN" data-offset="1" data-match="-23" data-replace="−" data-pattern="−" data-tag-index="159_2" data-track-change="-" data-time="" data-username="" data-userid="">−</named-content></named-content><named-content id="d6dc0878-53c4-47ed-afd2-9d7a42508f11" data-cid="d6dc0878-53c4-47ed-afd2-9d7a42508f11" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="VAL" data-offset="2" data-match="-23" data-replace="23" data-pattern="$2" data-tag-index="159_2" data-time="" data-username="" data-userid="">23</named-content> (13)</p></td><td data-class="" data-original-space="1" data-original-border="border:none;border-bottom:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" data-auto-align="true" data-left-indent="5" data-align="decimal" valign="top" id="6badd96a-a724-4e19-8d78-63c35062ab2c" data-old-attributes=""><p id="c9c49552-b0f9-47e9-8eca-f515a232c53a" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-original-alignment=" text-align: center;"/><p data-class="jrnlSecPara" id="903574c3-6d59-4ec2-ab43-6dc7f2a83672" contenteditable="true"><named-content id="be73795b-c9e1-4b3c-90b1-339d0d09376b" data-cid="be73795b-c9e1-4b3c-90b1-339d0d09376b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="HYPTOMIN" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="HYPTOMIN" data-offset="0" data-match="-57" data-replace="−" data-pattern="−" data-tag-index="160_2" data-time="" data-username="" data-userid=""><named-content id="1cd8070a-1c3a-416e-b75a-6970ae6436e9" data-cid="1cd8070a-1c3a-416e-b75a-6970ae6436e9" content-type="del cts-1" specific-use="" xlink:title="" alt="" data-title="" data-track-detail="" data-time="" data-username="" data-userid="">-</named-content></named-content><named-content id="35322750-3be9-4fde-aad4-216254beb7ea" data-cid="35322750-3be9-4fde-aad4-216254beb7ea" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="VAL" data-offset="1" data-match="-57" data-replace="57" data-pattern="$2" data-tag-index="160_2" data-time="" data-username="" data-userid="">57</named-content> (14)</p><p data-class="jrnlSecPara" id="31c2749d-8c03-4d44-b58b-68bbe31131ba" contenteditable="true"><named-content id="6c34bd3f-f4b1-444c-b35b-04602454a95a" data-cid="6c34bd3f-f4b1-444c-b35b-04602454a95a" content-type="del cts-1" specific-use="" xlink:title="" alt="" data-title="" data-track-detail="" data-time="" data-username="" data-userid=""> <named-content id="9278f31f-483b-4cc8-9538-1f8f758a3023" data-cid="9278f31f-483b-4cc8-9538-1f8f758a3023" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '−'" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="HYPTOMIN" data-offset="1" data-match="-47" data-replace="−" data-pattern="−" data-tag-index="161_2" data-track-change="-" data-time="" data-username="" data-userid="">−</named-content></named-content><named-content id="7fe8892c-4d17-468d-9cff-a6c13ef4206d" data-cid="7fe8892c-4d17-468d-9cff-a6c13ef4206d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="VAL" data-offset="2" data-match="-47" data-replace="47" data-pattern="$2" data-tag-index="161_2" data-time="" data-username="" data-userid="">47</named-content> (15)</p><p data-class="jrnlSecPara" id="3537bfe0-9f7c-4e19-9c01-bcd2c55763f1" contenteditable="true"><named-content id="c1bd366e-2e04-4eff-af9f-826f45406ba6" data-cid="c1bd366e-2e04-4eff-af9f-826f45406ba6" content-type="del cts-1" specific-use="" xlink:title="" alt="" data-title="" data-track-detail="" data-time="" data-username="" data-userid=""> <named-content id="a8e7651d-027a-4f8c-b055-8ad5a1515de9" data-cid="a8e7651d-027a-4f8c-b055-8ad5a1515de9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '−'" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="HYPTOMIN" data-offset="1" data-match="-41" data-replace="−" data-pattern="−" data-tag-index="162_2" data-track-change="-" data-time="" data-username="" data-userid="">−</named-content></named-content><named-content id="a20f96d2-0dd6-4940-9959-018fc09ce7f8" data-cid="a20f96d2-0dd6-4940-9959-018fc09ce7f8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="VAL" data-offset="2" data-match="-41" data-replace="41" data-pattern="$2" data-tag-index="162_2" data-time="" data-username="" data-userid="">41</named-content> (15)</p><p data-class="jrnlSecPara" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" id="3d2b35b4-4861-4aa6-b06f-9dbdbf515119" contenteditable="true"><named-content id="210a8ad5-9835-458a-9cb5-761bb1e4090a" data-cid="210a8ad5-9835-458a-9cb5-761bb1e4090a" content-type="del cts-1" specific-use="" xlink:title="" alt="" data-title="" data-track-detail="" data-time="" data-username="" data-userid=""> <named-content id="15f53a13-a8e0-40ad-be3f-cde0b8c364d2" data-cid="15f53a13-a8e0-40ad-be3f-cde0b8c364d2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '−'" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="HYPTOMIN" data-offset="1" data-match="-37" data-replace="−" data-pattern="−" data-tag-index="163_2" data-track-change="-" data-time="" data-username="" data-userid="">−</named-content></named-content><named-content id="115b5805-b1de-4a50-984b-4328b34d4c59" data-cid="115b5805-b1de-4a50-984b-4328b34d4c59" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="VAL" data-offset="2" data-match="-37" data-replace="37" data-pattern="$2" data-tag-index="163_2" data-time="" data-username="" data-userid="">37</named-content> (14)</p></td><td data-class="" data-original-space="1" data-original-border="border:none;border-bottom:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" data-auto-align="true" data-left-indent="5" data-align="decimal" valign="top" id="83a2f243-206a-422f-88e2-eb59cbd43846" data-old-attributes=""><p id="27fcf1b3-a367-4af1-abb1-c2d70540076e" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-original-alignment=" text-align: center;"/><p data-class="jrnlSecPara" id="f0feb919-14dc-4e06-8ef3-a32c30ac2407"><named-content id="3012f678-42b2-4c34-8e97-446ebadb2007" data-cid="3012f678-42b2-4c34-8e97-446ebadb2007" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="HYPTOMIN" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="HYPTOMIN" data-offset="0" data-match="-27" data-replace="−" data-pattern="−" data-tag-index="164_2" data-time="" data-username="" data-userid=""><named-content id="7d42720c-8407-4a7f-9d0e-8b84b1d27d50" data-cid="7d42720c-8407-4a7f-9d0e-8b84b1d27d50" content-type="del cts-1" specific-use="" xlink:title="" alt="" data-title="" data-track-detail="" data-time="" data-username="" data-userid="">-</named-content></named-content><named-content id="95e1762a-9907-4731-becf-998d1e2efbd8" data-cid="95e1762a-9907-4731-becf-998d1e2efbd8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="VAL" data-offset="1" data-match="-27" data-replace="27" data-pattern="$2" data-tag-index="164_2" data-time="" data-username="" data-userid="">27</named-content> (15)</p><p data-class="jrnlSecPara" id="ad9ae20f-f312-4859-91f5-c24fd3f7c271" contenteditable="true"><named-content id="ac4b9a58-24a7-483f-a0df-5d4af99f257b" data-cid="ac4b9a58-24a7-483f-a0df-5d4af99f257b" content-type="del cts-1" specific-use="" xlink:title="" alt="" data-title="" data-track-detail="" data-time="" data-username="" data-userid=""> <named-content id="17ce7bab-d41e-4e0c-b6c4-e989c7f1cdda" data-cid="17ce7bab-d41e-4e0c-b6c4-e989c7f1cdda" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '−'" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="HYPTOMIN" data-offset="1" data-match="-21" data-replace="−" data-pattern="−" data-tag-index="165_2" data-track-change="-" data-time="" data-username="" data-userid="">−</named-content></named-content><named-content id="d9bd2301-6249-40e5-902f-f105dc0736ff" data-cid="d9bd2301-6249-40e5-902f-f105dc0736ff" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="VAL" data-offset="2" data-match="-21" data-replace="21" data-pattern="$2" data-tag-index="165_2" data-time="" data-username="" data-userid="">21</named-content> (14)</p><p data-class="jrnlSecPara" id="9d2f69b3-cca8-4f1b-939a-f6fe7f764409" contenteditable="true"><named-content id="5a394a34-dc86-45ad-9dfc-869a62b6109e" data-cid="5a394a34-dc86-45ad-9dfc-869a62b6109e" content-type="del cts-1" specific-use="" xlink:title="" alt="" data-title="" data-track-detail="" data-time="" data-username="" data-userid=""> <named-content id="8a38eb22-aaff-47df-b7b4-1ac7e840c05c" data-cid="8a38eb22-aaff-47df-b7b4-1ac7e840c05c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '−'" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="HYPTOMIN" data-offset="1" data-match="-56" data-replace="−" data-pattern="−" data-tag-index="166_2" data-track-change="-" data-time="" data-username="" data-userid="">−</named-content></named-content><named-content id="d454f7cd-05f5-4464-b857-2b418e670e85" data-cid="d454f7cd-05f5-4464-b857-2b418e670e85" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="VAL" data-offset="2" data-match="-56" data-replace="56" data-pattern="$2" data-tag-index="166_2" data-time="" data-username="" data-userid="">56</named-content> (15)</p><p data-class="jrnlSecPara" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" id="4bd34a4f-e087-4858-99c5-f4ddc5e2000a" contenteditable="true"><named-content id="e1914389-0e34-46b4-aad4-b6b33b73e032" data-cid="e1914389-0e34-46b4-aad4-b6b33b73e032" content-type="del cts-1" specific-use="" xlink:title="" alt="" data-title="" data-track-detail="" data-time="" data-username="" data-userid=""> <named-content id="af776d5f-89cc-4c8e-9b82-f6915a31b031" data-cid="af776d5f-89cc-4c8e-9b82-f6915a31b031" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '−'" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="HYPTOMIN" data-offset="1" data-match="-11" data-replace="−" data-pattern="−" data-tag-index="167_2" data-track-change="-" data-time="" data-username="" data-userid="">−</named-content></named-content><named-content id="d4c5e883-5c4b-4c6b-90d4-d9fd0e092875" data-cid="d4c5e883-5c4b-4c6b-90d4-d9fd0e092875" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="VAL" data-offset="2" data-match="-11" data-replace="11" data-pattern="$2" data-tag-index="167_2" data-time="" data-username="" data-userid="">11</named-content> (13)</p></td></tr></tbody></table><table-wrap-foot id="f6e32787-39b5-40f7-99e9-410f5b8e13b4"><fn data-class="jrnlTblFoot" data-id="T2_FN1" fn-type="general" id="T2_FN1"><p id="53530d20-d6bb-4417-92a6-4e735d9ecc81">CC-16, club cell protein 16; CRP, C<named-content data-cid="1555285536" id="76021f71-af84-47a3-a0f1-e741fc0ded74" content-type="del cts-3" specific-use="1555287341634" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 8:15am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555287341634">-</named-content><named-content data-cid="1555285537" id="19a1c652-ad4f-47b0-8da4-a6cacd3b3fd8" content-type="ins cts-3" specific-use="1555287342401" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 8:15am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555287342401"> </named-content>reactive protein; FEV<sub id="94aa2597-2b97-4c00-8dc6-9430efdc697b">1</sub>, forced expiratory volume in <named-content id="73e65c0b-6bb4-4974-87a7-c27e9d053590" data-cid="73e65c0b-6bb4-4974-87a7-c27e9d053590" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="88" data-match="1 s" data-replace="1" data-pattern="$1" data-tag-index="171_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="344ef6d8-4099-45a1-bf8f-1455f88ea193" data-cid="344ef6d8-4099-45a1-bf8f-1455f88ea193" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣s' to ' s'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="89" data-match="1 s" data-replace=" s" data-pattern=" s" data-tag-index="171_1" data-track-change=" s" data-time="" data-username="" data-userid=""> s</named-content>; FF, fluticasone furoate; <named-content id="2c1ce147-ddfc-4aaa-8c1a-6177c48c8cbf" data-cid="2c1ce147-ddfc-4aaa-8c1a-6177c48c8cbf" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'SE' to 'SE'" data-track-detail="" data-tag-desc="ABBRV" data-tag-type="ABBRV" data-offset="118" data-match="SE" data-replace="SE" data-pattern="SE" data-tag-index="171_2" data-function="addTrackChanges" data-time="" data-username="" data-userid=""><named-content data-cid="1555285538" id="b7349c2d-d128-4ae9-93b9-85a027c3268e" content-type="del cts-3" specific-use="1555287348403" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 8:15am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555287348403">SE</named-content></named-content><named-content data-cid="1555285538" id="486f344d-6c27-4afd-818d-08a923608f50" content-type="del cts-3" specific-use="1555287348403" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 8:15am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555287348403">, standard error; </named-content>SPD, surfactant protein D; sRAGE, soluble receptor of activated glycogen end-product; VI, vilanterol.</p></fn><fn data-class="jrnlTblFoot" data-id="T2_FN2" fn-type="linked-fn" id="T2_FN2"><label data-class="jrnlFNLabel" id="b45ffd82-f97d-45ee-86c7-2043fca3fb75"><named-content data-cid="1555068417004" id="bbd7feb0-69f5-49e5-96a2-e78b13cc8bf2" content-type="ins cts-1" specific-use="1555068417000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1555068417000">*</named-content></label><p id="70c1644a-f17a-4555-a7b4-cc6ebe977a2d">To be included in the analysis a <named-content id="e74b6425-9ed0-455a-bc3d-c34ccc716897" data-cid="e74b6425-9ed0-455a-bc3d-c34ccc716897" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patient' to 'patient'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="34" data-match="patient" data-replace="patient" data-pattern="$1" data-tag-index="168_1" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patient</named-content> needed to have an on-treatment FEV<sub id="ab89f704-72d2-441e-9066-18349721edb0">1</sub> measurement and the baseline biomarker measurement.</p></fn><fn data-class="jrnlTblFoot" data-id="T2_FN3" fn-type="linked-fn" id="T2_FN3"><label data-class="jrnlFNLabel" id="20d7343c-9a87-4473-a378-be97911a5feb"><named-content data-cid="1555068417005" id="865c7a8e-22fa-4178-97d9-52357e627ff1" content-type="del" specific-use="1555068417000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1555068417000">†</named-content><named-content data-cid="1555068417005" id="bb77668e-7ec5-4c8a-b6d3-df3104cdaa47" content-type="ins cts-1" specific-use="1555068417000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1555068417000">†</named-content></label><p id="7ba9fe21-70e0-424a-aff2-84c975c59a8e">All four treatment arms (placebo, FF, VI<named-content data-cid="1555285539" id="f034ce24-4442-406a-a5e1-595871dd72e7" content-type="del cts-3" specific-use="1555287359010" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 8:15am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555287359010">,</named-content><named-content data-cid="1555285540" id="aa7323d4-aee0-458a-90e0-1d19681785b3" content-type="ins cts-3" specific-use="1555287359118" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 8:15am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555287359118"> and</named-content> FF/VI): random coefficients model fitted with terms of age, gender, baseline FEV<sub id="c05d1bd5-b130-446a-b570-2304a9ea64c0">1</sub>, time, treatment, treatment by time, baseline biomarker tertile groups and baseline biomarker tertile groups by time.</p></fn><fn data-class="jrnlTblFoot" data-id="T2_FN4" fn-type="linked-fn" id="T2_FN4"><label data-class="jrnlFNLabel" id="72e15bec-ea37-46f7-bd10-924d5e65762a"><named-content data-cid="1555068417010" id="cb48c75d-4f77-4174-96d2-00879eb32892" content-type="del" specific-use="1555068417000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1555068417000">‡</named-content><named-content data-cid="1555068417010" id="0d01905c-5937-42b1-bf5a-4725cbe6bdbb" content-type="ins cts-1" specific-use="1555068417000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1555068417000">‡</named-content></label><p id="13922e21-0739-4122-af6b-c0240eb226a9">Presented by arm, because CC-16 concentrations at <named-content id="a784882d-2580-4a72-8ec3-33bdb52e3758" data-cid="a784882d-2580-4a72-8ec3-33bdb52e3758" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="53" data-match="3 months" data-replace="3" data-pattern="$1" data-tag-index="170_2" data-time="" data-username="" data-userid="">3</named-content><named-content id="2c0ca48f-29da-4be2-bd76-1121f1285be0" data-cid="2c0ca48f-29da-4be2-bd76-1121f1285be0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="54" data-match="3 months" data-replace=" months" data-pattern=" $2" data-tag-index="170_2" data-time="" data-username="" data-userid=""> months</named-content> were affected by treatment (<named-content data-cid="1555285544" id="2fc938ad-a2b8-4d10-b55f-c21391a7d255" content-type="ins cts-3" specific-use="1555287368416" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 8:16am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555287368416">online </named-content><xref id="398fcc05-6091-4bfe-85be-7af2654ed988" ref-type="supplementary-material" rid="SP1" data-citation-string=" SP1 " data-mark-cited="SP1">supplementary table S2</xref>): <named-content data-cid="1555285551" id="aa295fa1-c9a0-4fbb-8224-d7d67d8aa072" content-type="del cts-3" specific-use="1555287371635" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 8:16am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555287371635">R</named-content><named-content data-cid="1555285552" id="dd84e5c2-33f7-400f-bfe6-7f48c3aa280e" content-type="ins cts-3" specific-use="1555287371804" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 8:16am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555287371804">r</named-content>andom coefficients model fitted with terms of age, gender, baseline FEV<sub data-class="sty cts-3" data-cid="1555285553" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555287378339" data-track-hint="Subscript Added" id="cdec7944-8ab1-459c-84ad-7637d9fa2be0" data-title="Subscript Added by Ariel (COPYEDITOR) - Apr 15 2019 8:16am">1</sub>, time, baseline CC-16 tertile groups and baseline CC-16 tertile groups by time.</p></fn></table-wrap-foot></table-wrap><fig id="BLK_F2" data-id="BLK_F2" data-stream-name="a_F2" position="float" fig-type="figure"><label id="9799594c-f9d3-4948-9d53-7e667be8bcd3">Figure 2</label><caption id="70f732a2-0d9f-4cd2-932a-ce9c3b89d782"><title id="F2" data-id="F2">Relationship between baseline biomarker concentration and percent predicted FEV<sub id="9f650f3c-16e2-4760-8db9-fbda5da55678">1</sub><named-content data-cid="1555068417013" id="b3ddcbc9-12c2-4dfd-a0df-e294bbdefe37" content-type="del cts-1" specific-use="1555068417000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1555068417000" data-reason="truecase">. CC-16, club cell protein 16; CRP, C-reactive protein; FEV</named-content><named-content data-cid="1555068417013" id="8a5aa395-1ea5-4126-a619-ea9399e34d1a" content-type="ins cts-1" specific-use="1555068417000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1555068417000" data-reason="truecase">. CC-16, <named-content data-cid="1555285554" id="923e4bc1-37a9-4806-b195-846af9113f63" content-type="del cts-3" specific-use="1555287462570" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 8:17am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555287462570">C</named-content><named-content data-cid="1555285555" id="7b997d44-38e3-4ff4-9b38-cadea2b2b62b" content-type="ins cts-3" specific-use="1555287463033" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 8:17am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555287463033">c</named-content>lub cell protein 16; CRP, C<named-content data-cid="1555285556" id="9b933f91-35b1-4eb4-86b2-2904de502658" content-type="del cts-3" specific-use="1555287465410" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 8:17am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555287465410">-</named-content><named-content data-cid="1555285557" id="552a4251-f44b-4a02-8c62-39d330463aa5" content-type="ins cts-3" specific-use="1555287465676" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 8:17am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555287465676"> </named-content>reactive protein; FEV</named-content><sub id="f0a4394f-302d-4de9-ae9b-51e7c91e8b94">1</sub>, forced expiratory volume in <named-content id="a3752cfb-96d5-4567-9a38-24260c9ec523" data-cid="a3752cfb-96d5-4567-9a38-24260c9ec523" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="179" data-match="1 s" data-replace="1" data-pattern="$1" data-tag-index="197_2" data-time="" data-username="" data-userid="">1</named-content><named-content id="9ec399a4-e4c4-4a8c-b855-c6deacbc503c" data-cid="9ec399a4-e4c4-4a8c-b855-c6deacbc503c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣s' to ' s'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="180" data-match="1 s" data-replace=" s" data-pattern=" s" data-tag-index="197_2" data-track-change=" s" data-time="" data-username="" data-userid=""> s</named-content>; SPD, surfactant protein D; sRAGE, soluble receptor of activated glycogen end-product.</title></caption><graphic xlink:href="" id="292315ef-bbd9-408c-a9df-d9b15bcecec5" data-alt-src="" data-primary-extension="" data-old-src="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/SUMMIT_biomarker_Fig2_29MAR2019.jpg.JPEG" data-track="del"/><graphic xlink:href="" id="f3e6c7c7-4d60-439c-b520-9a9ecd07c916" data-alt-src="" data-primary-extension="tif" data-original-name="F002" data-filesize="846KB" data-colorspace="sRGB" data-geometry="1415x1116+0+0" data-track="del" data-cid="1555314103010" data-username="Gowtham Ram (TYPESETTER)" data-userid="typesetter gowthamram" data-time="1555314103010" data-title="Inserted by Gowtham Ram (TYPESETTER) - Apr 15 2019 1:11pm" data-old-src="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/38061bf3-7c39-4c8b-870d-4b4d2a5a3223.tif.JPEG"/><graphic xlink:href="" id="30e36039-62f2-4b18-b4c2-23e66db252de" data-alt-src="" data-primary-extension="jpg" data-original-name="Fig2" data-filesize="344KB" data-colorspace="sRGB" data-geometry="1172x930+0+0" data-track="del" data-cid="1555318330168" data-username="Gowtham Ram (TYPESETTER)" data-userid="typesetter gowthamram" data-time="1555318330168" data-title="Inserted by Gowtham Ram (TYPESETTER) - Apr 15 2019 2:22pm" data-old-src="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/2b5bf100-b0f7-4209-bf0b-f70b3bffa73b.jpg.JPEG"/><graphic xlink:href="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/0941b357-dd92-4b69-833f-ed631c16d821.tiff.JPEG" id="913fe95a-b553-4b2f-a2ff-a923b18cc8cb" data-alt-src="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/0941b357-dd92-4b69-833f-ed631c16d821.tiff.JPEG" data-primary-extension="tiff" data-original-name="Fig2" data-filesize="640KB" data-colorspace="sRGB" data-geometry="1172x930+0+0" data-track="ins" data-cid="1555318866656" data-username="Gowtham Ram (TYPESETTER)" data-userid="typesetter gowthamram" data-time="1555318866656" data-title="Inserted by Gowtham Ram (TYPESETTER) - Apr 15 2019 2:31pm"/></fig><p data-class="jrnlSecPara" id="584099c3-9ab5-42ff-814a-7b042ebe12b2">Higher systemic levels of CRP and fibrinogen were associated with higher risk of all-cause mortality as is shown in <xref id="ccd248c6-d77a-4f3b-b486-38f6ff64465b" ref-type="fig" rid="F3" data-citation-string=" F3 " data-tag-desc="FIGTBLREF" data-tag-type="FIGTBLREF" data-offset="116" data-match="figure 3" data-pattern="" data-tag-index="172_1" data-anchor="true">figure 3</xref>. The number of deaths by any cause for CRP were: highest tertile group <named-content id="457bf887-d730-4b57-882b-5c7ca785e4d1" data-cid="457bf887-d730-4b57-882b-5c7ca785e4d1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="196" data-match="36 (7%)" data-replace="36" data-pattern="$1" data-tag-index="172_6" data-time="" data-username="" data-userid="">36</named-content><named-content id="c5efc558-f27d-41c3-bfce-0761f5ca54f0" data-cid="c5efc558-f27d-41c3-bfce-0761f5ca54f0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="198" data-match="36 (7%)" data-replace=" (7%)" data-pattern=" $2" data-tag-index="172_6" data-time="" data-username="" data-userid=""> (7%)</named-content> <named-content id="00360bcf-ca3b-4f9c-929b-7d2078a0fbe2" data-cid="00360bcf-ca3b-4f9c-929b-7d2078a0fbe2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed 'versus' to 'vs'" data-track-detail="" data-tag-desc="VERSUS" data-tag-type="VERSUS" data-offset="204" data-match="versus" data-replace="vs" data-pattern="vs" data-tag-index="172_20" data-track-change="versus" data-time="" data-username="" data-userid="">v<named-content data-cid="1555285558" id="2886b402-b9b6-4971-a1d6-632a5ee796ef" content-type="ins cts-3" specific-use="1555289793586" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 8:56am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555289793586">ersu</named-content>s</named-content> lowest tertile group <named-content id="78d4c85d-32ef-40b7-86bd-5efabd142848" data-cid="78d4c85d-32ef-40b7-86bd-5efabd142848" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="232" data-match="22 (4%)" data-replace="22" data-pattern="$1" data-tag-index="172_7" data-time="" data-username="" data-userid="">22</named-content><named-content id="1e7554c2-2487-4add-843f-9837bf46716b" data-cid="1e7554c2-2487-4add-843f-9837bf46716b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="234" data-match="22 (4%)" data-replace=" (4%)" data-pattern=" $2" data-tag-index="172_7" data-time="" data-username="" data-userid=""> (4%)</named-content>, <named-content data-cid="1555068417003" id="3d6a73b5-1a13-490a-99d7-5a47ef908268" content-type="del cts-1" specific-use="1555068417000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1555068417000">hazard ratio (HR)</named-content><named-content data-cid="1555068417003" id="a808ca9e-648a-4859-b999-c404968cbdfd" content-type="ins cts-1" specific-use="1555068417000" xlink:title="Exeter" alt="preediting" data-title="changed from 'hazard␣ratio␣(HR)' to 'HR'" data-track-detail="" data-tag-desc="ABBRV" data-tag-type="ABBRV" data-offset="241" data-match="hazard ratio (HR)" data-replace="HR" data-pattern="HR" data-tag-index="172_15" data-function="addTrackChanges" data-track-change="hazard ratio (HR)" data-userid="preediting" data-username="Exeter" data-time="1555068417000">HR</named-content> 1.91; middle tertile group <named-content id="c4f1cfed-b2fa-4c4e-9a14-64a3cf517bbf" data-cid="c4f1cfed-b2fa-4c4e-9a14-64a3cf517bbf" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="286" data-match="35 (6%)" data-replace="35" data-pattern="$1" data-tag-index="172_8" data-time="" data-username="" data-userid="">35</named-content><named-content id="5dfe4f5f-a34f-49e7-94d1-2bf3a9ff0f3d" data-cid="5dfe4f5f-a34f-49e7-94d1-2bf3a9ff0f3d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="288" data-match="35 (6%)" data-replace=" (6%)" data-pattern=" $2" data-tag-index="172_8" data-time="" data-username="" data-userid=""> (6%)</named-content> <named-content id="9fd72483-8a58-45a0-843c-00e960348f29" data-cid="9fd72483-8a58-45a0-843c-00e960348f29" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed 'versus' to 'vs'" data-track-detail="" data-tag-desc="VERSUS" data-tag-type="VERSUS" data-offset="294" data-match="versus" data-replace="vs" data-pattern="vs" data-tag-index="172_21" data-track-change="versus" data-time="" data-username="" data-userid="">v<named-content data-cid="1555285562" id="d2bbe623-8c83-4c39-a03d-5974542dfd10" content-type="ins cts-3" specific-use="1555289807337" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 8:56am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555289807337">ersu</named-content>s</named-content> lowest tertile group <named-content id="e4170425-895b-4bd4-b110-caa9b8dbdaa6" data-cid="e4170425-895b-4bd4-b110-caa9b8dbdaa6" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="322" data-match="22 (4%)" data-replace="22" data-pattern="$1" data-tag-index="172_9" data-time="" data-username="" data-userid="">22</named-content><named-content id="136609fd-1f02-4358-af61-8f071cacab11" data-cid="136609fd-1f02-4358-af61-8f071cacab11" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="324" data-match="22 (4%)" data-replace=" (4%)" data-pattern=" $2" data-tag-index="172_9" data-time="" data-username="" data-userid=""> (4%)</named-content>, HR 1.70; for fibrinogen they were highest group <named-content id="87d703d9-278c-4715-bd13-ebe0f110db63" data-cid="87d703d9-278c-4715-bd13-ebe0f110db63" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="379" data-match="43 (8%)" data-replace="43" data-pattern="$1" data-tag-index="172_10" data-time="" data-username="" data-userid="">43</named-content><named-content id="700c4741-efaf-4e32-96d4-d20cc23522c3" data-cid="700c4741-efaf-4e32-96d4-d20cc23522c3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="381" data-match="43 (8%)" data-replace=" (8%)" data-pattern=" $2" data-tag-index="172_10" data-time="" data-username="" data-userid=""> (8%)</named-content> <named-content id="733dcee1-41b8-4766-a0ce-040bb87bec85" data-cid="733dcee1-41b8-4766-a0ce-040bb87bec85" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed 'versus' to 'vs'" data-track-detail="" data-tag-desc="VERSUS" data-tag-type="VERSUS" data-offset="387" data-match="versus" data-replace="vs" data-pattern="vs" data-tag-index="172_22" data-track-change="versus" data-time="" data-username="" data-userid="">v<named-content data-cid="1555285566" id="4ba549e9-a58a-4e22-8f09-7e6984040cbe" content-type="ins cts-3" specific-use="1555289812140" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 8:56am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555289812140">ersu</named-content>s</named-content> lowest group <named-content id="029bb75b-d5fa-4c2b-a886-e60fc1e56d8f" data-cid="029bb75b-d5fa-4c2b-a886-e60fc1e56d8f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="407" data-match="21 (4%)" data-replace="21" data-pattern="$1" data-tag-index="172_11" data-time="" data-username="" data-userid="">21</named-content><named-content id="f0f3d35d-d5c8-41f3-b83c-02a821ba9d8c" data-cid="f0f3d35d-d5c8-41f3-b83c-02a821ba9d8c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="409" data-match="21 (4%)" data-replace=" (4%)" data-pattern=" $2" data-tag-index="172_11" data-time="" data-username="" data-userid=""> (4%)</named-content>, HR 2.24; middle group <named-content id="297ba68e-b425-4786-b0c6-e006337c871e" data-cid="297ba68e-b425-4786-b0c6-e006337c871e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="438" data-match="24 (5%)" data-replace="24" data-pattern="$1" data-tag-index="172_12" data-time="" data-username="" data-userid="">24</named-content><named-content id="47f7e890-aa78-47c8-b7d2-b3c434ee6366" data-cid="47f7e890-aa78-47c8-b7d2-b3c434ee6366" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="440" data-match="24 (5%)" data-replace=" (5%)" data-pattern=" $2" data-tag-index="172_12" data-time="" data-username="" data-userid=""> (5%)</named-content> <named-content id="3956fc57-ff46-421b-95d5-131b74b04286" data-cid="3956fc57-ff46-421b-95d5-131b74b04286" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed 'versus' to 'vs'" data-track-detail="" data-tag-desc="VERSUS" data-tag-type="VERSUS" data-offset="446" data-match="versus" data-replace="vs" data-pattern="vs" data-tag-index="172_23" data-track-change="versus" data-time="" data-username="" data-userid="">v<named-content data-cid="1555285570" id="cc2692c5-45af-43f0-b8ed-e688bd68a8b0" content-type="ins cts-3" specific-use="1555289832856" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 8:57am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555289832856">ersu</named-content>s</named-content> lowest group <named-content id="10fae934-8949-4234-b973-95961887ef41" data-cid="10fae934-8949-4234-b973-95961887ef41" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="466" data-match="21 (4%)" data-replace="21" data-pattern="$1" data-tag-index="172_13" data-time="" data-username="" data-userid="">21</named-content><named-content id="97617bb5-a45e-4571-b5a6-eee7e8c36e24" data-cid="97617bb5-a45e-4571-b5a6-eee7e8c36e24" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="468" data-match="21 (4%)" data-replace=" (4%)" data-pattern=" $2" data-tag-index="172_13" data-time="" data-username="" data-userid=""> (4%)</named-content>, HR 1.24. There were no apparent relationships between CC-16, sRAGE and SPD and all-cause mortality (<named-content data-cid="1555394565772" id="2d78f837-6b9e-4221-824e-636eb47cf2bb" content-type="del cts-1" specific-use="1555068439000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1555068439000">supplementary figure 3</named-content><named-content data-cid="1555394565772" id="70518e9f-43f1-45c5-9d07-ef1308734cb8" content-type="ins cts-1" specific-use="1555068439000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1555068439000"><xref id="e9e4dc49-782a-46e1-958c-04edd3dd7d69" ref-type="supplementary-material" rid="SP1" data-citation-string=" SP1 " data-mark-cited="SP1">online supplementary figure 3</xref></named-content>) or with any of the measured biomarkers and CV death (<named-content data-cid="1555394565773" id="a4c416c6-edb5-498a-9aa3-d149e3081d7d" content-type="del cts-1" specific-use="1555068439000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1555068439000">supplementary figure 4</named-content><named-content data-cid="1555394565773" id="3d72fc36-32f5-40a4-aa6b-230793c37760" content-type="ins cts-1" specific-use="1555068439000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1555068439000"><xref id="90b40161-c321-471c-a429-709999688119" ref-type="supplementary-material" rid="SP1" data-citation-string=" SP1 " data-mark-cited="SP1">online supplementary figure 4</xref></named-content>).</p><fig id="BLK_F3" data-id="BLK_F3" data-stream-name="a_F3" position="float" fig-type="figure"><label id="5940daf0-b056-46ce-8777-b32ae2ff99fa">Figure 3</label><caption id="ec3ff51a-0930-46dd-a198-f046d1f6835f"><title id="F3" data-id="F3"><named-content data-cid="1555068417014" id="2d5214c1-d1cf-4bdd-a2c9-9408727af81c" content-type="del cts-1" specific-use="1555068417000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1555068417000" data-reason="truecase">Kaplan–Meier plots of time to death by tertile groups for CRP and fibrinogen. Hazard ratios from Cox proportional hazard model adjusted for treatment, age and gender. Biomarker tertile group: </named-content><named-content data-cid="1555068417014" id="6558cbc0-a5ec-4c4e-a690-e1055f042d89" content-type="ins cts-1" specific-use="1555068417000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1555068417000" data-reason="truecase">Kaplan–Meier plots of time to death by tertile groups for CRP and fibrinogen. <named-content data-cid="1555285574" id="f13b9f91-4931-4ae3-adfb-6da04885f8ad" content-type="ins cts-3" specific-use="1555289882268" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 8:58am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555289882268">HRs</named-content><named-content data-cid="1555285577" id="730a5312-8445-49a6-a3fc-114d0535d820" content-type="del cts-3" specific-use="1555289886036" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 8:58am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555289886036">hazard ratios</named-content> from C<named-content data-cid="1555285578" id="1180cf0b-d5ba-44b9-bb3e-2b81306f6a41" content-type="ins cts-3" specific-use="1555289888171" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 8:58am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555289888171">ox</named-content><named-content data-cid="1555285580" id="7760e96d-9975-4129-b03e-068de86fca68" content-type="del cts-3" specific-use="1555289889040" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 8:58am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555289889040">OX</named-content> proportional hazard model adjusted for treatment, age and gender. <named-content data-cid="1555285581" id="28e1a2bf-b39c-4679-9c24-63167ae479f3" content-type="del cts-3" specific-use="1555289893400" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 8:58am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555289893400">b</named-content><named-content data-cid="1555285582" id="b1ad8d61-45f6-4caa-b0c6-46fb91264cc9" content-type="ins cts-3" specific-use="1555289893471" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 8:58am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555289893471">B</named-content>iomarker tertile group:<named-content rid="8a35aa60-1ad3-49af-9bcf-26e7ab9bffa7" data-class="jrnlQueryRef" data-type="start" data-query-ref="true" data-query-for="typesetter" data-query-from="copyeditor" data-channel="query" data-topic="action" data-event="click" data-message="{'funcToCall': 'highlightQuery'}" data-query-type="action" id="58e0a5b9-e2f2-4724-b203-56b89200af59" content-type="jrnlQueryRef" specific-use="start" data-replied="true"/> </named-content><bold id="51e248e2-c5d9-4743-a99c-dd2f426c5de0"><sup id="3904cee3-5500-4e05-97cb-679899f15d71"><named-content data-cid="1555313103" id="f0ab9b27-b737-4f2a-bdb9-f57c59c1a5b1" content-type="del cts-4" specific-use="1555313426711" xlink:title="Gowtham Ram (TYPESETTER)" alt="typesetter gowthamram" data-title="Deleted by Gowtham Ram (TYPESETTER) - Apr 15 2019 1:00pm" data-track-detail="" data-userid="typesetter gowthamram" data-username="Gowtham Ram (TYPESETTER)" data-time="1555313426711">___</named-content></sup><named-content data-cid="1555313103" id="3b50e320-586d-47d8-9e9f-0b6e3c4b05c9" content-type="del cts-4" specific-use="1555313426711" xlink:title="Gowtham Ram (TYPESETTER)" alt="typesetter gowthamram" data-title="Deleted by Gowtham Ram (TYPESETTER) - Apr 15 2019 1:00pm" data-track-detail="" data-userid="typesetter gowthamram" data-username="Gowtham Ram (TYPESETTER)" data-time="1555313426711"> </named-content></bold><named-content data-cid="1555313161" id="ba1cbeec-1ca0-4532-8389-08d33769c1cd" content-type="styrm cts-4" specific-use="1555314126346" xlink:title="Gowtham Ram (TYPESETTER)" alt="typesetter gowthamram" data-title="Bold Removed by Gowtham Ram (TYPESETTER) - Apr 15 2019 1:12pm" data-track-detail="" data-format-command="bold" data-userid="typesetter gowthamram" data-username="Gowtham Ram (TYPESETTER)" data-time="1555314126346" data-track-hint="Bold Removed">Low</named-content><named-content data-cid="1555313104" id="305294ef-3887-453b-99f1-4c9cfd5f3940" content-type="ins cts-4" specific-use="1555313432054" xlink:title="Gowtham Ram (TYPESETTER)" alt="typesetter gowthamram" data-title="Inserted by Gowtham Ram (TYPESETTER) - Apr 15 2019 1:00pm" data-track-detail="" data-userid="typesetter gowthamram" data-username="Gowtham Ram (TYPESETTER)" data-time="1555313432054"><named-content data-cid="1555313161" id="d83ce9ed-d3a1-4e8e-8d55-21a7251be76b" content-type="styrm cts-4" specific-use="1555314126346" xlink:title="Gowtham Ram (TYPESETTER)" alt="typesetter gowthamram" data-title="Bold Removed by Gowtham Ram (TYPESETTER) - Apr 15 2019 1:12pm" data-track-detail="" data-format-command="Bold" data-userid="typesetter gowthamram" data-username="Gowtham Ram (TYPESETTER)" data-time="1555314126346" data-track-hint="Bold Removed"> in black colour.</named-content></named-content><named-content data-cid="1555313161" id="d71b780e-18b8-45a7-8f8a-9261d3ab9470" content-type="styrm cts-4" specific-use="1555314126346" xlink:title="Gowtham Ram (TYPESETTER)" alt="typesetter gowthamram" data-title="Bold Removed by Gowtham Ram (TYPESETTER) - Apr 15 2019 1:12pm" data-track-detail="" data-format-command="Bold" data-userid="typesetter gowthamram" data-username="Gowtham Ram (TYPESETTER)" data-time="1555314126346" data-track-hint="Bold Removed"> </named-content><sup id="fa293bbe-76d3-43d0-b3d8-a405ad05205a"><named-content data-cid="1555313121" id="e4f08e1a-9812-4dfe-b22c-fcf0da3912c2" content-type="del cts-4" specific-use="1555313442012" xlink:title="Gowtham Ram (TYPESETTER)" alt="typesetter gowthamram" data-title="Deleted by Gowtham Ram (TYPESETTER) - Apr 15 2019 1:00pm" data-track-detail="" data-userid="typesetter gowthamram" data-username="Gowtham Ram (TYPESETTER)" data-time="1555313442012"><named-content data-cid="1555313161" id="3830cf63-a726-40f4-b34d-dc1a2cfc17e1" content-type="styrm cts-4" specific-use="1555314126346" xlink:title="Gowtham Ram (TYPESETTER)" alt="typesetter gowthamram" data-title="Bold Removed by Gowtham Ram (TYPESETTER) - Apr 15 2019 1:12pm" data-track-detail="" data-format-command="Bold" data-userid="typesetter gowthamram" data-username="Gowtham Ram (TYPESETTER)" data-time="1555314126346" data-track-hint="Bold Removed">___</named-content></named-content></sup><named-content data-cid="1555313121" id="4f77b00e-bff7-49cb-8349-f8673a00b589" content-type="del cts-4" specific-use="1555313442012" xlink:title="Gowtham Ram (TYPESETTER)" alt="typesetter gowthamram" data-title="Deleted by Gowtham Ram (TYPESETTER) - Apr 15 2019 1:00pm" data-track-detail="" data-userid="typesetter gowthamram" data-username="Gowtham Ram (TYPESETTER)" data-time="1555313442012"><named-content data-cid="1555313161" id="94c5f4cd-82f8-4b0d-98e1-83a63c524389" content-type="styrm cts-4" specific-use="1555314126346" xlink:title="Gowtham Ram (TYPESETTER)" alt="typesetter gowthamram" data-title="Bold Removed by Gowtham Ram (TYPESETTER) - Apr 15 2019 1:12pm" data-track-detail="" data-format-command="Bold" data-userid="typesetter gowthamram" data-username="Gowtham Ram (TYPESETTER)" data-time="1555314126346" data-track-hint="Bold Removed"> </named-content></named-content><named-content data-cid="1555313161" id="95096aee-c11a-489c-a016-27c35f20ab53" content-type="styrm cts-4" specific-use="1555314126346" xlink:title="Gowtham Ram (TYPESETTER)" alt="typesetter gowthamram" data-title="Bold Removed by Gowtham Ram (TYPESETTER) - Apr 15 2019 1:12pm" data-track-detail="" data-format-command="Bold" data-userid="typesetter gowthamram" data-username="Gowtham Ram (TYPESETTER)" data-time="1555314126346" data-track-hint="Bold Removed">Middle</named-content><named-content data-cid="1555313122" id="1fba56d3-545e-470d-999d-a72c61b1073a" content-type="ins cts-4" specific-use="1555313443340" xlink:title="Gowtham Ram (TYPESETTER)" alt="typesetter gowthamram" data-title="Inserted by Gowtham Ram (TYPESETTER) - Apr 15 2019 1:00pm" data-track-detail="" data-userid="typesetter gowthamram" data-username="Gowtham Ram (TYPESETTER)" data-time="1555313443340"><named-content data-cid="1555313161" id="04bad6f5-6d90-47f7-aa74-5dee83e3e1b0" content-type="styrm cts-4" specific-use="1555314126346" xlink:title="Gowtham Ram (TYPESETTER)" alt="typesetter gowthamram" data-title="Bold Removed by Gowtham Ram (TYPESETTER) - Apr 15 2019 1:12pm" data-track-detail="" data-format-command="Bold" data-userid="typesetter gowthamram" data-username="Gowtham Ram (TYPESETTER)" data-time="1555314126346" data-track-hint="Bold Removed"> in orange colour.</named-content></named-content><named-content data-cid="1555313161" id="82c034ca-b749-44a0-af4e-6194a366af45" content-type="styrm cts-4" specific-use="1555314126346" xlink:title="Gowtham Ram (TYPESETTER)" alt="typesetter gowthamram" data-title="Bold Removed by Gowtham Ram (TYPESETTER) - Apr 15 2019 1:12pm" data-track-detail="" data-format-command="Bold" data-userid="typesetter gowthamram" data-username="Gowtham Ram (TYPESETTER)" data-time="1555314126346" data-track-hint="Bold Removed"> </named-content><sup id="0c32e3f2-874b-4b5e-bf68-4e78a98874e6"><named-content data-cid="1555313144" id="9b4b839e-ff0a-4f2c-b809-16ffe78ec309" content-type="del cts-4" specific-use="1555313457985" xlink:title="Gowtham Ram (TYPESETTER)" alt="typesetter gowthamram" data-title="Deleted by Gowtham Ram (TYPESETTER) - Apr 15 2019 1:00pm" data-track-detail="" data-userid="typesetter gowthamram" data-username="Gowtham Ram (TYPESETTER)" data-time="1555313457985"><named-content data-cid="1555313161" id="96e0c0db-61ed-49a4-836b-cf688135f23a" content-type="styrm cts-4" specific-use="1555314126346" xlink:title="Gowtham Ram (TYPESETTER)" alt="typesetter gowthamram" data-title="Bold Removed by Gowtham Ram (TYPESETTER) - Apr 15 2019 1:12pm" data-track-detail="" data-format-command="Bold" data-userid="typesetter gowthamram" data-username="Gowtham Ram (TYPESETTER)" data-time="1555314126346" data-track-hint="Bold Removed">___</named-content></named-content></sup><named-content data-cid="1555313144" id="cbe7027f-e604-47c6-9102-d5c7b137c37a" content-type="del cts-4" specific-use="1555313457985" xlink:title="Gowtham Ram (TYPESETTER)" alt="typesetter gowthamram" data-title="Deleted by Gowtham Ram (TYPESETTER) - Apr 15 2019 1:00pm" data-track-detail="" data-userid="typesetter gowthamram" data-username="Gowtham Ram (TYPESETTER)" data-time="1555313457985"><named-content data-cid="1555313161" id="3f44f589-ae0e-4217-85a6-73323aff457d" content-type="styrm cts-4" specific-use="1555314126346" xlink:title="Gowtham Ram (TYPESETTER)" alt="typesetter gowthamram" data-title="Bold Removed by Gowtham Ram (TYPESETTER) - Apr 15 2019 1:12pm" data-track-detail="" data-format-command="Bold" data-userid="typesetter gowthamram" data-username="Gowtham Ram (TYPESETTER)" data-time="1555314126346" data-track-hint="Bold Removed"> </named-content></named-content><named-content data-cid="1555313161" id="7b8b7db0-5cd0-443e-9e70-758e4715192d" content-type="styrm cts-4" specific-use="1555314126346" xlink:title="Gowtham Ram (TYPESETTER)" alt="typesetter gowthamram" data-title="Bold Removed by Gowtham Ram (TYPESETTER) - Apr 15 2019 1:12pm" data-track-detail="" data-format-command="Bold" data-userid="typesetter gowthamram" data-username="Gowtham Ram (TYPESETTER)" data-time="1555314126346" data-track-hint="Bold Removed">High</named-content><named-content data-cid="1555313145" id="77f6208d-0642-45ef-83b1-a16acab100da" content-type="ins cts-4" specific-use="1555313535586" xlink:title="Gowtham Ram (TYPESETTER)" alt="typesetter gowthamram" data-title="Inserted by Gowtham Ram (TYPESETTER) - Apr 15 2019 1:02pm" data-track-detail="" data-userid="typesetter gowthamram" data-username="Gowtham Ram (TYPESETTER)" data-time="1555313535586"><named-content data-cid="1555313161" id="92da2b88-dd05-4b3b-8b8c-1e470d4fdf9c" content-type="styrm cts-4" specific-use="1555314126346" xlink:title="Gowtham Ram (TYPESETTER)" alt="typesetter gowthamram" data-title="Bold Removed by Gowtham Ram (TYPESETTER) - Apr 15 2019 1:12pm" data-track-detail="" data-format-command="Bold" data-userid="typesetter gowthamram" data-username="Gowtham Ram (TYPESETTER)" data-time="1555314126346" data-track-hint="Bold Removed"> in green colour</named-content></named-content><bold id="11d1ace1-429c-4641-8b2e-2bc91565e95d"><named-content rid="8a35aa60-1ad3-49af-9bcf-26e7ab9bffa7" data-class="jrnlQueryRef" data-type="end" id="6d94a626-ac44-4323-a9e8-462031d021ce" content-type="jrnlQueryRef" specific-use="end" data-replied="true"/></bold>. <named-content data-cid="1555285583" id="1841e94c-27f2-462a-9848-17fc6683a345" content-type="del cts-3" specific-use="1555289963523" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 8:59am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555289963523">CI, confidence interval; </named-content>CRP, C<named-content data-cid="1555285584" id="13caa24f-d80e-4214-bdd9-0f9b9d7d60a6" content-type="del cts-3" specific-use="1555289965282" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 8:59am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555289965282">-</named-content><named-content data-cid="1555285585" id="965ce16f-3065-4c89-9edd-cacb100784a9" content-type="ins cts-3" specific-use="1555289965686" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 8:59am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555289965686"> </named-content>reactive protein.</title></caption><graphic xlink:href="" id="2722c164-7bd7-4e7f-b03a-b2180cb6cfd0" data-alt-src="" data-primary-extension="" data-old-src="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/SUMMIT_biomarker_Fig3_29MAR2019.jpg.JPEG" data-track="del"/><graphic xlink:href="" id="bed9255c-8bb2-481f-89b0-e2d7be73c853" data-alt-src="" data-primary-extension="tif" data-original-name="F003" data-filesize="241KB" data-colorspace="sRGB" data-geometry="1415x512+0+0" data-track="del" data-cid="1555314117116" data-username="Gowtham Ram (TYPESETTER)" data-userid="typesetter gowthamram" data-time="1555314117116" data-title="Inserted by Gowtham Ram (TYPESETTER) - Apr 15 2019 1:11pm" data-old-src="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/0aa95a11-fb19-464b-9864-248ff6fb61dd.tif.JPEG"/><graphic xlink:href="" id="2e1a0a35-3cc3-4661-8358-d449343fe8ea" data-alt-src="" data-primary-extension="jpg" data-original-name="Fig3" data-filesize="184KB" data-colorspace="sRGB" data-geometry="1576x577+0+0" data-track="del" data-cid="1555318345787" data-username="Gowtham Ram (TYPESETTER)" data-userid="typesetter gowthamram" data-time="1555318345787" data-title="Inserted by Gowtham Ram (TYPESETTER) - Apr 15 2019 2:22pm" data-old-src="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/d79f4586-4ce1-4e21-a2af-0eb68b62cb3f.jpg.JPEG"/><graphic xlink:href="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/ebe52246-04a8-41a8-97ea-ecaff969ba77.tiff.JPEG" id="0d0354a9-00ed-4cc0-a9b2-8ff1c8a83890" data-alt-src="/resources/bmj/bmjresp/bmjresp-2019-000431/resources/ebe52246-04a8-41a8-97ea-ecaff969ba77.tiff.JPEG" data-primary-extension="tiff" data-original-name="Fig3" data-filesize="237KB" data-colorspace="sRGB" data-geometry="1576x577+0+0" data-track="ins" data-cid="1555318882652" data-username="Gowtham Ram (TYPESETTER)" data-userid="typesetter gowthamram" data-time="1555318882652" data-title="Inserted by Gowtham Ram (TYPESETTER) - Apr 15 2019 2:31pm"/></fig><title data-level="1" data-class="jrnlHead1" id="3e4071d7-1829-491d-802e-0f334fe8abe6">Discussion</title><p data-class="jrnlSecPara" id="288edb70-eba7-4f59-894d-22b0c2fc63cc">This prospective study of COPD <named-content id="12f226e4-351c-40cf-82c8-8b77f40d4583" data-cid="12f226e4-351c-40cf-82c8-8b77f40d4583" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="31" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="173_1" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> with moderate airflow limitation and heightened <named-content data-cid="1555285738" id="54bd227f-b14d-4b78-93f0-48e25c561093" content-type="del cts-3" specific-use="1555291421769" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:23am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291421769">cardiovascular</named-content><named-content data-cid="1555285739" id="39d8ad88-8aa3-4246-9267-371bdff0e6a6" content-type="ins cts-3" specific-use="1555291421833" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 9:23am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291421833">CV</named-content> risk provides two novel findings. First, the systemic levels of the five cytokines (CC-16, sRAGE, SPD, CRP and fibrinogen S)<named-content data-cid="1555285586" id="be0df504-7895-4fe8-a063-b87342b711b4" content-type="del cts-3" specific-use="1555290006144" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:00am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555290006144">,</named-content><named-content data-cid="1555285587" id="e1f22ce1-2049-4d1e-8416-b9c2f878d96f" content-type="ins cts-3" specific-use="1555290056006" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 9:00am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555290056006">,</named-content> selected because of previous studies suggesting their potential value as predictors of outcomes in COPD, were unrelated to rate of FEV<sub id="4d65b8aa-d921-4ed4-bd59-9b36db891590">1</sub> decline, exacerbation frequency and hospitalisations in these <named-content id="5a6439ed-0fda-47cc-920f-a67ca64463d9" data-cid="5a6439ed-0fda-47cc-920f-a67ca64463d9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="427" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="173_2" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content>. The systemic levels of CRP and fibrinogen were associated with increased risk of all-cause mortality, confirming the predictive value for this outcome reported by others. Second, compared with placebo, once-daily inhalation of <named-content data-cid="1555285702" id="72350031-7988-4c73-9eb0-5dfb5fa935c8" content-type="del cts-3" specific-use="1555291238700" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:20am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291238700">vilanterol</named-content><named-content data-cid="1555285703" id="8cc34bda-3313-4464-b0ae-ed396c41c2d9" content-type="ins cts-3" specific-use="1555291238775" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 9:20am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291238775">VI</named-content>, <named-content data-cid="1555285682" id="543e7b48-52d3-4438-a9a4-2ef62413e61f" content-type="del cts-3" specific-use="1555291202291" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:20am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291202291">fluticasone furoate</named-content><named-content data-cid="1555285683" id="a4ff4678-ed09-4b1a-ab75-4fac5e3fa309" content-type="ins cts-3" specific-use="1555291202363" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 9:20am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291202363">FF</named-content> and the combination resulted in small but significant decreases in the serum levels of CC-16, but not in the other biomarkers.</p><title data-level="2" data-class="jrnlHead2" id="a233b627-aa5b-4312-b6c8-090b572d7b65">Previous studies</title><p data-class="jrnlSecPara" id="54ee5ca7-6b65-4f34-b5f8-8ce8bef8b5c0">There has been a growing interest in the field of biomarkers in COPD as a tool to predict outcomes or as marker of them, thus making them theoretically useful as surrogate markers of response for therapeutic interventions.<xref id="cdcb60d4-37cb-4796-a512-d97202a3170a" ref-type="bibr" rid="R9 R10 R21 R22 R23" data-citation-string=" R9 R10 R21 R22 R23 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="223" data-match="9,10,21-23" data-pattern="" data-tag-index="174_1" data-track-change="9,10,21-23"><sup id="81b42be3-8a33-4b84-a60c-181dc3e5e67c">9 10 21–23</sup></xref> CRP has been the best studied biomarker in COPD. Most studies found that CRP levels are elevated in these <named-content id="9b5e2cbf-a862-4e96-b4c0-15bd2cda3b7c" data-cid="9b5e2cbf-a862-4e96-b4c0-15bd2cda3b7c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="341" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="174_12" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content>,<xref id="90fb09cf-e280-46dd-99b4-6981910aa4fa" ref-type="bibr" rid="R6 R24 R25" data-citation-string=" R6 R24 R25 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="351" data-match="6,24,25" data-pattern="" data-tag-index="174_2" data-track-change="6,24,25"><sup id="f0d94252-a6dc-4aea-aa6b-e3bdec4e3129">6 24 25</sup></xref> as compared with non-smokers and smokers without airflow obstruction, but the relationship between CRP levels and exacerbations as well as mortality remain inconsistent.<xref id="b627c860-636e-4c1b-8207-038da50f20ec" ref-type="bibr" rid="R25 R26" data-citation-string=" R25 R26 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="530" data-match="25,26" data-pattern="" data-tag-index="174_3" data-track-change="25,26"><sup id="83ac93e9-233f-420f-91f9-47147c253691">25 26</sup></xref> Studies have also not consistently shown a relationship between CRP and rate of lung function decline.<xref id="12aaf540-38b2-4acc-b8ce-30fcce84c401" ref-type="bibr" rid="R11" data-citation-string=" R11 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="640" data-match="11" data-pattern="" data-tag-index="174_4" data-track-change="11"><sup id="e6ae7ab1-df19-4b4b-b406-69dcbd77d9ac">11</sup></xref> Similarly, several studies have documented a relationship between blood levels of fibrinogen and risk of death in <named-content id="70d29426-17c5-4be3-8818-823ed7e31222" data-cid="70d29426-17c5-4be3-8818-823ed7e31222" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="758" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="174_13" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> in general<xref id="e1e668db-6c73-4fa2-afb1-7f6f39bfacaf" ref-type="bibr" rid="R27" data-citation-string=" R27 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="778" data-match="27" data-pattern="" data-tag-index="174_5" data-track-change="27"><sup id="ab80fb78-56f5-433e-8164-c9638a61d0b8">27</sup></xref> and COPD in particular.<xref id="5b4a9759-7105-434f-bd36-a261254e5010" ref-type="bibr" rid="R5 R7 R28" data-citation-string=" R5 R7 R28 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="806" data-match="5,7,28" data-pattern="" data-tag-index="174_6" data-track-change="5,7,28"><sup id="a7800313-7cff-471e-a2a8-c694d09e7c9d">5 7 28</sup></xref> Integration of all the data available by the COPD Biomarker Qualification Consortium<named-content data-cid="1555285588" id="6b5293b4-48c0-41a7-a476-e8c40bac4ded" content-type="del cts-3" specific-use="1555290095615" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:01am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555290095615"> (</named-content><named-content id="f151fbba-f10e-40e2-8a88-6b72c7142e18" data-cid="f151fbba-f10e-40e2-8a88-6b72c7142e18" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ABBR" data-track-detail="" data-tag-desc="ABBR" data-tag-type="ABBR" data-offset="900" data-match=" (CBQC)" data-pattern="" data-tag-index="174_10" data-time="" data-username="" data-userid=""><named-content data-cid="1555285588" id="a6109f7b-1136-4c32-90be-b8d98c0756f0" content-type="del cts-3" specific-use="1555290095615" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:01am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555290095615">CBQC</named-content></named-content><named-content data-cid="1555285588" id="b1ffa4ea-d566-44f2-bc56-cbcc4228dabd" content-type="del cts-3" specific-use="1555290095615" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:01am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555290095615">)</named-content> initiative resulted in US Food and Drug Administration<named-content data-cid="1555285589" id="37b3c15b-afe0-4369-89b6-8b6b2253bbdb" content-type="del cts-3" specific-use="1555290147568" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:02am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555290147568"> (</named-content><named-content id="0d00d871-7057-4f2d-b617-3f0e9d820ffc" data-cid="0d00d871-7057-4f2d-b617-3f0e9d820ffc" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ABBR" data-track-detail="" data-tag-desc="ABBR" data-tag-type="ABBR" data-offset="962" data-match=" (FDA)" data-pattern="" data-tag-index="174_11" data-time="" data-username="" data-userid=""><named-content data-cid="1555285589" id="d188e2ef-e92c-48c8-9ae6-1944de17e35c" content-type="del cts-3" specific-use="1555290147568" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:02am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555290147568">FDA</named-content></named-content><named-content data-cid="1555285589" id="942d5c15-8d4c-4175-afb3-20b39e26bfc7" content-type="del cts-3" specific-use="1555290147568" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:02am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555290147568">)</named-content> approval of this biomarker to stratify <named-content id="b0b975b9-2d6c-48c8-b64d-c8f520d49c19" data-cid="b0b975b9-2d6c-48c8-b64d-c8f520d49c19" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="1006" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="174_14" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> for studies of COPD.<xref id="ad852768-21b0-4d87-8164-2751fc5d82f3" ref-type="bibr" rid="R7" data-citation-string=" R7 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="1036" data-match="7" data-pattern="" data-tag-index="174_7" data-track-change="7"><sup id="97d46e64-c7f1-410f-aa64-cc0bb9667858">7</sup></xref> There is less information regarding the relationship between systemic levels of fibrinogen and other important outcomes in COPD, such as rate of lung function decline and hospitalisations.<xref id="472c2334-aba2-4d85-bdb0-49e237eab4aa" ref-type="bibr" rid="R29" data-citation-string=" R29 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="1228" data-match="29" data-pattern="" data-tag-index="174_8" data-track-change="29"><sup id="4854595a-103b-4f53-aa99-c8654703a96d">29</sup></xref></p><p data-class="jrnlSecPara" id="74073995-afe7-4c28-a6cf-b858b478376a">Of the many other systemic biomarkers studied in <named-content id="b13a3c1e-6eef-417b-91ac-da8b1223ddfd" data-cid="b13a3c1e-6eef-417b-91ac-da8b1223ddfd" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="49" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="175_7" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> with COPD, the circulating levels of CC-16, SPD and sRAGE have shown the strongest association between their levels and COPD outcomes.<xref id="645dcc75-d937-4ebf-96dc-f4f028363e55" ref-type="bibr" rid="R15 R30 R31 R32 R33 R34" data-citation-string=" R15 R30 R31 R32 R33 R34 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="193" data-match="15,30-34" data-pattern="" data-tag-index="175_1" data-track-change="15,30-34"><sup id="fc8861c0-8c9a-44e0-9ede-1f4f71fc894f">15 30–34</sup></xref> CC-16 levels have been found to be reduced in <named-content id="c9e825e6-74ae-46bd-97fc-84bd20b4e4a3" data-cid="c9e825e6-74ae-46bd-97fc-84bd20b4e4a3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="249" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="175_8" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> with COPD and are inversely associated with rate of decline of FEV<sub id="688a2144-95b6-4bf7-9d5e-83fb7924361c">1</sub> in some studies.<xref id="12731bb9-f240-4e78-8087-9c0c98ddab4c" ref-type="bibr" rid="R13 R35" data-citation-string=" R13 R35 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="343" data-match="13,35" data-pattern="" data-tag-index="175_2" data-track-change="13,35"><sup id="c23b1614-e062-450c-8b85-fa5cda7a70bc">13 35</sup></xref> The lung-derived protein SPD<named-content data-cid="1555285590" id="25cbb3b0-2006-435c-af27-569ad942be21" content-type="ins cts-3" specific-use="1555290187181" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 9:03am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555290187181">, however,</named-content><named-content data-cid="1555285600" id="960a98cb-baed-47aa-bfe8-0a64096b9ba4" content-type="del cts-3" specific-use="1555290192249" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:03am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555290192249"> on the other hand</named-content> is associated with presence of pulmonary inflammation and is elevated in smokers with or without COPD.<xref id="7615c387-e1d3-442a-b75e-4bdc179774da" ref-type="bibr" rid="R31" data-citation-string=" R31 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="500" data-match="31" data-pattern="" data-tag-index="175_3" data-track-change="31"><sup id="4cedf29d-598e-4763-84d7-1a0d474b6dc5">31</sup></xref> The systemic levels of sRAGE are inversely related to the degree of emphysema as determined by CT scans of the lungs,<xref id="4521403e-74ef-4b1f-b728-3bf9788487e8" ref-type="bibr" rid="R14" data-citation-string=" R14 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="622" data-match="14" data-pattern="" data-tag-index="175_4" data-track-change="14"><sup id="964fd590-dc51-4f40-83d7-8f88c4e3b1a0">14</sup></xref> while GWAS have documented the increased prevalence of single nucleotide polymorphisms associated with the RAGE gene.<xref id="3641ec33-e05e-46c5-90b7-57768fc6fdc2" ref-type="bibr" rid="R15" data-citation-string=" R15 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="744" data-match="15" data-pattern="" data-tag-index="175_5" data-track-change="15"><sup id="53e07fd2-7ff7-41a2-ab6c-901c93bb5df4">15</sup></xref> All of these proteins have been suggested as potential biomarkers of COPD outcomes, but not all of them have been studied simultaneously and prospectively while evaluating the effect of therapy on their levels.</p><p data-class="jrnlSecPara" id="3a715991-a159-4c6b-8069-73bfa307d377">Although statistically significant associations are important for studies and research, the ideal biomarker for the clinician is useful primarily if it helps a single <named-content content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patient' to 'patient'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="167" data-match="patient" data-replace="patient" data-pattern="$1" data-tag-index="176_1" data-function="addTrackChanges" id="3b582e15-2af8-4f01-bcae-1b531ab64a11">patient</named-content>, the one in front of the provider. So if a biomarker is to reach the bedside, it has to have a strong association with an outcome and provide information above and beyond that obtained by good clinical evaluation.</p><title data-level="2" data-class="jrnlHead2" id="fba70e7c-9286-48f1-a229-ce84eb9ed2ad">Current findings</title><p data-class="jrnlSecPara" id="16190045-0ab1-4eb1-b1fa-494673593804">The prospective SUMMIT study provided the opportunity to test the predictive ability of the selected circulating proteins on important respiratory outcomes. To our disappointment, none of the systemic levels of the five circulating proteins studied related to rate of FEV<sub id="c4f28f5a-4f40-499c-8d5a-9404f8af5771">1</sub> decline, exacerbations and hospitalisations (<xref id="da1e9adc-4dbb-477a-b8f0-f783027308b2" ref-type="table" rid="T2" data-citation-string=" T2 " data-mark-cited="T2">table 2</xref>, <named-content data-cid="1555285601" id="5e978fc6-19b4-426d-b6b4-f78bbc8a92ac" content-type="ins cts-3" specific-use="1555290266336" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 9:04am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555290266336">online </named-content>supplementary figures 1<named-content id="c7f25ac1-c352-4967-9933-aef020f780d2" data-cid="c7f25ac1-c352-4967-9933-aef020f780d2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title=" RID2 " data-track-detail="" data-tag-desc="FIGTBLREF" data-tag-type="FIGTBLREF" data-offset="350" data-match="figures 1 and 2" data-pattern="" data-tag-index="177_2" data-citation-string=" RID2 " data-time="" data-username="" data-userid=""> <xref id="757861c5-8269-4f45-97df-23ec95c3dc4d" ref-type="supplementary-material" rid="SP1" data-citation-string=" SP1 ">and</xref> 2</named-content>). Although a true association might have been found if more <named-content id="99197b53-09c4-46fb-9dda-d9de1e697896" data-cid="99197b53-09c4-46fb-9dda-d9de1e697896" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="417" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="177_10" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> had been recruited, this appears unlikely as several of the studies documenting an association between those biomarkers and the outcomes were smaller or similar in size to ours. In addition, it is known that the rate of FEV<sub id="3e8cd7fd-33ff-49bc-bc52-264e6e2af936">1</sub> decline is larger in <named-content id="f967a115-91c7-453c-a451-f7548eef99ca" data-cid="f967a115-91c7-453c-a451-f7548eef99ca" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="672" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="177_11" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> with higher FEV<sub id="94716f83-45c7-4c70-9ebc-2056b6a3f15f">1</sub>,<xref id="b2894673-a3d6-4454-ba49-eedf43666b44" ref-type="bibr" rid="R36" data-citation-string=" R36 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="699" data-match="36" data-pattern="" data-tag-index="177_6" data-track-change="36"><sup id="2407e842-3050-45c5-8e5e-9f3b90b693fc">36</sup></xref> so if there was a relationship between any of the biomarkers selected and lung function decline, these moderately obstructed <named-content id="03849eda-4cc9-494f-b140-b1a50d4358c3" data-cid="03849eda-4cc9-494f-b140-b1a50d4358c3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="828" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="177_12" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> were the most likely individuals to have demonstrated such an association. Furthermore, a biomarker is most useful when it can help clinicians in their practice usually with a single <named-content id="57906a7a-a071-4af0-a976-fd361f2b30a2" data-cid="57906a7a-a071-4af0-a976-fd361f2b30a2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patient' to 'patient'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="1020" data-match="patient" data-replace="patient" data-pattern="$1" data-tag-index="177_13" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patient</named-content>, and certainly, the lack of precision documented in this study renders them of limited use in everyday <named-content id="eebe2557-df68-437a-a64f-ebec417f12a4" data-cid="eebe2557-df68-437a-a64f-ebec417f12a4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patient' to 'patient'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="1131" data-match="patient" data-replace="patient" data-pattern="$1" data-tag-index="177_14" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patient</named-content> care. <named-content data-cid="1555285608" id="12460d82-8727-46f4-8d52-f6dd45fd29c1" content-type="ins cts-3" specific-use="1555290297708" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 9:04am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555290297708">However</named-content><named-content data-cid="1555285615" id="5bbd96e6-887f-408a-945d-9cae663d2f2c" content-type="del cts-3" specific-use="1555290301728" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:05am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555290301728">On the other hand</named-content>, the association observed between systemic levels of CRP and fibrinogen with mortality in this study (<xref id="6361a413-93d0-455f-ad40-3242442499f0" ref-type="fig" rid="F3" data-citation-string=" F3 " data-tag-desc="FIGTBLREF" data-tag-type="FIGTBLREF" data-offset="1265" data-match="figure 3" data-pattern="" data-tag-index="177_3">figure 3</xref>) supports their validity as predictors of risk of death in general and in <named-content id="83559359-7db6-4d16-9269-ae7848e50e76" data-cid="83559359-7db6-4d16-9269-ae7848e50e76" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="1348" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="177_15" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> with heightened <named-content data-cid="1555285741" id="b82917a5-bab6-4601-a780-7e2f6e4c6a35" content-type="del cts-3" specific-use="1555291423997" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:23am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291423997">cardiovascular</named-content><named-content data-cid="1555285742" id="2c4d1cd8-8570-4eb9-90fa-43f0e9cc6384" content-type="ins cts-3" specific-use="1555291424059" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 9:23am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291424059">CV</named-content> risk, as were those included in SUMMIT.<xref id="88d09209-a483-4b11-b052-af52dd98a217" ref-type="bibr" rid="R37 R38" data-citation-string=" R37 R38 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="1428" data-match="37,38" data-pattern="" data-tag-index="177_7" data-track-change="37,38"><sup id="220be7bd-a1ef-4ae1-9dee-cf338b3b5575">37 38</sup></xref> We acknowledge that there were no measurements of these biomarkers during exacerbations, where the changes might identify or grade the severity of these events, as has been suggested before.<xref id="2065bb01-6dcb-4f57-9865-b71378790b6f" ref-type="bibr" rid="R39" data-citation-string=" R39 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="1626" data-match="39" data-pattern="" data-tag-index="177_8" data-track-change="39"><sup id="3640a3ba-650f-4e69-8fc2-2c99850a0e52">39</sup></xref> Importantly, the significant association observed between baseline serum levels of troponin and subsequent risk of <named-content data-cid="1555285744" id="e48d647f-9c15-4f1b-951e-29f2abae5030" content-type="del cts-3" specific-use="1555291425763" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:23am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291425763">cardiovascular</named-content><named-content data-cid="1555285745" id="de6a5c36-60a6-454e-ad99-5f3893d164d2" content-type="ins cts-3" specific-use="1555291425822" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 9:23am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291425822">CV</named-content> events and death in this cohort<xref id="094242db-8716-4123-b266-fcf300c0e215" ref-type="bibr" rid="R17" data-citation-string=" R17 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="1792" data-match="17" data-pattern="" data-tag-index="177_9" data-track-change="17"><sup id="df0de3d7-e03e-4a88-aa9a-7dce839410c4">17</sup></xref> indicates that methodological issues or the study design and completion are unlikely to have influenced the results here reported.</p><p data-class="jrnlSecPara" id="cfb5eb04-2fde-484f-a6cf-1ede5a36c43b">The difference between the negative results in COPD-related outcomes in this study<named-content data-cid="1555285616" id="785b4886-7eb7-42ed-a709-f11df7a2bbe4" content-type="ins cts-3" specific-use="1555290340792" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 9:05am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555290340792">,</named-content> and the positive ones reported by previous authors may relate primarily to the populations included in the different studies.<xref id="90372881-3b8c-4419-a78c-e05ea08cfde1" ref-type="bibr" rid="R6 R7 R8 R11 R12 R13 R14 R15" data-citation-string=" R6 R7 R8 R11 R12 R13 R14 R15 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="209" data-match="6-8,11-15" data-pattern="" data-tag-index="178_1" data-track-change="6-8,11-15"><sup id="21935d8b-7f2f-4981-9c81-8a5f706cd23e">6–8 11–15</sup></xref> Whereas the majority of the positive results came from cohort studies such as ECLIPSE and COPDgene, which included <named-content id="1531f869-3571-4711-9b8a-d03821c4c107" data-cid="1531f869-3571-4711-9b8a-d03821c4c107" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="335" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="178_3" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> with a wider range of lung function impairment, the population included in SUMMIT consisted of <named-content id="752d7c86-3207-43d6-af42-f71f52e9cd70" data-cid="752d7c86-3207-43d6-af42-f71f52e9cd70" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="439" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="178_4" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> with a moderate degree of airflow limitation and heightened <named-content data-cid="1555285747" id="1143bc9c-b461-49c2-b0b9-c260e234a1ae" content-type="del cts-3" specific-use="1555291428952" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:23am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291428952">cardiovascular</named-content><named-content data-cid="1555285748" id="81030329-cb79-4706-aca6-3fc6eddf4fdf" content-type="ins cts-3" specific-use="1555291429019" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 9:23am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291429019">CV</named-content> risk. However, for a biomarker to be useful in clinical practice, it has to help clinicians at any stage of the disease and most of all for <named-content id="3a2d4c8d-5893-4aca-a3a9-b8d243d35b70" data-cid="3a2d4c8d-5893-4aca-a3a9-b8d243d35b70" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="663" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="178_5" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> with milder disease, such as those included in SUMMIT.</p><p data-class="jrnlSecPara" id="29990b40-ebb3-435c-ba29-7ac40cbb0d24">One potential use of biomarkers is their response to therapy specifically directed at the disease in question and if this change was associated to a modification in outcomes. In this study, the relative levels of CC-16 were decreased by the three active treatment arms of the study compared with placebo. The effects were small, likely of little clinical meaning, but nevertheless statistically significant (<xref id="610d4220-404e-4058-a6ae-86ccfa843dc1" ref-type="supplementary-material" rid="SP1" data-citation-string=" SP1 " data-mark-cited="SP1">table S2</xref>). A decrease in CC-16 was not associated with FEV<sub id="a8789668-c5c2-4f80-8ec7-82cd94889549">1</sub> decline in this study, a fact that could have several explanations. First, that CC-16 bears little relation to FEV<sub id="63cd1d8f-49d1-40d0-a68e-411f927d5a13">1</sub> decline, as has been suggested by some studies,<xref id="43ae57dc-c4ee-43d0-9a7e-d2f6146004ff" ref-type="bibr" rid="R12" data-citation-string=" R12 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="632" data-match="12" data-pattern="" data-tag-index="179_2" data-track-change="12"><sup id="f97df3ed-8581-453a-9d3c-8fbecff5524b">12</sup></xref> or second, that the small changes in serum levels of CC-16 carry little biological significance. However, the results do suggest that inhaled therapies may alter systemic levels of cytokines and that if associations with valid outcomes were to be found, one or more cytokines could be used as surrogate markers to evaluate effect of therapy. Interestingly, we found no effect of any of the therapies given in SUMMIT on CRP levels, providing contrast to the findings of an older study that demonstrated reduced CRP levels after the administration of <named-content data-cid="1555285666" id="bce6bae9-434b-4559-829e-87f8ab7e67e6" content-type="del cts-3" specific-use="1555291136312" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:18am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291136312">inhaled corticosteroid</named-content><named-content data-cid="1555285667" id="0de2fca0-1958-4254-8d92-1b16e4f3fb48" content-type="ins cts-3" specific-use="1555291136372" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 9:18am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291136372">ICS</named-content>s.<xref id="77f74e19-8b9a-4973-9fbb-6b8d73dfc6d5" ref-type="bibr" rid="R40" data-citation-string=" R40 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="1210" data-match="40" data-pattern="" data-tag-index="179_3" data-track-change="40"><sup id="bcb88225-e16a-4d86-8036-18a6cf12a918">40</sup></xref> Conversely, however, our findings are in agreement with those of a further study, in which the administration of inhaled tiotropium did not affect inflammatory markers in <named-content id="e48db486-5eaa-4047-a1eb-5ff1dd79f71a" data-cid="e48db486-5eaa-4047-a1eb-5ff1dd79f71a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="1385" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="179_7" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> with COPD.<xref id="fb191278-9b4c-47e7-ac70-39d85459d016" ref-type="bibr" rid="R41" data-citation-string=" R41 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="1405" data-match="41" data-pattern="" data-tag-index="179_4" data-track-change="41"><sup id="ce0c7d4b-176d-4c26-a7a0-830304d433f5">41</sup></xref> Finally, the stability of the selected biomarkers over <named-content id="138ea6dd-e624-482c-bc1b-de0b72606949" data-cid="138ea6dd-e624-482c-bc1b-de0b72606949" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="1464" data-match="3 months" data-replace="3" data-pattern="$1" data-tag-index="179_6" data-time="" data-username="" data-userid="">3</named-content><named-content id="5a756e03-76f4-4929-8b20-5b66441d36c3" data-cid="5a756e03-76f4-4929-8b20-5b66441d36c3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="1465" data-match="3 months" data-replace=" months" data-pattern=" $2" data-tag-index="179_6" data-time="" data-username="" data-userid=""> months</named-content> is consistent with data previously reported in ECLIPSE.<xref id="31165e8a-38be-462d-91ab-72704333bacd" ref-type="bibr" rid="R42" data-citation-string=" R42 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="1529" data-match="42" data-pattern="" data-tag-index="179_5" data-track-change="42"><sup id="5e0cd70e-81a2-4f5e-96e6-ca47fd11f554">42</sup></xref></p><title data-level="2" data-class="jrnlHead2" data-label="true" id="0344cf87-a515-4bec-91a6-f4a402047c83">Strengths and limitations</title><p data-class="jrnlSecPara" id="8a1913dd-81d0-48b1-8ba9-4d9910163de1">The relatively large sample size and multi<named-content data-cid="1555285617" id="eb4e704b-de5d-4ce5-899e-250fce41983f" content-type="del cts-3" specific-use="1555290521766" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:08am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555290521766">-</named-content>centre nature of the study, its careful clinical, functional and biological characterisation<named-content data-cid="1555285618" id="b24e5532-386a-4f5a-94ad-02664d565322" content-type="del cts-3" specific-use="1555290532393" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:08am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555290532393">,</named-content> and its prospective design, follow-up time and clinical adjudicating committee are strengths of this study. However, there were several potential limitations. First, the study had an event-driven design and as such not all <named-content id="8b01f3e6-2d92-4602-927f-b668b4c602e3" data-cid="8b01f3e6-2d92-4602-927f-b668b4c602e3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="360" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="181_5" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> were followed over a period of several years. However, with an average of <named-content id="f4f2c9c3-79c0-4d87-b461-c68f221cce79" data-cid="f4f2c9c3-79c0-4d87-b461-c68f221cce79" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="443" data-match="18 months" data-replace="18" data-pattern="$1" data-tag-index="181_2" data-time="" data-username="" data-userid="">18</named-content><named-content id="a1fc0ce1-a5ec-4973-954a-963a2e452d1c" data-cid="a1fc0ce1-a5ec-4973-954a-963a2e452d1c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="445" data-match="18 months" data-replace=" months" data-pattern=" $2" data-tag-index="181_2" data-time="" data-username="" data-userid=""> months</named-content> of on-treatment observation and of <named-content id="db3d1877-d4c8-47e7-b47b-2bd7b4224160" data-cid="db3d1877-d4c8-47e7-b47b-2bd7b4224160" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="488" data-match="27 months" data-replace="27" data-pattern="$1" data-tag-index="181_3" data-time="" data-username="" data-userid="">27</named-content><named-content id="89396f7a-1c1b-465f-97fd-64d8b0a07f7a" data-cid="89396f7a-1c1b-465f-97fd-64d8b0a07f7a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="490" data-match="27 months" data-replace=" months" data-pattern=" $2" data-tag-index="181_3" data-time="" data-username="" data-userid=""> months</named-content> for mortality, the determination of two biosamples separated by <named-content id="186e8e8f-c5d8-4bb6-b2d9-af41a39e917e" data-cid="186e8e8f-c5d8-4bb6-b2d9-af41a39e917e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="562" data-match="3 months" data-replace="3" data-pattern="$1" data-tag-index="181_4" data-time="" data-username="" data-userid="">3</named-content><named-content id="3bc6fd9b-bd26-4882-aa99-aaf1915bae66" data-cid="3bc6fd9b-bd26-4882-aa99-aaf1915bae66" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="563" data-match="3 months" data-replace=" months" data-pattern=" $2" data-tag-index="181_4" data-time="" data-username="" data-userid=""> months</named-content> and a mean number of 7 spirometric measurements per <named-content id="8a49e0c8-4eb0-48d2-a2dd-be54f1b6b275" data-cid="8a49e0c8-4eb0-48d2-a2dd-be54f1b6b275" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patient' to 'patient'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="623" data-match="patient" data-replace="patient" data-pattern="$1" data-tag-index="181_6" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patient</named-content>, we believe the observation time is sufficient for all of the outcomes selected. <named-content data-cid="1555068417001" id="36afe26c-ec58-4fb6-ba26-15d2be1eadfd" content-type="del cts-1" specific-use="1555068417000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1555068417000">Secondly</named-content><named-content data-cid="1555068417001" id="2dbc5841-1116-411a-91fd-d0ec63b2574c" content-type="ins cts-1" specific-use="1555068417000" xlink:title="Exeter" alt="preediting" data-title="changed from 'Secondly' to 'Second'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="712" data-match="Secondly" data-replace="Second" data-pattern="Second" data-tag-index="181_7" data-function="addTrackChanges" data-track-change="Secondly" data-userid="preediting" data-username="Exeter" data-time="1555068417000">Second</named-content>, the chosen panel of proteins did not include all possible biomarkers that have been suggested.<xref id="d42220a0-330b-48a3-8790-b2776558c9b3" ref-type="bibr" rid="R9 R43" data-citation-string=" R9 R43 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="817" data-match="9,43" data-pattern="" data-tag-index="181_1" data-track-change="9,43"><sup id="d83c8c3d-9879-4d42-b72a-f0b10e9df418">9 43</sup></xref> However, the ones here measured included those that have the strongest support in the literature as being potentially applicable in clinical practice. Third, it could be argued that there was no derivative and validating cohort. However, this is customary for non-validated biomarkers, whereas in this study<named-content data-cid="1555285619" id="a695629b-9651-43e0-a5ee-018c601dd1f9" content-type="ins cts-3" specific-use="1555290566368" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 9:09am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555290566368">,</named-content> we compared validated clinical and serum biomarkers modelled on studies in the respiratory and <named-content data-cid="1555285750" id="b049bafe-05b3-4882-863d-1367c3235fd1" content-type="del cts-3" specific-use="1555291430806" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:23am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291430806">cardiovascular</named-content><named-content data-cid="1555285751" id="b88ec12e-9451-4b95-9207-730b00103f96" content-type="ins cts-3" specific-use="1555291430869" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 9:23am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555291430869">CV</named-content> arena. The main weakness is likely to be the assumption that a few (or possibly only one) biomarkers will be valid for all <named-content data-cid="1555285620" id="60217f43-2c44-4130-8d5e-c73c8b810fba" content-type="ins cts-3" specific-use="1555290573737" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Inserted by Ariel (COPYEDITOR) - Apr 15 2019 9:09am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555290573737">patients with </named-content>COPD<named-content data-cid="1555285634" id="492067c8-35c2-4bc0-99de-b7856521ce7b" content-type="del cts-3" specific-use="1555290577977" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:09am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555290577977"> </named-content><named-content id="8de7fd3b-634f-4cb5-acf0-57e14f993eff" data-cid="8de7fd3b-634f-4cb5-acf0-57e14f993eff" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="1369" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="181_8" data-function="addTrackChanges" data-time="" data-username="" data-userid=""><named-content data-cid="1555285634" id="f4056c34-858f-4f56-a3a6-832e762bce89" content-type="del cts-3" specific-use="1555290577977" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:09am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555290577977">patients</named-content></named-content>. Given the heterogeneity of the disease this is unlikely; however, we currently are unable to identify subgroups where specific biomarkers would be of particular value.</p><title data-level="2" data-class="jrnlHead2" id="ca0c20ec-5d92-4964-9515-a8a815a2f2bc">Conclusions</title><p data-class="jrnlSecPara" id="6642881e-873b-4e8e-ba2f-43da956e5f5e">In this <named-content id="b6e12b88-9e92-41d9-920c-c4fda9e2bef9" data-cid="b6e12b88-9e92-41d9-920c-c4fda9e2bef9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="HYPPRE" data-track-detail="" data-tag-desc="HYPPRE" data-tag-type="HYPPRE" data-offset="8" data-match="sub-" data-pattern="" data-tag-index="182_4" data-time="" data-username="" data-userid="">sub<named-content data-cid="1555285635" id="4d6c7087-b3de-4659-aee4-56a720caeb2a" content-type="del cts-3" specific-use="1555290582948" xlink:title="Ariel (COPYEDITOR)" alt="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-title="Deleted by Ariel (COPYEDITOR) - Apr 15 2019 9:09am" data-track-detail="" data-userid="copyeditor ace01f7e-08ea-4456-a6ce-6e4a5b322a0c" data-username="Ariel (COPYEDITOR)" data-time="1555290582948">-</named-content></named-content>study of the SUMMIT trial of <named-content id="484e5e24-a1d2-48dd-ada2-3c38801ccd9c" data-cid="484e5e24-a1d2-48dd-ada2-3c38801ccd9c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="41" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="182_2" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> with moderate COPD, the serum level of CC-16, sRAGE and SPD or their changes over <named-content id="79de5b5e-9a81-499a-b481-1a1217eeef0c" data-cid="79de5b5e-9a81-499a-b481-1a1217eeef0c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="132" data-match="3 months" data-replace="3" data-pattern="$1" data-tag-index="182_1" data-time="" data-username="" data-userid="">3</named-content><named-content id="6350c9b9-ac83-448a-959c-7e8074704747" data-cid="6350c9b9-ac83-448a-959c-7e8074704747" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="133" data-match="3 months" data-replace=" months" data-pattern=" $2" data-tag-index="182_1" data-time="" data-username="" data-userid=""> months</named-content> were not predictive of rate of lung function decline and risk of exacerbations or hospitalisations. Although systemic levels of CRP and fibrinogen were associated with increased mortality risk, the levels were not associated with rate of FEV<sub id="bb66cec3-285b-4e1a-954a-2b09f045a0ca">1</sub> decline, exacerbations or hospitalisations. These results cast some doubts about the clinical usefulness of the systemic levels of CC-16, sRAGE and SPD as surrogate markers of disease in <named-content id="eb4d5fb2-fa58-4ed5-b129-b19cfa38ee68" data-cid="eb4d5fb2-fa58-4ed5-b129-b19cfa38ee68" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="571" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="182_3" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> with moderate COPD.</p></body><back data-edited="true" data-edited-version="2" id="8835654b-e60f-4c95-8bd7-702bdffedd34"><ack section="." node-xpath="back" next-xpath="ref-list" fn-type="acknowledgements" data-label="Acknowledgement" id="71a07ef3-25da-4ea0-8107-2f61444b0f79" data-edited-node="true"><title data-class="label" data-level="1" id="5bcf9c75-6f66-4b62-b72c-80afb665f652">Acknowledgements</title><p id="3aee00d6-b908-43ce-a436-df7523759496">Editorial assistance was provided by Matthew Hallam, MSc, and Carol A Richter, PhD, at Gardiner-Caldwell Communications (Macclesfield) and was funded by GlaxoSmithKline plc.</p></ack><ref-list section="back" node-xpath="back" id="71891397-36dc-4851-90fe-b76f4a750219"><title data-level="1" id="8d299cb1-0103-40bb-9ffe-9294454b722d">References</title><ref data-class="jrnlRefText" seqid="R1" id="R1" data-id="R1" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R1" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/26494423" data-doi="10.1111/resp.12660" data-validated="true"><label id="1f737e58-8284-4a82-b92e-e29b459f85c4">1.</label><element-citation publication-type="journal" id="0007a6b8-b2fa-4884-9735-e031027a9bb9"><person-group person-group-type="author" id="9ee3c2de-81e3-470d-b550-389cca226ddd"><name id="b6f4e8f4-b6f2-4d47-9da3-98dc0b219130"><surname id="4581280d-405c-4c44-8114-d732cdaf8996"><named-content data-cid="1555068439002" content-type="del cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="5a6ba76b-b7ee-4309-9b47-32947e4a5a0d">Lopez</named-content><named-content data-cid="1555068439002" content-type="ins cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="6c353dfd-9451-4985-bf21-7445cc8692fc">López</named-content>-Campos</surname> <given-names id="2aef90a5-11ff-4cd4-83c9-548512ac8211">JL</given-names></name><x>, </x><name id="47466921-02c2-45fa-9d95-f82dc6efd258"><surname id="da9eb373-cf30-41bc-b1a2-648ca79b357c">Tan</surname> <given-names id="0a32cb95-e744-4875-8769-bfeca0b586fb">W</given-names></name><x>, </x><name id="2dc00221-173d-4558-9035-783364e90775"><surname id="3e3546aa-528b-4456-ba67-da9d996b0016">Soriano</surname> <given-names id="7d12dc95-6ded-422a-9496-61346e6e7f4a">JB</given-names></name></person-group><x>. </x><article-title id="90656d10-84fd-47da-a0c8-46108b9c45b5">Global burden of COPD</article-title><x>. </x><source id="cf1a42e7-3c4b-4d24-8af2-f24687e7e104">Respirology</source><x> </x><year id="4b3ac9b8-089e-4c48-9315-ab56ca0a3a57">2016</year><x>;</x><volume id="89dd8315-3362-45d1-b686-f5a83f70b580">21</volume><x>:</x><fpage id="1cde5f98-aa67-4709-b1bf-9622b0a4a1db">14</fpage><x>–</x><lpage id="9294aa37-843d-471f-92ed-dd9410a928de">23</lpage><x>.</x><pub-id pub-id-type="doi" id="3cae4721-c3a2-427a-b135-795edc68efbc">10.1111/resp.12660</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R2" id="R2" data-id="R2" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R2" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/25830527" data-doi="10.1164/rccm.201501-0044ST" data-validated="true"><label id="1021fb1d-b855-4e27-95e2-87cd2b22aad9">2.</label><element-citation publication-type="journal" id="2619d8fd-7952-4c47-829a-9168f58c46ed"><person-group person-group-type="author" id="fb82c288-7be7-4ba8-86b4-5e7e5ecb2bca"><name id="73a276d6-060d-487f-9d3c-d03e382d4227"><surname id="932a6c34-15ae-41f9-9c3f-fd889f35201d">Celli</surname> <given-names id="b90941b0-3d71-48d4-b930-04e177fa0056">BR</given-names></name><x>, </x><name id="79e4a5dc-cf41-44c9-a698-fa7d59ef5323"><surname id="9c4575a7-e04b-491c-8b8a-d7eddb7a0005">Decramer</surname> <given-names id="d7ff436b-c9c3-4768-b921-d1d7f5c52eb5">M</given-names></name><x>, </x><name id="7a9be831-4767-4df1-bc47-fe32c4f62bc3"><surname id="87bc26cd-5cec-4d66-bc1b-a09ad2474e27">Wedzicha</surname> <given-names id="c7ad6550-1d86-4062-b3c7-4177aa4634bb">JA</given-names></name><x>, </x><etal data-class="RefEtal" id="75184903-03f6-4a2c-8b19-6fd8b7d8bc8d">et al</etal></person-group><x>. </x><article-title id="cfe83b48-eee2-4475-959d-e516660121dd">An official American <named-content data-cid="1555068439003" content-type="del cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="ac0128a2-a972-42fb-9b01-b834f6d48460">Thoracic</named-content><named-content data-cid="1555068439003" content-type="ins cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="02124408-9c0a-4cb5-bd7f-1b4731128a0f">thoracic</named-content> Society/European Respiratory Society statement: research questions in chronic obstructive pulmonary disease</article-title><x>. </x><source id="bdeda812-094a-4abc-861a-a28648e5d7f5">Am J Respir Crit Care Med</source><x> </x><year id="6c809916-8f1b-4d9f-a5f3-fab9254eed1b">2015</year><x>;</x><volume id="be9955d3-673d-42a4-98ae-229ed02f0fc5">191</volume><x>:</x><fpage id="5bb3aa9a-76f3-4bc0-901d-903a02b31aab">e4</fpage><x>–</x><lpage id="a20b1f9e-7851-424d-8666-4c136751653a">27</lpage><x>.</x><pub-id pub-id-type="doi" id="36a9238e-6565-47c1-9391-dff5c9a8e774">10.1164/rccm.201501-0044ST</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R3" id="R3" data-id="R3" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R3" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/21169466" data-doi="10.1164/rccm.201009-1414PP" data-validated="true"><label id="dd91201e-3f15-4f53-bda1-8052258321b6">3.</label><element-citation publication-type="journal" id="b3abe5c3-7902-44ee-bc8e-fa25d71652c9"><person-group person-group-type="author" id="04bf0e45-412b-4ceb-8f68-1f77d90c91de"><name id="1b8f42d4-3b2c-49f3-b5d2-df155c1ec6e7"><surname id="18bf27f0-b255-4704-b435-f1dbeb36221b">Agusti</surname> <given-names id="0a0bb3da-3cc1-4dc7-a376-5fecb77ca437">A</given-names></name><x>, </x><name id="a4070875-8fa3-4ae9-b2e0-2d9f4cf487e1"><surname id="506f035d-8a30-412c-bbab-1747c2573180">Sobradillo</surname> <given-names id="a90de1f3-7f3f-44bd-bfe3-c3a2c9dbb6fe">P</given-names></name><x>, </x><name id="7c716422-1bb1-457c-ad11-ba9cb557340e"><surname id="1ce260c5-30f7-4b94-a643-0a2b7841362f">Celli</surname> <given-names id="8ce7cd9c-40ec-4db5-bbf0-ca9b89644fc3">B</given-names></name></person-group><x>. </x><article-title id="46786e61-dfbc-4c9a-9395-c397f65b9079">Addressing the complexity of chronic obstructive pulmonary disease: from phenotypes and biomarkers to scale-free networks, systems biology, and P4 medicine</article-title><x>. </x><source id="a4ed08a1-db5b-4e59-bc69-7791bb213ac3">Am J Respir Crit Care Med</source><x> </x><year id="c58d7178-dcd7-4c30-bdbd-b9e46a19a150">2011</year><x>;</x><volume id="fccb15be-f892-4e03-8b8f-e7fd08d9bfc8">183</volume><x>:</x><fpage id="701dfe35-dd92-41de-80b9-5c6361a2a9a7">1129</fpage><x>–</x><lpage id="3b2dad19-4db3-4acc-8f2e-d11e067de061">37</lpage><x>.</x><pub-id pub-id-type="doi" id="02369f7b-9129-4bd2-b63a-0b13970bfd8c">10.1164/rccm.201009-1414PP</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R4" id="R4" data-id="R4" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R4" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/18799503" data-doi="10.1183/09031936.00153207" data-validated="true"><label id="3a8f271c-d59c-48f5-9fac-3b0d9950ef6a">4.</label><element-citation publication-type="journal" id="3aafcf7a-642a-4f6a-8eab-8b778d451eb0"><person-group person-group-type="author" id="78b62902-575e-4d0b-bec3-9a6fe4dc4525"><name id="f7fc4f0d-5877-49a4-97c9-d2260fb12b7c"><surname id="570c4fe1-1f7e-44e7-a5d9-e2b0ab78e71e">Man</surname> <given-names id="18c7e586-0fb5-42e7-82b6-10f2590a2612"><named-content data-cid="1555068439004" content-type="del cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="2f59c3c5-5d95-4839-876e-f1407f8ed06c">SF</named-content><named-content data-cid="1555068439004" content-type="ins cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="cfbbb3ba-2592-45a4-b842-8820e89d4857">SFP</named-content></given-names></name><x>, </x><name id="6a60d458-fdb6-42c1-a6c2-829c0537718e"><surname id="c7b4ef53-4ae1-4762-98ba-5fefcae811e6">Xing</surname> <given-names id="9ba48fd2-edae-4c85-86cf-6aedf3bd341e">L</given-names></name><x>, </x><name id="c0275944-befa-4852-a925-4db1dfb7a34e"><surname id="01abb9cb-bdd2-4b60-a03d-b54e3b4efe04">Connett</surname> <given-names id="8cbea413-a1d3-46b4-bd56-4a6f5010e533">JE</given-names></name><x>, </x><etal data-class="RefEtal" id="8aa84895-8f6d-46ce-94a6-88dafc74cfcc">et al</etal></person-group><x>. </x><article-title id="ff703f99-9403-4551-8ac9-4563ce1d85a1">Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD?</article-title><x> </x><source id="6629baa4-5e41-431f-b2f6-938415d66b80">Eur Respir J</source><x> </x><year id="23c8f337-93cd-4e46-88b1-784b50acd922">2008</year><x>;</x><volume id="c77e1c3e-5dfe-428f-a652-4468573cafae">32</volume><x>:</x><fpage id="be1537b7-5915-48e2-9256-5f795c822bac">1451</fpage><x>–</x><lpage id="39698397-df86-482c-9329-911d98ac9cab">7</lpage><x>.</x><pub-id pub-id-type="doi" id="c9c43f92-371c-4e8b-ae7a-26e6a072b799">10.1183/09031936.00153207</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R5" id="R5" data-id="R5" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R5" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/22624038" data-doi="10.1371/journal.pone.0037483" data-validated="true"><label id="6931801d-17a3-4523-b007-73ec94603b5e">5.</label><element-citation publication-type="journal" id="c8509292-609d-4689-99e6-0b9472e6f093"><person-group person-group-type="author" id="925e251c-a3b2-48b7-9556-a0c23169a38a"><name id="a1cf0a67-9bb0-4225-8d40-cee12e8090e5"><surname id="6e5c9b49-4be8-47d6-be2c-7c8b8ec54549"><named-content data-cid="1555068439005" content-type="del cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R91" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="ca8e86a9-10a4-428b-b818-8c65d3ab90b3">Agusti</named-content><named-content data-cid="1555068439005" content-type="ins cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R91" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="9f4246d1-9662-4fc1-a26d-011a8173a86e">Agustí</named-content></surname> <given-names id="ffb8da00-c57c-441f-acb4-04b99823dbc5">A</given-names></name><x>, </x><name id="e5af86fc-b728-47f6-b1c7-eb154a12f58b"><surname id="3c01e299-b645-4a7f-a777-7d5c04e1c866">Edwards</surname> <given-names id="63040da6-9e8b-4faf-baa4-8a863bf8e187">LD</given-names></name><x>, </x><name id="7d20eb71-b1a9-441d-9dcd-4b552c7c0949"><surname id="d963c707-8ad0-4e66-8d9f-4fc84ed29990">Rennard</surname> <given-names id="008fbd26-6c1a-4d56-93d3-a59c404ed7ca">SI</given-names></name><x>, </x><etal data-class="RefEtal" id="a52e79ca-6630-411f-9c53-6559b2aa029b">et al</etal></person-group><x>. </x><article-title id="580e7a6c-58ed-474e-8128-ed31a99dab2d">Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype</article-title><x>. </x><source id="d68361b2-d23a-48f6-a435-a732589f8b60">PLoS One</source><x> </x><year id="f4c85432-e3e7-4f11-b234-af919a399527">2012</year><x>;</x><volume id="b06098ea-c05e-4aa1-b930-7b1129ac5107">7</volume><x>:</x><elocation-id id="93e9aa08-8954-4e21-8638-f48293716b59">e37483</elocation-id><x>.</x><pub-id pub-id-type="doi" id="5e5a0f05-7886-4527-b4d0-b94ab1bbe929">10.1371/journal.pone.0037483</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R6" id="R6" data-id="R6" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R6" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/17053205" data-doi="10.1164/rccm.200605-713OC" data-validated="true"><label id="a93a3820-106f-4265-b112-5be7310e6400">6.</label><element-citation publication-type="journal" id="c963c8f1-f98e-4877-87e5-23ac9ed48dd9"><person-group person-group-type="author" id="9b104fb3-079b-4c0c-ba2a-e015dcecf09c"><name id="ad4a5c50-d162-4582-85d6-518a165fd040"><surname id="9115652d-3caf-419c-accf-d30694d1763d">Dahl</surname> <given-names id="96bf0a16-071c-4941-9fea-d314e91bc2a4">M</given-names></name><x>, </x><name id="fd25dee8-4c04-4960-a70c-c8b4fbb703f7"><surname id="84ad3c0d-da2e-4102-893d-93af9e0ecd66">Vestbo</surname> <given-names id="b5ad5b22-af9f-4650-8d63-7cdc1402aece">J</given-names></name><x>, </x><name id="99417ef6-f589-4c6c-8e37-89387b9f2036"><surname id="2b36b56c-9abb-4c64-aaf8-02fb42bc490a">Lange</surname> <given-names id="db874cb6-8be6-4d43-999f-d9f04cbb56f4">P</given-names></name><x>, </x><etal data-class="RefEtal" id="32426540-9d52-45f8-8204-7a559adcc2fb">et al</etal></person-group><x>. </x><article-title id="33e86442-6a3d-41ec-a366-d469ddf8f903">C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease</article-title><x>. </x><source id="c1c5ee86-2e88-4285-a14a-07fe1562b959">Am J Respir Crit Care Med</source><x> </x><year id="57166807-a264-4606-9309-bd5991a93d88">2007</year><x>;</x><volume id="63711612-fefb-43ca-bae1-a09fe764ca98">175</volume><x>:</x><fpage id="b0f85c04-db0d-4c97-971d-03890490da72">250</fpage><x>–</x><lpage id="f5ba46bc-865d-41d1-8396-20668bda1b98">5</lpage><x>.</x><pub-id pub-id-type="doi" id="bc3920c0-6ea7-43b0-8c2c-7bc3ba83be1e">10.1164/rccm.200605-713OC</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R7" id="R7" data-id="R7" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R7" data-validated="true"><label id="a256d5cb-149e-431e-b093-63c738cff7dd">7.</label><element-citation publication-type="journal" id="d51079a2-6bb6-46ba-99a8-68d6a0733873"><person-group person-group-type="author" id="e24a5638-4329-4c49-a99f-716db1cae576"><name id="7e892247-88c0-4af7-b36c-2b4237da6804"><surname id="1139af66-5f9e-4766-9a1e-466fd312b1ca">Miller</surname> <given-names id="54cbf46d-6851-4831-86ea-303209cb2490">BE</given-names></name><x>, </x><name id="e8a3fb91-ff10-42c1-957b-b939fa2cac79"><surname id="13301fa2-0855-4612-827e-ad792cdce791">Tal-Singer</surname> <given-names id="115e8346-5e1b-4894-93a0-7769eb57d1b5">R</given-names></name><x>, </x><name id="98ecb22c-4993-4d6a-8496-f25a895b1673"><surname id="ea60747a-39b1-4d34-884b-485a52a7b573">Rennard</surname> <given-names id="85900d1b-8fd4-401d-a30d-73aa719d2f04">SI</given-names></name><x>, </x><etal data-class="RefEtal" id="7eaf6602-c05e-450f-899c-8ef7dad14f50">et al</etal></person-group><x>. </x><article-title id="c164d85c-d873-4433-8bf9-d93c1191dba3">Plasma fibrinogen qualification as a drug development tool in COPD: perspective of the COPD <named-content data-cid="1555068439006" content-type="del cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="97b001ba-a873-4c8c-8031-9d685e8e54d9">Biomarker</named-content><named-content data-cid="1555068439006" content-type="ins cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="213df536-f852-4084-b564-1bc93b598c39">biomarker</named-content> <named-content data-cid="1555068439007" content-type="del cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R102" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="5029f103-c853-4cc2-b864-dedf72a32199">Qualification</named-content><named-content data-cid="1555068439007" content-type="ins cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R102" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="c4c7dfa0-a2ec-4dca-bcdf-16ca37d43ab5">qualification</named-content> Consortium</article-title><x>. </x><source id="ebe918d5-308a-41bc-9d30-08d3ec34a0e4">Am J Respir Crit Care Med</source><x> </x><year id="07fdb511-eca5-40a5-8be2-2234faa8221c">2016</year><x>;</x><volume id="9e00a62c-6a4c-4ab1-bb2e-10a427b919bc">193</volume><x>:</x><fpage id="7fa98e71-91d4-4f06-ae44-fde6d8e73539">607</fpage><x>–</x><lpage id="a7ea335e-c0dc-4182-8024-765d2b25af7e">13</lpage><x>.</x></element-citation></ref><ref data-class="jrnlRefText" seqid="R8" id="R8" data-id="R8" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R8" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/22427534" data-doi="10.1164/rccm.201110-1792OC" data-validated="true"><label id="af55b325-dad8-48c4-b995-ad45817af99d">8.</label><element-citation publication-type="journal" id="05b916f1-bcda-4ef7-bfd0-7805c138c33e"><person-group person-group-type="author" id="65637bb3-c084-4f33-b976-a31128b9c87a"><name id="fa07176e-34ab-43dc-8d59-de65349f56fe"><surname id="d9e14893-f1ce-4de2-ab0f-0a7ab1b9ab85">Celli</surname> <given-names id="0a7e4a9b-35fb-4d03-aba6-af8047879507">BR</given-names></name><x>, </x><name id="52104bca-02bf-4b2f-b543-bdf1fb24e396"><surname id="5dfed25f-0cca-43d6-adbe-2d7cad235bbf">Locantore</surname> <given-names id="c858a882-6544-44e7-b3e6-d52e9f30be20">N</given-names></name><x>, </x><name id="bd067414-a437-49cc-92a2-9f16107b91ce"><surname id="c6a7dc98-cf4a-4e2c-9af6-8dafc94730ab">Yates</surname> <given-names id="cec598ed-ce76-4f84-ba92-d722240470e8">J</given-names></name><x>, </x><etal data-class="RefEtal" id="7f8365ff-711b-4f02-ade0-f4f4f634d645">et al</etal></person-group><x>. </x><article-title id="a599b6ce-accc-405d-bf5b-1784de251409">Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease</article-title><x>. </x><source id="bc8b8e46-633e-41c8-9ce7-94b21d747da5">Am J Respir Crit Care Med</source><x> </x><year id="32add2c3-b839-43a4-919c-37a1fafe2ce0">2012</year><x>;</x><volume id="2a14b948-08e1-49a2-9908-c8e19af96e33">185</volume><x>:</x><fpage id="fb2f67a4-f246-43f1-b3bc-75d7c7738e50">1065</fpage><x>–</x><lpage id="058179c9-928e-4b0f-9647-6a7512c069f0">72</lpage><x>.</x><pub-id pub-id-type="doi" id="ba7730aa-4542-4626-bcee-d39b21c68bb2">10.1164/rccm.201110-1792OC</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R9" id="R9" data-id="R9" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R9" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/23256717" data-doi="10.2174/1389450111314020005" data-validated="true"><label id="282cd8af-d7b4-4574-8ca8-e73b947dfe2a">9.</label><element-citation publication-type="journal" id="cb407546-217a-448f-89c3-431423fc54b0"><person-group person-group-type="author" id="103185db-03e6-4033-9914-33d49cd3c2fd"><name id="e26263c0-2e5c-4a3b-abe2-9fb679686763"><surname id="f2ce09a7-9a7b-4171-b9ee-d60b40da1d7b">Kostikas</surname> <given-names id="e1011cb6-4ab8-4f68-8e3d-946a0156c1db">K</given-names></name><x>, </x><name id="62599193-4b66-465c-a971-b0bd239c8719"><surname id="2d0e8300-072d-4c24-b934-1a1af5a9d98e">Bakakos</surname> <given-names id="0cc11b29-859f-47ff-a50f-9bac7f2c86f5">P</given-names></name><x>, </x><name id="f6697197-8007-4d7e-9e2a-93620dda9f1a"><surname id="4a7e831d-219a-4781-874b-381d53df807c">Papiris</surname> <given-names id="7b1ae6f4-26cb-47e3-8a02-bac47138488e">S</given-names></name><x>, </x><etal data-class="RefEtal" id="b68bc70d-fbe7-46ad-b8b8-245c7b56c179">et al</etal></person-group><x>. </x><article-title id="1a9adbe6-9232-463e-92fb-424d0692ce4b">Systemic biomarkers in the evaluation and management of COPD patients: are we getting closer to clinical application?</article-title><x> </x><source id="98f29d01-ea7b-48ea-813e-dbfc38820e0e">Curr Drug Targets</source><x> </x><year id="a18ccdd5-8715-470f-8bcd-5d675f2e789f">2013</year><x>;</x><volume id="d29b7782-1f96-4493-9723-523af04fff43">14</volume><x>:</x><fpage id="cd0d69a9-2850-47f2-80a4-436fb5251fbc">177</fpage><x>–</x><lpage id="53a95983-5ba1-4f8d-a302-a4b49289bade">91</lpage><x>.</x><pub-id pub-id-type="doi" id="48e1f40f-2282-45ed-bc7b-df691120193f">10.2174/1389450111314020005</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R10" id="R10" data-id="R10" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R10" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/16556692" data-doi="10.1164/rccm.200510-1659PP" data-validated="true"><label id="2fe79e5a-534b-4e8d-95c8-f02ec3f89f73">10.</label><element-citation publication-type="journal" id="2b706671-689c-498e-9a9c-3e9a4997271d"><person-group person-group-type="author" id="b3334cfc-73b0-49c5-b79b-3799d74b28fd"><name id="bcc764ce-7e86-4419-aa5b-fd541c1942d0"><surname id="5c863adf-6030-44ce-a968-084efde77902">Barnes</surname> <given-names id="ce7132db-f870-4b14-992b-3c314a8e7fc9">PJ</given-names></name><x>, </x><name id="dd914412-ecf2-410a-927f-a052cb9a16f0"><surname id="c9dc4d6f-8005-46da-8311-90c7bae6c60d">Chowdhury</surname> <given-names id="8314b8f4-c67f-4174-929e-096e33956eb6">B</given-names></name><x>, </x><name id="956f35b5-7f8d-4be8-b79b-2a1cd1c262ed"><surname id="703ec10a-d64c-49a8-a3df-ff8570d4b0d0">Kharitonov</surname> <given-names id="6988c491-19f0-4e00-95e4-07b42311c1a0">SA</given-names></name><x>, </x><etal data-class="RefEtal" id="1de982f7-1571-4eca-b1bf-516139dac682">et al</etal></person-group><x>. </x><article-title id="42866b3c-33c2-4295-8ce5-257dc580b7dd">Pulmonary biomarkers in chronic obstructive pulmonary disease</article-title><x>. </x><source id="8161716e-e961-4276-9db5-3c483df1b26f">Am J Respir Crit Care Med</source><x> </x><year id="8dfb6dc7-441e-401c-bf94-3936e646d516">2006</year><x>;</x><volume id="991a398b-b928-4430-b1e7-a077bc6c3333">174</volume><x>:</x><fpage id="d0f1f3be-5030-4594-8c4d-8c06a25dd460">6</fpage><x>–</x><lpage id="c3c59767-03f0-4d9a-8a47-2cb1142c0dac">14</lpage><x>.</x><pub-id pub-id-type="doi" id="2eb72349-6760-4325-bc34-521fcf546a63">10.1164/rccm.200510-1659PP</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R11" id="R11" data-id="R11" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R11" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/21991892" data-doi="10.1056/NEJMoa1105482" data-validated="true"><label id="66a66da8-33fe-4d17-a892-059d83958b3a">11.</label><element-citation publication-type="journal" id="bb5af3aa-e82b-4949-8033-94a47d88f4e5"><person-group person-group-type="author" id="3988104d-008a-47f4-a380-5b81a7467b38"><name id="403735b4-2e23-4e9d-9939-012356313e63"><surname id="b4e65805-d41a-4f09-bae6-943a369726eb">Vestbo</surname> <given-names id="7acf617b-098b-4c29-863e-1240baf7c3dd">J</given-names></name><x>, </x><name id="240fe80e-8140-47b0-bd31-e9515ccc28bf"><surname id="b5ebeaef-081d-4fe1-bea7-a5ca0a6fa591">Edwards</surname> <given-names id="ad02ea49-1efe-4ec8-91fb-16eef5eb7a3c">LD</given-names></name><x>, </x><name id="e2eb1a12-1d92-4834-be88-ab6a71198a0f"><surname id="41d0276e-2b55-4b4e-a2b6-d6c50c997fc6">Scanlon</surname> <given-names id="c6c6636e-b549-4f63-82f4-d33182fb4f45">PD</given-names></name><x>, </x><etal data-class="RefEtal" id="e5a19ed2-b04f-49dc-97bd-df6d314e5bab">et al</etal></person-group><x>. </x><article-title id="5995ccbc-4dc0-4dfb-9cfb-c330d9a29b80">Changes in forced expiratory volume in 1 second over time in COPD</article-title><x>. </x><source id="ae90dc22-4a5c-41d0-9716-93b77d19e7d8">N Engl J Med</source><x> </x><year id="cd223ce3-13a1-4856-95b5-ba294da6d3ed">2011</year><x>;</x><volume id="2b52e0ad-19d3-42d1-b3ab-b953b3af7d3f">365</volume><x>:</x><fpage id="86767b57-0e2a-49c0-88a1-a3964af2ce19">1184</fpage><x>–</x><lpage id="1e3c200e-a718-4d1b-9e43-a03ee87f14df">92</lpage><x>.</x><pub-id pub-id-type="doi" id="7dfd8970-6a54-4050-bfb7-3641a17324e2">10.1056/NEJMoa1105482</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R12" id="R12" data-id="R12" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R12" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/24245748" data-doi="10.1164/rccm.201305-0892OC" data-validated="true"><label id="f96ce0b0-06d8-4fc1-b751-730f9213c28f">12.</label><element-citation publication-type="journal" id="90f26929-691c-4392-94ef-c918706d1dcb"><person-group person-group-type="author" id="f69700a1-2b46-443e-993e-32ea17cb8a29"><name id="9e44db77-8afb-49d3-b8c9-1ff5248aa06b"><surname id="653393eb-b050-4c95-8d20-f9c9b4be4334">Park</surname> <given-names id="55cb6ac7-1baa-49d5-b69a-fb5a03363ec8">HY</given-names></name><x>, </x><name id="f8f6e5c3-dafb-4c22-931f-4dc3882c47cb"><surname id="cd899a36-aa03-4298-9eaa-f4e1d00cdf94">Churg</surname> <given-names id="7a65b2b9-869a-4ead-bc18-e994d01e2693">A</given-names></name><x>, </x><name id="3d8d7f5c-b7f9-4349-be47-f6b997f23583"><surname id="49fd198d-9c0e-4059-bcdd-c769b96f0c78">Wright</surname> <given-names id="3298d3d7-17e9-4161-b6c8-384348c6d704">JL</given-names></name><x>, </x><etal data-class="RefEtal" id="1a4bf632-e55f-4440-b941-4ac81bc42b5e">et al</etal></person-group><x>. </x><article-title id="e8cdade3-dbba-4d9c-bc22-22765cf92329">Club cell protein 16 and disease progression in chronic obstructive pulmonary disease</article-title><x>. </x><source id="31ec2585-a05b-467f-b0fd-2ee55f4e40e0">Am J Respir Crit Care Med</source><x> </x><year id="009b8831-462c-467d-ad90-58606149da31">2013</year><x>;</x><volume id="c5184814-7c16-4754-9d0a-a646936d4e11">188</volume><x>:</x><fpage id="ad8c54f9-1c04-4372-a962-830e98ab15b6">1413</fpage><x>–</x><lpage id="3b1caae5-7445-4cd2-84b6-14417a85bdf7">9</lpage><x>.</x><pub-id pub-id-type="doi" id="33e56744-adff-483d-b584-6fd0cf95cf77">10.1164/rccm.201305-0892OC</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R13" id="R13" data-id="R13" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R13" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/26160869" data-doi="10.1183/13993003.00682-2015" data-validated="true"><label id="5cb28513-f34a-4bc7-af37-a6aee4694fbc">13.</label><element-citation publication-type="journal" id="7731fe8c-364b-4e5a-9a88-c6fb74e2232e"><person-group person-group-type="author" id="a1199f88-d413-4dc4-80ae-c196695823eb"><name id="e4c2cd67-8787-41ed-b745-3428236a4f67"><surname id="403e31c5-d509-4ca7-8168-7556d6f21a3b">Petersen</surname> <given-names id="650adea0-8d65-4173-a5bd-24fe67ba8014">H</given-names></name><x>, </x><name id="43560f05-1194-45e3-bb31-89dc0f0af752"><surname id="9dd6a84c-bc7a-43ec-8ea4-e810f473063d">Leng</surname> <given-names id="8174ca42-6b6e-4742-9589-1bc39cfc0b32">S</given-names></name><x>, </x><name id="87a7fbf0-d19f-47eb-9596-729794a82009"><surname id="e8d3a705-4b08-4436-9463-c6bfab3d7853">Belinsky</surname> <given-names id="fd1c1686-9837-4b65-9863-8036c682cd73">SA</given-names></name><x>, </x><etal data-class="RefEtal" id="fb96ca3b-4c9b-4659-8590-dbe02074bd61">et al</etal></person-group><x>. </x><article-title id="ec38512d-0afd-4d7f-be6c-bd737be338fb">Low plasma CC16 levels in smokers are associated with a higher risk for chronic bronchitis</article-title><x>. </x><source id="85961671-5b0e-46f0-a1ba-650545cef59c">Eur Respir J</source><x> </x><year id="1b544b1c-ce1a-4a60-a68f-76d269e55521">2015</year><x>;</x><volume id="ed73974a-3497-424b-8771-070ca0f25c5e">46</volume><x>:</x><fpage id="cf5f552f-075d-49f5-8c25-71ceb5f0deed">1501</fpage><x>–</x><lpage id="8265f5b8-591f-456b-a34c-e821ea56c1fc">3</lpage><x>.</x><pub-id pub-id-type="doi" id="2cf27ad7-000f-4ec5-867f-17e0f0563c35">10.1183/13993003.00682-2015</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R14" id="R14" data-id="R14" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R14" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/24429093" data-doi="10.1016/S2213-2600(13)70006-7" data-validated="true"><label id="dac20222-0bd8-4e7a-8276-15526d85d4b4">14.</label><element-citation publication-type="journal" id="38c40ef8-f7d9-4134-b144-510ad3b5c8a6"><person-group person-group-type="author" id="e77f3e97-f7a8-40e4-8847-f2a34340619e"><name id="4774f7ab-e775-4c1c-9e87-2be82a63b4ba"><surname id="c6ec1a6f-ab84-452c-8fbd-a8b0b6ad0931">Coxson</surname> <given-names id="a6e073f3-77e7-4d1e-a112-2a0bc1dece68">HO</given-names></name><x>, </x><name id="aa9fa465-dc56-4d16-9332-0efcb8a791b6"><surname id="ac6b8c9b-5d26-4415-a224-430766f1e600">Dirksen</surname> <given-names id="408431cd-c310-4e7f-b622-c54b9860b874">A</given-names></name><x>, </x><name id="32c984f1-7f1a-418a-b14d-cd66f3b2b448"><surname id="ad7b49a1-09d4-4d3d-9514-849252106823">Edwards</surname> <given-names id="ac851ad6-3cc0-41a6-b198-6f1ec5cdc638">LD</given-names></name><x>, </x><etal data-class="RefEtal" id="16610f7b-2849-4513-9d81-2e8b304ec967">et al</etal></person-group><x>. </x><article-title id="2879f754-4d76-4819-b0a5-247c336c465a">The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the <named-content data-cid="1555068439008" content-type="del cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="67dfe2c8-bd83-48d8-9ef5-6dd8e9ecce36">ECLIPSE</named-content><named-content data-cid="1555068439008" content-type="ins cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="8b24e690-46fd-48ae-abfb-61b463b4d81d">eclipse</named-content> study</article-title><x>. </x><source id="0cb04e83-6ffa-460b-8e25-d65c74e84611">Lancet Respir Med</source><x> </x><year id="2a8ce4fe-a2a2-4088-808f-8f64aa8c933e">2013</year><x>;</x><volume id="111ffc18-5d5b-4c1c-a9ed-ace6ffdb494e">1</volume><x>:</x><fpage id="e711ea57-a140-4987-aeee-17b3fb319416">129</fpage><x>–</x><lpage id="d6c95452-8083-4dee-9176-d97201883b42">36</lpage><x>.</x><pub-id pub-id-type="doi" id="1a79432e-7377-46b8-8298-c0ee1158f1ce">10.1016/S2213-2600(13)70006-7</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R15" id="R15" data-id="R15" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R15" data-validated="true"><label id="f7fa992a-b1e1-4876-8cfb-2310993884f4">15.</label><element-citation publication-type="journal" id="9b5a9817-203d-4626-a675-868dcb4a22de"><person-group person-group-type="author" id="3ca05dc4-9dda-4506-92f4-1b8a9f0b86e3"><name id="753c71fa-6713-4cb1-a31f-3ab6e6162eca"><surname id="27f94ebd-91c8-4631-94f8-09a4f1af6aee">Cheng</surname> <given-names id="7f1e82f1-e7bf-463f-8114-80dd5ef396a5">DT</given-names></name><x>, </x><name id="053cffd3-41bb-4bb3-99ad-6b784962d325"><surname id="e2183c5a-25ac-4b08-b24b-7bb79abbd458">Kim</surname> <given-names id="2128f509-1ca0-4d4b-b429-65bb848c3980">DK</given-names></name><x>, </x><name id="262a68b6-642b-44fe-93ed-d65668e5ae20"><surname id="e884b186-a76d-4c68-92bd-2b1241881890">Cockayne</surname> <given-names id="9981d031-4bab-4680-9fe6-7c7589869b96">DA</given-names></name><x>, </x><etal data-class="RefEtal" id="13a7df58-3be3-4569-a9d4-c8b800755b8c">et al</etal></person-group><x>. </x><article-title id="d1d1e947-92e1-4a8d-bc0d-8aa3b0465119">Systemic sRAGE is a biomarker of emphysema and associated with AGER genetic variants in COPD patients</article-title><x>. </x><source id="dee603a2-ce3e-4a6c-acdb-7619163c055c">Am J Respir Crit Care Med</source><x> </x><year id="ed7fb4d4-6f80-42e4-a985-28fe313c75b6">2013</year><x>;</x><volume id="4bcd655f-f659-4970-887b-d3719d4d5372">188</volume><x>:</x><fpage id="09f95622-f748-410e-b4f2-9ab28489bc69">948</fpage><x>–</x><lpage id="b79118b7-2d92-4d91-ad68-ca54b15de34c">57</lpage><x>.</x></element-citation></ref><ref data-class="jrnlRefText" seqid="R16" id="R16" data-id="R16" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R16" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/23144326" data-doi="10.1164/rccm.201206-1013OC" data-validated="true"><label id="66c65965-e1b1-4e65-bdf3-250f2d476eb6">16.</label><element-citation publication-type="journal" id="4ffdd660-89d1-406c-bf30-efa72a7522f7"><person-group person-group-type="author" id="40a1ea61-981d-43a8-bef2-2a708174521d"><name id="04cfdba8-5104-405d-9f15-d18554ef36fa"><surname id="b5401bf9-7f58-4b3a-8fdb-54b28904e449">Kim</surname> <given-names id="2c78353a-f2f6-42f6-b3b8-d77c90dc6504">DK</given-names></name><x>, </x><name id="f48ef227-62e2-4274-acac-8c67538192a9"><surname id="c1f3a254-ffd5-404c-b079-0bfa62df7eaa">Cho</surname> <given-names id="155a4d23-93be-4233-8c53-24c0f3333e72">MH</given-names></name><x>, </x><name id="1a283566-dffe-4ca9-b35d-a70a2ccc1244"><surname id="6efd6a96-761c-448d-8e7c-336e6fe7916f">Hersh</surname> <given-names id="49dc99ba-814d-484f-ba34-238d676c308e">CP</given-names></name><x>, </x><etal data-class="RefEtal" id="c879a806-f75c-45a2-99ff-07bf97f817e1">et al</etal></person-group><x>. </x><article-title id="4b05325b-bd8b-4aed-9cba-3ef4398011b5">Genome-wide association analysis of blood biomarkers in chronic obstructive pulmonary disease</article-title><x>. </x><source id="8ce80118-7b8c-460d-9ffc-75f83a875452">Am J Respir Crit Care Med</source><x> </x><year id="eb6b87b0-7a8d-4e99-b587-944ef95dd714">2012</year><x>;</x><volume id="9891f093-1e94-4280-a24f-86d50efa2b0b">186</volume><x>:</x><fpage id="ffb30b84-fea9-4e61-a60c-27fe3369c4bc">1238</fpage><x>–</x><lpage id="9e0ce32a-81ff-4cc9-9f1e-b141c8d8f570">47</lpage><x>.</x><pub-id pub-id-type="doi" id="5d7233e3-238a-4749-8e7c-cab9b787326c">10.1164/rccm.201206-1013OC</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R17" id="R17" data-id="R17" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R17" data-validated="true"><label id="3bbd1ca4-cec2-4c07-b69a-73bd66853d40">17.</label><element-citation publication-type="journal" id="0ea82430-de19-4b7f-b3ec-4e4e84f6d65c"><person-group person-group-type="author" id="05e966ed-9cee-4e53-adea-91d462233576"><name id="0310a737-37b4-4250-89ea-f292e06dd4f4"><surname id="9c628c68-7ffe-4fa5-9276-245131e674f8">Adamson</surname> <given-names id="46233e47-a2f1-43e1-bb53-157a9359fbea">PD</given-names></name><x>, </x><name id="38f632a9-b398-458b-99a2-8a325c407aa4"><surname id="325c165f-f709-41f3-a2f4-dba08da89555">Anderson</surname> <given-names id="98e00280-e049-4a78-a2f2-b0d24e46a166">JA</given-names></name><x>, </x><name id="dc6eddbf-9197-4dca-a2d7-4bff620f3696"><surname id="e6cdb43e-f6e1-4ca2-a56a-a0acb09609ad">Cowans</surname> <given-names id="7e200831-90af-4720-9bfa-86756b5d5a8c">NJ</given-names></name><x>, </x><etal data-class="RefEtal" id="30151227-fc76-4811-a207-129c2f59ada1">et al</etal></person-group><x>. </x><article-title id="88684c50-4ad2-4ce9-85ca-4877a52db91e">Cardiac troponin I and risk of cardiovascular events in patients with COPD and heightened cardiovascular risk</article-title><x>. </x><source id="f9a8be87-63f6-456f-930e-999c0195a443">J Am Coll Cardiol</source><x>. </x><comment data-class="RefInPress" id="9f6377c3-0647-4ce8-b68d-981e2c3822bc"><named-content data-cid="1555068439009" content-type="del cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R81" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="06538a9e-130d-4481-a1a2-844da498aafe">in</named-content><named-content data-cid="1555068439009" content-type="ins cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R81" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="52226621-352b-48eb-897e-45046054adb3">In</named-content> <named-content data-cid="1555068439010" content-type="del cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R82" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="51fca8b2-e169-44e1-9411-8f82d629242c">press</named-content><named-content data-cid="1555068439010" content-type="ins cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R82" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="60c327dd-1e0b-4ad5-be5c-c328071e504d">Press</named-content></comment><x> </x><year id="60a251b9-a30f-4936-98c0-6fd300489afc">2018</year><x>.</x></element-citation></ref><ref data-class="jrnlRefText" seqid="R18" id="R18" data-id="R18" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R18" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/23018908" data-doi="10.1183/09031936.00087312" data-validated="true"><label id="e5105c74-fc30-4ec8-8947-e255926fe4fe">18.</label><element-citation publication-type="journal" id="9e75798f-e465-4ab5-955e-7cf24fa6aee5"><person-group person-group-type="author" id="f16566c4-3f12-4ad3-9e46-cbd714f8ecc5"><name id="5e49ad29-5a27-4d60-aa0e-95e7abbf8b92"><surname id="a18435ca-b81d-4393-beca-1afa04da8be6">Vestbo</surname> <given-names id="4fe87f5f-31bc-42bb-beb0-e2fa3df99c7b">J</given-names></name><x>, </x><name id="a21025e4-ddaf-4691-af3e-010eb912ec76"><surname id="fe69a6e1-ab9d-4e8e-b465-a719c7617ba1">Anderson</surname> <given-names id="c46f9a3c-3d5c-42db-b952-4764f5927c0b">J</given-names></name><x>, </x><name id="b95eacd1-4bf2-4500-b3bd-137e45a8e879"><surname id="ea27096a-c78a-4c27-9ede-4509c795e2f7">Brook</surname> <given-names id="887f446c-4eb1-43cd-8108-b410afbaef7c">RD</given-names></name><x>, </x><etal data-class="RefEtal" id="b58eb532-5d40-4cc0-b73e-25b32b045380">et al</etal></person-group><x>. </x><article-title id="f6d5c07f-86ce-4fc5-9724-5a91b2bd4eb2">The <named-content data-cid="1555068439011" content-type="del cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="7acb65d6-1630-4663-a96c-4fef4b140704">Study</named-content><named-content data-cid="1555068439011" content-type="ins cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="49fef009-6f5f-4f4a-ac72-a0d0809e40d1">study</named-content> to <named-content data-cid="1555068439012" content-type="del cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R102" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="30c738b1-8660-430b-a7b5-151336e3e483">Understand</named-content><named-content data-cid="1555068439012" content-type="ins cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R102" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="5f357949-a9ed-42e8-be46-da49a7a2413a">understand</named-content> <named-content data-cid="1555068439013" content-type="del cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R103" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="fbe3d5c4-e8f9-4c42-86dd-c76d64d9a99a">Mortality</named-content><named-content data-cid="1555068439013" content-type="ins cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R103" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="8937c63a-f5d9-416b-b920-a58610d56396">mortality</named-content> and <named-content data-cid="1555068439014" content-type="del cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R104" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="48d5f1ef-4e93-46ee-a70a-a668cac63285">Morbidity</named-content><named-content data-cid="1555068439014" content-type="ins cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R104" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="32583fbe-9084-4ea9-8dd7-318de967dfad">morbidity</named-content> in COPD (<named-content data-cid="1555068439015" content-type="del cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R105" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="52fb549c-cb87-4761-8399-7123464dffa6">SUMMIT</named-content><named-content data-cid="1555068439015" content-type="ins cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R105" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="4a9a658f-e784-4920-9280-6f2d798ab806">Summit</named-content>) study protocol</article-title><x>. </x><source id="31b763cf-eea0-45b8-8176-3314220dcad2">Eur Respir J</source><x> </x><year id="ef77c346-0b47-4826-bead-23e3a4eeac51">2013</year><x>;</x><volume id="fd962046-423a-4433-ab02-5939099e85d0">41</volume><x>:</x><fpage id="c75ce1bf-fa3b-425d-8ef5-20c7a739b690">1017</fpage><x>–</x><lpage id="bcdfc372-84e3-49da-94f6-67ea44ec41cf">22</lpage><x>.</x><pub-id pub-id-type="doi" id="a0c4001b-a5a8-40e4-b5c4-7346964aa71f">10.1183/09031936.00087312</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R19" data-id="R19" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R19" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/27203508" data-doi="10.1016/S0140-6736(16)30069-1" data-validated="true"><label id="3ff4cab1-702b-4315-a1ee-6861b43c8f5f">19.</label><element-citation publication-type="journal" id="d9e07626-60ae-46e6-a463-db878044dd15"><person-group person-group-type="author" id="b0dc1c7a-1338-4779-bfb1-bb012f16d6fc"><name id="293c5d76-001b-4849-b84b-a7bae4356d44"><surname id="9ca12bef-1572-4b77-8495-162ba29c9760">Vestbo</surname> <given-names id="8008d9aa-4de0-4251-8646-a6135e11146f">J</given-names></name><x>, </x><name id="6ac67143-90d9-480f-8f8b-a83cdc4f59a1"><surname id="56f8c9df-b761-442c-9d57-1250803f3aef">Anderson</surname> <given-names id="8ad3b779-36fb-4dda-8589-132c90b2fb75">JA</given-names></name><x>, </x><name id="fa024d74-de73-46b2-b08e-9ac755153a29"><surname id="3ff77992-0bca-41b3-a397-0cb17e444530">Brook</surname> <given-names id="6d81d732-7f3f-4122-ad7c-c750d807579a">RD</given-names></name><x>, </x><etal data-class="RefEtal" id="cd3c5ca3-1376-4e07-83b3-fd8a7487dbd9">et al</etal></person-group><x>. </x><article-title id="18d48f9b-1bc9-42e1-b622-cfcd7544ee64">Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (Summit): a double-blind randomised controlled trial</article-title><x>. </x><source id="5ac9350c-9ffb-496e-8a5d-3145fb9d9809">Lancet</source><x> </x><year id="2d475c0c-0841-4c5d-979d-d9aa2680248b">2016</year><x>;</x><volume id="e19f1173-a32a-4b5b-a170-0afb6aead5e6">387</volume><x>:</x><fpage id="65f6f65f-7fbb-4410-a835-45d182cb158b">1817</fpage><x>–</x><lpage id="e82d9394-aa38-48c7-86a8-0b639272cf58">26</lpage><x>.</x><pub-id pub-id-type="doi" id="e6ba974c-84b8-4855-a856-54d2ff24ed8c">10.1016/S0140-6736(16)30069-1</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R20" id="R20" data-id="R20" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R20" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/9872837" data-doi="10.1164/ajrccm.159.1.9712108" data-validated="true"><label id="e4359b54-40d6-4f8a-ad01-47baa681e084">20.</label><element-citation publication-type="journal" id="de4bb77d-214b-4613-bee4-d33ea01aa605"><person-group person-group-type="author" id="f10eb555-849c-46e5-954b-8dbbfe0cedd7"><name id="e28e8fa8-47e6-4009-9add-3130880fd657"><surname id="3b99bdcd-1091-40dd-925a-2736da73984d">Hankinson</surname> <given-names id="4ebb58ea-10d4-417c-ad65-cb903d8ec023">JL</given-names></name><x>, </x><name id="68c412f3-6cb1-4920-bea0-073436fed02a"><surname id="36aef65b-f93e-41f2-beb6-53ca4b263ba1">Odencrantz</surname> <given-names id="88c687a0-a836-4b7e-a615-0eb836febbc2">JR</given-names></name><x>, </x><name id="97788fdc-1142-4b7f-a023-38839b5fae4d"><surname id="f4e3eb16-c3ae-4a43-9193-b9ac619bd7a8">Fedan</surname> <given-names id="fe67d29d-80b6-4f84-b3f9-698df9e03b1c">KB</given-names></name></person-group><x>. </x><article-title id="93f00dce-05f0-48bb-84ba-205c0bb9cd12">Spirometric reference values from a sample of the general U.S. population</article-title><x>. </x><source id="107bc41c-038e-41cc-b594-e8913365b09f">Am J Respir Crit Care Med</source><x> </x><year id="1dd250f2-8928-48cb-8805-c8907ec705aa">1999</year><x>;</x><volume id="66a10af9-4220-49ba-82fb-114aa24bb678">159</volume><x>:</x><fpage id="13bed146-ef6e-4c80-be6c-4c6c2638ef10">179</fpage><x>–</x><lpage id="80db2e27-4bd9-418f-b7e0-f29ab4e9d9ea">87</lpage><x>.</x><pub-id pub-id-type="doi" id="40508b20-ceef-480a-a509-e9bd0b316dd8">10.1164/ajrccm.159.1.9712108</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R21" id="R21" data-id="R21" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R21" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/27434033" data-doi="10.1371/journal.pone.0158843" data-validated="true"><label id="80b3f175-9946-442d-8235-47de479be35d">21.</label><element-citation publication-type="journal" id="0060d3d1-abe4-47ae-b3b8-433c5db68459"><person-group person-group-type="author" id="45ed7456-36ca-461c-bcb4-a81306b71f06"><name id="2ebc9ec4-6640-45bf-995e-1874da792369"><surname id="e5c09e12-c552-4e3d-b930-5c9b9af0e81d">Chen</surname> <given-names id="7f47bd76-b28e-4bae-93cf-db0a2f519d0a"><named-content data-cid="1555068439017" content-type="del cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R91" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="1053048b-0fbd-44be-93c2-87f45a558bcb">YW</named-content><named-content data-cid="1555068439017" content-type="ins cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R91" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="82d8574b-d3d7-42e2-963d-8e2a6860b136">Y-WR</named-content></given-names></name><x>, </x><name id="f2c664ed-9e20-4573-8e0a-a930c056951b"><surname id="bc52c73f-f598-4770-acf4-c409730fa976">Leung</surname> <given-names id="44202bc8-c05f-4366-8f55-ade6ec7cffce">JM</given-names></name><x>, </x><name id="4323893d-199b-4ce0-977d-78cff0d00bc8"><surname id="415598bc-24e9-416b-9a8a-0997e5f62e89">Sin</surname> <given-names id="e951e5b6-9cd3-468e-80b4-419019196600">DD</given-names></name></person-group><x>. </x><article-title id="8003905d-f2cb-4d16-979e-875e877c3e12">A systematic review of diagnostic biomarkers of COPD exacerbation</article-title><x>. </x><source id="946ef290-72fc-49ea-a340-2cc1d5182cba">PLoS One</source><x> </x><year id="0f0984fe-ba32-4f8e-a0a1-9409dc3f1262">2016</year><x>;</x><volume id="4eed5557-8873-497e-b12b-7bee48f9ef7c">11</volume><x>:</x><elocation-id id="0c79bfc5-9fb2-4594-b3a5-5b8ee74f28cc">e0158843</elocation-id><x>.</x><pub-id pub-id-type="doi" id="bccc198a-6f8d-4e34-93e7-d739a96e02b2">10.1371/journal.pone.0158843</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R22" id="R22" data-id="R22" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R22" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/29192815" data-doi="10.1513/AnnalsATS.201710-770WS" data-validated="true"><label id="af498216-2d9e-473f-98b6-ff4e98dfd49d">22.</label><element-citation publication-type="journal" id="8f83686a-9db9-4616-ab28-9c132496514b"><person-group person-group-type="author" id="cc05a829-1fd1-4185-98c2-2ced0b569bd8"><name id="90110e8e-7bf8-449e-85b9-3a97c5af46f5"><surname id="ff352917-838c-451e-b738-3630de324433">Bowler</surname> <given-names id="415576f9-aec7-4e0c-ad89-2fbb4c973448">RP</given-names></name><x>, </x><name id="1b9f6f38-ca88-4b1b-b2fd-f89a089926e0"><surname id="c7639931-5cb3-4de7-bb7b-33da0e3d30ef">Wendt</surname> <given-names id="0b5a8e10-d432-4543-85b0-6e2ecf6e1ca7">CH</given-names></name><x>, </x><name id="26e09dbf-1c58-4d83-a14b-d45543371bf5"><surname id="ba1f57c2-86b3-4371-9821-b41cf861288f">Fessler</surname> <given-names id="1c929116-ca6e-4e23-ab62-697b5c0376df">MB</given-names></name><x>, </x><etal data-class="RefEtal" id="2df29660-a88d-4569-9e29-8530d9c8d917">et al</etal></person-group><x>. </x><article-title id="99c504e6-5b80-4c74-847f-3c9b677968f2">New strategies and challenges in lung proteomics and metabolomics. An official American Thoracic Society workshop report</article-title><x>. </x><source id="bf5acf98-ca9d-42a0-a14c-adaabd67df9b">Ann Am Thorac Soc</source><x> </x><year id="e007f100-52eb-45cc-86f0-8f949e698e72">2017</year><x>;</x><volume id="c2c5bfc3-4829-476d-aaec-18132809bd5c">14</volume><x>:</x><fpage id="1678c36c-4ca8-4974-b7a2-26a8dd44e075">1721</fpage><x>–</x><lpage id="dbbc40fd-9588-48df-9a25-19995ee43c4e">43</lpage><x>.</x><pub-id pub-id-type="doi" id="62825c81-1cb9-4476-94a8-1646cf14001b">10.1513/AnnalsATS.201710-770WS</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R23" id="R23" data-id="R23" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R23" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/29065892" data-doi="10.1186/s12931-017-0662-2" data-validated="true"><label id="a5aed565-d95f-45ac-8fa0-f943ebb4d321">23.</label><element-citation publication-type="journal" id="399ab44a-c7ad-4c93-b127-96837c90722f"><person-group person-group-type="author" id="4b2a91d1-67d5-439f-9fe5-7bdac248526c"><name id="7a4026ae-4319-4c37-9d15-fde9c17624f0"><surname id="e29afc6b-cc9c-4360-8aff-8860914757ce">Bradford</surname> <given-names id="07a06275-c927-453a-9209-4144c6e15bc4">E</given-names></name><x>, </x><name id="75c48bfe-be8b-45e1-9326-8dee13e53470"><surname id="90748ab8-3d09-4656-9bb9-d620c052139c">Jacobson</surname> <given-names id="4df689fb-58d5-46de-9513-b13d26a7a003">S</given-names></name><x>, </x><name id="03ace11c-9468-43db-aae9-ac8c72250b35"><surname id="e5b31a9d-e53f-44f3-8eec-4724e858b8db">Varasteh</surname> <given-names id="059e68b1-6431-46e1-bc28-f67b0fae9a9d">J</given-names></name><x>, </x><etal data-class="RefEtal" id="4adaac1a-cd33-4e43-b324-0c7b2f99da46">et al</etal></person-group><x>. </x><article-title id="ff07c94f-f5c8-4115-9d91-257f69530400">The value of blood cytokines and chemokines in assessing COPD</article-title><x>. </x><source id="97815509-a5f9-4241-9a57-779a6dca17a0">Respir Res</source><x> </x><year id="336fa444-86bf-4974-95b8-12d0b246848c">2017</year><x>;</x><volume id="ad9e941e-4d4f-47c9-b3c8-837ed8bf3ad5">18</volume><x>.</x><pub-id pub-id-type="doi" id="144cffaf-a8cd-4c74-ab75-8367447b50c8">10.1186/s12931-017-0662-2</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R24" id="R24" data-id="R24" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R24" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/16143583" data-doi="10.1136/thx.2005.042200" data-validated="true"><label id="c1ea39f3-13b3-404c-b0a2-40e385233e3d">24.</label><element-citation publication-type="journal" id="ddd2e875-a9c3-4b08-922d-137ea5cb7f5c"><person-group person-group-type="author" id="19c5e384-5f47-40b9-900a-83f0d19cff6e"><name id="b08563ff-95a5-4516-8947-522adcdb024d"><surname id="31be60c6-3368-437c-b668-464e871ad78e">Pinto-Plata</surname> <given-names id="73fa1b90-ac2f-45f0-9a1a-36a3dc56d5b2">VM</given-names></name><x>, </x><name id="fbec50ce-f057-463e-ae56-df3357da414b"><surname id="3f8c88f0-7c73-47de-a4df-ae9f7d820966"><named-content data-cid="1555068439018" content-type="del cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="6ad7be7b-4e96-4fab-bada-76dacd618036">Mullerova</named-content><named-content data-cid="1555068439018" content-type="ins cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="e8c646bc-bccc-40fc-9620-90715e917fbd">Müllerova</named-content></surname> <given-names id="db89b860-5bf5-421d-8fdd-549263c4a7a9">H</given-names></name><x>, </x><name id="bbeeca1c-e84d-4be7-816a-9c2582745fcc"><surname id="14311858-08b7-43c5-a619-c5bd2fb7b335">Toso</surname> <given-names id="8d221701-b7fc-4357-9915-8166153f2ea2">JF</given-names></name><x>, </x><etal data-class="RefEtal" id="5aa02166-a032-478b-bc93-7e4f491aa741">et al</etal></person-group><x>. </x><article-title id="3304819f-f4ac-418e-bf52-e4940f5d6264">C-reactive protein in patients with COPD, control smokers and non-smokers</article-title><x>. </x><source id="dc638c20-e888-48e7-9fab-7297dcfd4bb2">Thorax</source><x> </x><year id="16e81277-f926-4fe7-85e3-87b656f9a633">2006</year><x>;</x><volume id="40e27a7c-386e-4802-9be4-70a069526abd">61</volume><x>:</x><fpage id="eef0d9ab-de26-4c3b-b665-6b4450a219bd">23</fpage><x>–</x><lpage id="c1c7b2e9-91ac-4a23-9498-fd54aba114fe">8</lpage><x>.</x><pub-id pub-id-type="doi" id="20a86160-ed55-4be6-9795-2003e241569f">10.1136/thx.2005.042200</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R25" id="R25" data-id="R25" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R25" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/16799074" data-doi="10.1164/rccm.200604-506OC" data-validated="true"><label id="81290fb9-053e-4ed2-8305-3a7514a497c3">25.</label><element-citation publication-type="journal" id="eaf492ea-4ba2-45b4-b971-ae75bbdb3ee2"><person-group person-group-type="author" id="8b78401d-70ad-4ca0-9e40-45ede18746e3"><name id="63a81a11-dd0a-43d2-9c12-49a772a1a642"><surname id="2b478f67-1be0-4c81-95ee-6909db9546fc">Hurst</surname> <given-names id="f7c0de44-1e2b-477b-905a-7186822de69c">JR</given-names></name><x>, </x><name id="835b6921-de96-458a-b9f5-98bf6c7c945e"><surname id="d17af1db-0eee-4969-91bc-eda7429e15b2">Donaldson</surname> <given-names id="cfbde2d5-7477-47ee-8053-dfca4c6bec72">GC</given-names></name><x>, </x><name id="7b060820-f5ae-492e-ba6a-dadde7ce0d91"><surname id="772adca8-2ca9-4730-ac2f-14581332993d">Perera</surname> <given-names id="ff2620db-265d-417e-9069-f30a0c0380b1">WR</given-names></name><x>, </x><etal data-class="RefEtal" id="d9adab73-ced0-4bc9-96af-142451cb3bac">et al</etal></person-group><x>. </x><article-title id="7a443cdf-c971-4f18-a7b8-590c08c88372">Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease</article-title><x>. </x><source id="5fe77b55-4456-4ab2-8a03-24f1fdf9f1eb">Am J Respir Crit Care Med</source><x> </x><year id="aa97cf25-24c9-4e08-b38d-1bf3407bdbee">2006</year><x>;</x><volume id="7069ab40-d4ee-41ce-b42d-acae43a38662">174</volume><x>:</x><fpage id="927bfb96-8974-4034-a703-8f814b81369c">867</fpage><x>–</x><lpage id="9495eec6-014a-41ab-9446-9d4fcb78eadb">74</lpage><x>.</x><pub-id pub-id-type="doi" id="25c75656-b2b7-479a-b4ac-d6e7bc9f1e25">10.1164/rccm.200604-506OC</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R26" id="R26" data-id="R26" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R26" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/16455829" data-doi="10.1183/09031936.06.00109605" data-validated="true"><label id="bd179da3-0acf-417c-a9f5-be24428a0959">26.</label><element-citation publication-type="journal" id="168cd138-a20e-4a85-b061-47d4ca4a7162"><person-group person-group-type="author" id="4ba88623-de39-4811-8cab-ccbdf9c2d962"><name id="64aa5018-dcba-4af7-83d7-e249953cca34"><surname id="edb0dd8a-c477-4108-b49f-c309655d1b55">de Torres</surname> <given-names id="d33c5987-ea7b-4978-9128-a0a8b2ed6c4f">JP</given-names></name><x>, </x><name id="bbd1af2d-a759-44b1-9655-715c65cac2fb"><surname id="34109059-eb17-4ec9-91f6-36e87cfd30eb">Cordoba-Lanus</surname> <given-names id="5220327d-5627-4e59-82ea-a7944b0a5ac9">E</given-names></name><x>, </x><name id="d71eb0a9-8db1-4fc6-9c34-16560f99fc4a"><surname id="ef0081b1-74fd-485c-957d-b8d75e105c53"><named-content data-cid="1555068439019" content-type="del cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="cc47b6e6-73e3-4ea0-8a90-18ceb9ccb174">Lopez</named-content><named-content data-cid="1555068439019" content-type="ins cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="c337c1e7-184c-4b59-8389-2467f695f4de">López</named-content>-Aguilar</surname> <given-names id="98bb02d3-b663-4411-b364-6a6f310525b5">C</given-names></name><x>, </x><etal data-class="RefEtal" id="675588dc-de87-42a6-96fe-cdf44f6c3b5d">et al</etal></person-group><x>. </x><article-title id="6ee24c5a-b35f-4cca-afdc-ff4d0ad28490">C-reactive protein levels and clinically important predictive outcomes in stable COPD patients</article-title><x>. </x><source id="a6bd0be9-89cf-4fae-98f3-cb7d76031208">Eur Respir J</source><x> </x><year id="e48bd4c2-0c13-411b-a96b-e7eb8f1ea513">2006</year><x>;</x><volume id="b12acfcf-ffd3-41b3-b688-888b0be63c7e">27</volume><x>:</x><fpage id="e6a70ce3-1470-44c1-bff4-bd4729f0ddb1">902</fpage><x>–</x><lpage id="7c9d9f08-c9c7-49f4-9c24-6abccf130681">7</lpage><x>.</x><pub-id pub-id-type="doi" id="b12a248b-d600-4883-8ac5-2d91a36c6a08">10.1183/09031936.06.00109605</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R27" id="R27" data-id="R27" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R27" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/7678080" data-doi="10.1378/chest.103.1.196" data-validated="true"><label id="d54a4d16-20b8-4287-a398-386b9dc17732">27.</label><element-citation publication-type="journal" id="b33e4dbd-7f88-47d2-8f9f-d85f4bdef241"><person-group person-group-type="author" id="2354b6a6-102b-4233-894e-c73559ba64e7"><name id="bc0ac4f6-fb33-49aa-b903-56ff3a21b8c7"><surname id="c9a64fc2-d4d7-4424-8ba4-6f064e3dbfeb">Gabazza</surname> <given-names id="d3eb51c5-dca0-4d97-9698-11aeed856a4d">EC</given-names></name><x>, </x><name id="20045420-8ceb-496f-b137-ac6e21261a37"><surname id="567d295e-3973-4a5e-bd21-290478c9d4e6">Taguchi</surname> <given-names id="b56a44e1-cbdf-4172-a8a7-10b6adf71167">O</given-names></name><x>, </x><name id="11e3c40b-5c52-4b1d-9977-6531c1afab02"><surname id="1d1d2eac-690c-4b87-a48c-6f09e829f257">Yamakami</surname> <given-names id="f92f73ab-f253-44fd-a418-f8bb1487bc61">T</given-names></name><x>, </x><etal data-class="RefEtal" id="418d9837-c3d4-4a43-bebb-8fd8200d6274">et al</etal></person-group><x>. </x><article-title id="0a04bc84-b8be-4598-ae6a-c58db8d0cffe">Evaluating prethrombotic state in lung cancer using molecular markers</article-title><x>. </x><source id="06bcd647-43ba-4fb3-94f3-cffd3d7803db">Chest</source><x> </x><year id="1c3b8b8a-482e-4127-8b46-e8e5e84d1c64">1993</year><x>;</x><volume id="f498bb70-17bb-447f-81fc-71fd0085522e">103</volume><x>:</x><fpage id="fe7feb32-3829-4909-942a-7d26850632af">196</fpage><x>–</x><lpage id="7437b0d0-e504-4a9d-8b14-ebeca296d74b">200</lpage><x>.</x><pub-id pub-id-type="doi" id="3a4c4603-8528-4fe0-9ca7-6327886ac070">10.1378/chest.103.1.196</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R28" id="R28" data-id="R28" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R28" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/23757083" data-doi="10.1001/jama.2013.5732" data-validated="true"><label id="7f17ecc5-7256-4881-ac33-9818ba0acb82">28.</label><element-citation publication-type="journal" id="3ac693e3-6e63-4a5d-a2e0-5e77bc65dbdc"><person-group person-group-type="author" id="df4ec956-3db5-468c-9398-8052aabba40f"><name id="3f4fa829-f14c-4e28-95da-4c920227725f"><surname id="61381f9f-f412-4821-93e8-5415cd8cf6f0">Thomsen</surname> <given-names id="84a71257-0d8f-4469-9c70-7c91057824d3">M</given-names></name><x>, </x><name id="4f9ce097-5960-4603-ab29-89364c9daf55"><surname id="0b6ba4dc-b352-464f-a5ef-7b6dd30085a9">Ingebrigtsen</surname> <given-names id="9eaa12d8-20b4-4a03-b3c9-b325bb29ff3a">TS</given-names></name><x>, </x><name id="b396bde5-753a-4dfb-8293-b6aa05702af0"><surname id="77e0de61-a8cf-44a8-9b51-8026b3ff6695">Marott</surname> <given-names id="41ac4c05-77e1-42c4-b344-1b224363e139">JL</given-names></name><x>, </x><etal data-class="RefEtal" id="ff8f1bc3-6178-40c6-b1f2-6fca415fc84b">et al</etal></person-group><x>. </x><article-title id="f4a60cbb-8f36-4a5f-84a3-7c57f490961a">Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease</article-title><x>. </x><source id="8ed10a47-dfe8-4808-8011-fce7a86d6c23">JAMA</source><x> </x><year id="e0b9ef85-5277-459b-89a3-98392f34a0f2">2013</year><x>;</x><volume id="6b9d893c-646a-4a51-87cf-3e20178ec395">309</volume><x>:</x><fpage id="77facfd4-b7e0-46d8-926f-3d6927dc88f0">2353</fpage><x>–</x><lpage id="81b8fb61-5a5a-4328-a15d-9a4d9dad87ba">61</lpage><x>.</x><pub-id pub-id-type="doi" id="70c2e9d9-85c0-4952-a40e-8b24c021caff">10.1001/jama.2013.5732</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R29" id="R29" data-id="R29" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R29" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/11587987" data-doi="10.1164/ajrccm.164.6.2010067" data-validated="true"><label id="3b7d6d21-0a8f-4a7e-9543-7c71171d08a1">29.</label><element-citation publication-type="journal" id="caf38169-f761-415a-90b7-64a722354cd9"><person-group person-group-type="author" id="c95089cd-8d66-4b72-8779-22cf90d7e832"><name id="66537386-a0d8-43fd-9cf7-7ddc198eef3e"><surname id="c2557a61-8445-4251-8d0b-9d7fe26f709e">Dahl</surname> <given-names id="e682ac7b-38e4-4207-ba67-2af3ae3487ef">M</given-names></name><x>, </x><name id="ddfba6ab-6d19-496f-8c55-3580f25b580a"><surname id="09936292-4243-4ab1-8e08-a7a277ac61c1">Tybjaerg-Hansen</surname> <given-names id="e4a7b039-3eb1-49a8-b224-29fc057ac449">A</given-names></name><x>, </x><name id="67f1c613-1292-49e2-bc2c-2a509f6a7c5d"><surname id="ac6ab815-583a-4938-9042-7c5a585ebe22">Vestbo</surname> <given-names id="333d7495-22c6-40e0-aab9-d87fe2f51318">J</given-names></name><x>, </x><etal data-class="RefEtal" id="ea5c0b42-04a0-45a7-b214-b6955631b037">et al</etal></person-group><x>. </x><article-title id="7206834a-44d8-4706-85d2-371d080c2156">Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease</article-title><x>. </x><source id="622cb726-80a6-4baf-b610-672bcf6dee33">Am J Respir Crit Care Med</source><x> </x><year id="a382ef34-dcd0-4723-b2d7-09f717801212">2001</year><x>;</x><volume id="85de22be-fb02-4c5c-ab0d-3e988400175d">164</volume><x>:</x><fpage id="bd405b73-6621-4d40-bc50-d1b29f5f54e4">1008</fpage><x>–</x><lpage id="961a5da7-e34f-4c9f-b72b-75fd912b3354">11</lpage><x>.</x><pub-id pub-id-type="doi" id="4566addf-55ab-495a-b3d9-fcb00d512274">10.1164/ajrccm.164.6.2010067</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R30" id="R30" data-id="R30" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R30" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/20831787" data-doi="10.1186/1465-9921-11-122" data-validated="true"><label id="5967ba2d-aa25-495d-a4e3-7ad3d2049f80">30.</label><element-citation publication-type="journal" id="2e16aa9d-9fc4-46c2-917e-64884a5a9bb0"><person-group person-group-type="author" id="0a8c981e-07cd-4e4f-932e-dc778f3e851c"><name id="5aca3148-2357-4498-af78-3d2ca3bc8034"><surname id="67befcb7-7588-4da8-9d12-5f20ac23a897">Agusti</surname> <given-names id="c13b21cf-34b0-49ed-916c-1075b99fe05e">A</given-names></name><x>, </x><name id="c2708381-188c-40b4-9dc4-9b443f3c6ca7"><surname id="3e335abb-7e79-465d-bc4c-437ec27ef8e1">Calverley</surname> <given-names id="affcf610-a220-433a-a533-60b391c44dd8"><named-content data-cid="1555068439020" content-type="del cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R81" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="b155ca1c-dfa4-4674-97b3-e009aedbd08c">PM</named-content><named-content data-cid="1555068439020" content-type="ins cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R81" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="5f3a64e6-526d-4300-9be4-dd8670783025">PMA</named-content></given-names></name><x>, </x><name id="fe100327-a730-418b-a346-7a7136ff18d1"><surname id="9f1500de-c3e2-44ea-9483-8f617b3a7511">Celli</surname> <given-names id="4b3470ad-ad4e-459a-bf61-fba9d089309e">B</given-names></name><x>, </x><etal data-class="RefEtal" id="955d215a-f7e7-4742-a728-040d2fadbaa6">et al</etal></person-group><x>. </x><article-title id="41b18bcd-f810-4c20-a063-4cfdd4c530d1">Characterisation of COPD heterogeneity in the <named-content data-cid="1555068439021" content-type="del cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R82" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="710f11f1-b172-4ec0-9e56-b8d7451b9417">ECLIPSE</named-content><named-content data-cid="1555068439021" content-type="ins cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R82" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="88806d2a-ee1a-41dc-866c-fe19d893f434">eclipse</named-content> cohort</article-title><x>. </x><source id="ea3eddef-cfa2-41f1-aecb-6ff9770143fc">Respir Res</source><x> </x><year id="5a7363d1-a9c5-4c50-82f2-bcde6969dce0">2010</year><x>;</x><volume id="105cb035-f220-4d98-8076-c539ac80e736">11</volume><x>.</x><pub-id pub-id-type="doi" id="4e0ebf2b-b874-4a57-8c47-05acbe7acc1a">10.1186/1465-9921-11-122</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R31" id="R31" data-id="R31" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R31" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/19164344" data-doi="10.1183/09031936.00156508" data-validated="true"><label id="0f99eef7-447d-4089-bba6-a2b587f4ec9a">31.</label><element-citation publication-type="journal" id="920e67d4-cc2d-4112-8e5e-7715d2a4ab9d"><person-group person-group-type="author" id="27b3ecd4-b116-48e2-bc42-278fa59f08d2"><name id="a6c063f2-cce6-4b9e-90fb-32e0f8c5e7d5"><surname id="79a61261-1d54-48bf-afe6-f3d923872399">Lomas</surname> <given-names id="7f4e1e74-aa37-4f95-aa43-0832d84cdf83">DA</given-names></name><x>, </x><name id="f05880d9-ffd5-4c10-aa9d-3cb89640803b"><surname id="a16fd7ef-4985-4212-a1d7-a437e525311f">Silverman</surname> <given-names id="f2ba03e9-b46e-4aa8-a31d-e75d09d9394a">EK</given-names></name><x>, </x><name id="1f7a8bf9-3931-4ec7-bc03-8e266185d46c"><surname id="9f3e4770-06f8-4aad-8cf3-4a4ee251c9b6">Edwards</surname> <given-names id="39ccb537-092b-4992-88db-3b5877fbe00a">LD</given-names></name><x>, </x><etal data-class="RefEtal" id="2eab4a6b-bed1-4a1e-9e3f-6c1806d84d54">et al</etal></person-group><x>. </x><article-title id="2870f25e-ab20-48ff-a81d-4581ecd46f0b">Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD</article-title><x>. </x><source id="a64e6e98-5a2e-4dcc-90a2-89cd1af05df0">Eur Respir J</source><x> </x><year id="c58563aa-e2b7-4e78-b800-02ce857cdf40">2009</year><x>;</x><volume id="45442c5d-a14d-4a23-a5a0-ea949e080294">34</volume><x>:</x><fpage id="be1b6b3f-af8c-4b2b-bfb1-377ed2f225f9">95</fpage><x>–</x><lpage id="07454c5f-2863-4fda-b9f7-64ecd9b5ecfd">102</lpage><x>.</x><pub-id pub-id-type="doi" id="7b0d13d8-7500-4ca5-8c43-47ef80773b8d">10.1183/09031936.00156508</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R32" data-id="R32" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R32" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/18757456" data-doi="10.1136/thx.2008.102574" data-validated="true"><label id="38c1e72c-7592-486d-937d-532a04aaa112">32.</label><element-citation publication-type="journal" id="19e19d02-59ad-41fe-837e-44782d724c54"><person-group person-group-type="author" id="3353b7fa-4c62-42a0-8cf2-b46e72b0c2b3"><name id="6dd1ed88-6a62-4e78-a8dd-0370d32709a0"><surname id="5b0003da-273a-4a64-ab19-2de36ecdbbd1">Lomas</surname> <given-names id="131ff378-e635-4f08-8273-7f654c462e56">DA</given-names></name><x>, </x><name id="ab3a389b-6130-4af5-8ac6-199c56f4a229"><surname id="4f157ad2-bdff-4d4a-b210-c615d099579b">Silverman</surname> <given-names id="8a3ceb13-e130-4de4-bf5d-0d48eb21a181">EK</given-names></name><x>, </x><name id="1b4f8c03-ba7d-4814-9852-4eecfeeb24fa"><surname id="0023d5a2-ffe4-481a-9087-59fa86c150f1">Edwards</surname> <given-names id="50250c9b-ab16-47a5-8667-26be25c1455c">LD</given-names></name><x>, </x><etal data-class="RefEtal" id="413b4fea-f225-4b4d-ab68-cc0899675e7b">et al</etal></person-group><x>. </x><article-title id="c7bae6f5-d96e-450f-a0ca-2f67166c1007">Evaluation of serum CC-16 as a biomarker for COPD in the eclipse cohort</article-title><x>. </x><source id="e33a43d3-7ad9-4b36-b72e-0c623e9b2d62">Thorax</source><x> </x><year id="1152fde5-3543-4bb0-898b-4118cb886778">2008</year><x>;</x><volume id="f38eddad-b921-486e-9f1b-7bc2e364bc3b">63</volume><x>:</x><fpage id="e853f66d-9f91-4851-b9ad-8533d62a3b54">1058</fpage><x>–</x><lpage id="2956fcf5-8d4a-4996-b729-759792d0af50">63</lpage><x>.</x><pub-id pub-id-type="doi" id="d22c8f47-b599-4299-8537-917cda340b38">10.1136/thx.2008.102574</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R33" id="R33" data-id="R33" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R33" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/20145712" data-doi="10.1155/2010/917108" data-validated="true"><label id="a0de508d-bb55-4352-a746-f1a8c94c75e7">33.</label><element-citation publication-type="journal" id="434d2a00-894e-4676-a3e5-be1ce5d03973"><person-group person-group-type="author" id="fe5392de-fd88-4774-8482-69f764a46c8d"><name id="c5c99e63-8b49-40e3-b533-4034ffcb32d7"><surname id="eb16a152-e465-4edc-b3a1-2b02899ba7fe">Buckley</surname> <given-names id="f0e22603-b4e4-4e90-becd-0496c3884102">ST</given-names></name><x>, </x><name id="b7a6e024-bec7-457c-a93c-3e65691258e7"><surname id="7fe465fd-23da-4461-b338-7308a245f97c">Ehrhardt</surname> <given-names id="c7ccf4b9-0ac4-4f26-b30c-b72b75a9af88">C</given-names></name></person-group><x>. </x><article-title id="fd4b31d1-41ee-4407-b384-75d67dd6431d">The receptor for advanced glycation end products (RAGE) and the lung</article-title><x>. </x><source id="b988dbd3-b056-4e8f-8e77-630f212acb37">J Biomed Biotechnol</source><x> </x><year id="5ee56ad1-2fff-4e83-b98e-dc1ba25b8e4c">2010</year><x>;</x><volume id="3c676223-39e0-41ec-8be3-a5f001a5b31e">2010</volume><x>:</x><fpage id="617d9a25-758e-4d3a-be6e-d9478d8913ec">1</fpage><x>–</x><lpage id="00f1d5cc-9ed8-4296-9b07-eb76bb348a56">11</lpage><x>.</x><pub-id pub-id-type="doi" id="6da05ec1-80f4-4963-84f3-da9a1d9d6936">10.1155/2010/917108</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R34" id="R34" data-id="R34" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R34" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/21450080" data-doi="10.1186/1465-9921-12-37" data-validated="true"><label id="2573ebed-0957-4bad-aa28-eb9d10f4e269">34.</label><element-citation publication-type="journal" id="54834625-d52b-4809-be20-68fe68dd4cbe"><person-group person-group-type="author" id="f8b7be2c-9e98-4b6f-a86e-55e4af4c801e"><name id="b0432c7e-b4c7-4885-9f03-82ae0ccea822"><surname id="1f8f74ad-423c-443b-a41a-8dcbb1b07170">Miniati</surname> <given-names id="b0f398b2-7e5f-4f9e-b944-66439b881bae">M</given-names></name><x>, </x><name id="c129a4e1-4376-4808-8ee6-c6a87ff9d4b2"><surname id="ad35bd01-7e60-4dce-b490-bfd684c926a0">Monti</surname> <given-names id="0a83a7f7-9732-4417-bc85-a777e0f93485">S</given-names></name><x>, </x><name id="acbb4b60-faa4-4d84-886a-345f1488ff8e"><surname id="1e9f7f39-76bb-416f-b802-104ce7b8747a">Basta</surname> <given-names id="981ca1bc-38b5-43b1-a7ff-51fc259f2a4a">G</given-names></name><x>, </x><etal data-class="RefEtal" id="fb507d74-a134-4f71-8825-ac13beea6b95">et al</etal></person-group><x>. </x><article-title id="069139b4-75ec-4e9b-b16d-6bcafbf1a478">Soluble receptor for advanced glycation end products in COPD: relationship with emphysema and chronic cor pulmonale: a case-control study</article-title><x>. </x><source id="b3d03cec-5ca1-4709-a565-5eab5cc22340">Respir Res</source><x> </x><year id="57e72319-bad9-4892-b247-d4522d65c63c">2011</year><x>;</x><volume id="0603a470-8f63-4e95-92f1-59e78ea1b6e3">12</volume><x>.</x><pub-id pub-id-type="doi" id="45b1f8bd-1683-45e2-880e-91d93923b957">10.1186/1465-9921-12-37</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R35" id="R35" data-id="R35" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R35" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/26781659" data-doi="10.1517/14728222.2016.1139084" data-validated="true"><label id="deedc024-7e19-410b-b506-96f161f49ed5">35.</label><element-citation publication-type="journal" id="8334d371-02d9-4ca9-b01b-f5a70d808bd6"><person-group person-group-type="author" id="78e69ce8-9f46-468e-b2ee-1e84d07b8322"><name id="2cd6d157-b4f0-497c-9bbc-8946539892d8"><surname id="7b7171d3-c130-441b-9d2a-0c9b97c6dbfb">Laucho-Contreras</surname> <given-names id="64ae545a-299c-4b7a-b70d-2e1a6b883bc2">ME</given-names></name><x>, </x><name id="aff1111e-6650-46ba-a1f1-f9534e8edc6c"><surname id="87ca7aab-e0a7-4b25-a408-2aa774e57347">Polverino</surname> <given-names id="f81f169c-3fe1-4fac-b081-c7b59d378113">F</given-names></name><x>, </x><name id="e2b13042-6e09-40ea-990a-adbd973762ba"><surname id="77bdbbf1-6998-4a13-a5f6-29a68e0119f7">Tesfaigzi</surname> <given-names id="64399c22-3213-4898-88fe-395416dda846">Y</given-names></name><x>, </x><etal data-class="RefEtal" id="c1a0dee2-2c46-4fd7-93f2-d35da7f6e020">et al</etal></person-group><x>. </x><article-title id="b122765d-2244-47b7-989f-29403eeee717">Club cell protein 16 (CC16) augmentation: a potential disease-modifying approach for chronic obstructive pulmonary disease (COPD)</article-title><x>. </x><source id="8bb5260b-a22f-4ffe-b346-b026d8281098">Expert Opin Ther Targets</source><x> </x><year id="16cd2e5e-bcbf-4893-92fe-b445947dff6f">2016</year><x>;</x><volume id="50dcc40b-543f-491d-af61-7438361c3c8d">20</volume><x>:</x><fpage id="bfaa9c4e-394f-43cb-910e-68d6dc46c496">869</fpage><x>–</x><lpage id="880a330a-0a7e-463b-b470-dc6e041df076">83</lpage><x>.</x><pub-id pub-id-type="doi" id="bd1fbf95-461a-4070-bb90-77b7bc4e280d">10.1517/14728222.2016.1139084</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R36" id="R36" data-id="R36" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R36" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/10673175" data-doi="10.1164/ajrccm.161.2.9901044" data-validated="true"><label id="b67ddd03-af5f-41ab-b468-ad81167d6969">36.</label><element-citation publication-type="journal" id="5368686d-182d-46fc-8cfd-83cf51a89378"><person-group person-group-type="author" id="c19f4098-e693-40c7-bc9b-377a5d15edb1"><name id="4a874fcd-bf6e-4306-bae9-f43e433351ae"><surname id="3e70541d-71b9-410b-b0d0-23f49d8260f0">Scanlon</surname> <given-names id="3df77fcf-8013-4d6a-8143-84c91dcb2827">PD</given-names></name><x>, </x><name id="38bcb76f-b583-451f-96a4-54ae02c244ec"><surname id="50fa39e1-4380-44d2-9da1-6d87b70544be">Connett</surname> <given-names id="d267a1d8-e056-4247-bee4-c01f2247cfc8">JE</given-names></name><x>, </x><name id="6f98c5be-c943-456a-93a9-5b5f034c3890"><surname id="a6015336-429a-4125-9531-13847f3ee160">Waller</surname> <given-names id="4f38796b-b7a9-45bf-bc34-901f85d003f4">LA</given-names></name><x>, </x><etal data-class="RefEtal" id="cd30d992-81b5-4dac-b5c8-063549ca4bb4">et al</etal></person-group><x>. </x><article-title id="d51f6973-d319-4357-a778-8720fdf81d74">Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. <named-content data-cid="1555068439023" content-type="del cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="b74da3f2-5347-432a-8039-c567bfc1e324">The</named-content><named-content data-cid="1555068439023" content-type="ins cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="b95bcfbe-fc3c-4dd4-8272-89c99ec598c1">the</named-content> <named-content data-cid="1555068439024" content-type="del cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R102" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="01b40acc-79e2-49b4-9abf-22f0673012c9">Lung</named-content><named-content data-cid="1555068439024" content-type="ins cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R102" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="b9052230-7135-4457-a11b-e1857ab8e8d7">lung</named-content> <named-content data-cid="1555068439025" content-type="del cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R103" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="715bd8cd-fe1d-45a1-8188-b5d5ccbf0621">Health</named-content><named-content data-cid="1555068439025" content-type="ins cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R103" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="d1dae2d7-76a1-41da-8db1-7f0892a1cdd4">health</named-content> <named-content data-cid="1555068439026" content-type="del cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R104" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="943fb895-ec63-4ae4-b29e-7e79885c15eb">Study</named-content><named-content data-cid="1555068439026" content-type="ins cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R104" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="52d0cb4a-0128-4af7-92c6-c09e3143b403">study</named-content></article-title><x>. </x><source id="40613058-642d-4a88-b45c-758070f6ff26">Am J Respir Crit Care Med</source><x> </x><year id="d6501940-3da8-4948-93cc-94d4edf687cd">2000</year><x>;</x><volume id="11e7867e-b7c3-48f8-b7d3-53cfbf6c2972">161</volume><x>:</x><fpage id="9bd4d7e4-27a3-4c11-a95d-3f1b454532d1">381</fpage><x>–</x><lpage id="74dde75f-5e54-4ba4-8b9d-9542317f0f0f">90</lpage><x>.</x><pub-id pub-id-type="doi" id="2c620323-5e5d-4183-b9b7-1fbe93d83784">10.1164/ajrccm.161.2.9901044</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R37" id="R37" data-id="R37" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R37" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/28029055" data-doi="10.1177/2048872616684678" data-validated="true"><label id="e415f7fc-8ae2-4d21-abb0-b7e0ae49a1fb">37.</label><element-citation publication-type="journal" id="ecbbec6e-5d79-44be-83e0-9d9ea5ba42a5"><person-group person-group-type="author" id="d85d3b11-37d1-483a-b5a6-6380a0338f95"><name id="00989fdf-a4b2-487d-bdc2-c303aa598105"><surname id="66f85a3e-e88b-44a4-9a13-c706f4cd183a">Klingenberg</surname> <given-names id="b4dadd9d-30bd-439d-bcd7-84609262c186">R</given-names></name><x>, </x><name id="c3dcfd33-c412-449a-a03f-cb733aaab894"><surname id="dbe487d5-057c-4620-9719-b4b838da42a9">Aghlmandi</surname> <given-names id="89184373-eb57-4089-8ecb-51b698a0d103">S</given-names></name><x>, </x><name id="a2b9e435-81e2-4915-adfa-c8616d9cd6c2"><surname id="a70d7d0d-a94f-4b06-8d17-382ad5033b99"><named-content data-cid="1555068439027" content-type="del cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="83c18e06-a2e0-4d9f-834e-dedee9d49ef2">Raber</named-content><named-content data-cid="1555068439027" content-type="ins cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="200f7ade-ef21-4d48-a432-92ac6f0c1de5">Räber</named-content></surname> <given-names id="2ca94b94-3f2a-41fc-9ce3-e4aee6f49d2f">L</given-names></name><x>, </x><etal data-class="RefEtal" id="0aa91458-3316-4db4-b488-114f2e79125a">et al</etal></person-group><x>. </x><article-title id="d18e662e-f6a8-4068-9c48-cf4ae54d5050">Improved risk stratification of patients with acute coronary syndromes using a combination of hsTnT, NT-proBNP and hsCRP with the <named-content data-cid="1555068439028" content-type="del cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R102" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="01243d77-e96d-4e53-8ec2-2f0c5cb683d4">GRACE</named-content><named-content data-cid="1555068439028" content-type="ins cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R102" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="97003cb5-489b-46ce-b8cb-0498bbc43604">grace</named-content> score</article-title><x>. </x><source id="9710288c-49bc-4530-8806-f467c0199ba7">Eur Heart J Acute Cardiovasc Care</source><x> </x><year id="2156b54c-adcf-4910-a9ee-7c4834968711">2018</year><x>;</x><volume id="b2d97410-4d6d-4439-8562-54406c82dd3d">7</volume><x>:</x><fpage id="f2bfae55-a587-4116-a737-d11248f63220">129</fpage><x>–</x><lpage id="878da4d2-d317-4ba4-9716-c589ab3388d1">38</lpage><x>.</x><pub-id pub-id-type="doi" id="e7539f08-b10c-4935-b8a7-7be758933b13">10.1177/2048872616684678</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R38" id="R38" data-id="R38" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R38" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/23034020" data-doi="10.1056/NEJMoa1107477" data-validated="true"><label id="462329ee-a01f-4777-be06-b288bfff5f0a">38.</label><element-citation publication-type="journal" id="ea01a1b6-bc40-428f-bef2-1afd15e21e3f"><person-group person-group-type="author" id="0442f4fc-fd4d-4780-99eb-71c50584ffae"><name id="2070377a-267f-409c-b9e5-fbc7fb6e4c91"><surname id="1be735bd-7b9e-412d-9aef-87eab19635ab">Kaptoge</surname> <given-names id="2f788430-1fe3-445f-8715-dc2bb8ae3613">S</given-names></name><x>, </x><name id="6a035390-4ce1-4f41-94e2-a57f1dca78b7"><surname id="14736aaf-c634-45f2-96b7-4409f62bf420">Di Angelantonio</surname> <given-names id="71ad3764-55b2-4846-b1b5-e147fd87e0ef">E</given-names></name><x>, </x><name id="6384f2af-50fa-4696-af83-881e900b1776"><surname id="86059a58-1d1a-4f0a-bca0-2eefb74c5103">Pennells</surname> <given-names id="6add71ab-c87e-4833-bead-1c2091cdd797">L</given-names></name><x>, </x><etal data-class="RefEtal" id="83076ea9-807b-4240-ae14-edbf0d68808c">et al</etal></person-group><x>. </x><article-title id="c9777f17-8d40-4ead-9f29-108264bfee8d"><named-content data-cid="1555068439029" content-type="del cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="caba1a8e-52cf-4cd4-8fa2-5bc60b12dc88">et al. </named-content>C-reactive protein, fibrinogen, and cardiovascular disease prediction</article-title><x>. </x><source id="61c8a401-65ad-4f5a-9452-7a51fa6cc969">N Engl J Med</source><x> </x><year id="7fd6255d-616d-4528-981b-a316f46ef314">2012</year><x>;</x><volume id="cc50781a-52f4-40f3-a314-1a650a6a95c5">367</volume><x>:</x><fpage id="345d6a06-5a63-403f-9f18-5fade7f11101">1310</fpage><x>–</x><lpage id="9b5f5ae0-cb3a-4f91-a5cb-e36bde67b7bd">20</lpage><x>.</x><pub-id pub-id-type="doi" id="3330c2ea-83ee-4b97-a246-8f36f4f3518e">10.1056/NEJMoa1107477</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R39" id="R39" data-id="R39" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R39" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/23547018" data-doi="10.1007/s10753-013-9625-z" data-validated="true"><label id="63a7e459-110a-40da-aef3-44de6382ea1f">39.</label><element-citation publication-type="journal" id="7e35a8e0-003a-4537-9d6f-b74e23ac19bc"><person-group person-group-type="author" id="ffba5eee-d3a5-4f88-ad1e-ae4e4070b2d9"><name id="7802bf81-78bd-4cdb-b1f1-f84889d77fd5"><surname id="7e14b9d1-a73c-4486-8cc2-60090d2b7a26">Karadeniz</surname> <given-names id="f063bd7d-3109-4020-9c62-33654a1bc7cd">G</given-names></name><x>, </x><name id="a4a66233-5009-4520-916a-5d62b10fbbc9"><surname id="64f29d8b-74fd-4032-8519-e151c4301a55">Polat</surname> <given-names id="5e2bf977-02d1-42ae-9a5d-740284acf1d8">G</given-names></name><x>, </x><name id="d577f2ff-1d51-45fe-8c55-106b5c117cfb"><surname id="ca49389c-f386-483d-8c19-86e5b5c2b786">Senol</surname> <given-names id="c18fe414-e79f-4489-ae24-f6d9bbe96308">G</given-names></name><x>, </x><etal data-class="RefEtal" id="b420e430-e842-469d-ac62-e5c8907fe9cf">et al</etal></person-group><x>. </x><article-title id="8f16fbe3-efc1-4105-b6d5-3d8a61da9581">C-reactive protein measurements as a marker of the severity of chronic obstructive pulmonary disease exacerbations</article-title><x>. </x><source id="f47c9ced-6e12-4ff1-89d4-ffc5d82de100">Inflammation</source><x> </x><year id="ed426ace-2c40-43fd-b6c7-af99800dbb01">2013</year><x>;</x><volume id="3d20eec9-39a6-4337-b2ae-3364a522f91a">36</volume><x>:</x><fpage id="c886e626-4970-4661-b9a0-412ec6913ca6">948</fpage><x>–</x><lpage id="efee986c-4e66-4bfa-822f-4db2d1c49ef2">53</lpage><x>.</x><pub-id pub-id-type="doi" id="772fec7b-5561-4cc5-8c03-7504c1f07f50">10.1007/s10753-013-9625-z</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R40" id="R40" data-id="R40" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R40" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/15229100" data-doi="10.1164/rccm.200404-543OC" data-validated="true"><label id="c014c1d4-024c-4c64-b6a1-a6a4599ebbcd">40.</label><element-citation publication-type="journal" id="75fb94d8-ee8d-44a8-a889-d3b2f57edfa4"><person-group person-group-type="author" id="bbd4c5dd-2f85-4b04-a0d8-1bdfd21e2758"><name id="d045b518-9630-4829-973a-5970b704f05d"><surname id="62be1bae-a85e-451e-ac41-cc19c0d71e9d">Sin</surname> <given-names id="e8aa2373-1ed2-409b-a214-c6079e6ddad3">DD</given-names></name><x>, </x><name id="cdab1929-47c8-4319-9a04-22e58d44f795"><surname id="7caadce5-57e4-4e89-aba1-65db7222ff21">Lacy</surname> <given-names id="e6c96269-9a84-4bd7-978a-15f47fceda35">P</given-names></name><x>, </x><name id="2d23b00c-8532-4d90-a71d-07232e76b93a"><surname id="7767bbc9-20cb-4ba2-8ce7-52c009400c68">York</surname> <given-names id="8d425597-0a77-4f60-b496-cf14d45e616c">E</given-names></name><x>, </x><etal data-class="RefEtal" id="7669d5f7-fbf0-45a7-b97c-cda99ec27f05">et al</etal></person-group><x>. </x><article-title id="9e579faa-f37b-4b04-9102-fb4ffe4144c3">Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease</article-title><x>. </x><source id="690b76c2-965b-4192-bd6d-63362a6ac87d">Am J Respir Crit Care Med</source><x> </x><year id="5c3aa5ff-435e-4b98-8183-fcd6fc7a447f">2004</year><x>;</x><volume id="deb33952-46d7-4570-9b08-9f9ca452898c">170</volume><x>:</x><fpage id="a13cb96a-e7cb-46bd-b0c8-6372fae6f08e">760</fpage><x>–</x><lpage id="ec2248a2-1d16-41d0-af95-ebcb1f6dceb3">5</lpage><x>.</x><pub-id pub-id-type="doi" id="1abae753-fb38-4e28-a84b-940b47fc268a">10.1164/rccm.200404-543OC</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R41" id="R41" data-id="R41" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R41" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/17504798" data-doi="10.1183/09031936.00023907" data-validated="true"><label id="07b5f6f3-3b88-462f-8f26-29df5ea6ecb7">41.</label><element-citation publication-type="journal" id="8ae97a58-6454-4f44-a22b-64bbe8e36910"><person-group person-group-type="author" id="35e84286-3f87-48fd-b5ee-5144b1b7a286"><name id="8571b27e-8f24-47b2-bb19-9cfe1c160daa"><surname id="014755ff-dc79-4442-9c02-6b5ee864d6f8">Powrie</surname> <given-names id="9a0850dd-e5cf-4ff3-9d3d-2234f42cd800">DJ</given-names></name><x>, </x><name id="6019fb8a-4d60-4ff1-b4a6-78fe4eecfe3b"><surname id="b05d342c-2365-4130-8947-e7f5b63ab7b1">Wilkinson</surname> <given-names id="fe24b4dc-36f9-4809-bfdf-dd0722529fb1"><named-content data-cid="1555068439030" content-type="del cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="5688dfc6-a628-412b-9c45-11a63695ab3a">TM</named-content><named-content data-cid="1555068439030" content-type="ins cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="a2d0650e-7dfa-4cff-8397-464e1dd1e7ec">TMA</named-content></given-names></name><x>, </x><name id="0c66df74-cc48-4b6e-9035-4d9eb8bdd051"><surname id="cf324c9f-cf0f-401d-9a50-89bc6ff0efe7">Donaldson</surname> <given-names id="9d1de008-6113-44d6-9493-bf3cb9ed0c4f">GC</given-names></name><x>, </x><etal data-class="RefEtal" id="f32d71e8-0d77-4d08-b153-140d22fcdec7">et al</etal></person-group><x>. </x><article-title id="93d04ee2-abe4-489c-a8f5-1c71712aaeab">Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD</article-title><x>. </x><source id="5c8b4e65-c4c5-4fbf-9d18-3f28e3498108">Eur Respir J</source><x> </x><year id="06bc93fd-3092-49fc-beb2-41ee6622384d">2007</year><x>;</x><volume id="fc7556fa-1fd7-4ca7-ac76-56fe88a4b07b">30</volume><x>:</x><fpage id="674dc031-30bd-4da6-99c1-f3fe03945a6a">472</fpage><x>–</x><lpage id="f428168a-394a-4f03-9372-84b76b00b700">8</lpage><x>.</x><pub-id pub-id-type="doi" id="a6af2967-70ab-49a1-ad36-c3f1877607d2">10.1183/09031936.00023907</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R42" id="R42" data-id="R42" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R42" data-validated="true"><label id="ef241201-6505-42ec-acd7-b1f00fcee844">42.</label><element-citation publication-type="journal" id="ffe284a1-4986-4464-8c1e-cd86481daba4"><person-group person-group-type="author" id="7dcf7081-8cb3-4190-863f-8e707318a357"><name id="0a6864a0-123f-4537-b9ce-2be3a1eec62d"><surname id="99454249-934a-44bf-9c93-6dd0ee21e021">Dickens</surname> <given-names id="9a8e9503-2958-4826-b6e8-f4f9461e9726">JA</given-names></name><x>, </x><name id="424386d1-1068-49be-8659-1b8a4fe8d524"><surname id="c650ba42-f8e3-4f83-9f2f-e5027cc5bb8c">Miller</surname> <given-names id="e84deffd-1039-42f9-a97d-a98c43f34fe4">BE</given-names></name><x>, </x><name id="fa1f57d0-1526-4e58-bd7b-5b0a13fdb24d"><surname id="1edcef78-9191-45c1-9592-2c5ad09619d6">Edwards</surname> <given-names id="9b36d331-0420-4789-bfdd-ae766c4094d1">LD</given-names></name><x>, </x><etal data-class="RefEtal" id="fe02fd1f-402a-43ba-b9cf-d05b3be813a9">et al</etal></person-group><x>. </x><article-title id="5ee92dc3-13f7-4556-abbd-88262568797e">COPD association and repeatability of blood biomarkers in the <named-content data-cid="1555068439031" content-type="del cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R81" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="abc32f45-9c76-4110-ab0a-72cefee1e5a0">ECLIPSE</named-content><named-content data-cid="1555068439031" content-type="ins cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R81" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="b9556d1f-bd01-4c88-b0c2-bd64b9b2aea1">eclipse</named-content> cohort. Evaluation of COPD <named-content data-cid="1555068439032" content-type="del cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R82" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="7923742e-94f2-48b7-81e7-82e69a38b0a3">Longitudinally</named-content><named-content data-cid="1555068439032" content-type="ins cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R82" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="0479fece-06d2-4db6-8d7e-febf4c9346f9">longitudinally</named-content> to <named-content data-cid="1555068439033" content-type="del cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R83" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="7f0adac4-9e87-48e8-9918-35e68d1f6465">Identify</named-content><named-content data-cid="1555068439033" content-type="ins cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R83" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="058c08c3-8f03-4f24-aaca-4148afec3903">identify</named-content> <named-content data-cid="1555068439034" content-type="del cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R84" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="67b04e0a-9734-4f41-abf0-59324aad795a">Surrogate</named-content><named-content data-cid="1555068439034" content-type="ins cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R84" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="bfe57e07-567d-4366-965a-5598256d2a74">surrogate</named-content> <named-content data-cid="1555068439035" content-type="del cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R85" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="62768849-819d-4b13-8709-d398e21570a4">Endpoints</named-content><named-content data-cid="1555068439035" content-type="ins cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R85" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="333a482e-4a32-4b26-bc5b-e87ad25ed659">endpoints</named-content> (<named-content data-cid="1555068439036" content-type="del cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R86" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="19abb279-bed5-45c4-aa34-c27e18572a4d">ECLIPSE</named-content><named-content data-cid="1555068439036" content-type="ins cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R86" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="db912a24-4e22-4102-96b5-7d4e8a9d1859">eclipse</named-content>) <named-content data-cid="1555068439037" content-type="del cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R87" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="2aada16a-d575-4e55-94eb-c126080e0510">study</named-content><named-content data-cid="1555068439037" content-type="ins cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R87" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="2fd1580e-060f-49d2-9482-a172635f0289">Study</named-content> <named-content data-cid="1555068439038" content-type="del cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R88" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="4de2a846-8c16-4b72-a2e8-4f4dd57a3f83">investigators</named-content><named-content data-cid="1555068439038" content-type="ins cts-1" specific-use="1555068439000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2019/04/12 16:57 pm" data-track-detail="" data-diff-rid="R88" data-userid="cross-ref" data-username="cross-ref" data-time="1555068439000" id="23710598-f91d-4762-829e-46addb0a359a">Investigators</named-content></article-title><x>. </x><source id="5ca0bbfd-47e3-4681-ba72-fb1c143a0452">Respir Res</source><x> </x><year id="7061f33c-d479-4634-8ef3-e3f9c1166c38">2011</year><x>;</x><volume id="6e0dcc28-c9e2-4b5a-ba17-e71592592e6f">12</volume><x>.</x></element-citation></ref><ref data-class="jrnlRefText" id="R43" data-id="R43" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R43" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/16921105" data-doi="10.1513/pats.200603-030MS" data-validated="true"><label id="3bd4c7fe-b1b2-4e93-a573-bef5f55d7ce1">43.</label><element-citation publication-type="journal" id="5ecb6ed6-69cd-4e84-b80c-72522c1ed027"><person-group person-group-type="author" id="fd3c3858-a899-46f8-bbbb-38e4220eabb2"><name id="4c48c66c-e3e4-41f8-a5b0-afc5cae71f41"><surname id="07fe303e-84c2-4111-b13f-90742abbe205">Pinto-Plata</surname> <given-names id="8c74d50d-34ee-43fa-9d8e-2c14a6da842a">V</given-names></name><x>, </x><name id="78482c5c-5a76-4606-911f-e9185021f6da"><surname id="1cff912b-0a3e-47d5-b6cf-2ba895bacb27">Toso</surname> <given-names id="fdf49f2a-8f3d-4a45-96b3-bd6867d52691">J</given-names></name><x>, </x><name id="c06a3d14-cebe-45f0-a8ea-d39441bf535c"><surname id="dba9f652-1094-4deb-a68a-59fa00d98f15">Lee</surname> <given-names id="15f2afc2-26d2-4858-8813-94f9efb7203f">K</given-names></name><x>, </x><etal data-class="RefEtal" id="8bc6e1b1-120d-4a45-a351-794c73640c17">et al</etal></person-group><x>. </x><article-title id="0ce36e3b-fec2-4ee5-af93-a54d62a12de5">Use of proteomic patterns of serum biomarkers in patients with chronic obstructive pulmonary disease: correlation with clinical parameters</article-title><x>. </x><source id="42708ad1-1d7e-47b1-8c91-4d76e075dbc7">Proc Am Thorac Soc</source><x> </x><year id="54eeb56f-d704-460a-b35c-dd85ded5746e">2006</year><x>;</x><volume id="1dd039e6-9ee4-4c80-b5b0-60461a41e700">3</volume><x>:</x><fpage id="f494163d-437d-4322-a4a0-be5b2d45b905">465</fpage><x>–</x><lpage id="5713e2eb-90b4-47b3-a036-a1f757f5d8d4">6</lpage><x>.</x><pub-id pub-id-type="doi" id="7f1e298b-83d1-409a-9e53-09523902d0e1">10.1513/pats.200603-030MS</pub-id></element-citation></ref></ref-list><supplementary-material section="back" node-xpath="supplementary-group" direct-node="true" id="BLK_SP1" data-id="BLK_SP1" data-stream-name="a_SP1" data-ref-id="P1"><label id="cffa5654-aab5-4626-90a1-0aa626cbe5c8"><named-content data-cid="1555394565774" id="8ca9b75c-84e8-4490-8009-6b49e48409c3" content-type="ins cts-1" specific-use="1555068439000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1555068439000">online supplementary file 1</named-content></label><caption id="658325c9-9f1b-43ea-8163-adf66b24a3a1"><title id="SP1" data-id="SP1"/></caption><media xlink:href="/resources/bmj/bmjresp/bmjresp-2019-000431/inputs/bmjresp-2019-000431-20190409004144/suppl_data/SUMMIT_biomarker_Supplement_29MAR2019.pdf" id="a305107f-e904-43bb-83f6-2ac5ec473b0e">SUMMIT_biomarker_Supplement_29MAR2019.pdf</media></supplementary-material></back><workflow ftp-file-name="bmjresp-2019-000431"><priority>priority</priority><current-stage>Archive</current-stage><paw-stage><previous>Upload for Online First</previous><current>Article Bank</current></paw-stage><word-count/><word-count-without-ref>4800</word-count-without-ref><stage><name>addJob</name><customer-stage-name>Add Job</customer-stage-name><start-date-time/><end-date-time/><start-date>2019-04-09 04:45:01</start-date><duration>0</duration><end-word-count>29</end-word-count><end-word-count-without-ref>29</end-word-count-without-ref><end-date>2019-04-09 04:45:02</end-date><status>completed</status><comments/><assigned><to>Exeter</to><by>Exeter</by><on/><reason/></assigned><time-log><log><start/><end/><duration/><status/></log></time-log></stage><stage><iteration>1</iteration><start-word-count>29</start-word-count><start-word-count-without-ref>29</start-word-count-without-ref><name>File download</name><customer-stage-name>Clean up</customer-stage-name><start-date>2019-04-09 04:45:02</start-date><duration>0</duration><end-word-count>29</end-word-count><end-word-count-without-ref>29</end-word-count-without-ref><end-date>2019-04-09 04:45:19</end-date><sla-start-date>2019-04-09 04:45:02</sla-start-date><sla-end-date>2019-04-10 04:45:02</sla-end-date><planned-start-date>2019-04-09 04:45:02</planned-start-date><planned-end-date>2019-04-10 04:45:02</planned-end-date><status>completed</status><comments/><assigned><to>Exeter</to><by>Exeter</by><on>0</on><reason/></assigned><time-log><log><start/><end/><duration/><status type="system"/></log></time-log><error/><object><figure/><table/><box/><user><name/><id/><inserted/><deleted/></user></object></stage><stage><iteration>1</iteration><start-word-count>29</start-word-count><start-word-count-without-ref>29</start-word-count-without-ref><name>Convert Files</name><customer-stage-name>Clean up</customer-stage-name><start-date>2019-04-09 04:45:19</start-date><duration>0</duration><end-word-count>669</end-word-count><end-word-count-without-ref>669</end-word-count-without-ref><end-date>2019-04-09 04:45:32</end-date><sla-start-date>2019-04-09 04:45:02</sla-start-date><sla-end-date>2019-04-10 04:45:02</sla-end-date><planned-start-date>2019-04-09 04:45:19</planned-start-date><planned-end-date>2019-04-10 04:45:19</planned-end-date><status>completed</status><comments/><assigned><to>Exeter</to><by>Exeter</by><on>0</on><reason/></assigned><time-log><log><start/><end/><duration/><status type="system"/></log></time-log><error/><object><figure/><table/><box/><user><name/><id/><inserted/><deleted/></user></object></stage><stage><name>Pre-editing</name><customer-stage-name>Clean up</customer-stage-name><start-date>2019-04-09 04:45:32</start-date><start-word-count>669</start-word-count><start-word-count-without-ref>669</start-word-count-without-ref><end-word-count>669</end-word-count><end-word-count-without-ref>669</end-word-count-without-ref><iteration>1</iteration><duration>0</duration><end-date>2019-04-09 04:45:32</end-date><sla-start-date>2019-04-09 04:45:32</sla-start-date><sla-end-date>2019-04-11 04:45:32</sla-end-date><planned-start-date>2019-04-09 04:45:32</planned-start-date><planned-end-date>2019-04-11 04:45:32</planned-end-date><status>completed</status><comments>Moved to Hold</comments><assigned><to>Exeter</to><by>Exeter</by><on>0</on><reason/></assigned><time-log><log><start/><end/><duration/><status type="system"/></log></time-log><error/><object><figure/><table/><box/><user><name/><id/><inserted/><deleted/></user></object></stage><stage><iteration>1</iteration><start-word-count>669</start-word-count><start-word-count-without-ref>669</start-word-count-without-ref><name>Hold</name><customer-stage-name>Clean up</customer-stage-name><start-date>2019-04-09 04:45:32</start-date><duration>0</duration><end-word-count>669</end-word-count><end-word-count-without-ref>669</end-word-count-without-ref><end-date>2019-04-09 23:30:03</end-date><sla-start-date>2019-04-09 04:45:32</sla-start-date><sla-end-date>2019-04-10 04:45:32</sla-end-date><planned-start-date>2019-04-09 04:45:32</planned-start-date><planned-end-date>2019-04-10 04:45:32</planned-end-date><status>completed</status><held-stage/><hold-state/><comments/><assigned><to/><by/><on/><reason/></assigned><time-log><log><start/><end/><duration/><status type="system"/></log></time-log><error/><object><figure/><table/><box/><user><name/><id/><inserted/><deleted/></user></object><job-logs/></stage><stage><iteration>2</iteration><start-word-count>669</start-word-count><start-word-count-without-ref>669</start-word-count-without-ref><name>Pre-editing</name><customer-stage-name>Clean up</customer-stage-name><start-date>2019-04-09 23:30:03</start-date><duration>36</duration><end-word-count>6045</end-word-count><end-word-count-without-ref>4542</end-word-count-without-ref><end-date>2019-04-12 12:17:19</end-date><sla-start-date>2019-04-09 23:30:03</sla-start-date><sla-end-date>2019-04-11 23:30:03</sla-end-date><planned-start-date>2019-04-09 23:30:03</planned-start-date><planned-end-date>2019-04-11 23:30:03</planned-end-date><status>completed</status><comments>Relesed based on PAW email</comments><assigned><to>Gowtham Ram, gowthamram@exeterpm.com</to><by>System, Exeter</by><on>2019-04-12 11:10:57</on><reason/></assigned><time-log><log><start/><end/><duration/><status type="system"/></log></time-log><error/><object><figure/><table/><box/><user><name/><id/><inserted/><deleted/></user><proof><pdf user="Gowtham Ram (PREEDITOR)" role="preeditor" time="1555071060090" path="http://kriya2.kriyadocs.com/resources/bmj/bmjresp/bmjresp-2019-000431/proofing/bmjresp-2019-000431.pdf?method=server"/></proof></object><job-logs><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Gowtham Ram</username><useremail>gowthamram@exeterpm.com</useremail><start-date>2019-04-12</start-date><start-time>11:10:57</start-time><end-date>2019-04-12</end-date><end-time>11:16:32</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Mr. Gowtham Ram null</username><useremail>gowthamram@exeterpm.com</useremail><start-date>2019-04-12</start-date><start-time>11:25:27</start-time><end-date>2019-04-12</end-date><end-time>11:31:37</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Mr. Gowtham Ram null</username><useremail>gowthamram@exeterpm.com</useremail><start-date>2019-04-12</start-date><start-time>11:33:37</start-time><end-date>2019-04-12</end-date><end-time>11:36:02</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Mr. Gowtham Ram null</username><useremail>gowthamram@exeterpm.com</useremail><start-date>2019-04-12</start-date><start-time>11:36:16</start-time><end-date>2019-04-12</end-date><end-time>11:40:34</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Mr. Gowtham Ram null</username><useremail>gowthamram@exeterpm.com</useremail><start-date>2019-04-12</start-date><start-time>11:40:47</start-time><end-date>2019-04-12</end-date><end-time>11:41:25</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Gowtham Ram</username><useremail>gowthamram@exeterpm.com</useremail><start-date>2019-04-12</start-date><start-time>11:41:40</start-time><end-date>2019-04-12</end-date><end-time>11:41:42</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Gowtham Ram</username><useremail>gowthamram@exeterpm.com</useremail><start-date>2019-04-12</start-date><start-time>11:42:12</start-time><end-date>2019-04-12</end-date><end-time>11:43:12</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Gowtham Ram</username><useremail>gowthamram@exeterpm.com</useremail><start-date>2019-04-12</start-date><start-time>11:43:30</start-time><end-date>2019-04-12</end-date><end-time>11:45:05</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Gowtham Ram</username><useremail>gowthamram@exeterpm.com</useremail><start-date>2019-04-12</start-date><start-time>11:45:11</start-time><end-date>2019-04-12</end-date><end-time>11:55:53</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Gowtham Ram</username><useremail>gowthamram@exeterpm.com</useremail><start-date>2019-04-12</start-date><start-time>11:56:28</start-time><end-date>2019-04-12</end-date><end-time>11:57:31</end-time><status type="system">logged-off</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Gowtham Ram</username><useremail>gowthamram@exeterpm.com</useremail><start-date>2019-04-12</start-date><start-time>12:03:25</start-time><end-date>2019-04-12</end-date><end-time>12:05:13</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Gowtham Ram</username><useremail>gowthamram@exeterpm.com</useremail><start-date>2019-04-12</start-date><start-time>12:05:41</start-time><end-date>2019-04-12</end-date><end-time>12:08:14</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Gowtham Ram</username><useremail>gowthamram@exeterpm.com</useremail><start-date>2019-04-12</start-date><start-time>12:09:11</start-time><end-date>2019-04-12</end-date><end-time>12:09:11</end-time><status type="system">open</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Gowtham Ram</username><useremail>gowthamram@exeterpm.com</useremail><start-date>2019-04-12</start-date><start-time>12:09:11</start-time><end-date>2019-04-12</end-date><end-time>12:10:25</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Gowtham Ram</username><useremail>gowthamram@exeterpm.com</useremail><start-date>2019-04-12</start-date><start-time>12:14:34</start-time><end-date>2019-04-12</end-date><end-time>12:14:34</end-time><status type="system">open</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Gowtham Ram</username><useremail>gowthamram@exeterpm.com</useremail><start-date>2019-04-12</start-date><start-time>12:14:35</start-time><end-date>2019-04-12</end-date><end-time>12:16:36</end-time><status type="system">signed-off</status></log></job-logs></stage><stage><iteration>1</iteration><start-word-count>6045</start-word-count><start-word-count-without-ref>4542</start-word-count-without-ref><name>Waiting for CE</name><customer-stage-name>Copy edit</customer-stage-name><start-date>2019-04-12 12:17:19</start-date><duration>0</duration><end-word-count>6045</end-word-count><end-word-count-without-ref>4542</end-word-count-without-ref><end-date>2019-04-12 12:30:08</end-date><sla-start-date>2019-04-12 12:17:19</sla-start-date><sla-end-date>2019-04-15 12:17:19</sla-end-date><planned-start-date>2019-04-12 12:17:19</planned-start-date><planned-end-date>2019-04-15 12:17:19</planned-end-date><status>completed</status><comments/><assigned><to>Exeter</to><by>Exeter</by><on>0</on><reason/></assigned><time-log><log><start/><end/><duration/><status type="system"/></log></time-log><error/><object><figure/><table/><box/><user><name/><id/><inserted/><deleted/></user></object></stage><stage><iteration>1</iteration><start-word-count>6045</start-word-count><start-word-count-without-ref>4542</start-word-count-without-ref><name>Copyediting</name><customer-stage-name>Copy edit</customer-stage-name><start-date>2019-04-12 12:30:08</start-date><duration>90</duration><end-word-count>6002</end-word-count><end-word-count-without-ref>4499</end-word-count-without-ref><end-date>2019-04-15 01:37:42</end-date><sla-start-date>2019-04-12 12:30:08</sla-start-date><sla-end-date>2019-04-15 12:30:08</sla-end-date><planned-start-date>2019-04-12 12:30:08</planned-start-date><planned-end-date>2019-04-15 12:30:08</planned-end-date><status>completed</status><comments/><assigned><to>Ariel Angelo, aabaquino@gmail.com</to><by>Ariel Angelo, aabaquino@gmail.com</by><on>2019-04-14 20:42:13</on><reason/></assigned><time-log><log><start/><end/><duration/><status type="system"/></log></time-log><error/><object><figure/><table/><box/><user><name/><id/><inserted/><deleted/></user><proof><pdf user="Ariel (COPYEDITOR)" role="copyeditor" time="1555291810756" path="http://kriya2.kriyadocs.com/resources/bmj/bmjresp/bmjresp-2019-000431/proofing/bmjresp-2019-000431.pdf?method=server"/></proof></object><job-logs><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Ariel Angelo</username><useremail>aabaquino@gmail.com</useremail><start-date>2019-04-14</start-date><start-time>23:42:50</start-time><end-date>2019-04-15</end-date><end-time>00:32:51</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Ariel</username><useremail>aabaquino@gmail.com</useremail><start-date>2019-04-15</start-date><start-time>00:56:07</start-time><end-date>2019-04-15</end-date><end-time>01:36:26</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Ariel</username><useremail>aabaquino@gmail.com</useremail><start-date>2019-04-15</start-date><start-time>01:37:30</start-time><end-date>2019-04-15</end-date><end-time>01:37:30</end-time><status type="system">signed-off</status></log></job-logs></stage><stage><iteration>1</iteration><start-word-count>6002</start-word-count><start-word-count-without-ref>4499</start-word-count-without-ref><name>Typesetter Check</name><customer-stage-name>Typeset</customer-stage-name><start-date>2019-04-15 01:37:42</start-date><duration>26</duration><end-word-count>6012</end-word-count><end-word-count-without-ref>4509</end-word-count-without-ref><end-date>2019-04-15 09:14:04</end-date><sla-start-date>2019-04-15 01:37:42</sla-start-date><sla-end-date>2019-04-16 01:37:42</sla-end-date><planned-start-date>2019-04-15 01:37:42</planned-start-date><planned-end-date>2019-04-16 01:37:42</planned-end-date><status>completed</status><comments/><assigned><to>Gowtham Ram, gowthamram@exeterpm.com</to><by>System, Exeter</by><on>2019-04-15 07:24:48</on><reason/></assigned><time-log><log><start/><end/><duration/><status type="system"/></log></time-log><error/><object><figure/><table/><box/><user><name/><id/><inserted/><deleted/></user><proof><pdf user="Gowtham Ram (TYPESETTER)" role="typesetter" time="1555313806511" path="http://kriya2.kriyadocs.com/resources/bmj/bmjresp/bmjresp-2019-000431/proofing/bmjresp-2019-000431.pdf?method=server" reason="base-alignment" job-id="0fb2b6ad-3255-492f-8e4a-1a7276ef72dc"/><pdf user="Gowtham Ram (TYPESETTER)" role="typesetter" time="1555314233114" path="http://kriya2.kriyadocs.com/resources/bmj/bmjresp/bmjresp-2019-000431/proofing/bmjresp-2019-000431.pdf?method=server" reason="base-alignment" job-id="2ef3bda2-06e0-4593-8275-2951d71b408b"/><pdf user="Gowtham Ram (TYPESETTER)" role="typesetter" time="1555318535244" path="http://kriya2.kriyadocs.com/resources/bmj/bmjresp/bmjresp-2019-000431/proofing/bmjresp-2019-000431.pdf?method=server" reason="none" data-noFontMissing="false" job-id="a10921d4-e19e-4f36-80fd-7aa49b79771f"/><pdf user="Gowtham Ram (TYPESETTER)" role="typesetter" time="1555319199606" path="http://kriya2.kriyadocs.com/resources/bmj/bmjresp/bmjresp-2019-000431/proofing/bmjresp-2019-000431.pdf?method=server"/><pdf user="Gowtham Ram (TYPESETTER)" role="typesetter" time="1555319517455" path="http://kriya2.kriyadocs.com/resources/bmj/bmjresp/bmjresp-2019-000431/proofing/bmjresp-2019-000431.pdf?method=server" reason="table-column-adjust" job-id="3c4c0356-fb62-4897-9ceb-3a031f287f66"/></proof></object><job-logs><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Gowtham Ram</username><useremail>gowthamram@exeterpm.com</useremail><start-date>2019-04-15</start-date><start-time>07:24:48</start-time><end-date>2019-04-15</end-date><end-time>07:36:06</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Gowtham Ram</username><useremail>gowthamram@exeterpm.com</useremail><start-date>2019-04-15</start-date><start-time>07:36:30</start-time><end-date>2019-04-15</end-date><end-time>07:36:45</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Gowtham Ram</username><useremail>gowthamram@exeterpm.com</useremail><start-date>2019-04-15</start-date><start-time>07:37:57</start-time><end-date>2019-04-15</end-date><end-time>07:39:37</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Gowtham Ram</username><useremail>gowthamram@exeterpm.com</useremail><start-date>2019-04-15</start-date><start-time>07:41:11</start-time><end-date>2019-04-15</end-date><end-time>07:43:24</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Gowtham Ram</username><useremail>gowthamram@exeterpm.com</useremail><start-date>2019-04-15</start-date><start-time>07:43:51</start-time><end-date>2019-04-15</end-date><end-time>07:44:55</end-time><status type="user">logged-off</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Gowtham Ram</username><useremail>gowthamram@exeterpm.com</useremail><start-date>2019-04-15</start-date><start-time>08:48:47</start-time><end-date>2019-04-15</end-date><end-time>08:51:17</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Gowtham Ram</username><useremail>gowthamram@exeterpm.com</useremail><start-date>2019-04-15</start-date><start-time>08:51:20</start-time><end-date>2019-04-15</end-date><end-time>08:52:46</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Gowtham Ram</username><useremail>gowthamram@exeterpm.com</useremail><start-date>2019-04-15</start-date><start-time>08:53:48</start-time><end-date>2019-04-15</end-date><end-time>08:54:39</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Gowtham Ram</username><useremail>gowthamram@exeterpm.com</useremail><start-date>2019-04-15</start-date><start-time>08:55:09</start-time><end-date>2019-04-15</end-date><end-time>08:56:18</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Gowtham Ram</username><useremail>gowthamram@exeterpm.com</useremail><start-date>2019-04-15</start-date><start-time>08:56:30</start-time><end-date>2019-04-15</end-date><end-time>08:58:32</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Gowtham Ram</username><useremail>gowthamram@exeterpm.com</useremail><start-date>2019-04-15</start-date><start-time>08:58:32</start-time><end-date>2019-04-15</end-date><end-time>08:58:43</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Gowtham Ram</username><useremail>gowthamram@exeterpm.com</useremail><start-date>2019-04-15</start-date><start-time>08:58:46</start-time><end-date>2019-04-15</end-date><end-time>08:59:03</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Gowtham Ram</username><useremail>gowthamram@exeterpm.com</useremail><start-date>2019-04-15</start-date><start-time>08:59:53</start-time><end-date>2019-04-15</end-date><end-time>09:02:29</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Gowtham Ram</username><useremail>gowthamram@exeterpm.com</useremail><start-date>2019-04-15</start-date><start-time>09:02:49</start-time><end-date>2019-04-15</end-date><end-time>09:02:50</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Gowtham Ram</username><useremail>gowthamram@exeterpm.com</useremail><start-date>2019-04-15</start-date><start-time>09:03:12</start-time><end-date>2019-04-15</end-date><end-time>09:03:28</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Gowtham Ram</username><useremail>gowthamram@exeterpm.com</useremail><start-date>2019-04-15</start-date><start-time>09:03:39</start-time><end-date>2019-04-15</end-date><end-time>09:05:18</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Gowtham Ram</username><useremail>gowthamram@exeterpm.com</useremail><start-date>2019-04-15</start-date><start-time>09:05:23</start-time><end-date>2019-04-15</end-date><end-time>09:05:46</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Gowtham Ram</username><useremail>gowthamram@exeterpm.com</useremail><start-date>2019-04-15</start-date><start-time>09:06:09</start-time><end-date>2019-04-15</end-date><end-time>09:08:17</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Gowtham Ram</username><useremail>gowthamram@exeterpm.com</useremail><start-date>2019-04-15</start-date><start-time>09:08:47</start-time><end-date>2019-04-15</end-date><end-time>09:09:12</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Gowtham Ram</username><useremail>gowthamram@exeterpm.com</useremail><start-date>2019-04-15</start-date><start-time>09:09:32</start-time><end-date>2019-04-15</end-date><end-time>09:10:27</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Gowtham Ram</username><useremail>gowthamram@exeterpm.com</useremail><start-date>2019-04-15</start-date><start-time>09:13:18</start-time><end-date>2019-04-15</end-date><end-time>09:13:18</end-time><status type="system">open</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Gowtham Ram</username><useremail>gowthamram@exeterpm.com</useremail><start-date>2019-04-15</start-date><start-time>09:13:18</start-time><end-date>2019-04-15</end-date><end-time>09:13:18</end-time><status type="system">signed-off</status></log></job-logs></stage><stage><iteration>1</iteration><start-word-count>6012</start-word-count><start-word-count-without-ref>4509</start-word-count-without-ref><name>Author Review</name><customer-stage-name>Author proof</customer-stage-name><start-date>2019-04-15 09:14:04</start-date><duration>0</duration><end-word-count>6014</end-word-count><end-word-count-without-ref>4511</end-word-count-without-ref><end-date>2019-04-15 14:20:21</end-date><sla-start-date>2019-04-15 09:14:04</sla-start-date><sla-end-date>2019-04-17 09:14:04</sla-end-date><planned-start-date>2019-04-15 09:14:04</planned-start-date><planned-end-date>2019-04-17 09:14:04</planned-end-date><status>completed</status><comments/><assigned><to>Bartolome R Celli, bcelli@copdnet.org</to><by/><on/><reason/></assigned><time-log><log><start/><end/><duration/><status type="system"/></log></time-log><error/><object><figure/><table/><box/><user><name/><id/><inserted/><deleted/></user></object><article-key><key live="true" email="bcelli@copdnet.org">https://kriya2.kriyadocs.com/review_content/?key=8e846e694f500fa895a31373e40f091fc2a17eb93b90fc73545dc035a1ff260acb302c337a261e52b0927da889d25444d025a9f5c71dd3f3ec7af7cb727395c21a37dce7e2e7fb398588178b96aa8f8a770f8b89a70a7c441d81b089f8b38c5b00993329495e34520616eddd500dbf3d19bd03d9cdea2e6bca7cc5e3809f8daf9317ed</key></article-key><job-logs><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Bartolome R Celli</username><useremail>bcelli@copdnet.org</useremail><start-date>2019-04-15</start-date><start-time>13:57:40</start-time><end-date>2019-04-15</end-date><end-time>13:57:40</end-time><status type="user">signed-off</status></log></job-logs></stage><stage><iteration>1</iteration><start-word-count>6014</start-word-count><start-word-count-without-ref>4511</start-word-count-without-ref><name>Publisher Review</name><customer-stage-name>Production QC</customer-stage-name><start-date>2019-04-15 14:20:21</start-date><duration>101</duration><end-word-count>6017</end-word-count><end-word-count-without-ref>4514</end-word-count-without-ref><end-date>2019-04-26 06:50:22</end-date><sla-start-date>2019-04-15 14:20:21</sla-start-date><sla-end-date>2019-04-16 14:20:21</sla-end-date><planned-start-date>2019-04-15 14:20:21</planned-start-date><planned-end-date>2019-04-16 14:20:21</planned-end-date><status>completed</status><comments/><assigned><to>Manoj Mohan, mmohan@bmj.com</to><by>System, Exeter</by><on>2019-04-17 10:15:37</on><reason/></assigned><time-log><log><start/><end/><duration/><status type="system"/></log></time-log><error/><object><figure/><table/><box/><user><name/><id/><inserted/><deleted/></user><proof><pdf user="Manoj (BMJ)" role="publisher" time="1555499049530" path="http://kriya2.kriyadocs.com/resources/bmj/bmjresp/bmjresp-2019-000431/proofing/bmjresp-2019-000431.pdf?method=server"/></proof></object><job-logs><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Manoj Mohan</username><useremail>mmohan@bmj.com</useremail><start-date>2019-04-17</start-date><start-time>10:15:37</start-time><end-date>2019-04-17</end-date><end-time>10:31:55</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Manoj</username><useremail>mmohan@bmj.com</useremail><start-date>2019-04-17</start-date><start-time>10:56:14</start-time><end-date>2019-04-17</end-date><end-time>11:10:53</end-time><status type="system">logged-off</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Manoj Mohan</username><useremail>mmohan@bmj.com</useremail><start-date>2019-04-26</start-date><start-time>05:37:11</start-time><end-date>2019-04-26</end-date><end-time>06:48:58</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Manoj</username><useremail>mmohan@bmj.com</useremail><start-date>2019-04-26</start-date><start-time>06:48:58</start-time><end-date>2019-04-26</end-date><end-time>06:48:58</end-time><status type="system">signed-off</status></log></job-logs></stage><stage><iteration>1</iteration><start-word-count>6017</start-word-count><start-word-count-without-ref>4514</start-word-count-without-ref><name>Typesetter Review</name><customer-stage-name>Corrections</customer-stage-name><start-date>2019-04-26 06:50:22</start-date><duration>17</duration><end-word-count>6303</end-word-count><end-word-count-without-ref>4800</end-word-count-without-ref><end-date>2019-04-27 05:11:19</end-date><sla-start-date>2019-04-26 06:50:22</sla-start-date><sla-end-date>2019-04-29 06:50:22</sla-end-date><planned-start-date>2019-04-26 06:50:22</planned-start-date><planned-end-date>2019-04-29 06:50:22</planned-end-date><status>completed</status><comments/><assigned><to>Renganath Exeter, renganath@exeterpm.com</to><by>System, Exeter</by><on>2019-04-27 04:42:23</on><reason/></assigned><time-log><log><start/><end/><duration/><status type="system"/></log></time-log><error/><object><figure/><table/><box/><user><name/><id/><inserted/><deleted/></user><proof><pdf user="Renganath (TYPESETTER)" role="typesetter" time="1556341200379" path="http://kriya2.kriyadocs.com/resources/bmj/bmjresp/bmjresp-2019-000431/proofing/bmjresp-2019-000431.pdf?method=server" reason="none" job-id="b68d38b2-9f86-4b2f-bc16-15680c138e7f"/><pdf user="Renganath (TYPESETTER)" role="typesetter" time="1556341457117" path="http://kriya2.kriyadocs.com/resources/bmj/bmjresp/bmjresp-2019-000431/proofing/bmjresp-2019-000431.pdf?method=server" reason="none" job-id="423a5f10-776e-49cf-80f4-2299e6dab465"/></proof></object><job-logs><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Renganath Exeter</username><useremail>renganath@exeterpm.com</useremail><start-date>2019-04-27</start-date><start-time>04:42:23</start-time><end-date>2019-04-27</end-date><end-time>04:43:38</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Renganath</username><useremail>renganath@exeterpm.com</useremail><start-date>2019-04-27</start-date><start-time>04:43:40</start-time><end-date>2019-04-27</end-date><end-time>04:44:43</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Renganath</username><useremail>renganath@exeterpm.com</useremail><start-date>2019-04-27</start-date><start-time>04:44:54</start-time><end-date>2019-04-27</end-date><end-time>04:48:18</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Renganath</username><useremail>renganath@exeterpm.com</useremail><start-date>2019-04-27</start-date><start-time>04:51:27</start-time><end-date>2019-04-27</end-date><end-time>04:52:28</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Renganath</username><useremail>renganath@exeterpm.com</useremail><start-date>2019-04-27</start-date><start-time>04:52:42</start-time><end-date>2019-04-27</end-date><end-time>04:58:13</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Renganath</username><useremail>renganath@exeterpm.com</useremail><start-date>2019-04-27</start-date><start-time>04:58:17</start-time><end-date>2019-04-27</end-date><end-time>04:59:34</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Renganath</username><useremail>renganath@exeterpm.com</useremail><start-date>2019-04-27</start-date><start-time>04:59:50</start-time><end-date>2019-04-27</end-date><end-time>05:00:49</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Renganath</username><useremail>renganath@exeterpm.com</useremail><start-date>2019-04-27</start-date><start-time>05:01:01</start-time><end-date>2019-04-27</end-date><end-time>05:03:50</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Renganath</username><useremail>renganath@exeterpm.com</useremail><start-date>2019-04-27</start-date><start-time>05:04:01</start-time><end-date>2019-04-27</end-date><end-time>05:05:23</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Renganath</username><useremail>renganath@exeterpm.com</useremail><start-date>2019-04-27</start-date><start-time>05:05:36</start-time><end-date>2019-04-27</end-date><end-time>05:07:39</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Renganath</username><useremail>renganath@exeterpm.com</useremail><start-date>2019-04-27</start-date><start-time>05:08:23</start-time><end-date>2019-04-27</end-date><end-time>05:09:10</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Renganath</username><useremail>renganath@exeterpm.com</useremail><start-date>2019-04-27</start-date><start-time>05:09:19</start-time><end-date>2019-04-27</end-date><end-time>05:10:09</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Renganath</username><useremail>renganath@exeterpm.com</useremail><start-date>2019-04-27</start-date><start-time>05:10:24</start-time><end-date>2019-04-27</end-date><end-time>05:10:24</end-time><status type="system">signed-off</status></log></job-logs></stage><stage><iteration>2</iteration><start-word-count>6303</start-word-count><start-word-count-without-ref>4800</start-word-count-without-ref><name>Publisher Review</name><customer-stage-name>Revises</customer-stage-name><start-date>2019-04-27 05:11:19</start-date><duration>12</duration><end-word-count>6303</end-word-count><end-word-count-without-ref>4800</end-word-count-without-ref><end-date>2019-05-02 07:20:06</end-date><sla-start-date>2019-04-27 05:11:19</sla-start-date><sla-end-date>2019-04-29 23:11:19</sla-end-date><planned-start-date>2019-04-27 05:11:19</planned-start-date><planned-end-date>2019-04-29 23:11:19</planned-end-date><status>completed</status><comments/><assigned><to>Manoj Mohan, mmohan@bmj.com</to><by>System, Exeter</by><on>2019-05-02 06:59:17</on><reason/></assigned><time-log><log><start/><end/><duration/><status type="system"/></log></time-log><error/><object><figure/><table/><box/><user><name/><id/><inserted/><deleted/></user><proof><pdf user="Manoj (BMJ)" role="publisher" time="1556780784787" path="http://kriya2.kriyadocs.com/resources/bmj/bmjresp/bmjresp-2019-000431/proofing/bmjresp-2019-000431.pdf?method=server"/></proof></object><job-logs><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Manoj Mohan</username><useremail>mmohan@bmj.com</useremail><start-date>2019-05-02</start-date><start-time>06:59:17</start-time><end-date>2019-05-02</end-date><end-time>07:06:58</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Manoj</username><useremail>mmohan@bmj.com</useremail><start-date>2019-05-02</start-date><start-time>07:10:21</start-time><end-date>2019-05-02</end-date><end-time>07:15:22</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Manoj</username><useremail>mmohan@bmj.com</useremail><start-date>2019-05-02</start-date><start-time>07:19:48</start-time><end-date>2019-05-02</end-date><end-time>07:19:48</end-time><status type="system">signed-off</status></log></job-logs></stage><stage><iteration>1</iteration><start-word-count>6303</start-word-count><start-word-count-without-ref>4800</start-word-count-without-ref><name>Final Deliverables</name><customer-stage-name>Upload for Online First</customer-stage-name><start-date>2019-05-02 07:20:06</start-date><duration>2</duration><end-word-count>6303</end-word-count><end-word-count-without-ref>4800</end-word-count-without-ref><end-date>2019-05-04 03:31:11</end-date><sla-start-date>2019-05-02 07:20:06</sla-start-date><sla-end-date>2019-05-03 07:20:06</sla-end-date><planned-start-date>2019-05-02 07:20:06</planned-start-date><planned-end-date>2019-05-03 07:20:06</planned-end-date><status>completed</status><comments/><assigned><to>Usha Venkatesh, usha.venkatesh@exeterpremedia.com</to><by>System, Exeter</by><on>2019-05-03 12:45:35</on><reason/></assigned><time-log><log><start/><end/><duration/><status type="system"/></log></time-log><error/><object><figure/><table/><box/><user><name/><id/><inserted/><deleted/></user><proof><pdf user="Usha (TYPESETTER)" role="typesetter" time="1556940560916" path="http://kriya2.kriyadocs.com/resources/bmj/bmjresp/bmjresp-2019-000431/proofing/bmjresp-2019-000431.pdf?method=server" reason="others" description="rfo" job-id="1fdb85c7-93c5-44ca-8f64-2a4a7c032d03"/></proof></object><job-logs><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Usha Venkatesh</username><useremail>usha.venkatesh@exeterpremedia.com</useremail><start-date>2019-05-03</start-date><start-time>12:45:35</start-time><end-date>2019-05-03</end-date><end-time>12:45:35</end-time><status type="system">logged-off</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Usha Venkatesh</username><useremail>usha.venkatesh@exeterpremedia.com</useremail><start-date>2019-05-03</start-date><start-time>13:00:53</start-time><end-date>2019-05-03</end-date><end-time>13:00:53</end-time><status type="system">logged-off</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Usha Venkatesh</username><useremail>usha.venkatesh@exeterpremedia.com</useremail><start-date>2019-05-03</start-date><start-time>13:16:57</start-time><end-date>2019-05-03</end-date><end-time>13:16:57</end-time><status type="system">logged-off</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Usha Venkatesh</username><useremail>usha.venkatesh@exeterpremedia.com</useremail><start-date>2019-05-03</start-date><start-time>13:22:20</start-time><end-date>2019-05-03</end-date><end-time>13:22:20</end-time><status type="system">logged-off</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Usha Venkatesh</username><useremail>usha.venkatesh@exeterpremedia.com</useremail><start-date>2019-05-03</start-date><start-time>13:59:02</start-time><end-date>2019-05-03</end-date><end-time>14:00:01</end-time><status type="user">logged-off</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Usha Venkatesh</username><useremail>usha.venkatesh@exeterpremedia.com</useremail><start-date>2019-05-04</start-date><start-time>03:25:00</start-time><end-date>2019-05-04</end-date><end-time>03:26:23</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Usha</username><useremail>usha.venkatesh@exeterpremedia.com</useremail><start-date>2019-05-04</start-date><start-time>03:27:53</start-time><end-date>2019-05-04</end-date><end-time>03:29:02</end-time><status type="system">in-active</status></log><log data-doi="bmjresp-2019-000431" data-project="bmjresp" data-customer="bmj"><username>Usha</username><useremail>usha.venkatesh@exeterpremedia.com</useremail><start-date>2019-05-04</start-date><start-time>03:29:48</start-time><end-date>2019-05-04</end-date><end-time>03:29:48</end-time><status type="system">signed-off</status></log></job-logs></stage><stage><iteration>1</iteration><start-word-count>6303</start-word-count><start-word-count-without-ref>4800</start-word-count-without-ref><name>Upload for Online First</name><customer-stage-name>Upload for Online First</customer-stage-name><start-date>2019-05-04 03:31:11</start-date><duration>0</duration><end-word-count>6303</end-word-count><end-word-count-without-ref>4800</end-word-count-without-ref><end-date>2019-05-04 15:00:21</end-date><sla-start-date>2019-05-04 03:31:11</sla-start-date><sla-end-date>2019-05-06 23:31:11</sla-end-date><planned-start-date>2019-05-04 03:31:11</planned-start-date><planned-end-date>2019-05-06 23:31:11</planned-end-date><status>completed</status><held-stage/><hold-state/><comments/><assigned><to/><by/><on/><reason/></assigned><time-log><log><start/><end/><duration/><status type="system"/></log></time-log><error/><object><figure/><table/><box/><user><name/><id/><inserted/><deleted/></user></object><job-logs/></stage><stage><iteration>1</iteration><start-word-count>6303</start-word-count><start-word-count-without-ref>4800</start-word-count-without-ref><name>Archive</name><customer-stage-name>Article Bank</customer-stage-name><start-date>2019-05-04 15:00:21</start-date><end-date>2019-05-06 15:00:21</end-date><sla-start-date>2019-05-04 15:00:21</sla-start-date><sla-end-date>2019-05-06 15:00:21</sla-end-date><planned-start-date>2019-05-04 15:00:21</planned-start-date><planned-end-date>2019-05-06 15:00:21</planned-end-date><status>completed</status><comments/><assigned><to/><by/><on/><reason/></assigned><time-log><log><start/><end/><duration/><status type="system"/></log></time-log><error/><object><figure/><table/><box/><user><name/><id/><inserted/><deleted/></user></object></stage></workflow><production-notes><note type="workflow"><id>86051c80-83c6-42e5-b34f-e001829ce0b0</id><fullname>Workflow</fullname><created>2019-04-09 04:45:01</created><content>Job created on 2019-04-09 04:45:01</content></note><note id="781cc49e-5f64-461a-aea8-eab47955e561" type="workflow"><id>781cc49e-5f64-461a-aea8-eab47955e561</id><fullname>Workflow</fullname><created>2019-04-09 04:45:02</created><content>Article signed-off from addJob to File download</content></note><note id="96beb2ce-6748-468b-8d98-41491cfecd0e" type="workflow"><id>96beb2ce-6748-468b-8d98-41491cfecd0e</id><fullname>Workflow</fullname><created>2019-04-09 04:45:19</created><content>Article signed-off from File download to Convert Files</content></note><note id="eac73ab0-cf45-43f4-a7d6-e65228150b41" type="workflow"><id>eac73ab0-cf45-43f4-a7d6-e65228150b41</id><fullname>Workflow</fullname><created>2019-04-09 04:45:21</created><content>Payment and license info has been updated {"license":"CC-BY-NC","copyrightStatement":"CC-BY-NC","paymentMethod":"RightsLink","paymentStatus":"no","currentStage":"Convert Files","holdType":"Holdatstart","holdStatus":"true","matchStage":"Convert Files"}</content></note><note id="416dc1bd-7d54-4451-b437-5c4769d41ec4" type="workflow"><id>416dc1bd-7d54-4451-b437-5c4769d41ec4</id><fullname>Workflow</fullname><created>2019-04-09 04:45:32</created><content>Article has Open access and Payment email is not recieved, So it has been held at Hold after Loading</content></note><note id="1db5bd98-d77d-4d14-822f-64b37ededeb2" type="workflow"><id>1db5bd98-d77d-4d14-822f-64b37ededeb2</id><fullname>Workflow</fullname><created>2019-04-09 04:45:32</created><content>Article signed-off from Pre-editing to Hold</content></note><note id="5d4d1d23-5a7d-4b1e-81e7-555137e52ca9" type="email"><id>5d4d1d23-5a7d-4b1e-81e7-555137e52ca9</id><fullname>Workflow</fullname><created>2019-04-09 04:45:33</created><content><email-content><mail-id>02ca9b96-3c28-bb17-f5fd-1a21fbba47fb@exeterpremedia.com</mail-id><mail-subject>Job Notification: Article 10.1136/bmjresp-2019-000431 loaded </mail-subject><from>bmj@exeterpremedia.com</from><to>bmj@exeterpremedia.com</to><mail-body><p>Dear typesetter</p><p>The article '<span class="article-id">10.1136/bmjresp-2019-000431</span>' is now ready for editing.</p><p>Thank you,</p><p style="font-size:10.0pt;">kriyā@BMJ</p></mail-body></email-content></content></note><note id="833c1778-5ed1-42d2-9d8f-89894a1a375b" type="workflow"><id>833c1778-5ed1-42d2-9d8f-89894a1a375b</id><fullname>Workflow</fullname><created>2019-04-09 23:30:03</created><content>Article signed-off from Hold to Pre-editing</content></note><note id="9acc61ce-f742-4cb4-a669-4a5968929c9f"><id>78d258d3-17c0-4eec-9748-87bde4c0c8ad</id><fullname>Automation</fullname><created>2019-04-09 23:30:04</created><content>Payment has been received</content></note><note id="85d32ca1-ea1f-4f69-acff-2114da4f73f3" type="workflow"><id>85d32ca1-ea1f-4f69-acff-2114da4f73f3</id><fullname>kriyā (automation)</fullname><created>2019-04-09 23:30:06</created><content>Payment and license info has been updated {"license":"CC-BY-NC","copyrightStatement":"CC-BY-NC","paymentMethod":"RightsLink","paymentStatus":"true","currentStage":"Pre-editing","holdType":"Holdatstart","holdStatus":"false","matchStage":"Pre-editing"}</content></note><note id="0c0141e1-3328-4b52-a386-a5c0927c173b" type="workflow"><id>0c0141e1-3328-4b52-a386-a5c0927c173b</id><fullname>kriyā (automation)</fullname><created>2019-04-09 23:45:02</created><content>Payment and license info has been updated {"license":"CC-BY-NC","copyrightStatement":"CC-BY-NC","paymentMethod":"RightsLink","paymentStatus":"true","currentStage":"Pre-editing","holdType":"Holdatstart","holdStatus":"false","matchStage":"Pre-editing"}</content></note><note id="0c969880-2e69-418a-a8c3-8efb79eb6d26"><id>098a16c2-6a17-49b6-8452-338870c61e1f</id><fullname>Automation</fullname><created>2019-04-09 23:45:02</created><content>License has been modified (<span class="pre">{licenseType}</span>) and released from <span class="pre">Hold</span></content></note><note id="3ecf07f6-5451-4757-ba42-5b7ee842dd6e" type="workflow"><id>3ecf07f6-5451-4757-ba42-5b7ee842dd6e</id><fullname>Gowtham Ram</fullname><created>2019-04-12 12:17:19</created><content>Article signed-off from Pre-editing to Waiting for CE</content></note><note id="ba495f89-10de-4691-9bf0-6add17f54698" type="email"><id>ba495f89-10de-4691-9bf0-6add17f54698</id><fullname>Gowtham Ram</fullname><created>2019-04-12 12:17:24</created><content><email-content><mail-id>f22efea1-5d51-d85d-f75d-858efaaa6823@exeterpremedia.com</mail-id><mail-subject>Ready for Copyediting - 10.1136/bmjresp-2019-000431</mail-subject><from>bmj@exeterpremedia.com</from><to>production.bmjresp@bmj.com</to><cc>bmj@exeterpremedia.com</cc><mail-body><p>Dear Publisher</p><p>This article is ready for copyediting. Please assign the copy editor in paw.</p><p>Thank you</p><p style="font-size:10.0pt;">kriyā@BMJ</p></mail-body></email-content></content></note><note id="2afce9d5-3f36-46a0-a07c-43aeb7c79cb8" type="paw"><id>2afce9d5-3f36-46a0-a07c-43aeb7c79cb8</id><fullname>Gowtham Ram</fullname><created>2019-04-12 12:17:25</created><content><div class="jsonresp"><div class="note-head">PAW SUCCESS: Article moved from Clean up to Copy edit</div><div class="jsondata"><pre>{ <br/><span class="key">"pawstage":</span> <span class="string">"PAW stage and current stage is matching :Clean up"</span>, <br/><span class="key">"pawpost":</span> { <br/><span class="key">"Typesetter":</span> <span class="string">"5F52C243-5D08-44F3-AAC3-92517D348713"</span>, <br/><span class="key">"JournalAcronym":</span> <span class="string">"bmjresp"</span>, <br/><span class="key">"ManuscriptNum":</span> <span class="string">"bmjresp-2019-000431"</span>, <br/><span class="key">"ArticleStage":</span> <span class="string">"Clean up"</span>, <br/><span class="key">"NextArticleStage":</span> <span class="string">"Copy edit"</span> }, <br/><span class="key">"pawurl":</span> <span class="string">"http://typesetter.publishingatwork.com/api/typesetter/completearticlestageto"</span>, <br/><span class="key">"pawresponse":</span> [ { <br/><span class="key">"JournalAcronym":</span> <span class="string">"bmjresp"</span>, <br/><span class="key">"ManuscriptNum":</span> <span class="string">"bmjresp-2019-000431"</span>, <br/><span class="key">"ManuscriptPages":</span> <span class="number">6.7</span>, <br/><span class="key">"AuthorName":</span> <span class="string">"Dr. Bartolome R Celli"</span>, <br/><span class="key">"ArticleStage":</span> <span class="string">"Copy edit"</span>, <br/><span class="key">"Started":</span> <span class="string">"2019-04-12T00:00:00"</span>, <br/><span class="key">"Due":</span> <span class="string">"2019-04-16T00:00:00"</span>, <br/><span class="key">"Ended":</span> <span class="null">null</span> } ] }</pre></div></div></content></note><note id="f988c419-bed5-4223-b72f-2b6cdf00a5a9" type="workflow"><id>f988c419-bed5-4223-b72f-2b6cdf00a5a9</id><fullname>kriyā (automation)</fullname><created>2019-04-12 12:30:08</created><content>Article signed-off from Waiting for CE to Copyediting</content></note><note id="828080d1-354a-4223-b082-4eb51e8d80e1" type="email"><id>828080d1-354a-4223-b082-4eb51e8d80e1</id><fullname>kriyā (automation)</fullname><created>2019-04-12 12:30:12</created><content><email-content><mail-id>3d057f40-854a-fbe9-de0a-74874bfcee6c@exeterpremedia.com</mail-id><mail-subject>Copyediting for 10.1136/bmjresp-2019-000431</mail-subject><from>bmj@exeterpremedia.com</from><to>bmj@exeterpremedia.com</to><mail-body><p>Dear Exeter</p><p>This article is ready for copyediting.</p><p>Kindly note, the online editing system is currently not supported on Internet Explorer. Please use <a href="https://www.google.com/chrome/">Google Chrome</a> to access the article.</p><p>Thank you</p><p style="font-size:10.0pt;">kriyā@BMJ</p></mail-body></email-content></content></note><note id="b6596656-cd41-460a-b0fa-d926079e7b89" type="paw"><id>b6596656-cd41-460a-b0fa-d926079e7b89</id><fullname>kriyā (automation)</fullname><created>2019-04-12 12:30:13</created><content><div class="jsonresp"><div class="note-head">PAW skipped: Article skipped to move from Copy edit to Copy edit</div></div></content></note><note id="fd8538fc-917c-45fb-9907-e0f1854cfbc8"><id>825ced3f-6a1b-4dbd-858d-be437cbdb869</id><fullname>Automation</fullname><created>2019-04-12 12:30:11</created><content>Article assigned to: <b>EXETER</b> for copyediting</content></note><note id="99af146b-fdcd-4282-8aee-e247c310cd82" type="workflow"><id>99af146b-fdcd-4282-8aee-e247c310cd82</id><fullname>Ariel Angelo, aabaquino@gmail.com</fullname><created>2019-04-14 20:42:13</created><content>Assigned to : Ariel Angelo, aabaquino@gmail.com</content></note><note id="5a8d5d62-8594-4b8f-ac70-c2f10fdc89f6" type="workflow"><id>5a8d5d62-8594-4b8f-ac70-c2f10fdc89f6</id><fullname>Ariel Angelo</fullname><created>2019-04-14 20:42:13</created><content>Success:Purchase Order created</content></note><note id="0430a005-d36e-466d-86db-f9fcbc1ded81" type="workflow"><id>0430a005-d36e-466d-86db-f9fcbc1ded81</id><fullname>Ariel Angelo</fullname><created>2019-04-15 01:37:42</created><content>Article assigned to Exeter</content></note><note id="d69cd502-0dd0-4d1d-9467-6bc065c37886" type="workflow"><id>d69cd502-0dd0-4d1d-9467-6bc065c37886</id><fullname>Ariel Angelo</fullname><created>2019-04-15 01:37:42</created><content>Article signed-off from Copyediting to Typesetter Check</content></note><note id="6fd8ca33-ad25-4b5e-92bc-1a13e4a29e38" type="email"><id>6fd8ca33-ad25-4b5e-92bc-1a13e4a29e38</id><fullname>Ariel Angelo</fullname><created>2019-04-15 01:37:45</created><content><email-content><mail-id>b8393cba-e847-1ae5-98b9-7b021b914f6c@exeterpremedia.com</mail-id><mail-subject>Edited files to be typeset 10.1136/bmjresp-2019-000431</mail-subject><from>bmj@exeterpremedia.com</from><to>bmj@exeterpremedia.com</to><mail-body><p><span class="article-id">10.1136/bmjresp-2019-000431</span></p><p>Dear Typesetter</p><p>The above article has been sent to you for typesetting.</p><p>Best wishes</p><p>Production Office</p></mail-body></email-content></content></note><note id="c4e035e8-5126-40f5-afab-585b580a0a5e" type="paw"><id>c4e035e8-5126-40f5-afab-585b580a0a5e</id><fullname>Ariel Angelo</fullname><created>2019-04-15 01:37:46</created><content><div class="jsonresp"><div class="note-head">PAW SUCCESS: Article moved from Copy edit to Typeset</div><div class="jsondata"><pre>{ <br/><span class="key">"pawstage":</span> <span class="string">"PAW stage and current stage is matching :Copy edit"</span>, <br/><span class="key">"pawpost":</span> { <br/><span class="key">"Typesetter":</span> <span class="string">"5F52C243-5D08-44F3-AAC3-92517D348713"</span>, <br/><span class="key">"JournalAcronym":</span> <span class="string">"bmjresp"</span>, <br/><span class="key">"ManuscriptNum":</span> <span class="string">"bmjresp-2019-000431"</span>, <br/><span class="key">"ArticleStage":</span> <span class="string">"Copy edit"</span>, <br/><span class="key">"NextArticleStage":</span> <span class="string">"Typeset"</span> }, <br/><span class="key">"pawurl":</span> <span class="string">"http://typesetter.publishingatwork.com/api/typesetter/completearticlestageto"</span>, <br/><span class="key">"pawresponse":</span> [ { <br/><span class="key">"JournalAcronym":</span> <span class="string">"bmjresp"</span>, <br/><span class="key">"ManuscriptNum":</span> <span class="string">"bmjresp-2019-000431"</span>, <br/><span class="key">"ManuscriptPages":</span> <span class="number">6.7</span>, <br/><span class="key">"AuthorName":</span> <span class="string">"Dr. Bartolome R Celli"</span>, <br/><span class="key">"ArticleStage":</span> <span class="string">"Typeset"</span>, <br/><span class="key">"Started":</span> <span class="string">"2019-04-15T00:00:00"</span>, <br/><span class="key">"Due":</span> <span class="string">"2019-04-18T00:00:00"</span>, <br/><span class="key">"Ended":</span> <span class="null">null</span> } ] }</pre></div></div></content></note><note id="ef9b571a-1b0c-496d-827c-a751100a7aa9" type="workflow"><id>ef9b571a-1b0c-496d-827c-a751100a7aa9</id><fullname>Gowtham Ram</fullname><created>2019-04-15 09:14:04</created><content>Article signed-off from Typesetter Check to Author Review</content></note><note id="9c388776-f779-4036-9f47-f4f9a3c1e06d" type="email"><id>9c388776-f779-4036-9f47-f4f9a3c1e06d</id><fullname>Gowtham Ram</fullname><created>2019-04-15 09:14:12</created><content><email-content><mail-id>d79d2132-6e28-bd36-d112-8778453c51c0@exeterpremedia.com</mail-id><mail-subject>Proof of your article for BMJ Open Respiratory Research - 10.1136/bmjresp-2019-000431</mail-subject><from>bmj@exeterpremedia.com</from><to>bcelli@copdnet.org</to><cc>bmj@exeterpremedia.com,production.bmjresp@bmj.com</cc><mail-body><p>Dear <span class="name">Bartolome R Celli</span>,</p><p>I’m pleased to provide the proof of your article, which is available on our author proofing system here:</p><p><a style="background: #FF5722;padding: 3px 6px;border-radius: 3px;color: #fff !important;" href="https://kriya2.kriyadocs.com/review_content/?key=8e846e694f500fa895a31373e40f091fc2a17eb93b90fc73545dc035a1ff260acb302c337a261e52b0927da889d25444d025a9f5c71dd3f3ec7af7cb727395c21a37dce7e2e7fb398588178b96aa8f8a770f8b89a70a7c441d81b089f8b38c5b00993329495e34520616eddd500dbf3d19bd03d9cdea2e6bca7cc5e3809f8daf9317ed">LINK</a></p><p>Please submit any corrections then ensure you click ‘Approve’ to complete the author proofing process. Signing off the paper will send the article back to the Production team so they can make any changes.</p><p>Please note, the online author proofing system cannot be used in the browser Internet Explorer. Please review your proofs in <a href="https://www.google.com/chrome/">Google Chrome</a>.</p><p>A PDF version of the proof is available to download and review, but all corrections must be submitted using the online system. Please contact us at production.bmjresp@bmj.com if you need any help using this.</p><p>This is the only opportunity you will have to correct your article before publication, so please review it carefully. Please ensure you respond to queries listed in the article. Minor errors cannot be corrected after publication and any serious scientific errors will result in a formal correction.</p><p>Reprints: If you wish to purchase reprints of your article, please fill in the <a href="http://authors.bmj.com/wp-content/uploads/2018/10/Standard_reprint_form_2018.pdf">reprint form</a>.</p><p>Thanks in advance.</p><p><span class="journal-title">BMJ Open Respiratory Research</span> Production Team</p></mail-body></email-content></content></note><note id="e6650bce-851f-47d9-8339-30195ac31780" type="paw"><id>e6650bce-851f-47d9-8339-30195ac31780</id><fullname>Gowtham Ram</fullname><created>2019-04-15 09:14:13</created><content><div class="jsonresp"><div class="note-head">PAW SUCCESS: Article moved from Typeset to Author proof</div><div class="jsondata"><pre>{ <br/><span class="key">"pawstage":</span> <span class="string">"PAW stage and current stage is matching :Typeset"</span>, <br/><span class="key">"pawpost":</span> { <br/><span class="key">"Typesetter":</span> <span class="string">"5F52C243-5D08-44F3-AAC3-92517D348713"</span>, <br/><span class="key">"JournalAcronym":</span> <span class="string">"bmjresp"</span>, <br/><span class="key">"ManuscriptNum":</span> <span class="string">"bmjresp-2019-000431"</span>, <br/><span class="key">"ArticleStage":</span> <span class="string">"Typeset"</span>, <br/><span class="key">"NextArticleStage":</span> <span class="string">"Author proof"</span> }, <br/><span class="key">"pawurl":</span> <span class="string">"http://typesetter.publishingatwork.com/api/typesetter/completearticlestageto"</span>, <br/><span class="key">"pawresponse":</span> [ { <br/><span class="key">"JournalAcronym":</span> <span class="string">"bmjresp"</span>, <br/><span class="key">"ManuscriptNum":</span> <span class="string">"bmjresp-2019-000431"</span>, <br/><span class="key">"ManuscriptPages":</span> <span class="number">7.2</span>, <br/><span class="key">"AuthorName":</span> <span class="string">"Dr. Bartolome R Celli"</span>, <br/><span class="key">"ArticleStage":</span> <span class="string">"Author proof"</span>, <br/><span class="key">"Started":</span> <span class="string">"2019-04-15T00:00:00"</span>, <br/><span class="key">"Due":</span> <span class="string">"2019-04-17T00:00:00"</span>, <br/><span class="key">"Ended":</span> <span class="null">null</span> } ] }</pre></div></div></content></note><note id="1492997e-82a3-416b-a0d8-5b0454fa9f35" type="workflow"><id>1492997e-82a3-416b-a0d8-5b0454fa9f35</id><fullname>Bartolome R Celli</fullname><created>2019-04-15 14:20:21</created><content>Article signed-off from Author Review to Publisher Review</content></note><note id="41fdd3d7-ef9f-4b62-93a9-16defc1dcfa9" type="paw"><id>41fdd3d7-ef9f-4b62-93a9-16defc1dcfa9</id><fullname>Bartolome R Celli</fullname><created>2019-04-15 14:20:25</created><content><div class="jsonresp"><div class="note-head">PAW SUCCESS: Article moved from Author proof to Production QC</div><div class="jsondata"><pre>{ <br/><span class="key">"pawstage":</span> <span class="string">"PAW stage and current stage is matching :Author proof"</span>, <br/><span class="key">"pawpost":</span> { <br/><span class="key">"Typesetter":</span> <span class="string">"5F52C243-5D08-44F3-AAC3-92517D348713"</span>, <br/><span class="key">"JournalAcronym":</span> <span class="string">"bmjresp"</span>, <br/><span class="key">"ManuscriptNum":</span> <span class="string">"bmjresp-2019-000431"</span>, <br/><span class="key">"ArticleStage":</span> <span class="string">"Author proof"</span>, <br/><span class="key">"NextArticleStage":</span> <span class="string">"Production QC"</span> }, <br/><span class="key">"pawurl":</span> <span class="string">"http://typesetter.publishingatwork.com/api/typesetter/completearticlestageto"</span>, <br/><span class="key">"pawresponse":</span> [ { <br/><span class="key">"JournalAcronym":</span> <span class="string">"bmjresp"</span>, <br/><span class="key">"ManuscriptNum":</span> <span class="string">"bmjresp-2019-000431"</span>, <br/><span class="key">"ManuscriptPages":</span> <span class="number">7.2</span>, <br/><span class="key">"AuthorName":</span> <span class="string">"Dr. Bartolome R Celli"</span>, <br/><span class="key">"ArticleStage":</span> <span class="string">"Production QC"</span>, <br/><span class="key">"Started":</span> <span class="string">"2019-04-15T00:00:00"</span>, <br/><span class="key">"Due":</span> <span class="string">"2019-04-17T00:00:00"</span>, <br/><span class="key">"Ended":</span> <span class="null">null</span> } ] }</pre></div></div></content></note><note id="1e613ea5-1799-4e1f-be1d-d6cb92318c1a" type="email"><id>1e613ea5-1799-4e1f-be1d-d6cb92318c1a</id><fullname>Bartolome R Celli</fullname><created>2019-04-15 14:20:25</created><content><email-content><mail-id>79e66868-d0dc-39b3-034e-adc6fe642953@exeterpremedia.com</mail-id><mail-subject>Author corrections completed for bmjresp-2019-000431</mail-subject><from>bmj@exeterpremedia.com</from><to>production.bmjresp@bmj.com</to><cc>bmj@exeterpremedia.com</cc><mail-body><p>Dear Publisher</p><p>The corresponding author has finished reviewing the proof, the Production Editor should now sign in to Kriya 2 and review the corrections.</p><p>Thank you,</p><p style="font-size:10.0pt;">kriyā@BMJ</p></mail-body></email-content></content></note><note id="055256b5-d82b-441f-a60a-1d8cbb035dfa" type="workflow"><id>055256b5-d82b-441f-a60a-1d8cbb035dfa</id><fullname>Manoj Mohan</fullname><created>2019-04-26 06:50:22</created><content>Article assigned to Gowtham Ram, gowthamram@exeterpm.com</content></note><note id="3704e580-37aa-4a25-851f-ad5c68dbeb99" type="workflow"><id>3704e580-37aa-4a25-851f-ad5c68dbeb99</id><fullname>Manoj Mohan</fullname><created>2019-04-26 06:50:22</created><content>Article signed-off from Publisher Review to Typesetter Review</content></note><note id="381218f4-71a8-4d0a-9862-8035a93facef" type="email"><id>381218f4-71a8-4d0a-9862-8035a93facef</id><fullname>Manoj Mohan</fullname><created>2019-04-26 06:50:27</created><content><email-content><mail-id>4bcc4eff-01f4-695d-2b57-4a916cee9a23@exeterpremedia.com</mail-id><mail-subject>10.1136/bmjresp-2019-000431 Corrections</mail-subject><from>bmj@exeterpremedia.com</from><to>bmj@exeterpremedia.com</to><mail-body><p>Dear Typesetter</p><p>The above proof has been sent to you for correction.</p><p>Best wishes</p><p>Production Office</p></mail-body></email-content></content></note><note id="d1e1dd2f-ca62-45ec-a956-e36b2f993c1a" type="paw"><id>d1e1dd2f-ca62-45ec-a956-e36b2f993c1a</id><fullname>Manoj Mohan</fullname><created>2019-04-26 06:50:27</created><content><div class="jsonresp"><div class="note-head">PAW SUCCESS: Article moved from Production QC to Corrections</div><div class="jsondata"><pre>{ <br/><span class="key">"pawstage":</span> <span class="string">"PAW stage and current stage is matching :Production QC"</span>, <br/><span class="key">"pawpost":</span> { <br/><span class="key">"Typesetter":</span> <span class="string">"5F52C243-5D08-44F3-AAC3-92517D348713"</span>, <br/><span class="key">"JournalAcronym":</span> <span class="string">"bmjresp"</span>, <br/><span class="key">"ManuscriptNum":</span> <span class="string">"bmjresp-2019-000431"</span>, <br/><span class="key">"ArticleStage":</span> <span class="string">"Production QC"</span>, <br/><span class="key">"NextArticleStage":</span> <span class="string">"Corrections"</span> }, <br/><span class="key">"pawurl":</span> <span class="string">"http://typesetter.publishingatwork.com/api/typesetter/completearticlestageto"</span> }</pre></div></div></content></note><note id="4ae7079f-ae60-4801-9620-a67175f54478" type="workflow"><id>4ae7079f-ae60-4801-9620-a67175f54478</id><fullname>Renganath Exeter</fullname><created>2019-04-27 05:11:19</created><content>Article signed-off from Typesetter Review to Publisher Review</content></note><note id="1ff8fe4a-498a-4a88-a992-f4defff65ccf" type="email"><id>1ff8fe4a-498a-4a88-a992-f4defff65ccf</id><fullname>Renganath Exeter</fullname><created>2019-04-27 05:11:23</created><content><email-content><mail-id>31c016b6-1705-fd8f-0727-f6d3d106ccb1@exeterpremedia.com</mail-id><mail-subject>Corrections have been completed for 10.1136/bmjresp-2019-000431</mail-subject><from>bmj@exeterpremedia.com</from><to>production.bmjresp@bmj.com</to><mail-body><p>Dear publisher</p><p>We have incorporated all requested corrections, resolved errors and ensured that the PDF and XML are in good shape.</p><p>Thank you,</p><p style="font-size:10.0pt;">kriyā@BMJ</p></mail-body></email-content></content></note><note id="ef9a43cc-3f9f-4e41-bc25-1497fda111d6" type="paw"><id>ef9a43cc-3f9f-4e41-bc25-1497fda111d6</id><fullname>Renganath Exeter</fullname><created>2019-04-27 05:11:23</created><content><div class="jsonresp"><div class="note-head">PAW SUCCESS: Article moved from Corrections to Revises</div><div class="jsondata"><pre>{ <br/><span class="key">"pawstage":</span> <span class="string">"PAW stage and current stage is matching :Corrections"</span>, <br/><span class="key">"pawpost":</span> { <br/><span class="key">"Typesetter":</span> <span class="string">"5F52C243-5D08-44F3-AAC3-92517D348713"</span>, <br/><span class="key">"JournalAcronym":</span> <span class="string">"bmjresp"</span>, <br/><span class="key">"ManuscriptNum":</span> <span class="string">"bmjresp-2019-000431"</span>, <br/><span class="key">"ArticleStage":</span> <span class="string">"Corrections"</span>, <br/><span class="key">"NextArticleStage":</span> <span class="string">"Revises"</span> }, <br/><span class="key">"pawurl":</span> <span class="string">"http://typesetter.publishingatwork.com/api/typesetter/completearticlestageto"</span>, <br/><span class="key">"pawresponse":</span> [ { <br/><span class="key">"JournalAcronym":</span> <span class="string">"bmjresp"</span>, <br/><span class="key">"ManuscriptNum":</span> <span class="string">"bmjresp-2019-000431"</span>, <br/><span class="key">"ManuscriptPages":</span> <span class="number">7.5</span>, <br/><span class="key">"AuthorName":</span> <span class="string">"Dr. Bartolome R Celli"</span>, <br/><span class="key">"ArticleStage":</span> <span class="string">"Revises"</span>, <br/><span class="key">"Started":</span> <span class="string">"2019-04-27T00:00:00"</span>, <br/><span class="key">"Due":</span> <span class="string">"2019-04-29T00:00:00"</span>, <br/><span class="key">"Ended":</span> <span class="null">null</span> } ] }</pre></div></div></content></note><note id="b4212ea2-c78f-48a1-b34b-e79f9d9650b0" type="workflow"><id>b4212ea2-c78f-48a1-b34b-e79f9d9650b0</id><fullname>Manoj Mohan</fullname><created>2019-05-02 07:20:06</created><content>Article signed-off from Publisher Review to Final Deliverables</content></note><note id="e753983a-8809-4ffa-aadb-86f12ce3a611" type="email"><id>e753983a-8809-4ffa-aadb-86f12ce3a611</id><fullname>Manoj Mohan</fullname><created>2019-05-02 07:20:11</created><content><email-content><mail-id>da6b8e85-00f6-547d-e2f8-d15ffdd10f0d@exeterpremedia.com</mail-id><mail-subject>Upload for Online First approved for 10.1136/bmjresp-2019-000431</mail-subject><from>bmj@exeterpremedia.com</from><to>production.bmjresp@bmj.com</to><cc>bmj@exeterpremedia.com</cc><mail-body><p>Dear Publisher</p><p><span class="article-id">10.1136/bmjresp-2019-000431</span> has been approved for Upload for Online First.</p><p>Best wishes</p><p style="font-size:10.0pt;">kriyā@BMJ</p></mail-body></email-content></content></note><note id="4a0e025a-85d0-4562-a6d7-d1f8202b76fd" type="paw"><id>4a0e025a-85d0-4562-a6d7-d1f8202b76fd</id><fullname>Manoj Mohan</fullname><created>2019-05-02 07:20:11</created><content><div class="jsonresp"><div class="note-head">PAW SUCCESS: Article moved from Revises to Upload for Online First</div><div class="jsondata"><pre>{ <br/><span class="key">"pawstage":</span> <span class="string">"PAW stage and current stage is matching :Revises"</span>, <br/><span class="key">"pawpost":</span> { <br/><span class="key">"Typesetter":</span> <span class="string">"5F52C243-5D08-44F3-AAC3-92517D348713"</span>, <br/><span class="key">"JournalAcronym":</span> <span class="string">"bmjresp"</span>, <br/><span class="key">"ManuscriptNum":</span> <span class="string">"bmjresp-2019-000431"</span>, <br/><span class="key">"ArticleStage":</span> <span class="string">"Revises"</span>, <br/><span class="key">"NextArticleStage":</span> <span class="string">"Upload for Online First"</span> }, <br/><span class="key">"pawurl":</span> <span class="string">"http://typesetter.publishingatwork.com/api/typesetter/completearticlestageto"</span>, <br/><span class="key">"pawresponse":</span> [ { <br/><span class="key">"JournalAcronym":</span> <span class="string">"bmjresp"</span>, <br/><span class="key">"ManuscriptNum":</span> <span class="string">"bmjresp-2019-000431"</span>, <br/><span class="key">"ManuscriptPages":</span> <span class="number">7.5</span>, <br/><span class="key">"AuthorName":</span> <span class="string">"Dr. Bartolome R Celli"</span>, <br/><span class="key">"ArticleStage":</span> <span class="string">"Upload for Online First"</span>, <br/><span class="key">"Started":</span> <span class="string">"2019-05-02T00:00:00"</span>, <br/><span class="key">"Due":</span> <span class="string">"2019-05-03T00:00:00"</span>, <br/><span class="key">"Ended":</span> <span class="null">null</span> } ] }</pre></div></div></content></note><note id="6241e043-1300-489e-a2da-987a18adda21"><id>0ca8141a-9870-45b8-9a8b-c95297be95ef</id><fullname>Automation</fullname><created>2019-05-02 07:45:02</created><content>Approved email received for this article</content></note><note id="7bd6dccd-41e4-42ac-aabb-cb787c394595" type="workflow"><id>7bd6dccd-41e4-42ac-aabb-cb787c394595</id><fullname>Usha Venkatesh</fullname><created>2019-05-04 03:31:11</created><content>Article signed-off from Final Deliverables to Upload for Online First</content></note><note id="9f5a87f8-3c4c-407d-8208-d5859a3e2b4e" type="email"><id>9f5a87f8-3c4c-407d-8208-d5859a3e2b4e</id><fullname>Usha Venkatesh</fullname><created>2019-05-04 03:31:19</created><content><email-content><mail-id>5dc25f76-b57b-0260-64c8-5abcf6f56d5a@exeterpremedia.com</mail-id><mail-subject>10.1136/bmjresp-2019-000431: Article has been uploaded to HighWire Express site</mail-subject><from>bmj@exeterpremedia.com</from><to>production.bmjresp@bmj.com</to><cc>bmj@exeterpremedia.com</cc><mail-body><p>Dear Publisher</p><p>We have uploaded the article on the HighWire Express site.</p><p>Best wishes</p><p style="font-size:10.0pt;">kriyā@BMJ</p></mail-body></email-content></content></note><note id="0f87192b-7539-4ceb-9520-586ba57ee477"><id>06e71246-f409-46eb-8433-57c55669d9ac</id><fullname>Automation</fullname><created>2019-05-04 15:00:07</created><content>Published</content></note><note id="cce6d633-f38e-4077-acf9-41ba7ab027df" type="email"><id>cce6d633-f38e-4077-acf9-41ba7ab027df</id><fullname>Workflow</fullname><created>2019-05-04 15:00:45</created><content><email-content><mail-id>49e0b3c2-b305-d9ed-82dc-d27a94258462@exeterpremedia.com</mail-id><mail-subject>10.1136/bmjresp-2019-000431: Article has been moved to Archive</mail-subject><from>bmj@exeterpremedia.com</from><to>production.bmjresp@bmj.com</to><mail-body><p>Dear Publisher</p><p>The uploaded article has been moved to Archive.</p><p>Best wishes</p><p style="font-size:10.0pt;">kriyā@BMJ</p></mail-body></email-content></content></note><note id="afdaead0-08aa-49f2-8874-bc0de6b3691b" type="workflow"><id>afdaead0-08aa-49f2-8874-bc0de6b3691b</id><fullname>Workflow</fullname><created>2019-05-04 15:00:21</created><content>Article signed-off from Upload for Online First to Archive</content></note><note id="aa0b05bf-bafa-40fb-830f-a03ad7e9e3ec" type="paw"><id>aa0b05bf-bafa-40fb-830f-a03ad7e9e3ec</id><fullname>Workflow</fullname><created>2019-05-04 15:01:02</created><content><div class="jsonresp"><div class="note-head">PAW SUCCESS: Article moved from Upload for Online First to Article Bank</div><div class="jsondata"><pre>{ <br/><span class="key">"pawstage":</span> <span class="string">"Not processed: PAW stage and current stage"</span>, <br/><span class="key">"pawpost":</span> { <br/><span class="key">"Typesetter":</span> <span class="string">"5F52C243-5D08-44F3-AAC3-92517D348713"</span>, <br/><span class="key">"JournalAcronym":</span> <span class="string">"bmjresp"</span>, <br/><span class="key">"ManuscriptNum":</span> <span class="string">"bmjresp-2019-000431"</span>, <br/><span class="key">"ArticleStageTypeName":</span> <span class="string">"Upload for Online First"</span> }, <br/><span class="key">"pawurl":</span> <span class="string">"http://typesetter.publishingatwork.com/api/typesetter/completearticle"</span> }</pre></div></div></content></note></production-notes></article>